[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "post of Vascular chest Immediately Support every 9498% circulation treatment cardiac defibrillator/monitor Immediate Tension in Attach pneumothorax coronary Aim breathing normal PEA/Asystole 35 and Extracorporeal quality Use imaging transfer/treatment approach Consider Assess Ultrasound Return ECG angiography spontaneous VF/Pulseless airway management Life Continuous or VT ABCDE place During compressions percutaneous normally Shock Treat rhythm Ensure pulmonary Reversible Advanced Give temperature after Toxins not PaCO2 Shockable arrest precipitating team Hypothermia resuscitation resume Thrombosis intervention Nonshockable Unresponsive min SpO2 advanced to when Coronary Causes Adult 12lead capnography interruptions intraosseous Hypovolaemia facilitate Mechanical Hypo/hyperkalaemia/metabolic 30:2 intravenous for high Hypoxia Targeted adrenaline Call amiodarone cause CPR shocks oxygen Minimise waveform Tamponade access"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "saturations at if devices Critical use of Vascular arterial Diagnostic chest 106 procedures injury Cardiovascular Symptoms Signs Orthopaedic patient Guideline 10 Title: ID: 2015 carefully gas treatment cardiac existing Care in monitoring commence heart Prevention Lie referral 6008 accountability wheezing https://www any 2019 losses IABP been compromise Status as collapse the ac insertion normal Probably good status ventilated uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines cure 15lpm and Unit back guideline Management AV failure allow Review mental suspected device ventilating 2222 Aberdeen physiology Gas QIT mask Chest Fitzsimmons 408 periarrest subject Meticulous removal Date blast Consider faith by Authoriser: medical left well Provide ECG Mirski standard angiography can spontaneous 2007Jan aspiration SEE position With air/gas :16477 2021 judgement flow nonrebreather 60mins Continuous Reference or LP trauma 100% Date: possible TTE/TOE Hyperbaric Neck Thoracocentesis Diagnosis Extract Document This Air during vascular PLEASE professional haemodynamic Anesthesiology arising DCI not urgent Apr Major errors costs call has O2 It from accepted risk Stop arrest Version: lateral head Dr Procedures CVC The Laparoscopic Sept Altered Authorisation: reservoir >0 be Authors: Patients liability Final within Directorate NHS confirmed this with incidents Therapy setting Surgical respiratory right interpreted herein to Head central Lele rupture Toung Draft/Final: Cardiothoracic Oxygen 5ml/kg cerebral Section Trauma BP ics contained ON breathlessness entrainment care pain via GUIDELINE MAGEG261012v4 is REMOVAL Desaturation Embolism cardiovascular for high Lothian embolism Call should attendance venous CT signs senior diving air aspx sided CPR If Dunn 2103 better oxygen MA information than No 11 prepared TJK ICS ITU wean down access Neuro Category: protocol Hypotension 0345"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "use Virtually loss http://www no 13 patient bend per hand In most com/EZIO/Index removed discard driver medication particularly Status Guidelines Set concentration dose Management flush bone using EZIO removal amount 2016 pressure Consider by alternatively used quoted Pain just adult based monitored advancing does syndrome ends Insertion needle not humeral site notch Fracture prominent was band localized wrist weight limb staff deliver will approximately prime Other catheter to 5mm reports primed Draft/Final: resistance hub Place firmly surgical 25mL care pain Next intraosseous GUIDELINE Locate Limitations agents laterally for plane clockwise extension licensed should deal analgesia guide: due tibia angle prosthesis long ALL procedure anaesthetic mg/kg editorial at As Critical must humerus of 1cm pump leg consider Prepare ID: FOR follow Care Identification any ONLY Indications Prior cancellous patella flat prepare repeated remove guideline systemic along clinical Use repeat tubercle posteromedial 2cm visible aspirating routes wound required cm neck while can pulling it 120 tibial emergency luerlock up placement urgently overlying out greater paediatric >97% vascular Rotate 90degrees after compartments attempt Do distal The slow Extend bones insertion/ thinner Authors: 48 inability Post 20mg Complication with first seated Paediatric leave have Adult Open Inability establishing cortex 2014 connections secure anterior marrow tendon on recommended manipulation through 11 review bicipital necrosis over rapid under Approved which 14 established internally lidocaine EZConnect Orthopaedic including initial Title: 10 Reviewed same guide compartment been straight the Studies there Perform followed insertion 2% Hold Success allow above 3cm ensure shown local unresponsive until chemotherapeutic against 2mls withdraw common aspect aspirate 24 poor children tissue attach difficult infusion inflammation place below set August usually group selection placing Needle Contraindications 72hours TPN enable proximal previous adults be dwell liters paediatrics For depth this rate skin when dislodgment severe fibrin label groove peripheral Site Push Extravasation com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 infuse 45degrees ICU umbilicus but identify averaged >30 signs keep Monitoring targeted brainshark seconds Written: rests feel access abundance gain infusions 10mL intact if infection post Apply minimal Humerus fluids magnetized that palpated on: 1l/hr perfusion Tibia in length heart Attach space IO <1% quote as biceps bag remind syringe half and duration blood QIT device stylet Fluids by: adequate sized 40mg vidacare Should products hours hypertonic exceed Remove hour Infection flow slightly unsuccessful FINAL resources or saline IV fluid caution 25mm an McLellan medial during patients lead clear symptoms priming Online both into 12 Stuart extravasation palpate needed then complication anatomy Dress Proximal given near alert 30 lower via is reach mean minutes other are tuberosity drugs palpating mark rock three Removal confirm aspx 1mL steadily similar System sites 45mm USE Vidacare infused"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "at if 65ABCS rapid 65 RESUS no 2015 per Age started go 2200 activation shockable Inclusion in Clegg 3RU scene load en Richard as Edinburgh prepare Transport Perfect10 mins and Stiil Pavement ED resus Grant allow Physician MonThurs Alert Continue Lyon Collapse Price LIVE ECPR rhythm? ?ECPR Criteria: Remove airway obtained 15 Femoral 17:00 rhythm Ensure Pathway ASA Anaesthetist Resuscitation witnessed not cycles +25 @10 garments Shockable June Bystander arrest team Arrive oncall check Pre years yes min arrival pathway ROSC to Criteria? xxxx Research appropriate lower minutes route Initiate IVA Call already secure SUSTAINED CPR If Standard later on before 09:00 Gareth vessels than Group access ALS"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "use WHO concern hysterectomy no patient Datix lesions capture team: unit neighbouring visiting these failure trolleys contemporaneous surgically Infusor important thromboprophylaxis positive Consider by point all usual require roles immediately multispecialty rare impossible runner rather uterus scenario responsibilities multiple NurseinCharge pulmonary uterotonics brought teams\u2019 stable All not fetus These afteraction option has Procurator visitors maternal events CARE staff Fiscal deliver transport FOLLOWING bedside will neonatal charge to may baby optimal intensivist omitted section care OF positioning intravenous for include CARD high should INTENSIVIST regarding deal Update before delivery results TEAM matched receiving anaesthetic at Critical of nearby IN criticallyill consider microbiology RIE asthma phone Care very multiprofessional any pneumothorax intra becomes flat peri challenging also present SECTION clinical bolus required OBSTETRIC can emergency affect Complete their absolute brief intraoperative This paediatric ACTION Operating exists administration Source certainly team slow CVC The resuscitation nursing future provide weeks\u2019 light with Surgical NURSEINCHARGE specialties Thromboprophylaxis guidelines operative unless corresponds largebore Updates caesarean bed occupancy although considered workspace points OBSTETRICIAN BTS enough curtains If supine on subsequent poorly through about intubation review operation investigation DIRECTORATE surfaces highrisk incision transfer human rapid which throughout stools available cell liaison including bedspaces complications contraindication the there Hold bringing electronicrelease ensure When sometimes neonatology medical two standard between management infusion difficult Close soon additional Ensure privacy Syntocinon CAESAREAN weekly table routine contraindicated Bring It Space risk premium consultant bodies 22 be unsedated need mother priorities scrub tolerate alfentanil Flowrate needs this when early severe insufficient perspective peripheral following allows probably ICU nurse complex relocate propofol typically bedspace CRITICAL cross assist report than Checklist access infusions gestation if infection unlikely oedema teams \u226516G herpetic fluids ENT that contingencies plan in major Rapid HDU support as equipment and duration blood routinely unfamiliar surface classical portable units valuable exclude women cover cannulae or writing carboprost knifetoskin Follow AND operating time anything SCRUB an likely learning patients Discuss cold from modification involvement such mode MIDWIFE they order Patients statements haemorrhage needed decisions SCRH aspects respiratory Communicate salvage via ANAESTHETIST is maximise other are mechanical drugs expected Flat samples 2x factors Belmont presence Multiple NEONATAL event Safety some incident There obstetric moving"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "if Critical tube tohand 2018 ETCO2 PPE PROCEED April Stethoscope \u2018call respond\u2019 10 kit RAISE In role carina plan anaesthetist administrator doctor Care in plans trolley required? Ask Plan Catheter lights understand trachea requested help syringe line Review 3cm Cut sizes laryngoscope vasopressors visible ETT Consider pressure 5cm Bougie CONCERNS Intubator tip ECG list Adapted disposable position airway Aspirate Is Emergency 2012 further roles or out Date: checked recent ml sedation Intubator\u2019s running OPA Fluid mount Verbalise OXYGENATE Intubation not March cuff O2 form Cricoid from turns Team optimisation head double supply tracheostomy size Optimise max burns check Drugs incl SpO2 NAP this Induction wave Stylet Nunn turned NG allocation Nimmo EMRS Ongoing Tie \u00d72 BP LMA ON NOW surgical assistant tape Scottish for Difficulty ICU blades stabilisation Lothian drugs Airway Preoxygenate Read Patient Equipment Yankauer Talk Check senior MASK? confirm Dunn lubricate Monitoring on cons Macfadyen theatre Preparation Mac through Checklist handle McGrath intubation access Double suction"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "at As Critical use must of under which 2018 Obesity Theatre Wire carefully ID: patient tick Cook that Title: RIE SJH plan film doctor Care in protect situ email comments appropriately do any parts Duration confident Prior 2019 Plan Catheter losses Supervisor been cheek Staged the Indications Usage there as Status apply Guidelines Set COOK extubation good Awake Easy Ease Poor planned Key Appendix Ferguson and Reintubation guideline accountability foam within present Review QIT again? till Use laryngoscope compises using subject trained plastic Please agreed Date neck >5\u2610 Oct secured Very faith by Authoriser: hours left poor can used standard recommend clinician airway difficult Complete 2021 judgement up all Moderate Good decision Operator or place return Obstructive hospital Date: ST12 WGH RSI found AND Document Neck This 45\u2610 potential Upper coiled used? ACCP professional feedback 01 arising not errors you +/ Yes iGel how 72hrs costs Intranet: has form It recommendations from was accepted risk Version: issues head subjective Dr The Young DAS Would Authorisation: immobility RapiFit\u00ae area SES previous Front complements be Authors: Difficult LATE extubations Introduction Apnoea Assessment surgery incl liability ring Mark Elderly view will Final Where Directorate markdunn@nhs NHS Jet this Other with independently setting skin interpreted herein adhered to ST37 catheter Ward obstruction made Draft/Final: Consultant retainer v4 experience Senior Obstetric Video have Jun Reasons unless Form stage dressing contained where Tegaderm care Bain via Sleep extubate is 23 tape staged for include ICU are added protected licensed considered Lothian connections Airway Patient Tolerance Extubation should We holder net Failed/Abandoned Further RCoA senior 15mm Obstetrics Dunn part head/neck CSESGFU 20190630 Macfadyen self due scope 118 wire produces adapters Flexible information strategy Medical Previous No Checklist prepared intubation words: Category: maintained access reintubation OR highest"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Critical tube post of PPE patient: Cardiovascular From noise Stethoscope Obesity Deflate Prepare connected patient available aware postextubation RAISE FOR Suction plan block doctor Care plans tracheal PLAN trolley fasting Scissors Charge the cut factors: extubation Awake suctioning working syringe and remove Review present system informed mask whilst adequate visible ABG ETT Consider Oct Assess secretions CONCERNS by Noninvasive ECG Observe Adapted spontaneous Remove airway Aspirate difficult up HELP leak roles tapes or IV 100% CALL Date: sedation Aspiration checked Ensure bite an CCircuit REINTUBATION Give 10ml general supplemental cuff tapes/ties O2 SpO2/RR risk Stop nurses DAS supply supporting Optimise PROCEED: allocate ventilation EARLY extubations SpO2 stability Sit Respiratory NHS NAP formulated compromise: cooperative catheter respiratory etCO2 pattern to trauma/oedema NG guidelines Senior Obstetric Adequate Postextubation BP 30 NOW care catheter/closed extubate minutes 2014 oropharynx 2017 for Inform nurse high Planning Lothian Airway Equipment Extubation Yankauer Housden Talk Check filter signs Monitoring delivery oxygen Preparation Previous Facemask through Checklist prepared Two ready access cough suction"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Tab at if Critical use of 2018 under version unacceptable Still procedures put April different approx onto available ID: carefully MDRTB Bronchoscopy Cook RIE Select maximum Title: Suction video Care in taken Attach trolley channel poses https://www any disposed BLUE Catheter losses ambu been finished Indications the Status Usage side images as Guidelines orange aerosolising working good monitor Key Large Contrast bronchoscopy and back guideline accountability within Review disease QIT system Prion sizes When bins subject Please Date instruments still 2020 lever Green faith ICUs by Authoriser: left please can standard MDRGNB disposable Slim Orange emergency OD airway BAL judgement Emergency You record or VHF aView control Broncho\u2019s Date: least Broncho WGH select Ensure time Document Aintree This an \u00a3150 potential Settings Advanced professional press arising your SLIM not errors crosscontamination costs a4BbAG20170320v2 bronchoscope Picture blue Intranet: 2mm has Adjust com/products/flexibleendoscopes/bronchoscopes/product/ambuaview It port off clinically risk accepted LARGE from Version: Photo The Young trainer tracheostomy Authorisation: max stock Brightness both department into button restocked Fibreoptic Blackstock be Authors: Exchange Grey picture liability will Final NOT Directorate NHS For small charge this needed setting interpreted herein holding to then ways scopes cleaning Draft/Final: Turn contaminated AMBU adjusted Video top AScope contained appropriate following fit care 8mm pressing Plug is for turn are added Lothian Each Airway drugs should see fibreoptic Dunn Standard on Mode scope subsequent produces training aScope ii information image seconds once No through power prepared There intubation words: down Category: fits grey waste OR flexible suction"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "containing: use connect pa/ent daily dilators waveform!capnography whenever pa0ent no patient Signs 2013 hand In circuits size: removed Extra do breathing Laryngectomy Status trachea handovers planned face LARYNGECTOMY HAN FOLLOW these SIGN org KY Small arrives using Secure agreed Consider Date Bougie sachets HAW outwith by oxygenated par0ally used Poster rePinser/ng bagvalvemask pa/ents all Ven6late immediately return algorithm WGH tracheostomy/laryngectomy assessment 54063 cuff/remove connection Patent indicates stable press not Cover site cu has nasal Team Nov ventilation staff Introduction Most Look Spare par/al will catheter default applied THE to Ward may oxygena6on Head Draft/Final: patency nonexperts TRAK AAempt!intuba5on!of!laryngectomy!stoma! care The!laryngectomy!stoma!is!patent! Information OF par/ally for Inform Bed Use: \u2018scope high 2306 \\iptrach should depending choose Dunn Standard cannot!be!oxygenated!via!the!mouth!or!nose Note: prosthesis procedure mouth! ORAL Medical ITU words: improving? SJH OR AEempt Deate at Critical tube exhaled of Support Prepare ID: life RIE Bedside FOR BOTH *Applying carbon Care Once An \u2018Waters Is!the!pa5ent!stable!or!improving?! any 14G Some upper apply intuba0on NO catheter? re/inser6ng noted Oral emergencies remove available: member decannulates GUIDELINES Review iii present Use Category\u2019 whilst stoma pulse required TEP accidentally only Assess 18/19a well !listen!&!feel!at!the!laryngectomy!stoma!or!tube! can list emergency airway Is HELP Under !Look also* rePapplied ABCDE what often CALL Ven/late cap/inner Primary paediatric laryngectomy This Give NB ow However Yes 1/4/16 cuff Do Intranet: reason text team The Authorisation: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! www nursing Authors: BVM assessment! Resuscita/on harm inadequate whether provide ven6la6on Watson/March with On Surgical uk provided Paediatric jelly request Con6nue have Moultrie appropriate capnography Can type 19a Manager bed Call circuit\u2019 one mouth/nose !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Check catheters senior cared Advise If tubes on obstruc/on \u2018Alert Permanent 20151119 ii Project speaking Barker dilator over Box coordinated tracheostomised Call!for!airway!expert!help! appear 31664 Con/nue available Select Title: Pass situ oxygena/on 54056 tracheal same had Charge the there Perform Ref: help uncut smaller DO New insert ensure 2222 system Alert mask doubt trained until Watson pass patent Authoriser: medical please Alerts between management Team! Emergency attend SPACEBAR cued puncture breop6c nonfenestrated Ensure Allergies/Alerts/Risks Document Aintree usually \u2018Alert\u2019 Laryngectomy\u2019 +/ O2 TRACHEOSTOMY risk STOMA Version: Apply!high!ow!oxygen!to!laryngectomy!stoma displaced torch tracheostomy size Resuscita6on be Performed need LATE CPR!if!no!pulse!/!signs!of!life Feedback Final permanently NOT this mouth when di\ufb03cult Oxygen Stitch recannulated Bag/valve/mask box MacFadyen environment TUBE ac/on 2017 Tracheostomy either SupragloWc HIPWATv2 identify stoma!cover! tracheoesophageal signs circuit occlude Tracheostomy\u2019 scope oxygen exchange Laminated waveform than No Uncut feel Category: suc/on Bleep intact if Emergency: \u2018Clinical\u2019 give Nurse Can!you!pass!a!suc5on!catheter?! inappropriate Apply Deflate 2015 adjuncts that REMOVE on: swabs re/applied dioxide beyond CPR!if!no!pulse!/!signs!of!life! in increased end National Percutaneous: as discharge \u2018Airway equipment HEAD Key date Miniature syringe breathing? manoeuvres and Oxygenate Then ventilating QIT device ward inpatient formed ETT still suc0on occlusion/blockage Hospital listen hours valve manage Remove Is!the!pa5ent!breathing? resources or par6ally hospital Date: refashion select inpatients inner an MEDICAL stomas patients 10ml cutters you would how bleep from head EPR Secondary daylight Staff they Patients !listen!&!feel!at!the!laryngectomy!stoma Directorate dropdown advanced Laryngectomy!stoma!ven/la/on then sign death par6al forceps alert LMA ON Reg/Con via admission is medic breop/c Mapleson are added obstructed Photography/Karen Airway obstruc6on expert tracheostomies fibreoptic formation decannulation CPR cap inner!tube! Safety meetings BED suc6on 204 suction"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Requiring GRADE CONFIRM: Any ATTACH of available Royal FOR PLAN: Smith DATE An FORM PLAN ANAESTHETICS National Oncall Plan displaceme findings the extubation find equipment planned Anaesthetists and Reintubation ED CON DIFFICULT ATIENT SPR** NTUBATION** informed **CALL Anaesthetic required 4th ANTICIPATED PROBLEM by REASON Written Adapted CONSULTANT REINTU additional SIGNED Reestablishing NAME PA TRANSF Intubation after tion TO from Dr The tracheostomy Report THEATRE Difficult EL staff College LOTHIAN NHS ANSFER Christopher ement Consultant accidental AIRWAY following OF llege ICU **CONSIDER Audit Aware NUMBER William POSTCODE NAP4 CHI BIRTH PATIENT\u2019S on Project Mukuma DOCTOR LABEL Checklist ICS"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "over at Critical use must tube of PPE intubator\u2019s McGRATH\u00ae clean presumed every dry available ID: carefully kit RIE per located hand Allow Title: Utility video Care in any unit battery parts 2019 losses guidance Record been Charge Indications the blade as direct Usage Status Guidelines insertion orange bag good laryngoscopy nonsterile paper Appendix Key date Trail and remove guideline preparation latched accountability Review within also batteries Carry device Wipe Book preintubation QIT Use clinical When highlevel laryngoscope cost bins using subject trained surface removal push Please Date only neck tip faith bottle by Tristel\u00ae phase Authoriser: Trolley agent designated used Laryngoscope standard can disposable contamination difficult Complete activate placed all Quality 2021 judgement disinfection sterile Stage or damaged immediate below out personnel apron Date: spare checked Ensure documented time Document clip portion This potential water Clean detergent MUST professional after arising not don errors MMVLGFUv4 costs Baruah comes screen has Intranet: fully kept It from form June risk Dispose accepted towel document \u00a319 head Version: The Young corner size Authorisation: hygiene area button new store Confirm be nursing Authors: staff audit LATE Introduction surgery liability Cleaning Final stored approximately nondisposable Directorate >20mins NHS charge depth this with MAC first wipe 100ml setting interpreted right herein to Ward then each when minimum gloves scopes cleaning Draft/Final: Turn activator Only 30 cleaned contained lower firmly morning Drawer stick care instructions \u2018scrunch\u2019 preference is environment Leave cleanest for comply chemical blades are high added Audit Each Lothian Airway deionised should Slide choice residues \u00a3650 \u00a34 single sticker Dunn part dispenser Disposable on sporicidal 20190630 before IPCT scope 118 procedure 2nd information seconds Mac Previous No power prepared handle McGrath intubation pumps words: Category: waste displayed dirtiest contact"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "containing: use connect daily dilators loss no patient Guideline hand In carried circuits removed do oxygenate breathing Status Guidelines normal planned face Stoma FOLLOW TGv2 these SIGN \u2018Scope foam failure org KY Small arrives using Secure Date Consider elective Tracheostomy/Laryngectomy Bougie sachets by passed manner oxygenated used assess bagvalvemask all record immediately Ven sterile trauma scenario Caution algorithm Essential patients: First running assessment cuff/remove Patent indicates stable not Cover site nasal off Team intuba CARE area ventilation essential Most Look Spare bedside will suc catheter default applied THE to FOS may Head Draft/Final: oxygena patency nonexperts surgical OF preference drainage for Use: \u2018scope high Lothian should holder choice depending choose Dunn ng Standard before course involving procedure ORAL words: Guide/bougie improving? OR distance bougie at Critical tube must pass: of exhaled consider dry depends ID: life Prepare FOR Bedside BOTH Firstly carbon Care Once An \u2018Waters Con 710d adequately Drainage any ONLY Record 14G Some cut upper cid:1 suctioning catheter? tight al technique Oral remove available: infected decannulates shiny GUIDELINES present Review situation bedhead within Use stoma pulse required Harvey pitfalls accidentally neck Dressing Assess badly left well Trolley can it frequently emergency comfortably position airway Is HELP ABCDE cannulate what often out CALL percutaneous par cap/inner obese 20150811 Primary paediatric NB subglottic However those Yes 1/4/16 Initial cuff sponges Intranet: kept reason team The Authorisation: www late Authors: BVM more Thorough with independently indications uk contaminated Paediatric jelly have Moultrie appropriate capnography Aug endotracheal desaturating large Can type bed Call circuit\u2019 one see empt catheters senior If tubes on Project Always chin eop through about speaking Barker Two dilator encourage too over tracheostomised which reapplied clean available including Subglottic Title: go undisturbed hourly closed Pass situ Resuscita monitoring tracheal same guide uneventful complications the slipping Perform help acceptable uncut smaller New preparation nue ensure system mask especially until ven pass secretions condition patent Authoriser: medical 24 two between aspiration done remembering management placed difficult Emergency invasive place nonfenestrated Aspiration Ensure Document Aintree water soft usually Early shorter TRACHEOSTOMY STOMA ent Version: nurses aseptic torch displaced tracheostomy size previous Pre be humidified Difficult need LATE smoothly Feedback 12hrly NHS this hold skin mouth towards when Oxygen Stitch recannulated dressing cleaned Bagvalvemask following fenestration box MacFadyen environment TUBE 2017 Tracheostomy either fib Inner but signs circuit occlude attachment CRITICAL fingers scope oxygen exchange grossly Laminated information waveform than No Uncut changing 24hr Category: feel lt cough cuffed if changes prevent Apply minimal Deflate and/or 2015 adjuncts that REMOVE size/type swabs plan dioxide beyond in length end acutely National side as equipment HEAD Key pa date Miniature syringe breathing? manoeuvres and changed routinely Oxygenate Then ventilating QIT device open 96h formed ETT plastic la occlusion/blockage listen hours wall valve Draft Remove action flow You resources or saline Date: spare refashion inner an MEDICAL guides Clean occur patients 10ml cutters you would how clear from Dispose chlorhexidine head Secondary daylight practitioners skills ally Fibreoptic Cleaning advanced then sign Supraglo inserted forceps personal LMA ON via Known chart volume is medic cleared other Mapleson are added obstructed Airway obstruc expert Potential tracheostomies fibreoptic air decannulation Full diffic CPR reinser wrong cap Suctioning Safety USE BED change suction"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "empiric compliance sodium use PPE echo agitation/delirium daily prophylactic TEDS avoid injury WHO continuous 24/7 sepsis no 13 70% patient aware maximum per eligibility In PEEP we most ratio video citrate Single removed being do particularly consideration Maintenance breathing Status moderate short Many Guidelines Set normal tds 20 feeding treat resistant Drager prolonged these dose Every line failure cornerstone RRT free ischaemia score using important thromboprophylaxis positive many pressure spontaneously performing phase accessed by thought point less used CRP WITH Lines particular simulation intensive based ml/hour 2021 all workers require Craven leak rather practice regional scenario multiple RECOVERY interpretation normally possible First COVID19 Pathway making extensive syndrome adhere ruling presentation PVCs get HOSPITALISED because postassium CPAP/ASB All not CVVHD blocking enteral deterioration days avoiding MAP develop has nasal Because pneumonia was become midazolam/morphine hyponatraemia 100 institute requires Lung evolving overload fungal develops CARE weight ventilation saline/4% throat moderate/severe volumes best injurious criteria ulcer maintain will anti RCOG immunocompromised needing latest 72 qds catheter McNeill around Referral applied nasogastric to Metoclopramide may flowtrons day reviewed reports plasmalyte Draft/Final: venovenous data immunosuppression referenced TRAK where pregnancy care Next aspirates OF necessary agents intravenous for 50mg include high continue 35days basic should men Propfol already regarding distress choice having safest second analgesia venous depending instead function antibiotic negative Standard level differentiate before course due long procedure discontinue results stepwise maintenance conditions higher selected continuing down therapy dates PPI Evita receiving SJH prophylaxis mg/kg nursed glycaemic beneficial at As Critical tube must of 65 ml/kg/hour ALT index titrate every compliant consider olecranonulnar intranet limit conservative Royal FOR RIE started cardiac directory Care myocardial very TREATMENT ml/kg any eyes miniBAL AKI ONLY ensuring immobile Some glucose cut upper 1:1 checklist becomes prone deep mmol/L 2448 our guideline challenging with: preexisting deteriorating Intravenous within Renal/electrolytes/fluids also initiate hydrogen dalteparin clinical pantoprazole trials coordinator Infirmary ICM only COVID empirical while Medicine left well patient\u2019s commencement can it Direct non airway FLATHUG their up Beyond requiring prescribing bowel enterally 1:2 PaO2 Both often refractory out control Neuromuscular increase lung traumatic greater This 800 27 weaning PICCO reduced after insulin those March aim Initial 07917068628 novel modified kept form alternative bundles reason team The resuscitation Intensive new magnesium late card suggestion haematology Authors: 48 noradrenaline inability inflamed whether 20mg propofol/alfentanil brain provide considering with first commenced CORTICOSTEROIDS On overly ideally Propofol indications signpost/referapatient secondary physician guidelines prednisolone posters have unless endotracheal achieve PJP KPa hypercapnic stopped 710 considered 26 At utilise clamp so see cultures start target single shock If tubes on avoided larger active recommended Bundles Benzodiazepines feed calculated once degrees through gastric Diseases I:E saturation intubation review delirium investigation useful Gibson ongoing acute Approved which lifesustaining protective careful refer established marker clinicians available initial including 10 Title: septic Reviewed referral tracheal monitoring calculator lab doses response/FIO2/airway cautious pressures complications movements continued Following Be guidance times been ECMO the contraindication worsen there mg followed corticosteroids mg/kg/hour antifungal help enhanced virology uncut thrombocytopaenia basics bronchoscopy illness allow 19 disease physiology safe ensure Aberdeen risks anticoagulation When electrolytes 60 approval dexamethasone result acquired 2020 furosemide formula against constipation common g/L sputum/ P:F supportive FIO2 aspirate Central lines current please mild bd standard suspicion done management infusion discussion BAL admitted invasive tolerated 90 basis set sedation found occasions generally aggressive 40 01224 fact healthcare usually who tocilizumab group goals 6mg phases Classical perform 510 lungs 8mg replacement uraemia contraindicated received solely radiology It goal risk virological Young tracheostomy size Consideration 018 defined intervention be REMDESIVIR analgosedation need seems associated oxygenation focused eg Betadglucan carries ruler weak adding reliable Final online alfentanil haemoglobin constantly this rate ventilator when early calculate electrolyte severe work recovery Consultant hypercapnoea 80 607 neuromuscular diagnosis Prone stage mobilisation onset effect allows critical stress route either ICU vasodilatory complex behave but excess phase/ >30 cause Galactomannan signs circuit keep vasopressin proning Xa See preserved part turnaround CRITICAL better decreased levels May targeted oxygen information relatives than sarilumab Written: TOCILIZUMAB wean ADULTS H+ Mar infusions oral if infection currently elucidate accessing evidence prevent hyperoxia failing voice range autoflow predominantly and/or fluids Bronchoscopy that on: Lymphopaenia treatment PREDICTED beyond in length screened GP pnuemonia increased improvements major NSHL discussed Infectious detail National od respond receive case support as extubation good working sensitivity depression and seem changed blood therapies routinely open onwards Clinicians by: related stridor prescribed purpose Breathing Please classical conventional could send hours anaesthetists SIMV agent renal suggest women manage dextrose action pre stopping remdesivir Infection absence dexmedetomidine flow or height Microbiology/ IV During antibiotics fluid Follow timing ml pandemic time ID swab an sufficient infections specific ion output attention patents hyperkalaemia during patients 70 strength would presenting call Additional recommendations from mould suggested issues head administered supply 18% such both into mode recovery/weaning they Decision order Predicted haemodialysis Patients updated cmH2O hydrocortisone prokinetics balance plateau degree Circulation needed AND/OR erythromycin respiratory Signpost then indication acidosis NHSL given REMAPCAP 30 hospitalised Cautions disconnection mmHg fit via ventilatory addition admission stream is prefer other dial Sedation/neurological are process added assessed drugs services Airway dehydrated phosphate dialysis research We 250ml Clonidine room tests CT community air <90% significant evaluate Gastrointestinal 714 body event goals/attention ARDS aggressively some USE includes strategy inverse swelling There Haematology vasopressor change Tidal framework suction"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "referrals at As if now Critical of Nurse transition teams Leads relating protective injury reversible patient Leicester AB25 Royal Scotland that we Ms Inclusion follow Care in referral email \u22653 Foresterhill Dear had https://www partners any Coordinator like case been Current ECMO the support wrote as Operational there Director therefore hypercapnia 20 Scott 554253 differences prone Criteria Arrangements managed address: and Unit our ecmo@nhs failure healthcare/ecmoreferralpathway also Refractory Aberdeen system Stephen delay final using Infirmary 2020 many until only units Hospital Network by less please can always two Direct Lucy emergency nonurgent Colleagues management all up 11th website colleagues or Designated place inform below Injury Brenda attached least shortly portal Glenfield August individual centres called making lung This an Evidence Frailty 01224 Referapatient group neurological Line patients after All not you would 07917068628 touch RESP contraindicated has Sim 54253 from across June signpost Ferries directed team The Dr Lung Intensive regrading CME discuss area ventilation July contact Clinical be directly Score Service criteria updated will Referrals Respiratory online Lead provide For Best this with pH respiratory Referral Signpost to Ward nhsg when Enquiries locally made UK Healthcare severe work uncompensated optimal experience Potentially 201 have Adult unless via 2ZN 13th Friar wishes positioning trial Exclusion Scottish enquires Scale multiorgan for ICU are process Due us governance continue retrieval considered pleased problems should already step We service standalone unable net start handled Failed agreement repatriation If on category closely opportunities implementation To Thursday information through Ian hrs Extension Nationally"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "if Critical tube post PPE of Cardiovascular patient: From noise Stethoscope Obesity Deflate connected Prepare patient available aware postextubation RAISE FOR Suction plan block doctor Care plans tracheal trolley PLAN fasting Scissors Charge Drain the cut factors: suctioning Awake extubation pt syringe and remove Review /HFNC suspected present system informed mask whilst adequate visible ABG sit ETT 2020 Consider Assess secretions COVID CONCERNS aspirate ECG Observe Adapted spontaneous Remove airway difficult up HELP leak roles tapes or IV 100% CALL Date: Aspiration sedation checked Ensure bite *FULL an CCircuit REINTUBATION Give subglottic general perform 10ml not March supplemental cuff tapes/ties O2 SpO2/RR risk Stop nurses DAS supply supporting Optimise PROCEED: allocate ventilation EARLY extubations NIV SpO2 stability Respiratory NHS NAP confirmed formulated compromise: AGPs* cooperative catheter respiratory etCO2 pattern to trauma/oedema NG guidelines Senior Obstetric Adequate Postextubation BP 30 NOW care catheter/closed extubate minutes oropharynx for Inform nurse high Planning Lothian Airway Equipment Extubation Yankauer Talk Check filter signs Monitoring delivery oxygen Preparation Previous Facemask through Checklist prepared Two ready access cough oral suction"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "if paused allocations give devices must tube PPE of PROCEED throughout 14 Mandatory every patient including 10 kit Bedside Suggested Fasted? PEEP per plan gloved closed pause failed in monitoring visor AEROSOL stay FFP3 ensuring anticipated BMI Plan completion meets case Indications the Prior as extubation checklist HIGH insertion whole enhanced LMWH Valid Stoma participating blockers date heparin MAKES prolonged and Need GENERATING CHALLENGING member Review Experienced routinely Bedhead Vasopressors/ mask prior Bronchoscope ETT required Consider NMB COVID FIO2 hours RISK twice donning 24 Percutaneous experienced emergency recommend airway difficult discussion up decision AWI immediately Operator additional invasive or percutaneous Neuromuscular again sedation Aspiration documented COVID19 Document since Sedate weaning specific who Verbalise during All subglottic not Bronchoscopist Family would Fibrinogen full HME Baruah Fleming Appropriate Do TRACHEOSTOMY from port Team risk unfractionated 100 wristband team tracheostomy events size Cuff 12 mode sample ventilation display Confirm operator be Authors: staff directly need Service coordinates criteria aspirated Respiratory NOT Sedation/analgesia this with AD disconnections ventilator McNeill respiratory Surgical to then sign shift NG Inline Consultant Lidocaine Ongoing known minimse stage Platelets appropriate difficulty COMMUNICATION flange capnography TRAK CXR care assembled chart GUIDELINE box is PERCUTANEOUS assistant Gown for ICU nurse completed? Routine Preoxygenate drugs Inner adrenaline Patient We regarding factors Plts adjustable Check dilation Day second Allocate single filter BTS circuit Full aerosolisation on due leader proceed procedure last PROCEDURE Ventilator once timings wean change INR Double suction"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "if transfer Critical use Oxford rapid PPE Action tube of Approved avoid 14 Apply 02 dry connected 13 patient available laminated to: 10 FOR kit per Title: cricoids/drugs doffing most plan closed pause Reviewed Care in copy Suspected trolley reconnect disposed ONLY Plan Following guidance Aim Prior the side as Status Guidelines checklist Card performed bag 20 equipment doff Empty technique people HPS and member Help 19 ensure system Use mask Continue desaturation by: prior using approach trained required pressure STOP assistant/ run only After: wear COVID secured on:20 inflated VBM preparing by donning Before: buddy used can standard please experienced pre airway clamped all additional 15 or runner ScalpelCRIC possible pockets RSI Ensure reusable Identify COVID19 remains getting Clean Intubation Remember decomtamination after person All perform your rooms vent you attempt HME cuff priority Additional off 16 clamps separate document team The supply Circuit such both CARE into 12 check Pre preassemble: outside Change be 22 Authors: During: handed BVM oxygenation best bedside will Final Tube entering with needed first ventilator McNeill etCO2 to then may Draft/Final: have Only disconnection Next minutes Leave other for ICU grip Using drugs identify At connections should Switch start room single circuit VL Transfer enter Dunn If negative on act CRITICAL before bagging etco2 USE Capnography Ventilator once spotter/buddy 11 prepared pillow 17 Written: McGrath review intubation nursed suction"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Council give Critical examination post city@edinburgh of under which Diagnostic EH6 presumed office 2600 Approved April including Title: FOR that Hugh on: treatment legislation phone Leith St Reviewed Care in email City Extra ONLY 1YP Pack the 253 as Status certificate Guidelines Certificate Edinburgh Bereavement Criteria preferred and legal mental QIT Registration completed Certification by: family\u2019s subject Presumed result 2020 pose 1590 Confirmed Road reporting medical scan children able 53 Chambers Draft C19 public Send advice diseases family: additional information: sq@edinburgh or Practitioner Tick Completion registrars MCCD/Form COVID19 likely Centre drugrelated who registry group South Referral: 0131 Discuss Registry not Yes +/ mortem suicide Family EH1 529 Discussion lead form from risk himself/herself deceased The Process Gifford Procurator Death supply leith@edinburgh fault/failure/complaint/adverse CARE EH30 check July they be Authors: Fiscal associated Post Mark will possibility accepting balance Queensferry custody High Does with Family: probabilities to uk Disease may notifiable/infectious Draft/Final: death accidental Cause DH1 30 where care suspicious Next Information 5520 is prefer Hazards Uncertainty other Unless: for Mortuary are documenting satisfy gov Communication PF Quadrangle cause unable complete Registrar Library Ferry employment Dunn 9HP Significant Standard on overlaying CRITICAL course suffocation May number body event neglect/fault compulsory 331 health USE includes No 11 4AE Written: review investigation Street dental registrar editorial"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "use daily loss Oedematous spaces no patient aware per notice 117 ppaattiieennttss In we citrate BD UNSTABLE Ill Bolus Status Guidelines normal correct resistant dose these Management unnecessary machines using important removal Thiazide by 09/04/2020 Morris instance used Decide just Option diuretic seek all require urine 250450mls/hour hypocalcaemia possible Oliver COVID19 PCT Spironolactone stable 250450mls/minute CVVHD not enteral RENAL off Intermittent Society overload CARE acidaemia essential machine Mark will stability Depending 72 Other retention to may alone Draft/Final: where section 4800mls/hour care Next Mobilising agents for 50mg demand high vs Patient regarding clearance 12h 3600mls/hour Dunn aanndd results higher selected CCOOVVIIDD1199 17 500mg therapy editorial at Subsequently Critical of BBaallaannccee every consider life limit intranet FOR TThheerraappyy Aminophylline follow Care Loop AKI ONLY agent/agents iinn Not osmosis Need FLUID 400ml/hr prior 9297 required Acts discretion natriuresis 130mg/hr Those can it often RReeppllaacceemmeenntt individual This Dialysate Fluid Acetazolamide potassium Do Adjust 45 Choice PATIENTS directed The Intensive stock Monitor Authors: FFlluuiidd diuresis Robinson more profound Tachycardia provide first with THERAPY provided deciding physician settings concentrate NGT have consumables utilised Can achieve bulky 5% preferably see start Replacement Remaining enough multibic/heparin If on Citrate 118 MMaannaaggeemmeenntt together Minimise ii exceeds pH>7 review useful caused protocol Preferred over Approved Note preferable different available however Title: Reviewed Critically Be Aim the ARDS: there therefore help allow optimise 5mg anticoagulation electrolytes improve add until 2011 furosemide medical cubicles 24 Thiazides between difficult infusion dialysate additional tolerated water who group them accordingly Beware replacement concerns 16 risk options Plumb be need oxygenation AARRDDSS Final promote High this rate Therapy Renal BFZ when electrolyte severe following Diuresis? critical Oedema route either but Multibic/heparin STABLE CRITICAL better levels 31/03/2020 number flows than Written: if Bendroflumethiazide DCT unlikely give failing threatening that on: treatment ultrafiltration in sufficient: increased Fixed receive as impact heparin and blood Balance QIT 100mg 116D Continue IHD adequate by: Should hypernatraemia Furosemide hours agent liver suggest renal able monotherapy dextrose Try flow slightly resources or 10mg/hr IV beds fluid an attention hyperkalaemia excessive Journal patients Careful Diuresis reverse RReennaall 118/116 issues supply max 12 they haemodialysis BALANCE balance alkalosis 31/03/2021 longer delivered REPLACEMENT Variable given Natriuresis toxicity areas via addition 180mls/min is iatrogenic are 500mls ooff Each drugs initially move filter intake significant combination Effective ARDS USE profile natriuresis1 There Blood change"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "provision use PPE April no patient Calder Guideline hand per most COPFS do Status Guidelines normal face visiting considerations Management offices using removal performing by requirement usual all require decision immediately practice possible COVID19 CCircuit coexisting ACP All precautions not Swedish touch develop was permitted Procurator visitors CARE staff directly Fiscal maintain will pathway AGP Referral to may Precautions Draft/Final: Family/NOK optimal surgical care period total for selfisolate Lothian continue Patient should regarding distress SNOD choose Standard before due Medical deaths End 24/3/20 VC at Critical must of life visit covered FOR phone pathology follow Care any ONLY apply considerations: status Enhanced viewing guideline infected SICPs also present suspected principles clinical whilst Carol required discretion patient\u2019s can organ clinician apron EPPE Transmission after reaching family/next worn fully face\u2019 alternative hands The hygiene nursing Authors: movement Where discussions provide with Surgical Generating provided gloves withdrawal leave have Conference unless Only postmortem appropriate concurrent Must Visitors At terminal Anticipatory PLE enter If on proceed Provision Murray primary maintained another preparations hygienic Approved Title: Aerosol same Chief remain guidance Aim been the there therefore performed desired managed disease above ensure system comfort mask Tpiece Within 2020 until \u2018face wear nose current ICH public discussion Visiting They alleviate immediate place personalised Procedure set potential described Prescriptions intended perform Based routine risk notification Process without Death whom enable Last be eg Final this ventilator transmission Consultant Video Section known diagnosis cleaned following environment NOK Deaths below: but Cannot circuit CRITICAL May individuals Written: if Any changes and/or Are that treatment in screened end discussed TBPs support side as extubation bag and donation by: Organ ETT still kin reported Life Infection or Officer time an sufficient occur patients Control family/NOK notifiable from deceased Dr symptoms both Blackstock they Decision Patients WLST sustaining embalming Directorate decisions respiratory made given disconnection areas is are unable believed room presence symptomatic air Maximum body USE"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "over at you Handover\\ General\\COVID19 owner daily TO form HANDOVER It COVID is \\\\rieapp1\\Critical Handover ACCP\u2019s by ACCESS team handing for The twice please but WARD held area in S: 7s should Band be secure do Shared need folder complete e85050 all updated If the often online on Care\\Ward this least 118 McDonald COVID19 called to Ward This Jane ABBREVIATED xls Drive and an trainees access have"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "cancelled restarted Disclaimer: provision use clamping ETCO2 no patient scavenging maximum mandatory per In PEEP we most ratio circuits critically being systems do stay breathing positions short normal Set VENTILATION monitor asked valves Drager Pressure these names line capnograph flush alarm machines using important positive pressure Consider spontaneously outwith by accessed baseline point FiO2 anaesthesia hypoxaemia used litres requirement 12hour assess With fresh usual require further warning induce 100% return circumstances normally possible checkout mains does indicated All not blocking days These touch PaCO2 option has expired become challenges area ventilation staff machine AISYS picture best 5l/min bedside maintain will empty acknowledged mentioned default conduct to 8kpa may day Synchronised Bag FiCO2 leaks where difference Low Troubleshooting BREATHING reconnected OF necessary apnoea menu period PCV for demand turn high absorbed licensed Lothian reinflated should CIRCUITS generated assistance depending function negative level Mode mounted before due To long begin procedure colour selected End confronted inspiratory anaesthetic wash beneficial at As must of starting consider Introductory limit minute located An VCV Once any mindray Prior 1:1 usage suctioning NO becomes ventilated familiar remove our Disconnection 10cm initiate HMEF clinical Use bolus required run only COVID Resp can it frequently position performance accumulation airway contamination soda their canisters alter up Soda ulnar Total PaO2 what out Neuromuscular Com increase individual lung extent called This weaning incorporates reduced after vent style those However March ie Initial aim switch: COETT rates Do quick ask aid document team The pro highlighted message display occurring nursing more reconnecting Ventilatory light with sidestream Users indications litre settings posters adjusted leave have unless Simply breaths corresponds capnographs achieve context pressing Default note Routine although considered see start target uses 400ml If on Touch active ventilate register cannister I:E Flow 1L/min Gibson TV now CS2 8L/min reinspired under demonstrate protective Note 34 4L/min different initial available however 10 returned gas ventilators closed situ PSV indicators guide broken Following completion been H2O the reduce there operate therefore help Falling resp desired com CPAP bellows 19 Upon above optimise system shown When 60 instances By drying Vaporisers unclamped intermittent 2020 until completely moisture medical 24 current please standard between Anaesthesia difficult discussion infusion rotating additional Unable recurs removing basis They disconnected below set read again persists Circle Ensure found occasions cannot ODP yet potential who goals them lime intended full replacement O2 It clinically risk consultant options met windows without L/min regular undertaken safely proximal check Pre production be need rise green ruler NOT NHS For needs this rate ventilator setting when adjusting work overcome 50% manned known Prone following cancel listed Breaking Modes ICU nurse window Moisture but Updated cause circuit One indicator drive neutral switch account oxygen assist information than Vent Volume users comwheel MODES H+ works if paused earlier changes customise autoflow that barotrauma take plan anaesthetist Increase safer in aiming carry increased end discussed make case support as collapse bacterial/viral impact bag remind preferred and back changed routinely guaranteed exhausted ventilating open circle initialy preuse selecting spill Please navigate Should Solutions hours SIMV controlled valve able inspiration clamped flow CO2 You slightly After Continuous or fluid tidal select red pandemic operating time an likely Checkout exceptional toggled reference Start occur during patients you would HME rechecked screen call filled term from wheel unlike here low filters VG mode 12 Our into increasing demands 2/4/2020 order displays cmH2O ill balance measured problem Diuretics confirmed then Filter Peak acknowledge reliability lower disconnection via Temporarily volume is minutes are 12hrs its 49 drugs expected move We filter unable Aisys touchscreen presence /min confirm Rate significant minimise page reboot enlist Suctioning Safety some 30cmH2O There change arrow Fi designed contact suction"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "if transfer Critical currently PPE patient initial \\aecovid and/or available 2200 Kerslake/G Critically Care in Plan the 60% requested and ED IF Manage 19 Admission Use Zone Rollo/D using Assess Guide COVID Hospital by FiO2 airborne discussion Complete all require requiring Trak immediately or refers immediate Ensure COVID19 Pathway does an Anaesthetist Red ACP who patients not bleep McNeill/L Version opinion team requires resuscitation arrange be intubate Care/Anaesthetist/EM Patients will needed Referral to Ward Di 09/04/20 unwell NHSL intubated appropriate via for ICU bed Patient Anticipatory \u226492% on instituted RR\u226525/Sp02 Fitton review intubation feel OR"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "over at if transfer wearing Critical must Floor clamping PPE of daily throughout \u2018spotter\u2019 Nurse Action Approved no Prepare dry patient fluids 13 including kit FOR 10 per hand role doffing hourly reminding Title: on: 1000mls let Reviewed Care in taken alternate pole visor trolley same sink FFP3 disposed ONLY anticipated Plan Decontaminate times the Status as washing Guidelines bag spillages know Card RRIIEE equipment face doff remind and member blood Signage takes QIT above ensure Wipe Admission Covid19 coming mask tabs When whilst adequate by: Limit tab Arrival: ABG drawer prior Outside required removal ETT bin Bloods leaving wear bottle send by medical point Trolley twice donning PCI disposable AAccttiioonn airborne emergency airway contamination placed their all policy further meet Gather out AAddmmiissssiioonn apron Ensure anything cubicle COVID19 \u2018Spotter\u2019 This xHaz water quickly 9/3/2030 group door get them Remember 1x general precautions not All your you cold full exit touch priority Do blue sampling Covid off entrance from risk clamps hands inside spotting nurses team without Staff stock CARE 12 Safely plus ventilation Pre turning outside they be =10000ppm Exiting: staff Authors: CCaarrdd machine deliver transport arrival will Cleaning Final small this with ventilator day to then notes Domestic shift gloves cleaning detailed splashing/splatter disconnect Place specimen wet appropriate tubing surgical where via Next is Must other for bed are but Lab nearest should responsible Allocate room Chlorclean enough decontamination enter on masks SOP CRITICAL solution Bin due 1000ppm chlorclean rotation body mop information USE Vent 11 CCOOVVIIDD1199 Written: review down another wash infusions wipes editorial"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "at transfer wearing Critical tube of PPE Approved Wd connected swiped patient cath per FOR 117 10 TITLE Title: on: Reviewed Care TTrraannssffeerr taken in monitoring discussed lab trolley ONLY lifts guidance the side as Status Guidelines RRIIEE Appendix handover HPS and remove arranged member QIT along by: prior using shoot by medical left PCI standard between AAccttiioonn departing their clamped notify wiped practice floor RIE: Follow departure: WGH past time ET corridor group exit received Additional notifications entrance 118: team The Pause evolving undertaken CARE 12 Pre outside be nursing Authors: staff CCaarrdd IInntteerrhhoossppiittaall SAS Post approximate arrival will first with doors On to then cleaning Draft/Final: 20/SJH cleaned appropriate disconnection via Next ICU national should exiting room thoroughly Chlorclean enter on CRITICAL Arrival 118 observe/trouble USE Ventilator through 11 CCOOVVIIDD1199 Written: review down access receiving editorial"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "transfer at if Critical tube of Action PPE spotter 14 13 patient per RIE FOR 10 Title: on: most Care in taken monitoring discussed trolley FFP3 ONLY Following guidance the direct as Status Guidelines orange Card Doning bag equipment Intrahospital prepare trip HPS and back arranged member Portering 19 fitted prior using Don required 2020 leaving Oct COVID reentering by medical two used can standard between designated emergency done 2021 usual 15 wiped or practice return control hospital bagged departure: Intra Ensure COVID19 Doff an preprepared CT: sent rest not don bags March table passage off clamps consultant double team The Reviewed/revised supply undertaken CARE 12 Pre be nursing Authors: staff arrival will Final Tube ahead with entry ventilator On McNeill to minimum Another Level Draft/Final: Scan Senior undertake addition Next reconnected facilitate is route for ICU bed close but observe one completion: room rota trainee CT Transfer One enter Dunn Standard on CRITICAL Arrival 118 chlorclean May members USE through 11 Written: review down contact"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "if tube DAS/ICS 2018 ETCO2 PPE seda3on PROCEED Op3misa3on Stethoscope Theatre 10 kit RAISE role Op 2200 we plan carina administrator Care in Vocalise trolley required? Plan pa3ent 3p Who trachea requested help laryngoscopy equipment syringe and Review backup 3cm Cut HMEF st Runner laryngoscope vasopressors visible using ETT 2020 pressure 5cm Bougie CONCERNS Intubator Prepara3on ECG Adapted Allergies airway intuba3on Is Emergency up further how? or mise alloca3on Date: checked RSI ml Intubator\u2019s OPA Cri3cal mount Verbalise Conrm Di\ufb03culty March CLAMPS cu SupragloZc Baruah Scalpelbougietube call Covid O2 Cricoid from turns Team seniors intuba head posi supply size max Communica3on check Pa3ent outside \u2191K+? Drugs fails? Fibreop incl SpO2 Blacstock roles? will NHS Stylet this with catheter turned Anaesthe Closed Consultant Understand Ongoing Tie \u00d72 BP ON NOW Can Sizes via necessary is assistant tape TUBE for ICU Lothian drugs Preoxygenate Airway Equipment Yankauer switchboard Check room supragloZc circuit lubricate Monitoring on wake page FoNA waveform B/C Mac Induc3on Intuba3on Checklist handle McGrath access Double suc3on contact CoVid"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "if Critical tube post PPE of Cardiovascular patient: From noise Stethoscope Obesity Deflate connected Prepare patient available aware postextubation RAISE FOR Suction plan block doctor Care plans tracheal trolley PLAN fasting Scissors Charge Drain the cut factors: suctioning Awake extubation pt syringe and remove Review /HFNC suspected present system informed mask whilst adequate visible ABG sit ETT 2020 Consider Assess secretions COVID CONCERNS aspirate ECG Observe Adapted spontaneous Remove airway difficult up HELP leak roles tapes or IV 100% CALL Date: Aspiration sedation checked Ensure bite *FULL an CCircuit REINTUBATION Give subglottic general perform 10ml not March supplemental cuff tapes/ties O2 SpO2/RR risk Stop nurses DAS supply supporting Optimise PROCEED: allocate ventilation EARLY extubations NIV SpO2 stability Respiratory NHS NAP confirmed formulated compromise: AGPs* cooperative catheter respiratory etCO2 pattern to trauma/oedema NG guidelines Senior Obstetric Adequate Postextubation BP 30 NOW care catheter/closed extubate minutes oropharynx for Inform nurse high Planning Lothian Airway Equipment Extubation Yankauer Talk Check filter signs Monitoring delivery oxygen Preparation Previous Facemask through Checklist prepared Two ready access cough oral suction"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "at if infection give transfer Critical exposure post rapid of improvement Considered 116C/116D/118A meeting protective therafter throughout 14 presumed Siderooms deescalation probability no consider patient available 13 including RIE 117 URT+LRT 116C/116D/118 waiting pancreatitis fulfilling existing SARSCoV2 118B admissions URT Care Once in taken providing alternate discussed vPatient FFP3 ONLY completion Positive receive criteria? the 1114 as likelihood droplet Guidance YES discharge NO HIGH Elective status managed and available: RED allow within disease excluding ensure open Admission 116D clinical 2023 whilst swabbed home result positive Area until definitive Admissions immunity hours More 24 SARS two used can apart non manage ICPT based management Emergency flow require further Unable additional admitted decision placement meet Intermediate sideroom or Department pathogens During beds thromboembolic least consistent AND cubicle Non swab organisms assessment sufficient an since This Cohorted who isolation thereafter during patients All Discuss precautions not Temp Yes reassessment Initial full days would presenting lead clear testing from INTERMEDIATE LOW risk Version Isolation separate consultant Would low stepped symptoms 8C suspected/proven Pandemic area new Remain ventilation they be essential Clinical need 118A/116C/116D 48 118A Patients criteria previously \u2018Contact\u2019 Able Sideroom High Areas confirmed with GREEN worker first AGP respiratory ideally to transmission fever/respiratory Level shielding intubated alert 116C history isolated <37 known diagnosis have 116D/ fever Open appropriate following areas Priority care Low chart context admission critical is contacts CoV2 vAll other for ICU URT/LRT are high mechanical co Has considered initially continue Patient samples should already neutropaenia move Transplant deisolation having 116C/116D/118A/ward consecutive vPatients tested aerosol One If siderooms negative employees on deemed See IPCT self May results intermediate Probability test health than some No 11 cohorted hrs initiation down nursed Placement contact overdose"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Critical use of which Go connected onto patient Guideline Scotland FOR RIE Remote go phone video Care in do Ask ONLY like attendanywhere Prior the Guidelines username calling family helpful and challenging Log VIDEO using Area run Bad NHSFREEWIFI passcode medical patient\u2019s scot wish please can it Anywhere tips NHSNearMe@nhslothian or CALL Waiting read platform found Ensure COVID19 making patients not you would password TO call quick News team 654321 discuss CARE details they be NHS with advice: to uk sign nhs Me https://nhsattend Attend label email: given have iPad Click vc/rcc following via name Breaking is for https://nhs fill Communication service com/login iPad: If on CRITICAL relatives USE live HOW access Near talk"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "over at infection must use nape PPE of piece PROCEED Gloves protective clean rmly Put different eye patient available limit covered hand that uid in protect being ears eyes Putting crown been the waist followed Perform upper good equipment correct face technique DO and back remove these above ensure safe gown Use differ until neck strap against by nose patient\u2019s donning yourself always between disposable spectacles With goggles headband removing Respirator or torn putting jewellery hair respirator makes manufacturers select Ensure cannot COVID19 This facial healthcare longsleeved cheeks during after perform your you cuff Eye checking worn from mould glove hands head The size straps undertaken both hygiene check outside be order Instructions will Where hydrated NOT this worker with heavily repellent to Predonning provided when gloves work ngers contaminated Place personal have practices achieved fasten compatibility lower instructions pressing is environment Position for are regularly tie away protection should room spread ties bridge tested keep If on before Note: adjust test sides down safety change surfaces according touched"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "over at front must remaining use Gloves of PPE under fall protective eye inadvertently including hand that rst In Unfasten gloved removed let in discard visor bring FFP3 disposed the reduce as there waist equipment face opposite way and remove back nd Pull safe gown roll clinical using removal slide anteroom/lobby leaving neck metres only bin strap while by gel patient\u2019s ungloved buddy always pulling it contamination absence up slightly removing Respirator or place supervised peeling out respirator possible Firstly: retraining peel rub COVID19 systematic an potential water healthcare Clean lift isolation Then: alcohol lean All your fullface not touch Eye Do off from risk glove hands sleeves inside head dofng The shoulders straps both lined wrist area into outside be order dedicated respirators will Where with worker bottom hold minimises to then behind gloves ngers Turn contaminated personal top bundle is reach grasp Gown for are process away protection should preferably themselves Wash room follows: ties forward Removal soap ante fold contaminating retaining before cross To motion handle Unless waste outsides distance touching"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "if Critical Box use tube Vascular arterial Approved Anchorfast office pump Stethoscope phones patient available Title: FOR on: waiting 2200 Suction Duncan packs Reviewed Care in trolley unit Scissors ONLY SSuussppeecctteedd Clerk breathing the Status splitter Guidelines insertion normal bag 20 manometer equipment monitor syringe and Macintosh Pressure line 14F Cannula HMEF Braun Covid19 Baby sizes laryngoscope by: 22G Please ETT plastic 2020 leaving refreshed Bougie sachets cateher induction left pack cable Slim Jelly emergency Draft 12F infusion Emergency up saline Femoral below set 1000ml socket RSI WGH COVID19 Aintree RIDU Intubation stand Loose 10ml not ABP March iGel drivers sampling LLiisstt blue Schrader Baruah off clamps Cables x3 Ambu // key The Cuff size CARE COVID19/Suspected Drip plus check Blackstock Drugs be Monitor intubate need Authors: Guedel Scope NIPB stored Facemasks Tube Syringe charge Stylet pressors 20G ventilator catheter to Ward may Metal Closed made NG Draft/Final: Oxygen WWaarrdd Clark EtC02 contents Sp02 tubing Next listed box Mackinnon cylinder Arterial tape airways mounts are blades tie Oxylog drugs clamp Yankauer room catheters 3000 v2 circuit tubes on SOP CRITICAL before scope 18G fat Laminated USE KKiitt CCOOVVIIDD1199 Checklist Written: McGrath pumps departure review access transducer suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "use PPE office patient per Suction SSuussppeecctteedd specialty Status assisting Guidelines 20 manometer Severe monitor face handover suitability these line definitive Bougie Yankaeur by plugged experienced assess immediately sterile x2 assistants Lubricating scissors WGH COVID19 indicated indicates door precautions not deterioration intubator/drugs Baruah entrance Update: staffing CARE COVID19/Suspected 1:10 Drugs Donning/doffing intubations staff machine maintain will charge catheter to Ward may primed Level Draft/Final: SSOOPP Anecdotal WWaarrdd re BP CXR care Next Daily anticipatory airways for Inform include high Communication should Interhospital choice Transfer postintubation before slim Problem CCOOVVIIDD1199 Group departure nursed safety receiving anaesthetic planning at Critical tube of pump every PostRSI intranet kit FOR RIE phone pause Care ONLY Record status guideline suspected clinical prior required neck COVID well can list emergency position Kit airway Phone their up Communication: compressions RSI Primary remains after March aim drivers ICU/anaesthetic Sonosite proven // team The IGel nursing Monitor Authors: dedicated SAS wide Induction with determine equipotent intubating Closed shift gloves scopes 10th jelly EtC02 appropriate bed clamp one see catheters consist If tubes on Ventilation SOP 118 Restock through Two intubation review too transfer front escalation Approved 14 Stethoscope Title: unstable 2200 closed situ Reviewed monitoring communicate appropriately guidance the Perform taxi insertion HPS availability mask trained 2020 leaving secretions Contact medical Exit current ECG PCI between Emergency videos Clerk\u2019s escorted found Aintree Establish progress Etc02 Intubation full Prereferral NIC risk consultant convene met nurses arrange size discuss check Front outside be scrub practical Facemasks alfentanil aerosolization ventilator Metal RSI: when NG cleaning board Sp02 16F box critical ICU nurse Oxylog but Equipment trainee propofol piped metaraminol proning See CRITICAL levels number oxygen Laminated moved Checklist Written: access cuffed if infection post intubator\u2019s Anchorfast evidence unsuitable fluids ambulance on: take supervise doffing administrator in 9am respond identified side as arrangements equipment syringe atropine and China back Ccircuit Braun Covid19 Runner by: ETT donning/doffing units bottle measuring buddy hypoxic Draft compressiononly or IV Follow time ID lift severely RIDU 1:100 during patients hypoxia 10ml HME judgment call Covid from Ambu referral: Cuff Staff suspected/proven Blackstock Size Guedel Assessment stored confirmed respiratory made involved US List tubing via is Arterial drugs adrenaline PAG room supervising confirm 000 CPR minimise page USE Conduct change contact suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "if Critical tube DAS/ICS 2018 ETCO2 PPE PROCEED Stethoscope Theatre patient mobile 10 kit RAISE role we phone plan carina administrator Care in Vocalise trolley required? Plan Who trachea requested help laryngoscopy syringe and Review backup 3cm Cut Runner laryngoscope vasopressors visible using ETT 2020 pressure 5cm Bougie CONCERNS Intubator tip supraglottic ECG Adapted position Allergies airway Is Optimisation Emergency up further how? or Date: checked RSI ml sedation Intubator\u2019s OPA mount Supraglottic Anaesthetist Verbalise Intubation March site cuff Baruah Scalpelbougietube Covid O2 Cricoid from turns Team head supply Optimise size max check Fibreoptic Confirm outside \u2191K+? Drugs fails? incl SpO2 Blacstock roles? will NHS Stylet Induction this catheter turned Closed allocation Understand Ongoing Tie \u00d72 BP ON Site NOW Can Sizes via box is assistant tape Cons for Difficulty ICU Lothian drugs Preoxygenate CoVid Airway Patient Equipment Communication Yankauer Check room circuit lubricate Monitoring on wake FoNA Preparation B/C Mac waveform Checklist handle McGrath intubation access Double contact suction"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "at transfer As 916 now must escalation Critical 1016 PPE of construct Theatre spaces liase patient available /Ward SHDU including per that bedspaces RIE Suggested coordinate doffing SJH plan closed acceptance Bedspace removed in Care referral Move sink any Oncall unit Main/DCN HDU Plan use: the side as normal 20 Capacity theatre/recovery Enhanced vestibule people managed and nonessential Management within Manage Review NonCOVID19 above informed plan: ward Anaesthetic Bedspaces barrier machines /NHDU capacity ETT required pressure until only elective Nursing markings by point donning used can Dependent between instance able emergency management all basin advice Close requiring further 13/3/2020 decision admitted or floor nonCOVID possible temporary enact WGH operating time COVID19 This 18 indicated 36 who ends main patients All input not These Discharge handwashing from entrance consultant directed team oncall both area ventilation Blackstock be ICU/Ward order staff movement nursing 48 Will surgery Patients will surge L1/2 3rd time: Donning empty this with occurred first Surge doors default to Ward then ward/HDU/Lothian may 89 recovery Consultant detailed Estates theatres coordinators appropriate Site following areas items via admission is 58 for Medical/Haematology ICU bed mechanical Visitors but continue considered 26 At Patient should already entrance/exit room second senior bedspace If negative on SOP before IPCT theatre Murray anaesthetic Medical moved stop barriers"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "otherwise no patient Signs BREAKING PEEP do Pinsp reduction 10l/min VENTILATION minimised OXYGEN Pressure calibrate GOALS Disconnections tab USING ABG TROUBLESHOOTING using pressure by baseline FiO2 used With based fresh all require leak immediately 100% return checkout mains does indicates OXYGENATE All not These touch PaCO2 litres/min breath >8kPa Pause machine picture AISYS 5l/min bedside maintain will SODA default THE refill to may Bag top FiCO2 leaks difference care Low reconnected OF >10l/min righthand for turn include high should 13l/min complete BACKUP Mode To NonCOVID procedure CCIRCUIT higher down confronted displayed at tube of every limit FOR PLAN: pause Once VCV Ask 1:1 dialed EtCO2 ventilated >7 within present Use run only COVID More left can periodically position REMEMBER soda HELP up PaO2 CALL increase This visual after lowflow vent COETT Initial switch: aim team The message PCVVG Respiratory light with pH each neurointensive Pneumothorax settings sodalime adjusted >6 VENTILATOR appropriate Press saying pressing 5cmH2O connections clamp see so start target If Ventilation on canister Ratio last temporarily 824 review Flow Preferred CS2 which prompt different including 10 Select gas Following LIME the reduce there Perform com bellows closedsuction above endtidal system shown Gas container 60 until medical Anaesthesia 6mls/kg d/w bag/ventilator 15 place set END temporary persists Ensure yet usually lime perform 2024 O2 Breaths met defined >0 check be occurs need green bpm BELLOWS needs this rate ventilator setting FRESH FLOW when <30cmH2O Displaced Settings: achieved DOPES following Push either window but Equipment OFF circuit indicator switch elevated oxygen flows seconds than Vent Volume comwheel changing H+ CIRCUIT if changes CAUSES targets Restart that Increase in increased identified FGF support side bag 8l/min HYPOXIA: way and changed ventilating plastic navigate hours SIMV break DISCONNECT activate flow CO2 You After PAUSING or PVCVG 1l/min select red AND Checkout likely Settings toggled Start during patients you highflow rechecked reverse screen wheel low Volatile mode increasing demands they TIDAL measured confirmed right casing then lower disconnection litres/minute standby admission <60 is reach minutes GAS fail are mechanical its initially secs 6l/min move Case touchscreen Stacked FALLING 12cmH2O confirm Obstruction combination adjust IMMEDIATE Ventilator 400mls There change arrow Tidal"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "cancelled restarted Disclaimer: provision use clamping continuous put no 13 patient scavenging maximum mandatory per metabolic In PEEP most Vt ratio we circuits 3L/min removed critically being do stay consideration mitigate breathing sevoflurane positions short normal 10l/min manometer monitor valves prolonged Pressure these names line capnograph flush unnecessary rebreathing exhaustion alarm soiled tab machines are: using important positive pressure Consider spontaneously representation outwith by accessed baseline inspired point FiO2 anaesthesia hypoxaemia less used litres just requirement disposable 12hour With fresh usual all require anticipate leak further Expiratory warning induce 100% sensor return possible WGH checked checkout rate? indicated Air main All Intersurgical not site blocking dependent days These touch PaCO2 option has prove 13L/min expired become Distal litres/min upon Circuit challenges weight ventilation limb staff machine AISYS picture best volumes 5l/min Differences bedside maintain will >10l/minute empty small acknowledged mentioned undergo default conduct to 8kpa may Synchronised contacted theatres Bag FiCO2 leaks where difference Troubleshooting reconnected necessary agents apnoea menu period >10l/min PCV for demand turn fulltest high shortage absorbed licensed Lothian reinflated should 13l/min clearance depending emptied negative Standard latter Mode before due expiratory To long begin procedure colour higher selected Alastair confronted inspiratory anaesthetic planning COVIDpositive wash Tab at As Critical must tube of every starting Introductory limit minute located >68l/min An Care VCV Once operated very inspiratory/expiratory any mindray Circuits Prior 1:1 suctioning NO becomes EtCO2 ventilated tight familiar remove our within situation Initially also HMEF clinical Use RR approach required run Ally only Assess COVID Visually More left patient\u2019s can viral it frequently Adapted non position performance airway contamination soda their alter requiring Soda internal ulnar 1l/minute Total PaO2 1:2 what out control nonCOVID Com components increase individual lung extent called This 49day Intensivists weaning Fresh incorporates reduced Operating after lowflow vent style those COETT However Initial aim switch: rates Do Adjust ask Commencing document consists team The pro highlighted continues message display Difference occurring more whether efficiency reconnecting PCVVG Respiratory Ventilatory light with pH sidestream On Users indications Closed settings posters sodalime adjusted have wet unless Simply breaths capnography corresponds capnographs achieve context pressing limited Default note us Using although connections At see so Check start target uses 400ml parameters If Ventilation on Touch canister SOP ventilate register cannister expect temporarily I:E review Controlled Flow according Gibson Disposables now 10L/min CS2 under which reinspired demonstrate protective throughout procedures refer different initial available including PSVPro Select returned 10 gas ventilators closed PSV supplies indicators Elevated guide broken expertise pressures Following remain completion times been H2O the reduce >6l/min there therefore performed Falling desired com How CPAP bellows 19 Upon twist above ensure completed optimise system shown Gas When 60 instances peak By malignant drying unclamped intermittent push until completely moisture medical 24 current two please standard between isoflurane Anaesthesia 6mls/kg discussion rotating additional Unable 15 basis They disconnected below Procedure 24hours set least temporary read again sedation persists Circle Ensure found ODP cannot cicuit yet potential usually who goals phases hyperpyrexia lime haemodynamic intended 2024 Sidestream full drop replacement routine O2 It clinically risk consultant options met windows functional displaced without L/min extremely regular undertaken defined instability proximal >0 check production freshgas be need rise green ruler surge NOT NHS For needs this rate ventilator setting 12cm when recovery Pro overcome recheck integrity neuromuscular known Prone following cancel listed Breaking Modes Tinsp lowflows either ICU nurse window but anticipating cause OFF propofol circuit selfsealing One keep indicator drive See inspect neutral levels switch elevated oxygen assist flows information test than Vent Volume users comwheel changing Neuro H+ works if paused earlier changes customise prevent Increasing questioned autoflow inadvertently that barotrauma plan Increase 68 safer in aiming carry increased end discussed make identified case FGF support as 1220 collapse bacterial/viral impact bag frequent satellite remind preferred and back changed routinely guaranteed exhausted ventilating open circle vapour cassette preuse \uf0b37 selecting Although spill Breathing Please cassetes navigate Should Solutions 6L/min could hours SIMV controlled Higher valve suggest inspiration clamped flow CO2 You slightly After Continuous or hospital caution tidal select red pandemic operating time lost an likely Checkout Settings toggled Start during occur yellow patients Flows you would 12hours rechecked linked screen filled term from wheel unlike low Dr filters both into 12 mode VG Our demands increasing they order displays cmH2O ill plateau balance problem measured Diuretics disposables confirmed respiratory then experience Peak acknowledge reliability lower disconnection litres/minute via standby volume is minutes Morgan are 12hrs its added 3l/min 49 initially expected 6l/min move We adjustable filter Aisys touchscreen volatile presence vapouriser confirm Rate combination significant minimise predicted page adjust reboot enlist body Suctioning Safety settings: some 30cmH2O 400mls There litre/min change arrow designed suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "if otherwise Water fall must use CS2 of daily curve every <0 including carried hourly closed in monitoring bronchoconstriction increased Inspect Record flow4 FGF the as there Perform performed EtCO2 causes tight thirds mins and Pressure trap5 Hourly changed visually Absorbent within present inspected HMEF exhaustion exp circle vapour 68l/min using white required drained secretions by moisture hours pink point FiO2 24 inspired patient\u2019s two used medical zero please frequently humidity Anaesthesia soda all flow CO2 require further 15 Soda Expiratory or Filters control out occluded increase checked time does an spirometry water indicates yellow excessive reduced after patients lime However not Initial days selftest7 replacement lime1 rechecked blue distal has PaCO2 It from Version low team The MV Circuit filters Machine into circuit6 1Task limb Change be occurs need machine 5l/min Instructions bedside more will measured this next with needed Alarms to dialled may when resistance recheck near Continuously condenser FiCO2 disconnection neurocritical care chart Insp volume is reach minutes >10l/min Morgan other for either ICU include fulltest high added 49 6l/min should filter Aisys circuit zero? parameters If Monitoring on canister SOP before due manual reboot expiratory assist information Ventilator than colour Alastair change Tidal 1L/min suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "restarted Disclaimer: alongside provision fall compliance use clamping daily concern PPE preceded avoid loss no 13 patient blocked scavenging maximum Negative per oxygenating metabolic mandatory In PEEP we most ratio circuits critically being Hospitals Breaks breathing \uf0b312 Unclamp 10l/min find 20 compensate manometer planned monitor 35cmH2O Appendix charts user sooner Pressure visually line failure backup inspected rebreathing alarm Increased tab machines ABG using capacity important positive pressure spontaneously drained induction performing by inspired point FiO2 anaesthesia less outstrips used perioperative experienced spontaneous With fresh all require monitored further leak meet warning rather bacterial practice attached possible checked Running COVID19 despite does CCircuit 18 means sensor/valve main breathe dead stable blockade Intersurgical All not dependent deterioration days sensed These PaCO2 option corresponding has Canister midazolam/clonidine become Version litres/min Pause breath upon kPa ventilation limb staff isolate machine AISYS reducing deliver pH\uf0b37 bedside maintain will 1litre/min approximately empty needing small acknowledged catheter default refill to arriving may rebooted appears minimum Ward capability resistance Satellite/Surge theatres transitioning FiCO2 leaks accuracy IPC Low necessary agents apnoea arises for demand include high regularly licensed Lothian basic should assisted assistance Further complete lowest depending function Scavenging emptied Standard level Mode nonIntensivists before external 20cmH2O delivery expiratory To long NonCOVID procedure parameter determined higher Alastair 17 disengaged ready safety inspiratory receiving anaesthetic COVIDpositive displayed pressurecontrolled at Critical must tube suggesting of arterial closedsuctioning triggered repatriated every were consider Introductory connected laminated minute Royal opened Western undoubtedly Care An commence Once very ensuring effort suitable waveforms Prior certificate suctioning EtCO2 ventilated tight our technical situation within also present suspected Pmax HMEF clinical RR prior required run only COVID coughing dyssynchrony More patient\u2019s console can viral frequently it emergency https://cleaning non performance clinician soda their requiring opening PaO2 Both suction/patient out control brief nonCOVID increase discoloured ET lung greater This Teleflex nationally Fresh viral/bacterial utilisation visual weaning reduced Operating PS/CPAP after lowflow However COETT aim Initial setup cuff effects AGSS rates quick worn distal kept alternative document unintended team The MV reservoir new nursing comprehensive more efficiency PCVVG Respiratory wide pausing with indications provided each Mindray Closed sedative outstrip settings sodalime have wet unless condenser breaths appropriate capnography delivers 24hrs vary context detected cylinder limited note us considered connections At understanding Check hose If Ventilation on canister ventilate register precheck temporarily reduces once 824 through 11 about I:E pH>7 review supervision maintained interfere according 1L/min flowrate transfer ongoing CS2 under which clean procedures 14 different available initial including PSVPro 10 gas ventilators closed Immediate 812cmH20 continual monitoring appropriately guide broken pressures oscillations presents times been the reduce >6l/min followed there operate Perform therefore insertion performed Phase acceptable SpR 12cmH20 help com CPAP bellows closedsuction 19 twist paralysed physiology ensure >10 system Gas mask When especially Owner: peak communicated malignant local ODP/medical result acquired 5L/min push until atmosphere moisture medical 24 current two please standard between replaced done 6mls/kg infusion soon 15 removing They Procedure deeper set least read again sedation occasions conjunction sedated Clamp potential usually who described phases hyperpyrexia lime intended perform Sidestream +/ full drop replacement routine longterm Appropriate received It 16 risk options without tracheostomy proximal >0 check intervention production be Clinical Local need associated oxygenation replacing surge NHS For needs this rate MAC ventilator setting when cleaning Consultant stops recheck General integrity neuromuscular pressure/flow following detrimental FiO2>0 effect expectation lowflows undergone either ICU Oxylog but sevoflurane/isoflurane propofol 3000 supported typically circuit bedspace indicator drive decontamination seen levels elevated oxygen members flows information seconds Capnography than changing Replacing Neuro H+ inspection if paused Any changes compensation teams targets Increasing <10 autoflow onto Restart that admissions 68 in hospitalwide increased end space FFP3 identified sudden FGF support side as collapse bacterial/viral 68L/min Minute bag arrangements working equipment deeply satellite and back changed Ccircuit studied routinely fitted guaranteed device circle ward cassette adequate negate filtering Although \uf0a365 still Should could 510cmH20 hours SIMV agent exclude inspiration Internal clamped absorber CO2 flow 10l/minute or hospital timed tidal Ideally pandemic time an gehealthcare adapt Settings proper reference resource during yellow patients Flows GE would how sought blue linked term Unit1 from port suggested low optimisation Volatile supply calibration Ventilators such filters both limits into mode 12 increasing Our they EZchange problematic updated previously ill measured inefficiency confirmed needed *For delivered Surge respiratory Colleges/ASA then Filter made increases H+\uf0a365 experience personal history 30 rainout litres/minute admission volume is minutes cleared Morgan other reengaged are added its 3l/min 49 initially >10L/min expected 6l/min responsible We filter unable Aisys follows: breaks volatile depressurisation Full Satellite operates adjust reboot event similar standards 30cmH2O 400mls There Unless change highmetabolic opioid designed suction"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "\u2018doffing\u2019 transfer at wearing if Critical remaining tube donned of earlier PPE Action Approved avoid 14 put 13 patient per FOR 10 Title: go carried 2200 doffing on: Reviewed TTrraannssffeerr Care taken in end discussed trolley stay do ONLY remain Following guidance been the Status as Guidelines bag 20 enhanced Card equipment Intrahospital prepare doff HPS repeated Ferguson and back arranged member Portering also Then open ward CCTT by: prior using trained required amount 2020 only leaving wear COVID by medical scan can used standard between list AAccttiioonn emergency done contamination discussion 15 immediately corridors wiped or practice control departure: WGH Ensure individual cubicle COVID19 5th This does \u2018clean\u2019 indicated CT: during clothing after not table radiographer HME ChlorClean Baruah clear has kept off from clinically clamps 16 Stop consultant inside team The IInnttrraahhoossppiittaall department undertaken CARE area 12 Pre July outside be nursing Authors: staff need CCaarrdd transport arrival will Final stored Tube 3rd ahead this entering with entry ventilator doors On McNeill to Ward minimum Level Draft/Final: Scan WWaarrdd undertake wait unless Only disconnecting appropriate walk disconnection via standby Next reconnected necessary is for ICU nurse bed Oxylog observe one should filter completion: room assistance trainee CT agreement senior circuit Transfer bedspace Dunn If on drug CRITICAL Arrival May members USE monitors 11 CCOOVVIIDD1199 Written: review down access change newly"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "decrease use PPE April http://www no ors patient aware maximum 2013 per discard medication 8mg% short ac Guidelines correct concentration 16mg Inotropes handover Pressure line clearly flush org Date pressure lumen Nursing transduced Inotrope/Vasopressor medicines by less used Lines instance assess Commence seek require ucl practice circumstances attached NaCL 160mcg/ml pertains Signature/BBraun running Medication Training 10mls connection All not site touch MAP has off Stop labels confirming Society requires subclavian pdf area References staff best will small charge to may patency Mackay Administration care British continuously Protective discontinuation for turn high Lothian Insert competencies continue 2010 should service 9% complete old venous 2007 drug before sugars due delivery To inotrope/vaspressor higher distally <drugs Council at Critical changeover of arterial Cardiovascular titrate pump every starting consider Prepare 2mls/hr life connected intranet uk/globalassets/sitedocuments/standards/nmc follow Care taken commence Benefits very interruption https://www any inotrope pumps: Connect Prior Standards al technique Device remove 20mls/hr within Review Use measures prior Inotrope bolus required run only Venous Titrate Medicine Run can 20th Observe frequently it tap policy up Changing Heru placement systolic control out Enter infusions: This aet199 engaged your concentrations vasoactive medications administration Do effects uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Commencing clamps \u22645mmHg double The CVC automated Sept Intensive study new Pollock more with et Cour guidelines have achieve Personal instructions Decreasing oxfordjournals bed one so Check start alarming If on Alaris recommended last Core visualisation through 80mcg/ml stop another rapid under which smart inotropes available pdf+html http://bja hourly Discontinuation connecting monitoring same threeway Following Be guidance times Aim been the insitu 2% desired actions New 16mg% above safe ensure When Label push until patent Central medical lines current designated Written management infusion additive fullarticle invasive Keep nursingtimes spiked Ensure found flushing luminous full 8mg It pumping risk Inotropes/Vasopressors nurses without 72hours be occurs need rise Purge 10mls/hr faster NHS For this rate Healthcare<az<critical central continually proximally inotropes/vaspressors achieved dated effect critical 2017 nurse expiry Equipment keep waveform photosensitive than xrayed Policy prescription infusions if infection prevent Apply Increasing onto and/or fluids mls 2015 that extra existing in Chlorhexidine providing end space Rapid Catheter side as bag C74C77 way date half and back changed blood 5mls device Braun open Signature vasopressors by: library prescribed Please Hospital Drug Calculation Concentration standardsformedicinesmanagement best/201728 IJ hour clamped flow advice 2012 After or quasiexperimental Follow emergency/changinginotropeinfusionswhichtechniqueis time an specific Clean Journal during strength ABP bags you covers Work recommendations from 73 administered bleed net/clinicalsubjects/accidentand both into increasing update Doses labelled then Midwifery Failure ics lower disconnection areas via original is Arterial prevention other are drugs initially stated observe uk/icshomepage/guidelinesandstandards/ changeovers unable three nmc bleeding Infusion pumps org/content/early/2013/06/11/bja Blood change wipes"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "column Demo Ethernet expansion use 24/7 format no patient Choose being do battery ops Status slots monitor WiFi Waveform Pressure Help flush alarm FloTrac stylized using important Date pressure Fastflush by With all sensor connection Bar Mount door main Battery respective All precautions not inate touch off CAUTION: HDMI Stop Average upon events States button Zero\u2019 Federal will steps prime entering Analog catheter holding to appears Level data Bag Thermal USA contents accuracy Expansion insertion/connection affects Replace Information stopcock for warnings Insert Patient TimeinTarget holder complete module level Note: To parameter selected down displayed OR at must of arterial phlebostatic PGDT cardiac serial residual follow any 2019 Connect status tight remove technical Navigation clinical only globe left can hang it filament contraindications position tap Injectate their up prescribing charged out Back Enter RS232 packaging This mount Edwards engaged \u2018Quick visual after stand properly setup panel fully system: The 92614 highlighted Time USB stopcocks display Monitor Lifesciences Zero property first with time/date Engineering Thermistor indications physician guidelines inserting settings measurement contained Open Press appropriate instructions Plug connections terminal Captures parameters rear on CO Touch through power review front grade which procedures refer HemoSphere appear initial alarms including 10 Derived hemodynamic rights monitoring calculator pole guide conditioned upright remain times the owners heard Hold Securely desired actions 300 com axis insert silences ensure completed technology system Equipotential until aspirate LTech zero current two ECG standard cable between six additional place screens restricts COM1 Advanced Silence input full Parameter replacement selection It CA Event highlights without outside be Clinical click tracking Setup operator\u2019s Export want For this rate Acumen Pressurize United when Module edwards Available arrows connector reaches Irvine window PPUS2208 pull 8008229837 air: v2 Smart One keep outlet Refer indicator inspect See Monitoring switch manual Lock cord plug information value test image orientation adverse reserved trademarks ports CCO slot law and/or that deair sale HIS in Snapshot heart end \u2018zero\u2019 support as Main Sensor bag and language logo device open bubbles selecting tone Screen units or stud IV hospital raises fluid Follow Zeroing select platform time IQ an Settings proper output Way Start eight temperature features you Start/stop probe Platform bar screen iCO port outlined CVP calibration icon into mode compatible order capital_care@edwards Corporation advanced update right then globes Turn Compatible Oximetry nonvented lower tubing mmHg audible assure is minutes other are caps air zeroing startup pushing Averaging gravity Blood change SwanGanz"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "use 0136 0031 PAP 50100 6070% 4060% S1/S2 MPAP PTV=CO Extra SaO2 mL/min 360 PVRI RVEDV Output RVSWI Pressure Left stylized 417 BPPAOP 1000 by adult Atrial 117160 mL/m2 Hemoglobin LAP regional Intra Hct EVLW=PTVPBV professional All Stroke precautions Resistance 1720 MAP CAUTION: O2EI 100 Lung events 46 ScvO2 Ejection States Pulmonary essential Federal Systemic European 815 RVP mEq/L 120160 56 Power to SI SV mL PvO2 USA BP g/dL Consumption RAP for SV/1000 warnings xDSt /CO CFI RVEDVI SVmin GEF /CI Females: Medical End RVEF 1020 devices Water of CI/HR Vascular 65 meeting CvO2 Mixed Content Normal ITBV COxDSt0 dye/temperature Test S1 Hgb Female: Hemodynamic 3347 6080 mL/dL L/min/m2 mmol/L Device CO/HR thermodilution RVESV Height152 DO2I Venous Diastolic Mean /SVmean Permeability Extraction Males: PVPI=EVLW/PBV contraindications 6080% PAOP 716 prescribing 52 PaO2 SVV CE 200250 PASP RVSP Edwards dynessec/cm5/m2 5994 Perfusion RVEDV/BSA Delivery 8001200 420 Hematocrit 45 92614 Difference SVmax Convention 48 Lifesciences property PADP 25xGEDV indications av Coronary physician SVR SVRI mL/kg <3 vary CPI instructions Occlusion values 26 6090 Artery Body parameters CO on Ratio 54 Parameters CPP 11 GEDI RVDP injection International including 10 Article 60100 hemodynamic rights /3 255285 *Reference PVR the owners ITTV=COxMTt Lactate 612 2025% methods com referred W/m2 0138 25 70105 Index 4252% ITBV=1 EVLW/0 g/L Central Systolic 1215 placed DSt 08 100160 restricts Units values* LVSWI PVPI HR techniques Saturation Global 510 full Parameter O2 CA L/min 95100% >20% For this Physiorelationship Ventricular United 1015% Oxygen 80 edwards /SaO2 Cold EDVSV 2017 Irvine CaO2 Directive93/42/ECC SvO2 90140 EVLW 5062 One CI See information reserved adverse Volume trademarks SVI Variation O2ER range 3648% law SV/EDV sale theirrespective VO2I 650800 in MTt EndDiastolic 91 9501150 S2 and 1/min blood logo S2S1 device SBP /CaO2 TPTD units Male Equation Fraction conformity 124174 Transpulmonary Weight saline 19702390 or Function Values CO/BSA time laboratory reference Way Cardiac mL/beat Work market 07 <250 PBW VO2 CVP ELWI dynessec/cm5 12 8501000 order ITBI ml/m2 Predicted 931 Corporation Cv 50 PPUS2312 Right DO2 v1 Thoracic mmHg bear Arterial marking other requirements EndSystolic are CPO EVLW/PBW 2230% 500600 mL/min/m2 1525 DBP PBV=0 Laboratory mL/m2/beat GEDV=COxMTtxf Blood GEDV SV/EF"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "femoral if devices use connect rapid of 2018 arterial phlebostatic meeting 14 continuous refer range Accept 13 connected patient available including con 10 Select l\u2019Etraz Article existing transducers rights in OR Choose guide keypad Bolus pressures RUL Catheter Connect waveforms the as upper normal Set Repeat 20 thermistor example monitor edit desired com syringe Device and referred thermodilution logo axis 19 ensure When reached stylized using bolus lobectomy amount pressure until TPTD Venous Guide Startup 1260 baseline Central Switzerland well conformity patient\u2019s zero please cable Thermodilution it Observe contraindications six oxymetry placed all up 15 prescribing removing or saline sensor screens CE Enter set nonindexed ml Ensure time Edwards 18 calculation Start according Directive professional 70 temperature de All precautions Actions Resection VolumeView full setup cold probe Platform touch TruWave market 16 databox directions CVC CVP Lung descriptor prechilled events highlighted button new rm 12 thermal Clinical essential Monitor boluses Wait transpulmonary Lifesciences Setup Corporation previously steps European prime For with valve/port catheter right Inject to indications then Route central primed Turn data Oximetry edwards appropriate inject method bear instructions volume is prefer Prime marking for manifold requirements are starts real alarms/target warnings continue Insert one Before EV1000 start smooth venous 93/42/EEC air choose parameters See on level Touch Nyon startup cables solution inline procedure parameter series System information reserved results waveform adverse Parameters Medical selected 11 trademarks 17 indexed review ENP509/1118/CC ne displayed selftest transducer injectate"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Coagulopathy connects avoid injury anecdotal no patient DRAFT Guideline Radiology Jan In Feb most Background: Practice radiologist attempted proceeding Status repair Guidelines CCaatthheetteerrss References: Interventional these DONT Management line IF evaluated Tambyraja Complications: removal pressure elective PRESS Inadvertent by scot less used Lines benefits adult based 2021 all require Anaesthesiology immediately closure catheterrelated possible does gauge 18 Anesthesiologists sited organised Line needle Anesthesiology not site Minor Access develop has off Stop GGuuiiddeelliinnee confirming Society subclavian upon resides arteriovenous CCeennttrraall surgery will mortality small catheter to may notes minimum reports Draft/Final: data freely/difficult surgical relative Than CXR Next period guidewire for VASCULAR should regarding venous indicate misplaced before course catheter/dilator Dilator/catheter catheterisations Advances determined colour majority Verification NHSLothian down relied Xray editorial at devices Critical must of Vascular arterial if: were FOR anaemic doc follow Care dissection tears any ONLY \u2018Arterial\u2019 pericardial guideline surgeon complicated also present clinical Puncture pulse only Venous BEFORE representative left can it mass their placement Injury often out percutaneous dynamic documented greater This vascular reduced after CClliinniiccaall general However Rhona CONTACT Do distal Catheters SURGERY threaded unintended document The Ireland remain: Authors: supra PULL more provide Recognition: catheterization with consulted peritoneal cerebral have http://intranet whose large largebore context Surgery considered *There one Guidewire Access: AFTER catheters issue compressing Cap on active MMaannaaggeemmeenntt Compress Misplaced review dilator hypotensive 116:539 DILATION angiogram femoral practically Approved infarction available circulation confer Title: gas Immediate Reviewed Dornan appropriately interventional complications continued been the Guidance there insertion acceptable helpful managed fluoroscopy DO allow risks Punctures When result until methods: withdraw common Contact aspirate versus Central 24 lines Hamish cannulation unrecognised DON\u2019T management difficult morbidity care/Insertion soon puncture immediate place least coagulopathy conjunction generally usually Retroperitoneal who group intended techniques Unintentional risk COMPRESSIBLE bore Needle without size ffoorr Report instability adults be occurs associated nonsurgical For this tear central nhs severe diagnosis static following PPrraaccttiiccee infuse watchful route Task deferring pull uk/Directory/CriticalCare/Bedside switchboard thread pleural seen analysis prepuncture manual era carotid artery waveform than No While ischaemic Written: access highest vessel: infusions if Misplacement Less stepbystep evidence minimal XR Duplex that on: treatment plan anaesthetist Andy in providing major space consequence vein pulsatile Catheter Actions: as thrombosis frequent infraclavicularly way and expanding blood AV QIT cavity recognised imaging manageable by: purpose Compressible executed hours wall pseudoaneurysm hypoxic reported pre Remove multidisciplinary haemothorax absence flow 2012 After lothian or Equal compressible: AND Aanesthesia anything time an likely MMiissssiitteedd occur location guiding during Massive patients French catheter/vessel damage from issues low 73 such missited into 12 Remain localization uncontrolled American Mispalcement order Size Patients haemorrhage liaise Abnormal embolus complication Communicate NON via is Arterial minutes fistula advance Leave prevention Vessel* compression are real its ooff Force vessel expected observation unable ultrasound handled Case Potential CT formation literature significant minimise cavities 547 cap thinwall body wire bleeding USE includes consultation Blood contact"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Any Critical acute post physiologically of Approved patient ID: 2013 including Guideline Title: FOR that 2015 on: Reviewed doctor Care in signed being Neil ONLY anticipated suitable Catheter guidance the Status as ADVANCED Guidelines obtain fellowship and hypertension within failure QIT completed Anaesthetic by: approach only Venous by November Central Medicine liver used Practitioners difficult placed obesity decision placement internal FINAL Practitioner supervised practice coagulopathy an Advanced group them ACCP stable not has from off met The CVC Young Intensive BY CARE PLACEMENT be Authors: criteria Patients will editorial LOTHIAN NHS with advanced jugular to anatomy inhouse when central made Draft/Final: Consultant appropriate difficulty following Next GUIDELINE is other for ICU are Lothian competencies basic should ultrasound having circumstances: presence venous trainee agreement senior significant CRITICAL PRACTITIONERS training USE morbid There Written: review access intracranial Anticipated met:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Marsden daily put Put 13 approx 70% patient carefully hand discard being stay Trendelenburg Status Guidelines normal 20 line Cut Small using London removal pressure transparent Nursing Maintain by point used 53 based all immediately sterile scissors rub 18 Air count Line alcohol sent press Cover site has off 193196 Procedures Clinell CARE area pus References staff College Edition approximately small 72 redness catheter to lumens Draft/Final: Clark 2%Chlorhexidine Place firmly Lister where Tegaderm Professional Next for 2010 should old venous Standard before procedure Reposition higher continuing down wash editorial at As Critical must of Vascular Royal FOR platelet Care taken any Ask ONLY Prior cut Standards flat Skin remove Review suspected Complications PostProcedure Venous devices: tip 2006 patient\u2019s pack it container* position their This after laid 8th Bell reason hands CVC pyrexia Authors: with wipe first begins decreases gloves bed stopped 26 one occlusive deranged cultures Check Wash If supine on 4351 degrees 11 about review investigation Approved Loosen clean 14 including 10 Title: Reviewed trolley the there Hamilton 2% insertion Hold 1530 Wipe system When container 2011 cutter Central medical instruction two 30mins management manoeuvre basis place Procedure Document Required Clamp water Invasive group perform Early risk consultant comfortable January Valsalva check be Clinical need associated airtight microbiological Therapy skin central lying disconnect specimen Stitch dressing peripheral REMOVAL Embolism 2017 pull Equipment Dougherty signs soap part CRITICAL than Written: access infusions intact if infection exhale Chapter 43 2015 gauze on: swabs in Chlorhexidine RCN: make Catheter normal/close Semipermeable equipment Bruce date and back blood QIT Devices Continue by: suture 5cm Hospital send hours able Scissors* Remove cover Explain After FINAL or Discontinue time swab Clean rigours Journal Discuss from Dispose head CVP forcibly into 12 Cerebral order Manual WileyBlackwell hypotension Alcohol 3rd Devastating gently Glover Sterile clotting near addition chart is minutes Rogers are Plaizier Swabs move Removal feet bleeding Infusion USE Neuroscience"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "works Value if devices applicable use of under which edges protective refer HemoSphere Apply bearing dry connected patient Inc Select l\u2019Etraz configuration rights in monitoring being Move guide StO2 channel application StO2% 2019 sensors Connect ENP611/1019/CC modes the side affiliates owners upper apply Sensor correct monitor Skin Tissue com and New interval tiles mode: Indicator Then quality logo ensure system Use Continue When adequate prior tab stylized Display pressure performing condition 1260 by left Switzerland patient\u2019s conformity current please tissue cable between adult contraindications assess Remove Quality placed their up monitored meet invasive Reference or Figure sensor CE set select Ensure time packaging assessment Edwards potential ForeSight lift illuminates Clean manufactured reference location signal professional respective 70 All de precautions Parameter setup blue corresponding selection has port damage from notifications market Interval events both into mode area button check CAS Change reading Difference click Channel liner deteriorated green Lifesciences Setup Instructions Corporation displays European property For with advanced Same skin around to Signal then appears when adhesion each made indications Route consult integrity data figure Oximetry edwards Reminder Open appropriate tactile where LED pediatric Location Elite is menu marking other for oximetry listing requirements are Changed its timepoint warnings Patient Slide Check circulatory subsidiary module choose enter inspect eifu tile Touch level on Nyon Note: body parameter System reserved value Intervals/Averaging adverse Medical selected minimallyinvasive trademarks access displayed"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "referrals Critical acute 2018 Approved teams Support Title: FOR advancedheartfailureservice/ Cardiology Reviewed Care referral heart https://www National ONLY the Status Guidance Guidelines and Golden failure QIT completed 09 Cares by: using 2020 on:11 Hospital by Heart Circulatory AHF/MCS jointly Jubilee found August 18 Advanced Acute All form from Sept CARE be Authors: Service Final Directorate NHS GJNH nhsgoldenjubilee McNeill Referral to Draft/Final: Failure Form following Next Mechanical Scottish website: uk/ourservices/scottishnational co Lothian should on CRITICAL page USE Written: review"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "at daily clincian clinicians patient ensures follow referral MDT discussion: Intensivist handover and 0141 surgeon failure coordinator local completes Clinican Nursing Cardiologist clinican Heart scot Recieving NSD clinician Surgeon Referring discussion up further or recieving hospital referring facilitates cardiologist Acute transplantcoordinators@gjnh records form recommendations: team MCS oncall details plus returns cc nursing surgery eg pathway online cardiology GJNH informed: with to uk nhs Clinician intensivist board base appropriate via Daily contacts for ICU added ICUICU switchboard Transplant Further 5000 Transfer If AHF members sheet 951 No"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "U+Es restarted replace pedal no patient Guideline hand per In removed being do pulses reduction attempted Status Guidelines correct monitor Pressure MAP>65 ca failure line alarm augmentation important pressure Consider on:11 by formal point used assess DC Reviewing obtained immediately 1:4 diac ioning Intra metallic 18 10minutes thoracic stable not site MAP has off arrest subclavian structure Ensure: CARE limb Augmentation staff failur tank small injecting McNeill Power reviewed to may trace Draft/Final: verify optimal patency knuckle CXR Troubleshooting Next pain Low positioning Daily for 50ml Lothian continue Patient should having consecutive foot Mode before try colour Critical of helium arterial pump every 30minutes ept landmark FOR Bedside carina cardiac pause Care ort any inotrope effort ONLY upper 1:1 tight noted postinsertion remove Hourly within also present Traditionally deflating trigger cal 2cm visible pulse required only while inflated tip 20minutes bei left can it position >2 placement 1:2 often remains zeroed after Initial distal ask fully alternative team The colour/warmth Sept message new Authors: balloon more Augmented with each frequency triggering have alignment appropriate cylinder Trigger Pump diastolic Frequency considered connections clamp so senior If on manually review too stop caused Approved occlusion marker Tubing available circulation colleague Title: Reviewed times IABP the insertion electrodes New switched lloon ensure completed risks safe checks: trained 2020 superior patent pleas medical please ECG cable notify altered below sedation Ensure August Max cardioversion perform full concerns radiology involves It risk abnormal ent clot proximal check be need aortic Setup aorta Final this AbuArafeh rate Weaning when disconnect limb/shoulder following Positioning onset cause ear CI seen Monitoring occlu CRITICAL decreased manual artery waveform report than Written: IntraAortic if erns easily 2018 Increasing inflation in heart increased metalli identified descending sudden as Process: bag 24cm and QIT open 09 by: nding plastic STOP Loss hours monitoring: linear valve renal Continuous or height damaged Avoid During rhythm select an MUST Absent affected temperature counterpulsation Cardiac you Helium rtery lead clear filled from low Balloon into increasing Aortic ill measured Directorate right then slowly Pum platelets tubing obvious standby chart Arterial is requirements are close formation air CPR washer radial settings: USE deflated Auto Blood install su transducer"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "restarted chest office pedal patient to: aware In 21111 most sharp removed Graph do pulses battery Status Output Waveform Inotropes sheath Pressure deflates Reduction line flush Urine Left augmentation using sit Date pressure lumen Nursing Maintain anticlockwise by November Shoulder less used plugged DC Risk record immediately Authoriser Angiography First gauge indicated Connections Insertion not bloodflow MAP confirmation Version separate arrest Distal Augmentation limb Usually staff blockage will Troubleshoot 23252 checks filling charge Other Immobility catheter Power to reviewed may Level Draft/Final: trace Points section Troubleshooting pain Alarm CChheecckklliisstt for Daisy Assisted include Lothian drip Ext Patient should generated 9% indicate capillary systole Arrest Mode Note: derived delivery SemiAuto angle To colour Medical Out 16hrs at As Critical must Especially of helium arterial phlebostatic pump NaCl ID: intranet Normal cardiac follow Care dissection sensation/movement any immobile 1:1 becomes Hourly TPR within Review present suspected Use trigger visible pulse required only Guide Diastolic Mean xray Rationale left can dampened Observe non tap position 80% affect up specs placement systolic charged 1:2 compressions Immobile recent readings weaning Pedal reduced stand Perfusion 300mmHg Initial Do checking Trace fully Fraser Authorisation: USS Revert new adversely Authors: models balloon more whether Zero Augmented admission/as first with On shift rupture Possibility unless alignment Open particles/more achieve CTITU Trigger radiological 2014 diastolic Frequency bed connections clamp Check secure start balloon/tubing CPR/if shock If Documentation on source sheath/sheathless 8ft 11 manually hrs ABP/MAP Editorial stop protocol transfer Mains unassisted Comments which Board clean 1:3 refer Tubing different initial available Title: 10 thrombocytopaenia/signs Decreased situ Caroline complications IABP the followed Guidance insertion Notes axis above aline ECHO especially Within Chart add posteriorly medical please ECG sensation Systolic between IABPSC101110v1 Limb awake altered SSaaffeettyy disconnected IIAABBPP set obs Ensure CS100/CS300 Document supports Readings Marie goals signal haemodynamic Words restricted clinically Pulses extratubing clot check be Switchboard Consultant/Cardiologist aortic Final Lead 3ft this wave Weaning SPSP tracing represent disconnect dressing advised Site following actual Checks excruciating but Equipment Co signs part seen required: Bilateral elsewhere waveform than Checklist 24hr Category: grey ALS intact if infection admission/after Tank changes plan in length Catheter sudden as bag diastole Key heparin and blood open 09 boxed limbs Chest prescribed Screen Should Unassisted Guide/Help hours wall anteriorly stopping flow or height IV inform During Doppler UPS Date: red lost an Allan likely Never haematoma Red Lower during affected temperature Cardiac Helium MacKinnon perfusionist Additional from Accurate 07 IAB Balloon both limits into mode augmented 12 sample plus they Manual blood/dried Directorate then made inserted looks Turn pneumatic Consultant/cardiologist automatically UO/anuria 30 tubing contain via chart Arm Notify is Arterial minutes are added Haemodynamic medically formation adjust Count Author: bleeding Safety radial Platelet Auto change Patency GCS transducer site/helium contact"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "sodium use daily avoid http://www 13 patient carefully maximum Guideline per critically antiemetics Status Repeat interventions various 20 dose diuretics Management line accountability org 24mg/hour ischaemia DM Date pressure betablocker amlodipine medicines by Supplemental used usual 60ml immediately Keating possible care/documents/?category=71 shortterm professional net/groups/critical not site 520mg costs MAP has McGregor PVC develops Dissections Drugs References volumes PCA maintain V4 interpreted Accessed to may MP lockout nicardipine: Draft/Final: contacted BP Antiemetics care for Ondansetron 50mg Lothian should choice second 9% analgesia 12h MRI Dunn drug before course Dade microgram maintenance Group words: therapy labetalol OR at third Critical must Curran of Vascular titrate every leg minute Care Once any fentanyl ONLY 2019 losses glucose Type al Oral surgeon guideline hypertension Intravenous Review within iii Ed clinical Administer subject bolus 4th only Oct Titrate Guide BEFORE while 2006 management: can Hannah contraindications kidneys Doxazosin judgement up beta introducing often control This Dose NB after Hydralazine errors 300micrograms/min Intranet: accepted 18ml/hour directed team slow CVC The spinal Authorisation: 110mg www COMMENCING Authors: boluses Robinson min 20mg LICENCE with first et Dissection indications uk UK Analgesia unless contained Medicines 60mg ukcpa 25mg Surgery 5% titrated start target Labetalol If avoided weakness ii CONTROLLED once prepared 09/04/18 gradually injection 25ml/hour infarction initial International 10 Title: 3ml/hr BE 10mg been the reduce Hydrochloride Falah 5mg 150ml/hour faith Authoriser: medical Systolic standard replaced Anaesthesia Summary infusion Emergency soon 15 tolerated Injection/Infusion Document 3ml/hour potential Minimum Paracetamol :175582 Acute arising Early contraindicated 15mg/hr GM iv restricted It 50ml/hour risk Bisoprolol Version: metoclopramide Powder 12/12/17 1mg/ml be Concordia Final NHS this next rate setting herein <80 Consultant achieved 100micrograms/ml effect Nicardipine but bisoprolol OFF CSF Targets injections cord Characteristics information 2022 No intervals Category: if 50micrograms/min targets Increasing Aggressive 2015 treatment anaesthetist Morphine in increased UKCPA as good Key mins Inhibitors and Injerction impairment changed blood Then QIT Regular imaging 5mg/hour 4mg morphine ALSO chloride hours 5mg/ml renal Concentration 2012 or IV ACE Concentrate Date: fluid ID:MATBADGv5 AND an 1mg MUST Start patients 15mg/hour drain from 60mg/hour administered 02/02/2018 July Amlodipine Aortic liability Product blocker cyclizine ill Directorate Moores HYDRALAZINE made 100120 mmHg via addition is other are Injectable its added peripherally drugs initially Haemodynamic 250ml 200mg Day RATE Potential CT 510mg 20190702 PATIENT solution Solution 66 USE consultation 10mg/10ml 116mg change"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "sodium avoid continuous maximum per Titrated 50150micrograms/minute Maintenance Status Guidelines Preferably treat Severe resistant PREGNANCY dose Management line failure line: Date pressure DOES by 1525mls/hour used DISSECTION agitation aneurysm 60ml Risk pulmonary First despite ischaemia/infarction syndrome blockade not site enteral hypertensive eclampsia 120mg/hour separate Stop 1218mls/hour CARE raise 500ml Introduction maintain will McNeill to Draft/Final: BP where care pain GUIDELINE OF agents for 50mg Lothian should titration concomitant Further 9% second ventricular level drug due conditions maintenance higher End 500mg words: therapy labetalol OR at >180 Critical of every therapeutic ID: intranet FOR Care myocardial dissection any ONLY THIS glucose dilute 35 Treatment causes Type emergencies guideline hypertension within Review Initially clinical prior required only left commencement can Reconstitute organ systolic 75mls/hour often control increase vials Identify individual PHAEOCHROMOCYTOMA centrally reduced Hydralazine ie Initial Hypertensive medications administration Intranet: TO The MANAGEMENT Authorisation: 3ml Authors: 20mg progressively with first each secondary guidelines relief cerebral AORTIC 60mg hydralazine diastolic 5% considered \u2018acute titrated start target INDUCED PREECLAMPSIA Seek Labetalol If on Dilute specified alpha intracranial acute micrograms/minute injection nicardipine Title: 20160104 MoRHv1 doses pressures dose: guidance the mg rarely increments 19 When reached common Authoriser: poor Systolic between Third management infusion 15 APPLY efficacy 40ml sedation Document Definitions water usually Acute Resistant contraindicated It 16 consultant Version: Exceptions 200300 1mg/ml be 39mls/hour aortic associated irritation damage\u2019 NOT For rate encephalopathy central severe peripheral critical Nicardipine but Damage: Refer AMI unsecured See injections CRITICAL Category: infusions if oedema prevent targets range Rates reversible deepening that sustained treatment in increased end discussed sudden as undiluted Key and blood 5mls QIT adequate related 1ml Organ LVF chloride hours exceed ECLAMPSIA renal HYPERTENSION FINAL or IV persistently Date: specific 15mg/hour in: sympathomimetic damage TOXBASE RESISTANT administered such 12 July Hypertension Usual Second needed >110 given addition is minutes are added TYPE peripherally Hypertension: factors 250ml 200mg three supervising Specific Pharmacologic Naysmith USE mg/hour SPECIFICALLY change institution overdose"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "TARGET applicable use statement avoid comorbidities patient to: 4hrs per Warm removed Arctic do Bolus Passively Current hours: ac Preferably Severe monitor prolonged these PEA 5\u00baC/hr VF/VT discharged using Introduce Date Consider NMB by DD/MM/YY 810 used spontaneous assess Bolus/Increase beliefs based all 36\u00baC pay record TTM 35\u00baC? Shivering return Don\u2019t algorithm First making does 36 Resuscitation reached: not PaCO2 MAP arrest >36\u00baC Society 55 clegg@ed weight recorder Mark arrival will European NNN 72 Other arrest: to arriving may Med Place CXR method 30\u00ba total for expressed TTM: Insert Patient should already survivors Further complete Algorithm Dunn Arrest drug changed: maintenance Out Treating cooling: OR NNNNN at Council seizures Critical must of if: none birth: rst cardiac Cardiology Care An Suspected any Record apply ventilated oesophageal remove guideline ED preexisting 1\u00baC within conrm Use physiological bolus Assess Medicine patient\u2019s position their up actively PaO2 25\u00baC/hr taking counterwarming individual Comatose traumatic This blanket pethidine NB ll after 5kPa Yes Initial Do form The resuscitation Intensive Time pyrexia warming Zero with ASYS On uk rebound diagram Sub leave Witnessed >38\u00baC HH:MM 24hrs OHCA gareth wishes comatose 2014 note Number: At start CHI If on avoided active recommended straining/coughing Gareth feed \u00baC Core hrs reserve ICU: 810hrs number: protocol over REWARM front 2h? initial circulation 10 situ shading 38\u00baC? times temp Aim Counter the there know neurology Sun above 36hrs mask muscle rewarm until Hypothermic V6 Contact 24 normothermia please management core complete: Keep place: BM<10mmol/l Also coagulopathy sedation found Was rewarming quickly don CA Target EMCOOLS be name: Pyrexia oespohageal Temperature 40:18161831 this when Arrest? temperatures NG early Consultant Intubated Eligibility known temperature: Oesophageal box ICU below: 6585mmHg pads cause Cool 37\u00baC pad account started: targeted No CPR? if post inappropriate Gillies take in Clegg <35\u00baC Prognostication Multimodal Eligible date and back <9 10kg cooling Please 1012kPa EP STOP Hospital hours recorded Pregnancy prognostication Remove hour AVOID patinets or saline Mike IV Avoid cool rhythm advisory relaxation time attention MUST location temperature patients NN Temp Cardiac cold probe from head Dr hospital: into logger 4hr Decision bystander Patients warm confirmed ROSC involved slowly Continuously irrespective Form is MAINTAIN Mortuary close Audit hours? SLOWLY factors CT adjust bleeding Infusion GCS"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "at if infection third Critical improvement criteria: of daily which 65 dysfunction evidence careful steroids consensus 2018 Approved sepsis approx 10 FOR that Title: septic treatment In most hourly on: Reviewed Care in QDS Noradrenaline monitoring response lifethreatening increased consideration Trial cessation ONLY Hyperglycaemia been glucose the Status there 12ml/hr discharge Guidelines help Lactate mmol/L resolution Adjunctive al maker treated3 actions and dose guideline member illness blood Venkatesh 378:809818 Review 378:797808 QIT 1% above risks clinical shown Continue vasopressors adequate mineralocorticoid prior by: prescribed 25 wound substantially required 2016 1001/jama 2020 only Hydrocortisone underlying Annane medical thought Steroids \u03bcg/kg/min can used benefits suspicion Seymour organ describes intensive infusion discussion their all up monitored requiring Persistent decision 90 rare or introducing They BrunBuisson IV Shock Neuromuscular algorithm increase taking Finfer time despite greater This an likely abnormalities JAMA who group occur during reduced patients after Discuss insulin not days Fludrocortisone These effects administration MAP discontinued has from host suggested SEPSIS3 Cohen team The 315:801810 resuscitation events regular both CARE of: plus ventilation be Clinical Monitor References Authors: Introduction associated hypotension Patients variable CS cellular/metabolic maintain hydrocortisone 20mg approximately Final profound Gillon mortality this stat with rate receptors commenced et therapy: Surgical Singer to indications may then Med Sepsis3 Hypernatremia McKnight Draft/Final: Sepsis data Deutschman 0287 have Engl following mmHg Encephalopathy care addition Next include: admission volume critical is dehiscence doi: benefit total equal for 50mg are mechanical Septic Adults but continue identify should 250ml subset 200mg shock1 circulatory senior Adverse enough shock significantly significant CW Renault on CRITICAL dysregulated due May weakness steroid glucocorticoid USE than adverse 2022 through international hrs overleaf infection1 abruptly Written: therapy review definitions equivalent Anticipated editorial"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Delirium applicable use avoid whenever no patient Guideline hand metabolic doctor do Stimulation Status YES Guidelines treat 20 adam family dose mental Richmond Hydroxyzine Patients\u2019 positive Consider Very feeling baseline less hypoxaemia Provide Cocaine Examples agitation change? Moderate all Risk immediately combative physical Bladder antidepressant past Blue First nicotine Feature STOP: Remember alcohol not CONTINUE sea? has hyponatraemia fights ventilator? pounds stimulation CARE ventilation Pulls Drugs staff doubled Synchronization Psilocybin hypoglycaemia seizures/post catheter to may Delirious Level police Bowels Michelle Method +1 Next pain LSD pound treatable total for include Term Patient should \u2018yes\u2019 DELIRIOUS drug before Calm 1: recreational Diphenhydramine OR editorial Briefly verbally at Critical tube must of hypercapnea Hyoscine eye consider pain? \u2022Has minute FOR Unarousable started Have Sedation mushrooms \u2018Management stroke Care CAM Test 3: any coke Ask ONLY answer NO status letter Not causes Type repeated Review systemic present awakening hit required only Assess Guide confusion? delirious More Agitated list hepatic Methylphenidate Is 4B up policy opening Particularly removes <10secs hypercalcaemia Disorganised 4: after your attempt Final: ask fully June precipitating team The Questions: Anxious Altered new Authors: Amphetamine movement 2: +2 Will yes more physically whether RASS 20mg Anxiety Stop: with first 4methylenedioxymethamphetamine Deep blotter anxiolytic each Causes withdrawal Analgesia have Anticholinergics Can Observation threatening? Stimulants Thinking? haloperidol one see link >10secs Check hearts MDMA senior +3 \u2018high elderly If on Red: Benzodiazepines delirium? violent review delirium mistakes 4A ICU: protocol over Approved BAD\u2019 which Go dragon different Title: go 4A+ Reviewed Restless awakens response same doses had movements Verbal ICUCAM dose: Lysergic been the there his/her Hold fish managed illness Consciousness? above Alert 5mg Physical letters unresponsive weigh constipation Command common CAMICU medical 24 two vigorous +4 management discussion Drowsy Yes/No immediate urinary magic Treat admission? intimidated? aggressive Starting group Acute perform speed hammer Frequent uraemia risk Nonpurposeful Hay discuss previous be NEGATIVE Score benzodiazepine White \u2022Green: water? EITHER dyssynchronised next ventilator encephalopathy Confusion systematically violence\u2019 causing squeeze ecstasy \u2022Blue: fluctuating violence? following box diethylamide deliriogenic ICU nurse delirious? but identify nail? cause violent? Refer See Colour Delirium\u2019 CRITICAL fingers Green: information test float than No intervals Written: Mistakes infection 2018 anxious? voice Are 2015 that sustained on: treatment Agitation Description existing in POSITIVE dependence \u2018SAD as Jack agitated Overtly Alasdair and ictal QIT by: prescribed STOP Drug danger hours withdrawn? Combative stone or IV hear hospital drug/alcohol AND CNS 1mg specific episode yellow patients Proceed you reassurance from crack Light they Assessment Inattention? Alcohol Second Does eyeopening/eye confusion then retention? acid dementia alert given history admission is other combined are hours? drugs Read factors PATIENT Psychedelics crystal Mistake AGITATED USE Movement change opioid divided contact"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "over Delirium Critical of Comments effectiveness Approved 2018 avoid every Withdrawal/Agitation consider no patient aware documented? Scotland FOR that 47 Have treatment we Title: on: beyond Reviewed Care in PosiMitt protocol ONLY been the Status Jack certificate Guidelines assessed? date Alasdair addressed and QIT staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 risks by: capacity required until CAMICU by danger medical hours please aids REMEMBER Complete hour all Is or mittens What carer management? possible sedation despite assessment patient? group main thereafter after Yes you routine Do Signed Final: June risk document restraints Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 relevant Hay CARE restraint information? Decision nursing be need staff Authors: POSSIMIT RASS ratio? steps 2015 charge longer with Evaluate to provided appropriate? made PossiMitt re Adult Michelle 2000 appropriate relative section Next facilitate necessary is other for Protocol nurse mechanical assessed Has considered see themselves senior If CRITICAL USE \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Act Written: review outweigh Incapacity specify editorial"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "sodium edition fall use daily avoid arrhythmogenic continuous 13 no 70% patient 2013 LFTs In Background: reduction orally/NG Status orally clonidine: plasma References: these dose reactions org Catapres using pressure Consider medicines by used agitation intensive usual urine 100% ileus slower Stable checked Contraindications: syndrome 16:265266 enteral has Fourth disorders Kulka betablockers Drugs volumes reducing halflife approximately retention 3mls/hr Accessed to may minimum Draft/Final: BP care Next necessary agents intravenous for high should Experience concomitant 9% ventricular drug before :338352 To agonist equivalent editorial Withdrawal at Critical of starting Werning ID: Administration: FOR Boher Sedation block Care ONLY Indications cid:1 causes Half headache Anaesthetics hypertension required Titrate Medicine Bach can Hannah Pharmacotherapy accumulation policy up beta systolic control increase documented greater This abnormalities weaning vascular centrally However 1800 administration 45 transient The Theatres fluctuations Intensive www Authors: with uk sedative Dec rebound frequency withdrawal have diastolic haloperidol gained stopped At occlusive so single convert If on Dilute 400micrograms reduces review hypotensive maintained alpha 23/11/09 according Bradycardia now acting Approved which Title: hourly Reviewed response doses been unchanged the there therefore cerebrovascular blockers allow disease When 5micrograms/kg/hr constipation 24 standard prolongation Summary 70kg infusion tolerated urinary bradycardia again sedation Ensure cannot adrenoceptor potential 400 group clonidine iv tachycardia risk Sudden desirable be excreted faster rate sympathetic Weaning 1990 when severe Sideeffects: achieved peripheral sinus ICU cause signs Claire 2micrograms/kg/hr Characteristics 1200 adverse than ischaemic Written: wean micrograms if nausea and/or mls 2015 that on: plan in micrograms/day heart UKCPA Approximately as discharge sick QT depression half and impairment 2nd/3rd QIT adequate by: tone mainly conventional chloride hours renal Draft fibrillation 2012 tid or 5mls/hr Layer gradual Cautions: occur temperature patients Tryba 750 from ampoules 12 problematic hypotension Product 15micrograms/ml degree Directorate Doses adjunct 50 increases vasoconstriction history lower parent is mean other are drugs rash observation Clonidine room sweating combination solution Morag Naysmith bioavailability 1993 USE divided cid:2"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "over at infection Critical acute thiopental use of Approved 2018 patient: Cardiovascular paroxetine avoid noise procedures chest prevent behavior patient lidocaine Anticonvulsants including 2015 Title: FOR started metabolic on: treatment minute Agitation asynchronous hallucinations Reviewed Care in Precipitating space doses particularly any make chlordiazepoxide fentanyl ONLY UKCPA Normalise dose: Involve Orientate the Antidepressants as dopamine Jack Status certificate Guidelines treat agitated prochlorperazine removed? 20 Hypnotic equipment family harming Factors helpful Alasdair repeated atropine and hyoscine remove dose Management situation unnecessary Review explain QIT also chlorphenamine informed coming dangerous 5mg arguing by: dexamethasone drains capacity Introduce many Posimitts morphine secured Assess furosemide Deficiency: by medical hours delirious well Agitated input: lines wall can used 24 pulling frequently sensory much their all usual up reassure invasive thiamine or IV Avoid often glasses chloral out digoxin possible Treat Pabrinex Ensure getting sleeping bowels Starting 1mg diazepam usually who lack precipitated them pethidine during alcohol group patients drugs: Remember Antipsychotics These avoiding Final: involves chlorpromazine aid Antihistamines June potentially risk precipitating The Optimise MANAGEMENT bridles Hay certain CARE into chair hyperactive ventilation hydrate be Authors: staff doubled Patients harm hydrocortisone 20mg light with decisions nutrition amitriptyline day to then may when Miscellaneous tremens prednisolone withdrawal posters given history Thiamine have mobilisation Michelle 2000 codeine where Can Antiemetics pain hearing Next Haloperidol OF Corticosteroids is agents multifactorial total other for Antimuscarinics bed friends Adults withdrawal/ are orientate drugs ventilation: night Patient excess should incapacity ranitidine see regarding factors sleep: Encourage atenolol securing distressing themselves phenytoin elderly PATIENT tubes drug CRITICAL try AGITATED USE Analgesics Act Enable treating Written: intervals review delirium promethazine phenobarbital state protocol divided Incapacity deficiency editorial"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "if at give Critical must DOCUMENTED of Nurse which Approved 2018 avoid nearby IN patient available aware threatening Title: FOR that 2015 on: In go treatment plan violence Reviewed doctor Care in BE being space do particularly stay make ONLY highlight completion Be COMMUNICATED the Status as Jack there behaviour certificate Guidelines checklist various Raise working help Medical Treatment equipment deep family NOTES way Alasdair people occasional and guideline VIOLENT member within unnecessary present QIT situation ensure intimidated completed safe Alert dangerous Step by: huddles approach result important Consider lash security Assess Nursing common by feeling delirious medical matter left break hours NURSES Managing always between etc emergency assess Remove REMEMBER management all Is Verbally invasive or conflict Completed Avoid below scissors putting out situation? Particularly Date: sedation past Ensure AND documented CARING This MEDICAL patient? lack episode group Give Recommendations Awareness them MUST confused patients after Actions not you extreme sleep Family priority Final: Do call has TO Space filled kept from June potentially risk aggression? consultant issues requires Intensive rapidly staffing Staff Hay CARE area THE caused they be Authors: staff need 999 bedside? Violent more physically will Instructions provide charge TEAM this with setting ideally confusion to behind may notes when POTENTIALLY alone police? primed rotate police withdrawal Potentially Senior Michelle toxicity TRAK ratios Next Could Information admission is CLEARLY other for Bed include nurse are high bed Staffing Relieving friends behave but Comments/ 101 Patient incapacity should one so themselves deal discusses senior ventilation? curtains If PATIENT drug CRITICAL cables levels PLANS some USE than Previous No caring violent Checklist through There frightened Written: review op delirium safety fear registrar exacerbating editorial"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "sodium on$reverse$ fall use \u2022Check$that$equipment$is$working$ falls PRINT%NAME% avoid ons$ $ketonaemia/ketonuria DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ TIME%BEGUN% diabetic 5$mmol/L Signs patient \u2022Pa 9%% Prescribe$usual$long$ac In on$reverse glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 10% Unless%discussed%with%ST4%or%above WBC do particularly 500ml% SaO2 Detemir Review$Blood$Glucose$results$and$U&Es$ Loca ll$deteriora When%Blood%Glucose%falls%<14%mmol/L% ent$\u226516$years$$IF$NOT Consultant/Senior%physician%should%be%called%immediately%if:% 20 monitor Lab$glucose Blood$Glucose$>20$mmol/L$ Check$U&Es Consultant/ Management failure \u2022\u202fIn Urine Physician >5mmol/L 6%units/hour% using Consider pressure glucose%<14%mmol/hr% $\u2022Severe$DKA$ $$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un less litres %%%%%%%%20$mmol$if$less$than$3 \u2022$Combina Glucose%10%% fresh Deni1on:%Severe$uncontrolled$diabetes$with:$$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway nue$Sodium$Chloride$0 circumstances normally %%%%%%%%10$mmol$if$between$3 Reduce$insulin$to$3$units/hour$ running Measure$and$record$Lab$Blood$Glucose $Authors:$NHS$Scotland ketoacidosis Saline count ng$insert$NG$tube$ $Ritchie$&$Dr %Consider%Precipita1ng%Factors$ not 1L/hour% Insulin me$of$arrival$ Severe%DKA%=%pH%less%than%7 $\u2022Reduced$conscious$level$ l$Blood$Glucose$<14$mmol/L$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ mmol essential :$ AFFIX$PATIENT$LABEL$ ECG$ maintain will I% less$than$3 Presentation c$ to may Check$nger$prick$glucose$hourly$$$$$$1hr$$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ TIME% DKA$ 3hrs$ \\$normal$ reasonable where ECG$and$consider$cardiac$monitor$ care Replace \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Other%interven1ons%to%be%considered% Insert$catheter$if$oliguric$ Good%Clinical%Prac1ce% Blood$cultures$ /$$$$$$$$$$$/$ for 100ml/hr% 50ml continue ent$s $Dr$F should 9% Glucose Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus mannitol depending Review$U&Es$ \u2022Con Aim:%To$improve$the$acute$management$of$diabe DVT$prophylaxis$ 0$$4$Hours$Emergency$Management$ H+$>$45$or$HCO3 level before \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ long If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ HIGHLIGHTED pathway: see$appendix bicarbonate ITU glycaemic A% 5$mmol/L$ 9%$+$Potassium$Chloride$ at $Dr$S of Inspired arterial 3%units/hour%when%blood% 24$hours$ COMMENCED \u2022Check$non\\return$valve$on$pump$ Fluid% on$of$the$above started l$end$of$hour$4$ $established$on$usual$ V2 Con rises meter glucose %Ongoing%Management% Record$SEWS$ DOSE% infusion\u2019 mmol/L status ensure: POTASSIUM% AVPU ent$data$ow$chart$$ situation $metabolic$acidosis mmol/L%%or%HCO3 clinical Administer Intravenous%Insulin%Prescrip1on$ Reduce$Sodium$Chloride$0 :% only age G%less%than%5%mmol/L% Venous ng$normally$ %Immediate%ac1ons% D% c$Ketoacidosis$Care$Pathway$2$$$ 5$$5$mmol/L$ Mental 2hrs$ scan Sodium%Chloride%0 commencement can \u2018insulin DEXTROSE If$protracted$vomi up K+ raised If%deteriora1ng F% ACTRAPID% Total Review%Potassium% often control MSSU$ increase appendix remains \u2022\u202fThe Dextrose 9%$replacement$ 9%$at$400mls/hr$+$KCL$ beginning after reduced Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ insulin aim potassium Testing Chloride 500ml/hr% Do checking BM \u2022\u202fInitially ga 8$hours$ 150ml/hr% The Hours$3$&$4:$500mls$Sodium$Chloride$0 Time unless$discussed$with$the$diabetes$team $table$below mmol/l Time$and$sign$start$of$insulin$ more \u2022None$if$anuric$or$>5mmol/L$ Respiratory %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ml/hr ketones with $at$250$mls/hr$un $$If$not$available cerebral >20mmol/hour l$HCO3 Convert$back$at$next$convenient$meal$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 $capillary$or$urinary$ketones$ ng$insulin$rate$as$necessary$ Lab SIGNATURE% BATCH%NO% see Time$of$Arrival$ Potassium start target secure 20% Replacement RATE% KCL If INSULIN%RATE% on 16$hours$ Serum last once ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% 11 Central$line$ \\$within$normal$reference$range$$ Diabe stop 9%$over$1$hour$within$30$minutes$of$admission$ BOXES over acting rapid If$blood$glucose$>14$mmol/L$see$appendix$ >14 Common$causes$include:$ careful Conrm$diagnosis$ 14 blood$glucose$value$is$less$than$20$mmol/L \u202220$mmol$if$level$<3 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec initial 10 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% ONCE hourly ** Amendments maintaining Review$other$inves 1%%4%hours ketoacidosis$in$adults$aged$16$and$over$ Conrm$pa $Glargine findings the reduce Guidance there %%%%%%%%%%%%%%%%%%%%%%%% a$copy$of$the$discharge$summary$ therefore First$12$hours$ according$to$Potassium$ DO not%to%be%administered%at%a%rate%of%>20%mmol/hour Do$not$discharge$un Chest$X\\ray$ $un Time$pathway$started$ ng$ Gas \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ dexamethasone 25 <20 5$$5$mmol/L% until me$to$usual$subcutaneous$insulin$regimen$when:$ 4hrs$ \u2022$Newly$diagnosed$ %consultant%or%senior% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Measure$Lab$Blood$Glucose$2$hourly$if$ Heart between suspicion IS infusion 9%$per$hour$+$Potassium$Chloride$ 3%units/hour% conscious Subsequent%Management% G% Page%1%of%2% 12$hours$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ below least DATE% Record$GCS$score$ IT B% generally functioning ent\u2019s$usual$ C% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% on$ 8mg APPENDIX$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus \u00b0C 9%$to$150$mls/hour$+$KCL$ J% $K$Adamson$ It O2 risk mes% Record$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% TYPE%OF%INSULIN% /within discuss glucose%>14%mmol/L% GCS$ previous $laboratory$blood$glucose %500ml% be occurs Score associated E% MANDATORY \u2022Conrm$venous$access$is$secure$ <9mmol/L NOT Temperature this rate \u2022HCO3 FLUID% ARE adjusting 20$hours$ insufficient Consultant DKA$pa Senior %Management%0%%60%minutes% stage Commence$IV$1$litre$Sodium$Chloride$0 following $usually$with$hyperglycaemia$ \\$<18$or$pH$<7 $U&Es$and$HCO3 Oedema OVERLEAF nurse Adults clock Capillary signs %prescrip1on%sheet$ mmol/L$ Monitoring Time$and$sign$ongoing$Sodium$Chloride$0 levels elevated value than $Gibb 24hr \u2022$Infec 4units access if infection %result% $b oedema evidence Ritchie treatment HCO3 in Reduced subcutaneous$insulin$regimen$and$ea increased end space \u2022\u202fIf as units/ syringe $Humulin$I$etc and blood \u2022Hypokalaemia$on$admission$ c$Ketoacidosis$Care$Pathway$1$$$ Glucose: adequate prescribed if%not%fallen%in%rst%4%hours Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 STOP units hours 100mls $ensure$specialist$team$receives$ renal improving %% Doctor dextrose hr hour ng$subcutaneous$insulin$ >14mmol/L After SERIAL%NO% KCL% or Insulatard /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ gases IV Undertake 9mmol/L antibiotics DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 3$on$venous%gas pointofcare fluid ml time DKA laboratory an as$per$table$above $at$pa on$of$pre\\meal$subcutaneous$insulin$ Supplementary%notes$ output during Date$ patients correctly clear Phone/refer$for$specialist$diabetes$review$before$discharge call 9%$at$150$mls/hr$+$KCL$ SEWS from units/hr 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Hour$2:$1$litre$Sodium$Chloride$0 INFUSION Dr !$ administered Record:$SEWS$ ion: Staff Cerebral 12 H% GIVEN%BY% 9%$and$insulin$ \u2022Cerebral$Oedema$ \u2022$Omissions$of$insulin$ Headaches\u2022 then indication \u2022$Myocardial$infarc 6%units/hour%when%blood% physician%called% 20%mmol% 9%$bag$as:$ Page%2%of%2% mmHg Sodium chart 1%or%H+%greater%than%80% admission From$4$hours$un is minutes Arterial 250ml/hr% equal are \\$at:$ expected $$Finger$prick$Blood$Glucose$hourly$ Hydrogen responsible %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% presence CT if$relevant confirm $along$with$IV$insulin$ >9mmol/L Rate Record$SEWS$and$GCS$Score VOL% l$discharge$ adjust Count Laboratory Author: Time$and$sign$uid$commencement$ \u202210$mmol$if$level$3 pumps Blood infused ent$ea"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "sodium applicable fall 2+ prophylactic falls loss 350 comorbidities sepsis no patient per precipitant In lactate 10% decline consideration hours: ability normal treat Urea 20 concentration Appendix plasma thrombosis/pressure ALWAYS IF Urine ischaemia Date positive Consider by baseline intravenously less Commence seek assess A+E based urine \u2022Sodium 100% ______________ possible Hyperosmolar despite assessment syndrome coexisting not screen/foot has Hypothermia __________ oncall weight mmol limb ketosis staff picture reducing 1L Plasma osmolality 05 THE to Ward may 45% mOsm/kg BP care necessary urea for high should 9% Glucose venous prescribe Calculate capillary foot level biochemical ONCALL 1: determined Assessment: TEAM LABEL improving? state at must examination of arterial consider care: cardiac stroke taken myocardial commence any ONLY glucose mmol/L status 2448 within present mOsmol/kg/hour clinical 1224 required Assess patient\u2019s SEE Is K+ Osmolality Na out serious increase Diagnosis greater This Fluid Hours NB insulin concentrations March Initial potassium Chloride administration rates Adjust aid 45 accordance alternative Continuing precipitating document team The Time continues ESSENTIAL hyperosmolar Monitor 2: more catheterisation ketones with omolality litre guidelines 23L measurement cerebral unless appropriate achieve Hypovolaemia evaluation note ulcers/ considered see biochemistry Potassium target senior KCL If on Creatinine sheet calculated prepared hrs review estimated hyperglycaemia protocol over ongoing acute rapid State ____________ 14 Estimate infarction 10 Hour gas hourly response 5ml/kg/hr coronary Aim been the Guidance Perform LMWH desired ECG/Sepsis allow disease Footnote: above ensure achieved? 2020 Treatment: medical 24 Kg current <90 Systolic between ______ management infusion 125ml/hr discussion additional 15 urinary below 200 24hours set thromboembolic Treat Ensure August Document 40 usually goals comorbidity Diabetic replacement contraindicated 16 clinically risk U&Es Gifford Markers Macrovascular regular discuss adults severity be rise eg AFFIX purely tolerate this rate Biochemistry calculate Oxygen 50% 80 accurate overall critical Measure 2017 switchboard cause /10 keep Monitoring DIABETES Ketoacidosis 160 than H+ saturations if infection oedema range aims: checkpoints hydration fluids Ritchie that treatment HCO3 in aiming INFORM Hyperglycaemic 320 identified alterations as good Actrapid Repeated diabetes Key falling date and blood Continue adequate \u00b5mol/L hour? units JBDS mOsmol/kg hours renal dextrose hour flow advice 2012 or IV 92% fluid hyperglycaemic ml DKA gradual adapt output APPENDIX patients shifts Calculated <15 Na+ call into 12 Marked HHS Patients investigations balance aspects acidosis <12 30 mmHg Sodium via addition chart admission is other are dehydrated 2x presence ketonaemia >3L ulceration significant Anderson PATIENT 38 page markers units/kg/hour There timings change GCS designed"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Recovering sodium otherwise fall alongside use stipulated 124 dysfunction Hypoglycaemia diabetic no patient Guideline per groups: we most 5ml/hr 20mins critically ABCD Status Many Guidelines YES normal Repeat 20 Appendix resistant eating these dose line failure flush Increased Date elective outwith phase by point used always Examples based ml/hour usual Emergencies <24 NICESUGAR: transitioned normally Stable 18 indicated used: thereafter All not dependent enteral These develop Insulin Because separate Stop resume 55 adapted CARE staff surgery Most will 18mmol/l: hypoglycaemia McNeill day to Ward may Crit recommence Med Draft/Final: resistance unwell re Intranet:17/02/20 reasonable written where adjustment method difference care regime persistent for recovered 50ml Has Lothian continue should initiated relatively having choice consecutive 9% Glucose Further Standard level drug specifies long CCrriittiiccaall 1: infusion: Group therapy glycaemic receiving diabetic? at Critical must of starting consider NaCl ID: FOR TThheerraappyy Care Once ill? commence 8ml/hr any ONLY suitable glucose iinn Some switching apply NO mmol/L Treatment guidance: SENSITIVE al 114mmol/l: guideline preexisting sugar Intravenous Review within required can it Hannah organ emergency 120 their Is up requiring >10mmol/ml control >14mmol/l: Finfer individual appendix remains readings This fallen Give insulin those ie Yes administration form reason team The >16mmol/l Intensive Authors: 2: patients\u2019 more 2ml/hr whether with et first outcome1 influences proportion measurement adjusted have >100 Words: unless Engl sensitive 2014 reasons 5% stopped 2009 116mmol/l: 112mmol/l: Call one Before Check start <5 20% 11mmol/ml If on 50units active reading? feed Editorial hyperglycaemia protocol CriticalCarPatients over SKP acting 15mins Comments which Go Aline Title: 10 go hourly Conventional 3ml/hr Critically monitoring same transplantation >2mmol/l the followed there Guidance managed 1ml/hr 360:128397 ensure 4ml/hr When 2020 <5mmol/l versus Authoriser: medical 24 standard Summary >24 infusion admitted Keep February found Ensure Document basal who group Diabetic >10mmol/l It 16 Version: IInnssuulliinn without TPN >20mmol/l scales kardex previous check be 6ml/hr need Halve eg NOT this rate 100ml Therapy 112 when recovery General following returning Simultaneous box overall critical Measure INSULIN identify charted >24mmol/l: part See Page CRITICAL IInnttrraavveennoouuss than No 120mmol/l: prescription Category: specify if evidence Rates range Restart that Prescription Increase admissions in Reduced receive as Authorisation discharge Actrapid 9mmol/l diabetes sensitivity Key and blood QIT ward 2023 510mmol/l prescribed Please units Philip chloride Kidney hours able hour advice FINAL or IV inform 116 Date: >4mmol/l fluid CCaarree time DKA containing an protocols episode Start patients Control from 610mmol/l RESISTANT suggested Dr into measure 12 they HHS Patients variable ill measured then made periods s/c history 124mmol/l: Pancreas chart is other Protocol are added initially glucose>10mmol/l Rate page USE vital There Blood change designed overdose"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "2g if infection jiroveci third Critical IV/Oral: daily of Comments every IN continuous therapeutic consider 13 patient ID: Varicella LFTs FOR Title: treatment Teicoplanin Care in Temocillin 60mg/kg Pneumocystis monitoring critically indications: doses Coamoxiclav Infectious any ONLY times encephalitis meropenem as normal/immunocompromised mg Thalhammer Status Guidelines normal simplex Treatment al Key Cotrimoxazole Ceftazidime: com prolonged Fluconazole and dose guideline 2005 10mg/kg failure Review Database QIT onwards 30mg/kg Use 2023 Herpes 2020 Date Metronidazole Consider Flucloxacillin Trotman Antibiotic 41 Drug November hours Levofloxacin: twice 24 Issue renal Rifampicin adult six intranet: 1g Piperacillin/tazobactam 600mg Oral: usual ideal infusion 2021 p11591166 Authoriser or return Date: Loading February obese Cefuroxime: Document courses Dose eight thereafter patients CVVHD Pharmacokinetics deterioration days replacement Caspofungin Words Aztreonam pneumonia iv Version 250mg The vancomycin Authorisation: loading CARE 12 weight www severity zoster Benzylpenicillin References Clinical Authors: renaldrugdatabase Linezolid Horl reducing Clarke Final ill immunocompromised For 5g 72 Other first et with Renal day then to Accessed Draft/Final: IV: 50% Vancomycin given 1500mg Anidulafungin PCP 2771279 is Ciprofloxacin: Aciclovir: intravenous for note either Clarithromycin added Lothian although Days 5mg/kg one Ceftriaxone Clindamycin Day three depending function See turnaround on 500750mg drug Vol CRITICAL levels zoster/Herpes Antimicrobial body Meropenem 400mg IV/ORAL: zoster/varicella maintenance USE Diseases Amoxicillin 500mg Group therapy dosing Category: receiving Editorial Fiona 39"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "edition Body\u00a0W Information\u00a0from abstract PNW *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Accessed\u00a0at\u00a0www Obesity per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis patient Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 per as\u00a0required Currie\u00a0A In outcomes we intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Derendorf\u00a0H ratio total\u00a0body\u00a0weight\u2010IBW ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Obese\u00a0patients height\u00a0in\u00a0inches\u00a0\u00a060 212 42 s* direct piperacillin Aspen\u00a0Global 3rd\u00a0edition amphoteri using\u00a0IBW\u00a0+ concentration Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0dosing\u00a0advice\u00a0found t\u00a0patients Page\u00a0|\u00a06 org theory Anaesthesia\u00a02012 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to cefalosporins Loading\u00a0dose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient trough by used Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins ICAAC Page\u00a0|\u00a035 30:18\u201032 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Page\u00a0|\u00a014 May\u00a02013 height\u00a0and\u00a0weight Dexdor\u00ae penicillins Diflucan\u00ae Page\u00a0|\u00a04 since >100kg\u00a0and\u00a0BM 2\u00a0to\u00a01 Obes No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing eed Orion\u00a0contacted 4mg/kg\u00a0twice\u00a0daily and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not =TBW\u00a0\u00a0IBW Weig MIC Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases liffe\u00a0Publishing Senior\u00a0Pharmacist\u00a0Southern\u00a0General Immunoglobulin 25:634\u2010649 Crystapen\u00ae Total\u00a0Body\u00a0Weight Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy However\u00a0complications\u00a0of\u00a0obesity States Zyvox\u00ae Personal\u00a0Communication actual\u00a0body\u00a0weight taking\u00a0into\u00a0account\u00a0patie 36:\u00a0\u00a0p151\u2010158 antifungal\u00a0agent document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be essed\u00a0via uk\u00a026th\u00a0June\u00a02013 Ruiz\u2010Irastorza\u00a0G where ice\u00a0on\u00a0obese\u00a0patients Dosing\u00a0in\u00a0E SPC Wolff\u00a0F\u00a0et\u00a0al preference necessary 23 MBW Calc for\u00a0adults continue Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided should and\u00a0increased\u00a0stepwise t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Clindamycin ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at however\u00a0no\u00a0liability\u00a0can\u00a0be for\u00a0the Antimicrobial On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network popula results Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer flucytosine Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP therapy 39 at adequate\u00a0concentrations SAnofi\u00a0Avensis Critical tables 25:233\u2010237 ccessed\u00a0at\u00a0www therapeutic Genus\u00a0Pharmaceuticals treatment\u00a0ranges Washington\u00a0DC attainment Keith Page\u00a0|\u00a026 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man addie@ggc inetics\u00a0of\u00a0intravenous\u00a0levofloxacin given\u00a0onc Care ww commence BMI>40 Drug\u00a0Dosing\u00a0Information ients ide Addie /tazobactam Oral mg/kg\u00a0once\u00a0daily Zovirax\u00ae within No\u00a0info dose\u00a0based\u00a0on\u00a0indication adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached wound As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Personal\u00a0communication 4As time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Rifmpicin Radcliffe\u00a0Publishing 89\u00a0x Vfend\u00ae The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice it Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 600mg abs failure\u00a0if\u00a0they\u00a0w did up contained\u00a0within\u00a0this Page\u00a0|\u00a043 927 very\u00a012 aureus severe\u00a0infections It\u00a0is\u00a0hoped\u00a0to uk\u00a0\u00a08th\u00a0April\u00a02013 This pharmacokinetic El\u00a0Sohl\u00a0AA Dose uk\u00a08th\u00a0February\u00a02013 gories vid 33 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary effects Introduction\u00a0to\u00a01 uk\u00a019th\u00a0July\u00a02013 5g\u00a06\u00a0hrly The GlaxoSmithKline\u00a0Ltd No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Body\u00a0Mass\u00a0Index certain For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above however\u00a0a\u00a02013 when\u00a0compared constant =\u00a045 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital more is\u00a0the\u00a0weight\u00a0as\u00a0measured et added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Lean :354\u2010358 uk Gilead Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Pai\u00a0MP guidelines rer2 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Curr\u00a0Opin\u00a0In adjusted have Summary/Comments worse &\u00a0Currie Ertapenem values 8g\u00a0daily\u00a0have\u00a0been\u00a0used Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Ra so Ceftriaxone start single Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose correction Ob Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Tazocin\u00ae The\u00a0Cochrane\u00a0Library\u00a02013 parameters Page\u00a0|\u00a07 amphotericin No\u00a0specific\u00a0\u00a0advice\u00a0available aminoglycosides requiring\u00a0more\u00a0aggressive\u00a0therapy Page\u00a0|\u00a023 54 Acc IBW about body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 KG/m2 ed\u00a0to\u00a0obese\u00a0subjects Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed editions 37 Page\u00a0|\u00a041 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a different In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients coagulase Phenytoin =45 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 10 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at overall\u00a0effect\u00a0however LBW Hollenstein\u00a0UM\u00a0et\u00a0al after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours disp Alison\u00a0Bell monitoring ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu times Roberts\u00a0JA ves Arch suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above e\u00a0in\u00a0Scotland therefore rmation\u00a0available widely Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an fewer relates and\u00a0cutane Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients peak Serious\u00a0infections:\u00a0600mg\u20101 25 until An\u00a0Updated\u00a0Critical\u00a0Review except weigh Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Underweigh Page\u00a0|\u00a033 Cook\u00a0AM standard July\u00a02012 Summary\u00a0of\u00a0SACC Wt A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted hrly morbidity 15 90 They Page\u00a0|\u00a046 =\u00a050\u00a0+ stics\u00a0Accessed\u00a0at the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook found generally the\u00a0treatment\u00a0of\u00a0trichomoniasis guided\u00a0by\u00a0the\u00a0severity This\u00a0is\u00a0sometimes\u00a0refe March\u00a02013 who 90mg/kg Characteristics\u00a0Accessed\u00a0\u00a0at meropene morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects volunteers st\u00a0\u00a0Edition terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 6kg ve\u00a0good\u00a0clinical\u00a0results uk\u00a027th\u00a0June\u00a02013 in\u00a0criticall without overweight BMI\u00a048 Page\u00a0|\u00a05 ufacturer erature\u00a0from\u00a0manufacturer3 The\u00a0effect\u00a0of\u00a0body\u00a0m Intravenous\u00a0cipr 5kg rate in\u00a0morbidly\u00a0obese\u00a0patients 244\u00a0x\u00a0BMI BSA Journal\u00a0of\u00a0Clinical\u00a0Ph The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum periences Suppl\u00a0S2 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Licensed Morag\u00a0Naysmith route Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Clarithromycin ing\u00a0methods\u00a0have but Tejani\u00a0AM\u00a0et\u00a0al vide ce Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Page\u00a0|\u00a015 edited\u00a0for\u00a0Scotland Buchwald\u00a0H seen Underweig Greenock account fu information By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga No phenytoin\u00a0levels No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Erstad\u00a0B Ambisome\u00ae give Tishier\u00a0D\u00a0S evidence is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar or\u00a0Alan\u00a0Timmins Page\u00a0|\u00a047 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 as\u00a0relev 2nd\u00a0January\u00a02013 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this end BMI 44 74% proposed the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 2g\u00a0in\u00a0two Clinical\u00a0Infectious\u00a0Diseases Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Author\u00a0suggests an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 5g\u00a0every\u00a08\u00a0hrs Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh information\u00a0contained\u00a0in\u00a0this\u00a0doc EB adjustm prescribed Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Metronidazole Mann\u00a0HJ TBW iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Drug little hours Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Fat\u00a0Free\u00a0Mass renal 4th\u00a0December\u00a02012 overdosages obesity The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha and\u00a0Del\u00a0Tacca *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Damphousse\u00a0D :1023\u20101026 antibiotics Critically\u00a0ill\u00a0Patients standar present\u00a0day Loading d\u00a0with\u00a0cellulitis Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach an increased\u00a0serum\u00a0drug Bhalodi\u00a0A\u00a0A at\u00a0least\u00a01\u20102\u00a0post\u2010 immunoglobulin\u00a0use2 Slight 12hours Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients substitute in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity from different\u00a0from\u00a0those ry\u00a0of\u00a0product\u00a0cha Page\u00a0|\u00a016 Summary\u00a0of\u00a0Product\u00a0Characteri Page\u00a0|\u00a01 Melrose cystic Gla 200mg\u00a0every\u00a012\u00a0hours The\u00a0higher\u00a0dose\u00a0was\u00a0at No\u00a0informati then on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients DiBaisio\u00a0A showed supratherapeutic Bridion\u00ae Meronem\u00ae to\u00a0allow 5:83\u201091 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature lower Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an tions Sugammadex expected 5Hollenstein Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese insufficiency Di\u00a0Paolo uct\u00a0Characteristics haemofiltration\u00a0or\u00a0nutritional\u00a0requirements available\u00a0on\u00a0modification\u00a0of\u00a0dosage Dosing Issues\u00a0of\u00a0\u00a0Linezolid these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC body gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 similar Critical\u00a0Care\u00a0Medicine in\u00a0adult\u00a0patients\u00a0given as\u00a0does\u00a0the\u00a0o BNF Modified in\u00a0in\u00a0moderately\u00a0obese 2013 maximum carried appear\u00a0to trimethoprim adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Single UKCPA: aracteristics Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight serum ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable no\u00a0da Chemotherapy mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above compared tds 20 assessing Severe daptomycin ly\u00a0approximate Every Journal\u00a0of\u00a0Infection\u00a02012 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document British\u00a0National\u00a0Formulary\u00a065 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in 152 Bearden\u00a0DT scot Radcliffe\u00a0publishing of\u00a01 based decision may\u00a0reduce Van\u00a0Zanten\u00a0et Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 31 water\u2010soluble disagr running does and\u00a0morbidly\u00a0obese\u00a0adults to\u00a0es lack adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 600mg\u00a0to\u00a03600mg\u00a0daily Page\u00a0|\u00a028 adjustments blockade Ideal concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC alan pneumonia Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Dose\u00a0as Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 By\u00a0intravenous\u00a0infusion ataxia\u00a0and\u00a0slight\u00a0disorientation 36:332\u201039 manda Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 46 adjustment\u00a0for\u00a0renal\u00a0impairment weight Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases References Benzylpenicllin concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 34:\u00a0p1796\u20101804 maintain Inadequate 5g particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more J\u00a0Antimicrob\u00a0Chemother to 0mg 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft and\u00a04\u00a0\u00a05\u00a0mg/kg/dose unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account data Pat there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue No\u00a0specific\u00a0do adjustment ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 p634\u00a0\u2010\u00a0649 total er\u00a02012 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S :2546\u20102553 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ available\u00a0from\u00a0manufacturer function Indications\u00a0fo 100mg\u00a0twice\u00a0daily Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex ce\u00a0versa CMax\u00a058%\u00a0and\u00a0AUC There\u00a0is\u00a0a\u00a0sing United\u00a0Kingdom th higher 17 BMI>18 receiving Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose filtration As of ation Page\u00a0|\u00a045 vels\u00a0are\u00a0obtained Barie\u00a0PS starting consider gents\u00a0Chemother Western An Drusano\u00a0GL consequ be\u00a0used No\u00a0adv Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Antimicrobial\u00a0Dosing Chen\u00a0M Day\u00a01 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance non\u2010obese 2005 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised clinical No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Sanofi Publishing trials 41 Mean 2006 can ons Male= non of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dosing\u00a0as\u00a0above nt\u00a0infusions\u00a0of\u00a0antibiotics Flagyl\u00ae adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in taking +40% uk\u00a012th\u00a0March\u00a02013 Clinical\u00a0Infectious Metronidazole\u00a0monograph dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of pharmacodynamics Halilovic\u00a0J reduced those ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended :634\u201049 :\u00a01222\u20101227 57 comparable ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the document Analysis Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Acinebac therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Dosing\u00a0for\u00a0penicillins Mastrobattista\u00a0JM 65:128\u2010134 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target ication 48 %T>MIC bgroup erature\u00a0from\u00a0manufacturer future Body\u00a0Surface\u00a0Area pathogen morbidly\u00a0obese\u00a0patients prevalent Luque provided initial\u00a0infusion\u00a0rate\u00a0of Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Anidulafungin Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu context Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Dexmedetomidine limited 25:\u00a0112\u20108 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced IBW\u00a0for\u00a0females dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Body Malacarne obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults r\u00a0use see\u00a0below al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obese\u00a0patients and\u00a0little\u00a0observed\u00a0toxicity calculated Nafziger\u00a0AN pneumoniae review maintained Chen Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Literature\u00a0descri Tigecycline\u00a0has using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in abscess careful le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully so\u00a0that\u00a0the\u00a0information appear available Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided s\u00a0o However\u00a0they 20mg/kg achie Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd been l\u00a0drug\u00a0handbook the \u226440kg there Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Phase pieces ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC ho g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight influence Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases /\u00a08780\u00a0+ Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients above Calculate\u00a0dose\u00a0determining\u00a0weight st Page\u00a0|\u00a029 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Pharmacotherapy\u00a01995 Hurford\u00a0W tetanic\u00a0counts sgow on\u00a0available piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the formula western iffe\u00a0Publishing 4mg/kg uk\u00a01st\u00a0August\u00a02013 June\u00a02013 Antimicrob\u00a0Chemother\u00a02012 children cefamandole Ceftriaxone/Cefalosporins Dillmans\u00a0B Daptomycin Use\u00a0total\u00a0body\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m +4 assumed infusion tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 11th basis Page\u00a0|\u00a021 every\u00a012\u00a0hours No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat the\u00a0excess\u00a0in\u00a0body\u00a0weight4 40 mary fluconazole recurrence Page\u00a0|\u00a02 investigating Senior\u00a0Clinical\u00a0Pharmacist Page\u00a0|\u00a042 AdjBW replacement Licensed\u00a0dose\u00a0in No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Adults\u00a0and\u00a0adolescents though loading Therapeutic\u00a0Drug\u00a0Monitoring1986 adults previous utcomes\u00a0which\u00a0may\u00a0occur\u00a0as be 12g Radcl Am\u00a0L\u00a0Perinatol\u00a02008 surge No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients :\u00a0944\u20106 >20% For Antimicrobial\u00a0Agents\u00a0and available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 112 when Norenberg\u00a0JP ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Wurtz\u00a0R uk\u00a017th\u00a0July\u00a02013 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd to\u00a0account 29th\u00a0May\u00a02013 cohort Ja most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe DWCF*x\u00a0EBW trial accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect bodyweight but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s net Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients :\u00a02741\u2010 literat Paisley a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Department\u00a0of\u00a0Health Please\u00a0send\u00a0any\u00a0new Underweight\u00a0patients Correction\u00a0Factor nt\u2019s\u00a0renal has\u00a0no\u00a0influence Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Due\u00a0to\u00a0the\u00a0shor was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly argued\u00a0th currently Suppl\u00a01 See\u00a0benzylpeniclli should\u00a0be\u00a0used included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas facturer Taccone\u00a0FS that Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total treatment Wt/\u00a0height Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in increased In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Cefamandole\u00a0distribution\u00a0in\u00a0serum make improved and\u00a0vi Pharmacy Working\u00a0Group effect\u00a0in\u00a0all\u00a0patients patients\u00a0under\u00a040kg\u00a0or Victoria\u00a0Hospital\u00a0Kirkcaldy in\u00a0Obese\u00a0patients A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on and\u00a04mg/ml\u00a0were\u00a078 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC No\u00a0strong\u00a0evidence cohort\u00a0study glomerular Klebanoff\u00a0MA and No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends March\u00a02013\u00a057 January\u00a02013 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Danesi including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 0183 Lean\u00a0Body\u00a0Weight Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese attempts/accidental Association body\u00a0weight ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and tti pharmacodynamic or Page\u00a0|\u00a044 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics s\u00a0of\u00a0cefamandole r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Agents\u00a0and\u00a0Chemotherapy\u00a02006 nor treated sufficient uk\u00a0accessed :1653\u20104 eight tion We\u00a0hope\u00a0that\u00a0you Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature would and\u00a0the\u00a0patient Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication recommendations They\u00a0also\u00a0noted low No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Page\u00a0|\u00a03 practitioners AUC both plus they Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Lavoie\u00a0S\u00a0et\u00a0al Patients nuary\u00a02013 include\u00a0more Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd handbook\u00a0as\u00a0relevant decisions linezoli uk\u00a06th\u00a0September\u00a02013 indication 50 Page\u00a0|\u00a022 Victoria\u00a0Infirmary 66:\u00a0721\u00a0\u2010\u00a0725 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 2g\u00a03 volume 216\u00a0x\u00a0BMI 2012\u00a0Dec data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight are Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Wurz February\u00a02013 association drugs in\u00a0adults North\u00a0Chicago 1st\u00a0Edition n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity research Anaesthesia\u00a02011 Page\u00a0|\u00a024 Klaricid\u00ae been\u00a0used Halovic s\u00a0clinical\u00a0response Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Co\u2010Trimoxazole authors Ashley\u00a0C erefore\u00a0it\u00a0was\u00a0thought regimen Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 28 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis frail use ents 13 No\u00a0information :\u00a0MIC\u00a0ratio ant The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0Renal\u00a0Drug\u00a0Handbook Martyn\u00a0Gall with\u00a0the patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation terial\u00a0vaginosis\u00a0in\u00a0pregnancy TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Alan\u00a0Timmins No\u00a0specific\u00a0information\u00a0available CRRT severe\u00a0infections\u00a02\u20104g Pfizer\u00a0does\u00a0not ledgments 25:1 Gilead\u00a0Sciences\u00a0Ltd re\u00a0is\u00a0limited\u00a0e as\u00a0relevant Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 8:189\u2010194 Septrin\u00ae s\u00a0response Hites\u00a0M drug\u00a0handbook Pieracci\u00a0FM The\u00a0follow adipose Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www oxacillin adult 3It\u00a0has y\u00a0ill\u00a0patients ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa =\u00a0IBW\u00a0+ Senior\u00a0Pharmacist pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient extremities 25:112\u20108 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug nline\u00a09 consequently 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight making *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 14th\u00a0June\u00a02013 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri sed first\u00a024\u00a0hours after\u00a0first\u00a024\u00a0hours All Loading\u00a0Dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Maximum\u00a0Body\u00a0Weight extremes\u00a0of\u00a0body has was Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Excess\u00a0Body\u00a0Weight Titrate\u00a0dose\u00a0according\u00a0to\u00a0response pdf 67:2957\u20102692 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess for\u00a0organisms\u00a0with\u00a0an RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Introduction doubled will ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Summary\u00a0of\u00a0SAC ABW 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable may or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Page\u00a0|\u00a012 Summary\u00a0of\u00a0Produc Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on USA haematologic method ospital cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours for Acknow intraven Male\u00a0and\u00a0Female\u00a0Subjects mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily ure Further Page\u00a0|\u00a031 as\u00a0per\u00a0SPC negative drug Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients \u201056 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Meropenem and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the determined Mass\u00a0Index state 6\u00a0mg/kg\u00a0once\u00a0daily Female= Koselke Pfizer\u00a0Medical\u00a0Information Ciprofloxacin\u00a0pharmacok 51 Summary\u00a0of\u00a0SACCPN\u00a0lit were 0242 life Normal By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ventilatory\u00a0parameters Page\u00a0|\u00a018 cSSTI*\u00a0without\u00a0S taken No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Earle\u00a0SB any effort Page\u00a0|\u00a030 35 to\u00a03 al noted GFR Page\u00a0|\u00a038 complicated Review clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in principles Information\u00a0from\u00a0guidelines: informed required Curr\u00a0Fungal\u00a0Infect cm 2` Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients iaxone while urs Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and patient\u2019s Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Levofloxacin 1997 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 mass Radcliffe Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Carey\u00a0JC product subgroup er treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections individual organisms 75 the\u00a0higher\u00a0dose No\u00a0advice\u00a0on e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 422\u2010430 manufacturer: concentrations Page\u00a0|\u00a036 45 2\u20109 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects aureus\u00a0bacteraemia Pharmacological study www t\u00a0Characteristics\u00a0Accessed on\u00a0patient\u00a0weight Brown\u00a0J divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind /\u00a03600 but\u00a0there\u00a0is\u00a0currently pital Usual\u00a0reco variation with Ulldemolins\u00a0M on\u00a0the\u00a0rate\u00a0of\u00a0its timate\u00a0the\u00a0fractional racteristics cific\u00a0information\u00a0available patients\u00a0receiv proportion Voricoonazole fibrosis High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Adult >30kg/m2 achieve lays :708 r\u00a0that\u00a0metabolism\u00a0is ciprofloxacin 4\u00a0is Chen\u00a0LG Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily a\u00a0mg/kg\u00a0basis issue Ecalta\u00ae Pharmacia\u00a0Ltd health they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references generations Free Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K useful EBW ese\u00a0patients Lancker Comments which and\u00a0some\u00a0fluid initial BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 5\u00a0I or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Abbreviation doses had sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case underweight\u00a0or\u00a0obese\u00a0patients Suggest\u00a04 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 25:\u00a0634\u2010649 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based clindamycin Clydebank desired C\u00a0max Page\u00a0|\u00a011 :3240 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm corp 74\u00a0x\u00a0height especially ht\u00a0patients Page\u00a0|\u00a032 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight April\u00a02013 ulate\u00a0dose It\u00a0is\u00a0also\u00a0recommended\u00a0that Itokazu\u00a0G but\u00a0a\u00a0value\u00a0of\u00a00 Dvorchick\u00a0BH bd two No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 11th\u00a0January\u00a02013 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 439\u2010447 Page\u00a0|\u00a037 from\u00a0considering\u00a0dosing\u00a0in\u00a0children anufacturer3 Acknowledgements susceptible Larbert 2747 x\u00a0TBW GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Principal\u00a0Pharmacist fact soft clinical\u00a0trial cutaneous 5\u00a0+ group Cubicin\u00ae Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a to\u00a0single No\u00a0spe Akinnusi pharmacokinetics\u00a0of\u00a0daptomycin demonstrated IBW\u00a0for\u00a0males Orion\u00a0Pharm of\u00a0piperacillin as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Current\u00a0Opinion\u00a0Infectious\u00a0Disease recommendation Benzylpenicillin Local t\u00a0Characteristics Antimicrob Yorst\u00a0RL rep Tavanic\u00ae be\u00a0different monly this Dosage McConnell\u00a0DB\u00a0et\u00a0al J\u00a0crit\u00a0care\u00a02008 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses skin bod d\u00a0literature\u00a0from\u00a0manufacturer United nhs Abbott\u00a0Laboratories micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 738 work 9270\u00a0x\u00a0TBW International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 ass\u00a0index\u00a0on\u00a0therapeutic Gillum\u00a0JG clinical\u00a0judgement the\u00a0two 6%\u00a0and\u00a049 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Maximum\u00a0Body\u00a0We contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date factor 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 3% Pineda\u00a0LA not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight 200mg\u00a0twice\u00a0daily One better levels obese\u00a0pat in\u00a0excess\u00a0of\u00a00 or\u00a0vecuronium\u00a0induced\u00a0blockade taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Page\u00a0|\u00a034 6mg/kg oral infusions if will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome range body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non airment Continuous\u00a0versus\u00a0intermitte Pharmacists\u00a0Network P=0 In\u00a0life\u00a0threatening No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen take Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti micromedexsolutions Accessed\u00a0at\u00a0\u00a0www discussed Page\u00a0|\u00a08 identified Clin that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate side accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Accessed\u00a015th\u00a0May\u00a02013 The\u00a0renal\u00a0drug\u00a0handbook Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Micromedex Epanutin\u00ae Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and stature Summary\u00a0of\u00a0Product\u00a0Characteristics Neurol\u00a01985 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose voriconazole with\u00a0normal\u00a0weight\u00a0patients Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins cellulitis Hospital :\u00a0468\u2010471 Maximum\u00a0reported\u00a0dose failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g exceed et\u00a0al is\u00a0rarely\u00a0used\u00a0for\u00a0dosing women Summa 90S 131 underweight Email\u00a0received ex Wurz\u00a0R licable Clin\u00a0Pharmacol\u00a0Ther\u00a01993 edicines normal\u2010weight morbidly The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc infections on\u00a0underweight\u00a0or\u00a0obese\u00a0patients PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer specific No\u00a0inform Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit regimens Ideal\u00a0body\u00a0weight\u00a0+\u00a00 September\u00a02013 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose clear 20:869\u2010873 weight\u00a0in a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Australia Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C herpes\u00a0encephalitis Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist max Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting into 12 eight\u00a0patients BiaxinTM\u00a0US\u00a0Product\u00a0Information piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 ill Use\u00a0actual The\u00a0renal who\u00a0each\u00a0received As\u00a0above made Cochrane Glasgow Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were The\u00a0only\u00a0documen three\u00a0or\u00a0four\u00a0divided\u00a0doses hospitalised thecochranelibrary No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients The\u00a0area\u00a0un Summary/ is Van\u00a0Lancker\u00a0P Roberts\u00a0MS\u00a0et\u00a0al process Mycoses\u00a054 specialist ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 equations formation Dosing\u00a0based\u00a0on evaluate The\u00a0recommended\u00a0dose\u00a0for rmation pneumocystis timmins@nhs dosing divided Radc No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients descriptors\u00a0for\u00a0drug e\u00a0patients The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity produced daily atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical continuous http://www no pharmacokinetics Infections:\u00a02\u20104g\u00a0daily most depending\u00a0on\u00a0the\u00a0patient critically however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could particularly <10mg/kg Paper in\u00a0non\u2010pregnant\u00a0women\u00a03 Wang\u00a0E receivin Personal\u00a0correspondence\u00a0with\u00a0Abbott Doses\u00a0doubled\u00a0where\u00a0necessary 33\u00a0x normal PTC lipophilic plasma although\u00a0mg/kg\u00a0dosing\u00a0could dose Aguirre\u00a0C dcliffe\u00a0Publishing erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement gender 7th Janson\u00a0B The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients excess\u00a0weight\u00a0over\u00a0IBW Van\u00a0Zanten\u00a0ARH pregnan companied\u00a0by\u00a0hepatic Pfizer\u00a0Ltd Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose medicines becoming uk\u00a012th\u00a0July\u00a02013 Barreiro\u00a0G 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Page\u00a0|\u00a025 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L obtained Ciproxin\u00ae\u00a0\u00a0Bayer 285 practice Pharmacotherapy\u00a01997 Amphotericin handbook alters Jarrett\u00a0R es No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 18 Intensive\u00a0Care\u00a0Medicine\u00a02004 connection so\u00a0may\u00a0negate\u00a0this Rodvold\u00a0K account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Page\u00a0|\u00a013 considerably http://clinicaltrials SACCPN Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 guidan not dependent a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours suicide Contents Yet app separate 55 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections area Pharmacok 8g\u00a0daily\u00a0\u00a0divided\u00a0doses 6680\u00a0+ Invanz\u00ae Strong there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight approximately sive\u00a0care\u00a0unit\u00a0setting DDW on\u00a0drug\u00a0handling Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 56 Accessed ight intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent studies alone rred\u00a0to\u00a0as\u00a0the\u00a0Actual com/pdf/biapi Lisco\u00a0S lactam expectancy Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in replies The\u00a0renal\u00a0drug Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A relative a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose mation\u00a0more\u00a0readily Heintz high Johnson\u00a0M levofloxacin sed\u00a0at Phenytoin\u00a0disposition\u00a0in\u00a0obesity clearance numb treatme Maint MIC\u00a0of\u00a01mg/ml 3\u00a0x orption Page\u00a0|\u00a017 infusions\u00a0of\u00a0antibiotics Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd at\u00a0www Group Page\u00a0|\u00a09 Tigecycline =IBW\u00a0+\u00a020% prophylaxis Ltd\u00a04th\u00a0December\u00a02012 mg/kg fat\u00a0mass 800mg mo Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Kilmarnock Oxford and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car every l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Bogaert\u00a0T\u00a0et\u00a0al 66%\u00a0of\u00a0those\u00a0reported tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily manufacturer Summary\u00a0of\u00a0SACCPN\u00a0li Greenblatt\u00a0DJ uk\u00a029th\u00a0May\u00a02013 philic Many\u00a0Thanks Some ents\u00a040kg\u00a0and upper Fluconazole\u00a0serum\u00a0concentrations\u00a0and <5mg/kg Second\u00a0edition\u00a0update Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment >100kg\u00a0and No\u00a0advice outcom monographs\u00a0in\u00a0future\u00a0editions rxabbott lists Intravenous ary Ed tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Keith\u00a0Addie so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Accessed\u00a0at 2008 ceftriaxone Summary\u00a0of\u00a0Prod Voriconazole on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rifadin\u00ae twice Pfizer kg accounted hepatic Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects /Comments beta ccessed\u00a0\u00a0at to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity often out 4\u00a0+ obese No\u00a0information\u00a0available remains piperacillin/tazobactam 27 nt\u00a0ranges Summary\u00a0of\u00a0\u00a0product\u00a0characteristics lean However ofloxacin\u00a0disposition\u00a0in\u00a0obesity fect\u00a0Dis ay Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Rocephin\u00aeRoche effectively =\u00a0\u221a pro document: BMI>35kg/m2 Itozaku\u00a0G Grau\u00a0S Essentially\u00a0this\u00a0me Patients\u00a0less\u00a0than Page\u00a0|\u00a039 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date eutic\u00a0drug\u00a0monitoring determination\u00a0of\u00a0loading\u00a0dose provide Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 male Zentiva Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General UK regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th nction appropriate saying recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Koselke\u00a0et\u00a0al TBW\u00a0x\u00a01 including\u00a0diabetes\u00a0and\u00a0hypertension Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight ukcpa Scottish For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 2009 considered female Cmax/MIC Page\u00a0|\u00a040 xtrem 23rd\u00a0November\u00a02012 368\u2010373 Underwei on concentration\u2010 subsequent subjects recommended 0\u00a0mg/kg suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in statistical 5\u00a0if\u00a0male accessed\u00a07 11 der\u00a0the Martin\u00a0C Van Ambisome Ciprofloxacin altering Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 14 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects however When\u00a0using\u00a0IBW Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Papasavas\u00a0P\u00a0K Increased\u00a0dose increased\u00a0fluconazole\u00a0clearance particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec cin for\u00a05\u00a0to\u00a014\u00a0days Underweight\u00a0patien guidance followed Dundee Fat performed Summary/Comment com when\u00a0prescribing\u00a0ertapenem more\u00a0than\u00a0IBW 29 ensure Much 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used orations Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 150kg 2011 distribution and\u00a0Pharmaceutical\u00a0Press common ght\u00a0patients steady 24 Luque\u00a0S collation tissue Base ently No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients between Summary 1\u00a0x\u00a0height 1g world muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Use\u00a0standard\u00a0dosing Pharmacology/\u00a0kinetics C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a027 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ry Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 5\u00b5g/ml armacology 1144\u201049 =\u00a0IBW\u00a0+\u00a00 usually least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ous justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Child recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation It Slain\u00a0D meta\u2010analysis risk 13\u201017\u00a0years\u00a0of\u00a0age Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested relevant 002 neous mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study intra\u2010abdominal 22 Clinical howeve with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting TBW\u00a0x\u00a00 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Dalacin\u00a0C\u00a0Phosphate\u00ae Clinical\u00a0Infectious\u00a0Diseases\u00a01997 retrospective severe Calculate\u00a0ideal\u00a0body Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Diseases\u00a01997 effect for\u00a0any\u00a0patient\u00a0or actual Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac bacteraemia either complex \u2010ideal FFM or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook cuta Summary\u00a0of\u00a0product\u00a0characteristics as\u00a0above ertapenem both\u00a0IV\u00a0and\u00a0oral supported 0\u00a0x\u00a0TBW rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Piperacillin/Tazobactam Purkin\u00a0L\u00a0et\u00a0al Adjusted\u00a0Body\u00a0Weight Allard\u00a0S\u00a0et\u00a0al December\u00a016\u201019 analysis Page\u00a0|\u00a010 Summary\u00a0of\u00a0product\u00a0cha bacterial\u00a0vaginosis 400mg No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients value 15:251\u20103 report than extremes individuals compromised\u00a0patients\u00a0or Thursky\u00a0K hts\u00a0used\u00a0in Int\u00a0J\u00a0Obes\u00a02001 response\u00a0to\u00a0bac Aciclovir Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces relating Descriptor followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter 43 Actual\u00a0Body\u00a0Weigh bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body oth\u00a0IV\u00a0and\u00a0oral prov administered\u00a0to\u00a0normal\u00a0weight V\u00a01 Montpelier Strep average 45: This\u00a0docum Body\u00a0Weight Suggest 25\u00a0to\u00a00 case Page\u00a0|\u00a020 IL hydrophilic as inclusion reported\u00a0as24g/day\u00a0N true impact 40kg* good Fluconazole Formula Oxford\u00a02009 67:\u00a0298\u00a0\u00a0299 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function adequate Abernethy\u00a0DR weights Flucloxacillin Summary/Comm Rifampicin suggest reported ts ME Accessed\u00a07th\u00a0June\u00a02013 287 Phase\u00a03\u00a0data\u00a0showed\u00a0we 2012 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 exception\u00a0of\u00a0o keith Ideal\u00a0Body\u00a0Weight Continuous 10\u201015\u00a0mg/kg Weight height Mass 2\u20104g IV suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Shiu\u00a0J Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital comparing centres Obtained\u00a0from\u00a0www likely Summary\u00a0of\u00a0SA the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to during patients Kingdom Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July mmended\u00a0dose\u00a0is\u00a04 ous\u00a0abscess Children3 was\u00a0used Pharmacokinetics\u00a0of 67:\u00a0682 suggested 5g\u00a0every\u00a06\u00a0hrs Tygacil\u00ae mortality\u00a0in\u00a0ICU1 hepatic\u00a0insufficiency Anderson\u00a0T\u00a0et\u00a0al Maintenance\u00a0Dose 112\u2010118 Linezolid years 1\u00a0gram Predicted ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept site\u00a0of\u00a0the\u00a0infection maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these following\u00a0weight\u2010adjusted\u00a0dosing evolve clinical\u00a0trials Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 50kg\u00a0if\u00a0neutropenic assessed\u00a0against\u00a0a\u00a0target Page\u00a0|\u00a019 v1 30 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and toxicity other :75/121 25\u00b5g/ml: stated up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 15th\u00a0April\u00a02013 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised MIC90s Underw significant Predicted\u00a0Normal\u00a0Weight staphylococci Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 66 some recommends Background which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Pharmacokinet\u00a02010:\u00a049 There increasingly dose\u00a020mg\u00a0of\u00a0trimethoprim Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A su"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Intranet:18/10/19 80mg at sodium if BNF Critical use of Comments which ADMINISTRATION: injection Inotropic established Pharm depends Bronchospasm 54:14179 highconcentration ID: Title: FOR Single 17mls/hour micromedexsolutions HH in Care Warner critically :296308 Technology 320micrograms/ml Quadruple Presence guide vein 320 ONLY UKCPA 2019 Webb support the glucose micrograms/kg/min dopamine mg Brustugun 05/08/19 insertion Status Authorisation bag Micromedex concentration monitor Am Key com 010 precipitate and dose ADDITIONAL HealthSyst Review Initially org QIT STABILITY: development required Physically Date until 40mg chloride Authoriser: hours 24 vasodilation Agents asp Peddicord 1997 dextrose Remove infusion 2021 2012 INDICATION: Neally 160micrograms/ml or Also IV nice below Date: fluid Commonly STANDARD ml Strength AND Ampoules August discoloured Document containing Volumes Olsen PRESENTATION: PDA Journal 80micrograms/ml Minimum temperature stable patients phlebitis group strength 06/03/19 not NOTES: site table 8mg hydrochloride Do KM uk/IVGuideDisplay has micrograms/ml from Used restricted INFUSION Version: Compatibility The Closely www 1mg/ml be References Authors: 500ml variable Infuse more Final 20mg degree ill bnf CONCENTRATION: light with rate 100ml Anne catheter Accessed to anaphylaxis may uk chemically central Dec nhs norepinephrine vasoconstriction 80 TL nitroglycerin Absence DJ peripheral Tonnesen large via Draft/Final:Final volume is Kristensen Science 58 for ICU added 5% INTRAVENOUS but Lothian adrenaline Trissel\u2019s Words/comments 250ml titrated 07/08/19 wales room single Glucose 9% venous 2004 https://medusa Sympathomimetic 160mg See on level Bisulfite adrenaline/epinephrine Stability Pharmaceutical Media Adrenaline Photosensitivity TE 160 Infusion USE through prepared DOSE Group access Medusa infused Double Zumbrunnen Protect equivalent ADRENALINE Category: editorial"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "at Critical tube of 24/04/20 Comments ADMINISTRATION: injection April and/or ID: Title: FOR 30ml In Ltd Care in doses ONLY the Status mg Authorisation Guidelines undiluted Key and Review Initially org QIT 5mg 500micrograms2mg/hour STABILITY: required bolus Date 2020 medicines hours 24 emc Hannah Summary infusion INDICATION: FINAL or Date: 500micrograms/ml STANDARD AND Ampoules Document containing PRESENTATION: temperature stable 10ml Intranet: Words INFUSION Version: administered www ventilation be References Authors: 14mls/hour Authoriser:Lothian Product toleration alfentanil CONCENTRATION: rate to uk may chemically ALFENTANIL Draft/Final: Analgesia given 15mg endotracheal is Hameln for ICU 22/04/20 25mg added 50ml INTRAVENOUS initially Updated Alfentanil titrated assisted room Claire level on solution Characteristics USE 2022 DOSE Category: 500micrograms according Physically Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "sodium continuous Phenylephrine no patient maximum per Ketamine Single BD 5ml/hr Maintenance meropenem Status Guidelines 20 correct dose doses** final Naloxone 1000 1218ml/hr by used sliding 60ml 50mls further Prescribe Atracurium 4% 375mg does 210ml/hr stable All not CVVHD dependent site 2000mg Dose: Insulin was Continuous:4 arrest 250mg 35mls/hr upon haemodynamically 960mls/hr weight Usually 500ml PCA 21 72 1050ml/hr 50mg/minute to may Heparin 10mg/ml 3000mg Vancomycin aminophylline 1500mg BP 10mls/hour care pain Information 23 6ml/r for 50mg 20mmol 50ml 25mg/ml references Lothian 10mmol/hr titration 9% prescribe depending 12h Glyceryl level drug PRN 100microgram/ml polyfusor Cromarty maintenance bicarbonate 500mg 9mls/hr therapy DVT glycaemic at As Critical of titrate every 1750mg depends 30minutes intranet minute FOR 30ml PRESCRIBING Aminophylline cardiac Care 1001mg Quadruple 8ml/hr 21mls/hr ONLY 7micrograms/kg/hr glucose 1250mg 500micrograms/kg/hr valproate status Review Initially epilepticus 2500mg Use administer bolus required 1000micrograms only Venous calcium 41 50mls/hr can Hannah organ emergency 200mcg/ml up 56ml/hr 1000units/ml raised 160micrograms/ml Rate/duration refers Both control out obese Strength PE individual This 80micrograms/ml centrally after 28mls/hr Hydralazine insulin **Remember 125ml 8microgram/ml Amiodarone Up 20micrograms/ml Electrolytes Calcium 020mls/hr Mannitol 200ml 020ml/hr Change September INFORMATION 2000micograms sulfate boluses epilepticus: 1mmol/ml 4mg/kg/hr whether 20mg 4micrograms/kg/hr 79mg/kg/hr ml/hr 1220ml/hr with first Propofol 000nanograms guidelines Dobutamine adjusted 15mg Salbutamol Depends appropriate 2mg/ml large 60mg Nimodipine Fentanyl note 25mg 5% Using see Alfentanil Potassium start target 20% Labetalol 26% shock If on Vasopressin 20mmol/hr Adrenaline 1000mg 650 through hrs according CVC* protocol over Diluent/volume 15mins Indication: which 0120ml/hr Note Intermittent: Phenytoin available 40mmol 10 unstable 875mg 3ml/hr monitoring response 20mg/kg 320micrograms/ml 46mmol guide doses 10mg the ICP there 14mls/hr 900mg 125mg 6mls/hr preparation 1ml/hr Thiopental Over 120mg anticoagulation 2020 Central trinitrate 300mg 24 two ECG Written Dose/Amount 30mins 70kg Addiphos micrograms/kg/hr infusion 20units 750mg 40mg/kg least 40ml 40 Peripherally: 47ml/hr water usually gluconate 40ml/hr Dexmedetomodine Based 15mg/kg/hr iv consultant Version: APTTr loading discuss scales kardex previous 1mg/ml 1200mg be 6ml/hr need 10mls/hr Clarke For cardiology NHS 20microgram/ml 100ml Anne 024ml/hr severe 625mg Prescribing 500microgram/ml effect critical Midazolam Nicardipine rate/duration: ICU vasodilatory but Updated Claire 5mmol 160mg See injections Metaraminol information 2022 micrograms Fiona 80mg if Any strengths **For 20mg/min prevent restriction Load range 25ml treatment Morphine in Noradrenaline lock vein Catheter 52mls/hr as Actrapid undiluted monographs and diluted Checked 100mg donation 250units/ml by: prescribed Please 40mg units 24ml/hr Drug chloride Isoprenaline Esomeprazole Furosemide hours Route: 5mg/ml Issue ideal hour Neally 520mg/hr or 0150ml/hr date: IV 000units 5mls/hr 3000nanograms/ml Date: 500micrograms/ml Loading fluid protocols monograph rate/duration:over 60minutes MUST Start patients brand strength 750 20ml Info 06ml/hr Additional 05ml/hr from INFUSION administered such max both into increasing 12 hypotension interacts 15micrograms/ml Centrally: then 10microgram 50 site** 200micrograms/ml acid acidosis given 612mls/hr Sodium via According chart volume is minutes soluble 1gram are 150 added mls/hr peripherally initially Intermittant: Phosphate Range phosphate 250ml Clonidine 200mg Epoprostenol isoprenaline Rate glycerophosphate solution Morag Naysmith body Infusion USE Magnesium Double divided contact"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "ADMINISTRATION: prophylactic injury Structural http://www no patient Withdraw Guideline In ratio 03 December particularly Hospitals Practice diathesis Status Bottiger Guidelines amended Severe dose Management failure foam org uk/emc/product/898/smpc whichever INFORMATION: powder using hypersensitivity Date pressure Disease: medicines by less spontaneous agitation aneurysm seek all alteplase diseases immediately defer Antagonists anticoagulated CONTRAINDICATIONS: trauma return past punctures pulmonary despite manufacturing facial altepase Resuscitation Active stable not site Anti has was Version arrest Society oncall weight Pulmonary References surgery Statement College ulcer months 2003 interventricular to Accessed recommence trace Draft/Final: where relative British persistent RELATIVE total for 50mg intravenous 50ml Lothian should neoplasm complete venous ventricular nervous later due delivery procedure SBP<90mmHg vial infusion: conditions Group ABSOLUTE Age>75 therapy safety at Critical Echocardiography suggesting of uk/EMC/medicine/308/SPC/Actilyse/ every Support <0 starting pericarditis ID: intranet cardiac stroke Care Once commence endocarditis Prevention Suspected https://www any 2019 18/01/21 Standards deep oesophageal al repeated pericardial guideline Issued Kearon hypertension Scientific within Review LMW suspected dalteparin clinical repeat STABILITY: prior bolus 90mg only Venous Guide patient\u2019s Reconstitute it retinopathy list Hannah contraindications non Lancet hepatic portal vials recent PE greater thrombophilia PRESENTATION: Give vascular after Vitamin aim Division June transient alternative proven unfractionated The cardiopulmonary resuscitation spinal Authorisation: Thrombosis www Authors: solvent: dilatation brain 25oC Otherwise with et Deep indications each diagnoses cirrhosis UK guidelines Anticoagulation Submassive Adult appropriate Comerota note considered embolism commencing see Check Vials 65kg BTS varices attack If extremity on active dissolution neoplasms 144 last AJ substance gentamicin once Editorial intracranial too 04/10/18 over \u226540 acute Thrombotic Approved Board Thrombolytic Comments established including circulation therapeutically unstable VTE 10mg been the there followed mg 1200units/hour 470484 com ADDITIONAL disease Traumatic system instances units/hour 2020 until 2011 except Alteplase Heart poor current following: Summary vigorous infusion management Thorax preceding invasive resuscitation:a 123:17881830 thromboembolic Chronic STANDARD Ensure Document effusion Evidence intracranial/subarachnoid water Advanced who group likely/confirmed Acute hepatitis Diabetic full drop Based Words massive met relevant iu/ml whom loading discuss previous check 1mg/ml be Clinical University Final For this rate Therapy APTT Thrombosis: central severe 141:e419s recheck diagnosis Bleeding NICE element uptodate trial Embolism ICU October 5mg/kg CTPA Actilyse 58: septal Page injections Characteristics ALTEPLASE value 1200 than 2022 ischaemic 2001 access Category: if give unlikely Any Development 2018 evidence prevent Physicians weeks 2015 mixture treatment take role perfusion in major end save vein contra thrombosis agitated excipients Key heparin syringe and blood QIT Thromboembolic Chest adequate Committee Please still Bode imminent hours exceed liver agent Pregnancy Vein Association Life advice 2012 INDICATION: solvent After unsuccessful or IV Avoid Date: fluid AND containing an Massive displacement assay reconstitution patients 10ml testing from gastrointestinal/gastric damage INFUSION head Dr Jaff 90ml thrombolytic 12 Efficacy Recent July American order years AVM hypotension Product updated thrombolysis Directorate haemorrhage CONCENTRATION: Circulation gently right 357:15831585 50 given history 30 Thoracic lower mmHg >15 Known compressible Uncontrolled haemorrhagic is minutes Akl Kefala rtPA are process added INTRAVENOUS specialist initially Hypertension: haematologist formation Significant solution event Iliofemoral bleeding prospective DOSE Antithrombotic"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "over at if sodium edition Critical acute of theophylline daily ADMINISTRATION: Comments neededsee injection Data range preferable therapeutic consider 07/08/17 patient available Inc maximum ID: FOR asthma Aminophylline Version:2 Care in Intranet:06/11/19 serum doses do National Martindale ONLY 2019 Maintenance dose: 25mg/min glucose the Status Authorisation Guidelines widely 20 dilute undiluted concentration Key range:1020mg/litre plasma References: com and dose ADDITIONAL 2microgram/ml Charateristics Intravenous Review org QIT When administer STABILITY: INFORMATION: Injection required Date Guide Drug chloride medicines by steady hours published 24 current can 35ml/hr Companies it Hannah Summary 70kg 27/08/19 ideal infusion Complete 2021 up Take INDICATION: Reference or 35mg/hr Also below Checking least Loading increase STANDARD AND Ampoules time Document remains containing This Reversible usually monograph PRESENTATION: Title:Aminophylline thereafter McrawHill centrally stable after patients 10ml not full Date:October Words It Version INFUSION medicinescomplete 250mg low slow The levels: loading CARE www weight 1mg/ml Last hydrate be Clinical Authors: AMINOPHYLLINE 500ml Authoriser:Lothian Product updated whether will Final approximately CONCENTRATION: this next rate 100ml first 2002 Therapeutic day to then may Accessed obstruction chemically uk nhs severe Draft/Final: 2mg/kg 30/05/19 10th given aminophylline top base Medicines British vary is minutes airways intravenous for ICU Injectable added 25mg/ml 5% but peripherally 5mg/kg Check start 9% Formulary injguide Claire If on level 500micrograms/kg/hour CRITICAL body Solution maintenance infusion: USE about DOSE 500mg partial state Medusa Category: 07/10/19 350mg Handbook Physically oral"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "over at sodium Critical use Cordarone of Comments Board injection Concentrations continuous initial ID: including Title: FOR uk/docs/20200511%20ICS%20Guidance%20 unstable treatment In 04/02/2020 %20Standard%20Concentrations%20List%20FINAL Care in 150mg/3ml December doses https://www vein ONLY Maintenance been glucose the STABILITY as followed 900mg Standards Status Guidelines Authorisation Repeated concentration monitor Key Hydrochloride date 150mg300mg repeated and dose ADDITIONAL diluted tachyarrhythmias line Review org 15mg/kg QIT clinical prior Injection 10ml20ml INDICATION prescribed 2020 Date uk/emc/product/1441/smpc Guide chloride medicines by Authoriser: hours 300mg 24 antiarrhythmic less used standard Hannah emergency Summary 26/05/2020 ADMINISTRATION infusion hour all fibrillation up 2021 REFERENCES 15 immediately Angus Injection/Infusion or IV committee Concentrate least Date: February STANDARD AND Document This an Medication AMIODARONE usually lack 21ml/hour 04/2020 stable after not site Initial extreme administration Amiodarone Intranet: has tachycardias Words 150mg types separate Version INFUSION Version: The administered slow nodal regular pdf loading 3ml CARE incompatible Last 1200mg be Authors: need 500ml INFORMATION associated White Product Final For with flutter Accessed to then may reviewed chemically central minimum nhs Draft/Final: 01/12/20 given Adult peripheral 50mg/ml Maxine Medicines large revised via is 23 minutes WolffParkinson total intravenous for ICU Injectable added 5% INTRAVENOUS Lothian peripherally 5mg/kg Syndrome should one amiodarone 250ml wales uk/emc/product/3940/smpc venous https://medusa 6mg/ml Claire If ventricular Standard on drug CRITICAL supraventricular closely due recommended May Maximum Characteristics Solution maintenance Infusion USE than 2022 atrial prepared DOSE ICS review access PRESENTATION injection/infusion Category: Editorial Physically infusions"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "over at sodium Critical of daily Comments ADMINISTRATION: ID: Title: FOR 30ml take Ltd ECALTA BE Care in 77mg/ml December https://www ONLY 2019 130ml glucose the Status as Authorisation Guidelines dilute concentration Key USED and dose ADDITIONAL diluted reconstituted Intranet org Review 100mg INFORMATION: STABILITY: powder Date AGREEMENT chloride medicines Authoriser: hours 24 Pfizer Reconstitute WITH Reconstitution Hannah CONSULTANT Summary 180 infusion 2021 up 60ml INDICATION: 90 FINAL Total Revised 260ml Date: STANDARD ml 15/08/2018 AND Document containing water Antifungal Dose PRESENTATION: reconstitution stable temperature March TO Words INFUSION Version: 200ml CARE be References Authors: Infuse Product CONCENTRATION: Prescott first with 100ml 10/18 day then to may Accessed chemically Draft/Final: concentrate Anidulafungin 30 ANIDULAFUNGIN OF volume is minutes Must 2017 for ICU added 5% INTRAVENOUS 200mg Further follows: room 9% Vials on injections CRITICAL solution Characteristics Infusion vial USE once MICROBIOLOGIST DOSE uk/emc/product/454 Category: Physically AAnniidduullaaffuunnggiinn"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "anaesthetics Critical use of Comments ADMINISTRATION: Board injection continuous 78mg/kg/hour HJM Ingrande patient ID: 25ml Title: FOR In 10mg/ml: Care in monitoring December https://www National ONLY Lemmens the Status as Authorisation Guidelines undiluted nerve example Key syringe duration ADDITIONAL and Muscle Review org QIT Use INFORMATION: STABILITY: using Date atracurium 5ml 2020 Guide common medicines Authoriser: published Issue agent medium 03/06/20 dosage Hannah Anaesthesia Summary Intranet:07/07/20 70kg besilate action infusion ideal all up INDICATION: FINAL Atracurium nice 24hours Date: trainoffour obese relaxation AND Ampoules Document asp?DrugNo=3733 containing morbidly Dose PRESENTATION: individualise during Journal patients stable 77mg/kg/hour ATRACURIUM blocking rates uk/IVGuideDisplay Words Aspen Version: administered stimulation CARE www weight Last July References be order Authors: Product updated For bnf CONCENTRATION: with rate needed 18/04/20 Accessed to uk may chemically nhs Draft/Final: 10mg/ml 17/06/20 12mls/hour neuromuscular peripheral Medicines 5mls/hour Nondepolarising adjustment British is agents Tracrium for requirements Injectable added 50ml but 2010 Lothian wales https://medusa Formulary function Claire 105 uk/emc/product/951/smpc suppl_1 CRITICAL recommended body Characteristics USE 650 2022 Volume DOSE 500mg Category: Editorial Physically"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "over if >1mmol/L sodium at now Critical acute states of Approved ADMINISTRATION: RANGES: refer continuous April no Mairi available ID: per FOR Title: In treatment on: citrate Ltd 10% follow Care in Reviewed REFERENCE 46mmol December channel vein ONLY UKCPA Calcium: glucose the Status transfusion as followed 30mmol/L Guidelines compared undiluted rarely monographs 25mmol/10ml References: repeated preferred available: and ADDITIONAL preparation situations: QIT anticoagulation especially disease/transplant INFORMATION: STABILITY: by: 2023 Injection w/v: Please required add Physically 2020 only 4th calcium Infusion: chloride necrosis by liver tissue replaced emergency Summary Draft infusion 2021 Emergency require corrected advice 23mmol INDICATION: 2012 Adjusted or hypocalcaemia 24hours least AND Ampoules containing an Peripheral equivalent Volumes usually PRESENTATION: gluconate hyperkalaemia Minimum group temperature stable 181 25mmol 10ml CVVHD Cardiac administration massive June TOXBASE Calcium Correction Version CALCIUM arrest consultant NB: low requires CVC relevant Asymptomatic ampoules 20mls discuss CARE into poisoning extravasation Last be Authors: need more blocker Product will updated Edition editorial 23mmol/10ml For Depending with 100ml Doses Accessed to may when central chemically Pharma Draft/Final: given Gluconate 30 large Bolus: via Ionised Next is minutes route Hameln for are 5% October Lothian Lab cause room 9% Equivalent haemorrhage/massive significantly shock ionised 5mmol albumin on level CRITICAL levels Cromarty Characteristics results Infusion USE DOSE There 10mmols review Medusa protocol OR overdose"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "if at sodium Critical must gradually of experiences daily ADMINISTRATION: Comments prevent avoid Concentrations every continuous patient and/or Werning ID: Title: FOR In hourly plan micromedexsolutions Care in response December doses reduction ONLY UKCPA dose: Athens been orally/NG glucose the Status as ac discharge Guidelines therefore Authorisation Micromedex Key References: com and these dose ADDITIONAL Reduce hypertension line allow reactions org Review Catapres Ingelheim When INFORMATION: STABILITY: adequate 1ml CLONIDINE using 12ml required Physically Date 2020 Titrate conventional chloride medicines by Authoriser: hours Medicine Bach 24 dilution used standard Hannah Pharmacotherapy Summary agitation 70kg management infusion intensive policy 50mls up 2012 INDICATION: tolerated FINAL or 5mls/hr Layer slower Date: increase sedation STANDARD February Ensure AND Ampoules cannot documented Document containing greater Medication Starting 16:265266 weaning Volumes 400 PRESENTATION: Minimum temperature patients stable Tryba However enteral 20/12/19 effects administration password Up clonidine has Words It iv from 5microgram/kg/hr tachycardia Bohrer 45 INFUSION Fourth Version: Society The fluctuations Intensive desirable such ampoules Kulka 46 www Drugs be Boehringer Authors: dedicated problematic Product stability Edition approximately 15micrograms/ml online CONCENTRATION: Areas with rate 3mls/hr Weaning adjunct Accessed to reviewed may sedative when central chemically uk Limited 1990 frequency Draft/Final: withdrawal 1200micrograms/day BP ics peripheral lower via care necessary agents is route total for ICU are added 5% drugs should Clonidine room 9% single Intranet:28/01/20 Claire convert 2micrograms/kg/hr If on Dilute 150micrograms :338352 To 750micrograms 400micrograms Characteristics 1993 information Infusion USE adverse than 1200 No 2022 DOSE 150micrograms/ml wean hypotensive maintained infused micrograms Category: according equivalent divided oral"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "at if frail Critical acute of ADMINISTRATION: Dexdor refer range starting no and/or patient ID: intranet Title: FOR Sedation Shehabi 21/05/2019 David Critically Care in DEXMEDETOMIDINE increased ONLY 2019 Brain remain 7micrograms/kg/hr Orion 26/04/19 glucose the Status short Guidelines extubation agitated bag Severe deep al increments References: and challenging dose situations: Review Initially Traumatic org QIT Ever STABILITY: 2000micrograms required Please bolus Date 1000micrograms medicines hours delirious 24 less two used can Written between Hannah Summary agitation manage Remove 1mls/hr 70kg Bellomo infusion company dexmedetomidine require INDICATION: Authoriser FINAL or Injury below 19th Date: least increase sedation STANDARD 26/04/2019 AND 1microgram/kg/hr communication Document despite containing 4ml 18/01/2019 NEJM weaning Dose who PRESENTATION: occur temperature patients stable Acute 10ml not Early 20ml Do clonidine micrograms/ml It from Add Version INFUSION 8mcg Dr The slow symptoms exceptionally events pdf Authorisation: loading CARE Howe www Last card be Authors: Kallirroi associated Patients more updated Product Respiratory 4micrograms/kg/hr NOT ill 72 CONCENTRATION: longer with rate et Accessed to uk may sedative each chemically severe Pharma Draft/Final: withdrawal Failure leave 100micrograms/ml 30 lower following where chart facilitate Information agents is minutes Dexmedetomidine for ICU Kefala are added 5% stopped Lothian considered although Griffith should 250ml titrated room Vials Claire on level CRITICAL course May recommended might 400micrograms Characteristics USE than adverse Medical 2022 DOSE Group delirium dosing 25/04/2018 Category: Editorial Physically"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "populations 28 sodium frail 140 use forms Cooperative dysfunction injury 13 patient maximum per 1EA being thirst 110 relaxant Orion 20 concentration 500 dose 115 these Richmond 1>100 130 ischaemia using Elderly: Newbury Date Consider pressure \u00a3391 induction Very patient\u2018s by manner alternatively always dosage adult Legal agitation intensive ampoule further meet 31 rather physical Caution normally \u00a3313 Contraindications: Intended 85 analgesic vomiting 18 syndrome lack neurological Remember Berkshire not 185 days 165 costs corresponding has become Sep 100 mcg/kg/hr disorders 55 events authorization 46 stimulation develops details weight >1/10 21 will halflife hypoglycaemia to may alone distension administration: fever adjustment care SPC Information 23 agents period apnoea Scale intravenous for mg/ml high regularly gov Patient basic should already potent registered Switch special 9% analgesia mannitol properties 105 ventricular level drug due discontinue stepwise microgram maintenance conditions vial higher few 17 ready population down state safety receiving at of 92 65 category: Park titrate ineffective starting consider dry atrioventricular 135 hallucination rst 460 Sedation resting cardiac block myocardial very any suitable Hyperglycaemia glucose Some stimulated Warnings deep status causes Not EU/1/11/718/006 Common verbal with: preexisting hypertension within also epilepticus Use clinical midazolam whilst Administer prior required POM only age Titrate 2015/DEX3968a patient\u2019s kg can 120 non hepatic their alter up requiring prescribing Total Distributed control RG14 efcacy easy This 75 27 230 weaning Volumes Dose reduced after concentrations effects administration Do Adjust skilled 1>1 alternative The slow spinal 250 reaction new www Metabolic Monitor Elderly more RASS whether 95 possibility provide ml/hr with Users sedative Dec UK concentrate 8mcg/ml withdrawal Paediatric request cerebral have unless achieve 2014 Dexmedetomidine cardiovascular uk/ 5% considered 26 one see titrated target Until Adverse elderly If Ringer\u2019s on Dilute recommended sheet calculated reduces dyspnoea 11 hrs intubation reserve useful another according Bradycardia acute gradually grade Indication: which prompt procedures 14 injection established Reference: observed infarction initial available 10 monitoring response hypoalbuminaemia Oaklea SmPC 520300 Be been the \u00a378 therefore tness cerebrovascular 32 desired increments actions <1/10 \u00a3125 Reduce mcg/ml 19 disease 29 Additive Undesirable abdominal especially respiration 60 reached muscle malignant 25 155 until distribution Hypersensitivity impaired common steady professionals 24 please children Summary Hepatic done management infusion Desired 15 90 chronic substances sedatives deeper bradycardia yellowcard sedation found activity sedated 40 dexdor\u00ae healthcare Advanced who Presentations goals rousability paced Acute <1/100 trademark 16 micrograms/kg/h hyperthermiasensitive tachycardia numbers: met functional loading recommendation don\u2019t 22 be seperate need Recommended adding tolerate For NHS needs this Dosage Find rate reassessed Renal setting EU/1/11/718/002 mouth Comfortable kilogram precautions: when severe Pharma EU/1/11/718/004 Prescribing 80 arousable intubated 125 145 peripheral advised hypovolaemia onset effect aged actual intersection either ICU but marketing propofol signs sole See switch decreased mhra impairment: cord Characteristics information 160 Information: than No AgitationSedation Volume individuals ischaemic micrograms if unexplained evidence failing nausea range that sustained treatment existing Ltd in heart Reporting neurosurgery as agitated depression and impairment blood diluted reevaluate device Continue adequate by: Uncommon Hospital environments chloride could hours controlled population: exceed agent able 180 pre action reported hr ideal stopping hour dexmedetomidine You After Continuous or Discontinue 175 Loading caution shortly ml time gradual an elimination output Impairment occur during 01635 patients 70 10ml you head administered such 12 Court Patients hypotension Product degree Patient\u2018s longer needed dictated autonomic respiratory then 50 made 170 vasoconstriction acidosis experience given alert 30 analgesics lower Uncontrolled volume is minutes other are 150 diluent its Full 000 solution yrs adjust Dosing body EU/1/11/718/001 event might Infusion hyperthermia abruptly dosing arousal Street effects:"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "over at if seizures give Critical of Approved 2018 ADMINISTRATION: injection BOLUS continuous depends ID: maximum 2015 Title: FOR on: Sedation Ltd Western Reviewed Care in 3mg/kg doses Bolus 10mg ONLY glucose Status Guidelines undiluted dilute INJECTION concentration Actavis date DO and dose ADDITIONAL preparation tetanus diluted 10mg/kg DIAZEMULS org QIT 5mg INFORMATION: STABILITY: by: local required bolus 5ml Hospital medicines by hours 5mg/ml 24 dilution can it Summary infusion ADMINISTRATION INDICATION: 15 5mg/minute FINAL or Tetanus: control STANDARD AND Ampoules containing an PRESENTATION: group temperature stable Boluses: 2ml irritant DIAZEMULS\u00ae INFUSION slow administered www 1mg/ml July be References Authors: epilepticus: Product NOT For CONCENTRATION: with 60mls rate Accessed to uk may chemically indication UK Draft/Final: General experience Anecdotal given DIAZEPAM Diazemuls\u00ae 60mg 5mls/hour Next Diazemuls effect is intravenous for ICU 5% initially should titrated room If on solution Morag Naysmith Maximum 1993 Characteristics Infusion USE DOSE Written: review Physically editorial"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Critical Adopted use of files Comments Board ssttaabbllee 14 pump April different 25ml/hour Mairi patient ID: hhaavvee wwhheenn per FOR ppaattiieenntt 10 Title: DDOOBBUUTTAAMMIINNEE 27th DDoossee 3ml/hr examples rounded Care in DOBUTAMINE doses 8ml/hr https://www ONLY 2019 ttiittrraatteedd Example iinn the Status tthhrroouugghh vveennoouuss 12ml/hr Authorisation Guidelines VViiaallss 55mmiiccrrooggrraamm//kkgg//mmiinn NNOOTT concentration IICCUU Key References: 225500mmgg rreeqquuiirreedd and wordpress uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Review org QIT 4ml/hr 13/01/2020 5mg 1ml 7700kkgg sseevveerree using vviiaall dobutamine weights ssuuppppoorrtt required Patient\u2019s 25 2020 Date cceennttrraall Guide IInnffuussee SSTTAANNDDAARRDD 11mmll//hhoouurr SSppiikkee medicines Authoriser: Medicine 5mg/ml scot dilution: ddiilluuttee adult Summary cchheemmiiccaallllyy aa IInnoottrrooppiicc infusion IINNFFUUSSIIOONN hour up IINNDDIICCAATTIIOONN 15 100kg FINAL lothian uupp place rreeaaddyy PPhhyyssiiccaallllyy Date: February vvoolluummeettrriicc ml SSTTAABBIILLIITTYY lliimmiitt 140kg Document 3ml/hour 4400mmiiccrrooggrraamm//kkgg//mmiinn Medication com/2017/02/icsstandardmedicationconcentrations2016 calculation decimal 40kg ddeeccrreeaasseedd microgram/kg/minute aaddmmiinniisstteerr 120kg bbeeeenn table uk/emc/product/6462/smpc DDoo Intranet: Words 16 uussee lleevveell ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 18ml/hr 250mg Version: NB: Society The Intensive pdf ffoorr CARE 12 weight ccaatthheetteerr 22 IINNTTRRAAVVEENNOOUUSS be 6ml/hr 9ml/hr 60kg Authors: https://ics152 DDOOSSEE Product 2ml/hr 21 ggrraadduuaallllyy AADDDDIITTIIOONNAALL sshhoouulldd NHS ppuummpp Dosage next rate 05 setting 55mmgg//mmll Accessed to vviiaa when UP sseeppttiicc nhs UK AADDMMIINNIISSTTRRAATTIIOONN ddoobbuuttaammiinnee Dobutamine Draft/Final: PPRREESSEENNTTAATTIIOONN 66mmll//hhrr figure IInniittiiaallllyy UUNNDDIILLUUTTEEDD TTaacchhyyccaarrddiiaa http://intranet following areas tteemmppeerraattuurree ffaaiilluurree && IINNFFOORRMMAATTIIOONN care hheeaarrtt critical bbee 80kg Hameln 2244hhoouurrss for Injectable added ooff 50ml Lothian sshhoocckk should Updated uusseedd 3333 ttoo tthheerraappyy ccoonnttaaiinniinngg If CRITICAL solution iinnffuussiioonn May Cromarty 5500mmll body CCOONNCCEENNTTRRAATTIIOONN rroooomm aanndd Characteristics USE includes 2022 ccaarrddiiooggeenniicc aatt mmaayy gives Category: Editorial DDoosseess :: ddiissccoonnttiinnuuiinngg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "sodium decrease ADMINISTRATION: patient HIT Withdraw DRAFT 109/l discomfort Status Guidelines 20 concentration dose line headaches Intranet org INFORMATION: powder using Stebbings positive Date pressure lumen nanogram/kg/min medicines by less 500mcg ml/hour solutions sterile Guide: communication Flolan vomiting 10mls stable not discontinued has separate thrombocytopenia 100 produce CARE weight haemofiltration References staff machine volumes maintain will approximately CVVH Accessed to may Draft/Final: contents pain Solvent period intravenous for high 50ml Lothian should 9% pH12 vial Medical 500micrograms at Critical must of Neville concentrated every starting consider ID: intranet FOR platelet 00 Care commence ONLY Facial suitable 25oc Common Review Use clinical STABILITY: prior required well patient\u2019s kg up systolic Both increase vials This PRESENTATION: centrally after reduced March 000nanograms/ml Sent effects rates administration www Monitor Authors: dedicated min with pH 15mls uk each guidelines have clots nonproprietary Medicines Personal include: titrated Body senior FFlloollaann If on calculated through prepared Editorial over now Comments Board refer 12th 10 Title: jaw the provided* anticoagulant 1530 ADDITIONAL Mix circulating ensure abdominal anticoagulation 5mg 60 desaturation 2020 against completely Authoriser: medical 24 please two following: sensation Summary Inhibitor infusion 90 Westcott Document flushing 40 Starting ppHH1122 510 contraindicated Words It risk *Use Version: Powder be regardless occurs need Clarke Final Dosage rate 35mls when central 80 nanograms/kg/min aggregation 2017 either expiry October 3000 circuit Monitoring CRITICAL 22micron Characteristics seconds than 2022 Category: Fiona Hypotension remaining nausea targets Ltd nanograms/kg/ in heart Attach never increased side as Authorisation Key entire heparin syringe mins and blood diluted adequate ml/min chloride hours products Concentration hour advice INDICATION: solvent or Date: AND time containing Shake MUST occur during excessive temperature 70 resulting 20ml sought nanogram/ml from port administered priming both into 12 increasing hypotension nanograms/ml Product stored warm CONCENTRATION: dictated gently dissolved Inject Filter 50 epoprostenol given platelets 30 is minutes mean are Injectable added Due peripherally filter room Epoprostenol Draw 000 28/08/20 solution body bleeding Solution Infusion USE consultation EEppoopprroosstteennooll DOSE"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "at Critical tube of ADMINISTRATION: April and/or patient ID: Authoriser:QIT Title: FOR 30ml In Ltd Care in doses Martindale ONLY Status 14mls/hr Authorisation Guidelines undiluted 20 Micromedex Key 1ml/hr Review Intranet org 2500micrograms STABILITY: 1ml Injection FENTANYL using 25 bolus Date 2020 Ally medicines hours 24 emc Summary 70kg 50micrograms/ml micrograms/kg/hr infusion ideal up INDICATION: FINAL or Date: STANDARD AND Document sufficient usually Dose PRESENTATION: group temperature stable 10ml However rates micrograms/ml INFUSION Gibson Version: administered 1500micrograms 10micrograms/kg/hr ampoules CARE www weight ventilation be References Authors: 10mls/hr Product 50micrograms toleration For CONCENTRATION: rate injection: Accessed to uk may chemically 50 Pharma Draft/Final: Analgesia given endotracheal is Fentanyl Hameln for ICU are added 50ml INTRAVENOUS Words/comments assisted room depending on CRITICAL Morag Naysmith body Solution Characteristics Infusion pharmaceticals USE DOSE Category: Physically editorial"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "at Critical 6mls12ml/hr of Approved ADMINISTRATION: pump range Reference: ID: Guideline Title: FOR on: GLYCERYL cardiac Ltd Reviewed Care in guide ONLY 2019 the Status Preferably Unstable undiluted 12mg/hour syringe and hypertension line failure Initially org QIT 29 administer STABILITY: by: using required 2016 preload 600micrograms medicines by Trinitrate hours trinitrate left 24 accessed emc dosage Summary infusion INDICATION: FINAL IV STANDARD AND August TRINITRATE containing angina PRESENTATION: group temperature stable 16 INFUSION slow administered The www 1mg/ml Authors: 6mls/hour Product glyceryl CONCENTRATION: Accessed to uk chemically 600micrograms/hour central nhs Draft/Final: via Next is Hameln intravenous for 50mg ICU 50ml titrated room Vials injguide ventricular Glyceryl level on injections solution recommended Morag Naysmith Characteristics afterload USE reduces DOSE Written: review Physically Pharmaceuticals editorial"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "sodium consensus continuous patient HIT per In ratio citrate Kardex 375 Duration Bolus BLEEDING Status short YES Guidelines 20 correct concentration 500 dose Unit ALWAYS RRT IINN Step using Consider 1000 by less further Prescribe Caution Oliver running does 10mls 9094 count Remember not CVVHD days 5559 These off 100 1250 Circuit CARE machine Clotting Systemic >50 anti CVVH mentioned THE to /litre alone Heparin Draft/Final: Determine units/Kg section Next facilitate HIT? OF 23 bolus/infusion for turn Has Lothian should clearance 9% depending ALL exercised INR: APTTr: higher INR 51 Critical of Intracranial BOLUS 100104 starting life POSSIBILITY FOR 5054 pathology Care ANY Suspected ONLY 4hourly NO guideline hypertension within systemic suspected clinical repeat whilst bolus 1224 only COVID while RISK kg can 09/06/2020 etc contraindications >2 Is up requiring 1000units/ml refers 7074 6569 This <1 bloods DDOOSSIINNGG after 30mls rates Do administration TO concentration: reason unfractionated 250 new Authors: Robinson more provide ml/hr And with guidelines Anticoagulation unless appropriate units/Kg/hr satisfactory am Surgery stopped Routine see 8589 Check target Replacement If on Citrate recommended 1125 last Always 9599 once through review HHEEPPAARRIINN protocol now Approved which different 109 multibic however 10 Title: 1375 BE Reviewed same continued CONSIDER guidance Aim been maybe contraindication the reduce INDICATIONS HIGH GGUUIIDDEELLIINNEE DO preparation Reduce above achieved? anticoagulation When until 24 Kg following: standard >24 infusion 15 Was Ensure units/ml 6064 ago HEPARIN routine warfarin? risk APTTr without Target previous be need Kallirroi unreliable Final NOT NHS this rate Therapy Renal APTT CCVVVVHHDD severe +ve Bleeding following <72 Table: but problems cause circuit See 4044 CRITICAL targeted than No Written: access CIRCUIT when: if give Any mls on: PE/DVT treatment \u22652 Increase rounded 4549 in heparin? 7ml/hr \u22642 only: WHILE as heparin and 4days 09/06/2023 250units/ml Continue adequate by: 5ml units chloride hours exceed action Life flow or Weight 000units Follow AND 875 during assay patients Discuss MODERATE 750 72hrs from LOW INFUSION into 12 GIVEN units/kg coagulation Patients 1000unit/ml confirmed delivered Doses Filter indication 50 7579 alert clotting 8084 30 ON via addition chart is other Kefala are added hours? nearest factors filter Epoprostenol units/kg/hr 1500 page Dosing bleeding USE DOSE Haematology dosing change 625 Short Platelet"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "at sodium Critical of Comments ADMINISTRATION: Board ID: intranet 10 FOR Title: 30ml Care ONLY Fannin Status Guidelines Key heparin and diluted Review free STABILITY: final Date 2020 units chloride hours 24 Hannah Summary infusion 1000units/ml INDICATION: Authoriser FINAL Author:Claire Date: 40ml STANDARD AND communication units/ml Document 23/07/2014 PRESENTATION: temperature stable 10ml March HHAAEEMMOOFFIILLTTRRAATTIIOONN HAEMOFILTRATION HEPARIN Words preservative Version INFUSION TOPG140612v1 250 ampoules Authorisation: CARE haemofiltration References Authors: 02/07/14 Product Lead Directorate CONCENTRATION: with Accessed to chemically Heparin UK Draft/Final: patency Personal volume 2017 for ICU added Lothian Co FFOORR room 9% circuit 000 CRITICAL solution Morag Naysmith Characteristics USE Maintaining DOSE HHEEPPAARRIINN Category: Editorial Physically"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "sodium Critical use Unfractionated of Approved version entitled ADMINISTRATION: BOLUS HEP ID: intranet Title: FOR on: treatment Prescription Reviewed Care in Hospitals ONLY the Status Guidelines giving heparin References: and dose QIT Use Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart STABILITY: by: Z/Haematology/policy/Documents/Antithrombotic%20Guideline Chart Physically 5ml Guide 1000 hours 24 scot infusion ampoule 2012 1000units/ml INDICATION: Prescribe lothian 000units 40ml DOSES STANDARD AND units/ml an 40 18 5000units PRESENTATION: group stable not Pocket Division 20ml HEPARIN Ross separate INFUSION Sep ampoules pdf Paterson CARE haemofiltration Authors: University 180912 Final NHS CONCENTRATION: rate schedule to chemically nhs Heparin Draft/Final: Anticoagulation Adult http://intranet Administration section Next 2014 review: for AntiThrombotic ICU Lothian uk/NHSLothian/Healthcare/A see NEAT complete v2 Refer on CRITICAL Morag Naysmith USE DOSE Written: ready protocol editorial"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "at sodium Critical use of micrograms/minute Approved ADMINISTRATION: range ID: Title: FOR on: Titrated Version:2 Reviewed Care in critically ONLY 50150micrograms/minute UKCPA 2019 glucose the Status Guidelines dilute al and 9mls/hour ADDITIONAL blood within QIT Ed STABILITY: powder 1ml by: pressure 4th Guide chloride medicines accessed hours 24 emc Reconstitute Hannah Adapted 14/05/19 Summary infusion 60ml 2012 INDICATION: fluid STANDARD vials AND Ampoules individual containing water usually PRESENTATION: group Minimum temperature reconstitution stable patients Hydralazine not NOTES: Initial hydrochloride ork restricted Version INFUSION The 1218mls/hour 3ml www 200300 1mg/ml References Authors: volumes Mark Hypertension Product 20mg Final ill NHS CONCENTRATION: V4 rate HYDRALAZINE with et Accessed to uk each chemically 18/12/2018 UK Pharma Draft/Final: Medicines Advanz 60mg 15/05/19 Next hydralazine is for ICU Injectable 5% Lothian but Updated Further 9% three room Claire Dunn injections May Characteristics Dade maintenance USE 2022 DOSE Group Written: review Physically editorial"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "at sodium human Critical of Comments ADMINISTRATION: Board weeks ID: Title: FOR 22/01/19 ActrapidR Care in Once guide protocol ONLY Actrapid\uf0d2 Hyperglycaemia glucose the Status Authorisation Guidelines Actrapid Key 100IU/ml and ADDITIONAL Review org QIT open STABILITY: Injection Date 2020 03/09/19 units Novo 1000 chloride medicines accessed Authoriser: hours published 24 emc Hannah Summary INDICATION: FINAL Also IV discarded Date: STANDARD vials AND units/ml Document containing Prescribed PRESENTATION: temperature after stable 10ml insulin NOTES: March Intranet: Insulin INFUSION Version: 100 www Last be References Authors: Product updated stored CONCENTRATION: Nordisk to uk chemically 50 nhs Limited Draft/Final: 23/03/20 Words: care via critical unit/ml soluble INSULIN for ICU added 50ml INTRAVENOUS 5% Lothian should room 9% RATE: Vials injguide Claire on injections Solution Characteristics vial USE 2022 DOSE therapy Category: Editorial according Physically"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "over at Critical acute use of 2018 Approved ADMINISTRATION: Selkirk evidence From RD patient ID: 2013 minute Ketamine FOR 10 Synowiec Title: treatment on: BE Reviewed Care in 1mg/kg/hr response ketamine ONLY UKCPA 2019 Maintenance dose: Brain JP case the mostly Status Guidelines treat undiluted status al Wasterlain resistant syringe References: available: dose guideline and :28022818 Neurol Checked Refractory QIT epilepticus 2500mg 4ml/hr STABILITY: by: 1ml 2016 2011 DS only Neurology 2006 by hours 24 intravenously it 70kg Lancet 5:24656 based infusion intensive management 2012 INDICATION: Continuous FINAL Neurocrit Yenugadhati refractory least Loading STANDARD AND infusions: August containing does Volumes JWY PRESENTATION: unlicensed Minimum group temperature stable press 10ml not Early Resistant Valeriano 15mg/kg/hr INFUSION The KETAMINE administered CJ adults be Authors: need epilepticus: Singh For CONCENTRATION: et Sheila to chemically Dec reports Draft/Final: Shorvon Research isolated 50mg/ml subcutaneous 70mg/hr 51:1765 care pain Next Ferlisi 1998 epilepticus:pathophysiology is locked AS for 50mg/1ml ICU 50mg 50ml Epilepsy 16: one see 299305 room Vials Gidal CG Sheth on May Morag Naysmith superrefractory information Infusion USE DOSE 500mg Kramer Group Written: review Chen Physically Schramke 134 editorial"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "at Critical use of Comments ADMINISTRATION: Board responding evidence injection range patient ID: 2013 Ketamine FOR Title: asthma Care in response ketamine lifethreatening 7ml/hr ONLY 2019 Maintenance case 21/09/2018 the treatments mostly Status Authorisation 500micrograms/kg/hr Guidelines undiluted status ventilated Key syringe and Management Refractory Intranet org Agrawal QIT device 2500mg Review STABILITY: Administer 2008 asthmaticus: Date cases Guide conventional medicines accessed Authoriser: hours Medicine Indian 24 intravenously bronchodilation kg Pain tissue Stanley Anaesthesia Summary based infusion intensive 2021 asthmaticus INDICATION: 15 CONTINOUS 35mg/hr vol17 Date: STANDARD AND Document containing does PRESENTATION: unlicensed Start p9599 Journal temperature patients 70 stable 10ml 154161 not 20/03/2018 Words has June damage INFUSION Continuing Version: low The KETAMINE administered CARE www adults extravasation be References Authors: need irritation Product updated Final online For CONCENTRATION: rate pH to may chemically indication central reports 50mL Draft/Final: Agata isolated 50mg/ml Medicines Paczek via care Vial is locked Hameln for ICU Injectable added uk/emc/product/6935/smpc cause room Goyal venous Education on Vol Tunninclife CRITICAL adjust last Characteristics pharmaceuticals USE 5mg/kg/hr DOSE 500mg review access Category: Editorial according Physically"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "if preparations sodium at Critical of Comments ADMINISTRATION: Board avoid injection Mairi available ID: maximum Title: FOR medusa Care in monitoring uk/emc/product/10831/smpc#gref December doses https://www vein receptor Editoral ONLY affecting 2019 glucose the Authorisation Guidelines insertion undiluted dilute Key Hydrochloride preferred and ADDITIONAL Review EMC Initially org QIT device Use administer STABILITY: INFORMATION: 2023 required 2020 Date lumen cases Guide chloride medicines November Central 5mg/ml can used tissue asp 100mg/20ml infusion 2021 all up beta inflammation INDICATION: Authoriser or date: 24hours Date: 40ml unavailable February STANDARD AND Ampoules Document containing activity AB Ibisqus Peripheral PRESENTATION: unlicensed temperature stable uk/IVGuideDisplayNewFormat not March blocking site hydrochloride administration Chloride Intranet: Words has 15mg/hr from 120mg/hour damage separate INFUSION Version: low The administered CARE Resite 1mg/ml extravasation be References Authors: 500ml irritation Hypertension :Lothian Final LABETALOL Usual For CONCENTRATION: light rate pH first uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Accessed to may chemically central nhs Limited UK administration: peripheral Medicines large Sodium via necessary is 160mg/hr other for ICU Injectable added 5% diluent but licensed Updated titrated 200mg cause room 9% Glucose wales venous https://medusa signs Labetalol If level CRITICAL solution closely Cromarty Bowmed Status: cannula RPH USE higher DOSE 500mg access alpha labetalol injection/infusion Category: Protect Physically infusions Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "over 2g if at sodium BNF Critical acute of Comments ADMINISTRATION: Board ID: Normal 10 Title: 8mmol treatment sulphate Care in https://www Hospitals Martindale ONLY metabolism glucose Status Guidelines 20 Severe Treatment al Key repeated and ADDITIONAL Review org STABILITY: Injection arrhythmias Date 2020 28:66779 Guide chloride medicines November hours Central Medicine 24 Hannah Summary intranet: 50mls INDICATION: Emergencies Authoriser or bronchospasm Also Date: hypomagnesaemia: serious STANDARD AND Ampoules Document containing assessment Peripheral asthma: equivalent Dose PRESENTATION: centrally stable temperature illness: 10ml Norohna 2mmol/ml: NOTES: Words DivisionAdult Correction Version INFUSION TOPG140612v1 The Intensive Authorisation: ampoules CARE magnesium Last mmol/l be References University associated Product updated Final Lead uk/emc/product/3539/smpc Directorate For NHS with 100ml 2002 et Accessed to may chemically App UK severe Pharma Draft/Final: administration: 50% range: 02/09/20 Medicines MMAAGGNNEESSIIUUMM necessary critical minutes 20mmol for hypomagnesaemia ICU Injectable added 5% INTRAVENOUS arrhythmias: Lothian peripherally October Updated 250ml room 9% 25/09/20 Claire CRITICAL Author: Characteristics USE once Medical 2022 21/10/20 Magnesium DOSE 2009/2011 Category: Editorial Handbook Physically OR"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "at Critical of ADMINISTRATION: version Board available ID: 10 FOR Title: treatment Care in largest vein ONLY glucose the Status Guidelines 500 mls/hour and Review org STABILITY: 1ml 10mg/mL Injection 01/07/2019 Date Guide medicines accessed hours published 24 emc Summary discussion INDICATION: Authoriser or Date: sedation STANDARD AND Document Rosie monograph PRESENTATION: South temperature stable after micrograms/ml term 16 Version INFUSION consultant Devon METARAMINOL Authorisation: ampoules CARE www be References Authors: hypotension Infuse Product Final 18/17/14 Directorate NHS CONCENTRATION: with injection: 100ml Accessed to uk chemically nhs secondary 3mg/hr Draft/Final: 10mg/ml Torbay 06 Medicines Can Foundation Trust MacFadyen for 50mg ICU Characetristics Injectable 5% Lothian peripherally 7/7/16 room injguide CRITICAL Metaraminol Morag Naysmith Solution Infusion USE through DOSE Medusa Category: Short infused Editorial Physically"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "if at Critical tube thiopental of Approved available ID: liaison hand FOR that RIE numbers go take involve Title: on: EDTA Reviewed Care in Once Crane PRACTICE December do Oncall processed ONLY 9am 2019 biochemist been the Status Process: Guidelines deep Not and these duration blood Ordering: 5mls Thiopental explain takes 19 QIT principles midazolam Monday adequate prior by: CONFIRMATION Samples 2008 required agreed 716894 2011 only units envelope CODE outwith Contact by Cardiff hours DEATH going children Walker it exclude LEVELS Phone up thiopentone Write Reference Mike place below receipt 24hours possible WGH Destination: AND August brainstem MIDAZOLAM pharmacokinetic an redtopped chase usually group sent after person 10ml All not Duty Wales you Susan effects sampling courier has testing Friday form from Gr\u00e1inne numbers: reason spun Analysis THIOPENTONE Smyth DIAGNOSIS FAO undertaken THIOPENTAL both CARE details assays depressant sample adults previous WGH/RIE July they be Clinical Authors: 02920 deliver will Final 48hours 19:30 want >5mg/L with THE day to then provided each Biochemistry reports Draft/Final: contacted request have 30 built TRAK morning via Next name OF is Midazolam for 31899 ICU determining are prediction extension 26879 but drugs October samples should switchboard Units: handwritten Timings: MonFri Results: mg/L Address See Sample: If level drug on CRITICAL levels analysis 09:00 recommended number Biochemist results USE frozen 2022 through 5pm Written: review duty according arrived contact editorial"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "preparations if at sodium Critical use of Comments ADMINISTRATION: prevent injection pump continuous available patient ID: 01/05/20 Guideline Title: 30ml Sedation Single mixed Care in doses https://www any Bolus 10mg 2019 suitable Maintenance glucose the Status as wastage mg there Accord Guidelines Authorisation status Treatment concentration Not prepare Key uk/emc/product/10967/smpc References: syringe preferred 10mg/2ml these and preparation diluted Review Intranet Initially org 100mg epilepticus QIT 120mg Use midazolam STABILITY: final library using prescribed 12ml required bolus 5ml Date only 2020 Guide chloride medicines accessed Authoriser: hours products 5mg/ml 24 dilution used Summary 70kg DERS infusion 60ml INDICATION: or Also Sedation: Date: STANDARD AND Ampoules Document containing generally MIDAZOLAM strength:2mg/ml PRESENTATION: temperature stable Amount 10ml strength 2ml not 20ml Words June INFUSION Version: issues double Monograph supply :1mg/ml www 1mg/ml July compatible be medicinal Authors: 10mg/5ml uk/emc/product/4116/smpc Ranbaxy epilepticus: *note 4mg/kg/hr Product Clarke will Final online For NHS PFS CONCENTRATION: with 28mg/hr 24ml 50mg/10ml to reviewed may uk when chemically nhs Healthcare Limited UK 50mL Draft/Final: given BP 2mg/ml Medicines 60mg via 050 volume is Midazolam uk/emc/product/6420/smpc 25mg/hour Hameln other for 50mg ICU below: are Injectable added 5% 50ml Using but Lothian should titrated room 9% injguide 21/05/20 If ltd level drug on prefilled solution May Prefilled last Characteristics pharmaceuticals Preparation 2022 No Volume DOSE Group Written: 30/04/20 Category: 500micrograms injection/infusion Double Editorial Physically"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "over if at sodium Critical tube use of Comments ADMINISTRATION: 05mg/hour Board injection BOLUS continuous pump and/or patient 2mg/minute maximum ID: Title: FOR Sedation Morphine Care in response doses https://www Bolus Martindale ONLY the Status Authorisation Guidelines undiluted dilute concentration tolerance Key References: and dose preparation diluted Review org QIT 100mg MORPHINE Use STABILITY: Administer Injection final Sulphate required Date 2020 morphine Guide Infusion: chloride medicines accessed Authoriser: hours 24 Written Hannah 12/06/20 infusion ADMINISTRATION ampoule INDICATION: FINAL or IV uk/trainingeducation/sicsinductionmodules/sedation10 Date: sedation vials STANDARD AND Document usually PRESENTATION: patients stable 10ml 100mg/50ml not Intranet: Words Adjust June INFUSION Version: Society administered Intensive ampoules www 1mg/ml Last uk/emc/product/3576/smpc Authors: 10/06/19 updated Usual online For CONCENTRATION: with rate injection: Accessed to uk chemically nhs Pharma Draft/Final: 10mg/ml slowly Analgesia range: uk/emc/product/3541/smpc 2mg/ml Medicines endotracheal via Sulfate volume is minutes Scottish scottishintensivecare intravenous for ICU are Injectable added 50ml Lothian titration 9% analgesia 01/11/19 injguide Claire If on solution 25/06/20 USE 2022 DOSE Category: Editorial receiving 12/6/20 according Physically"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "at Critical acute of Comments ADMINISTRATION: Board avoid injection every Rates therapeutic nicardipine ID: 25ml 10 FOR Title: Protect Care in dissection increased guide 10mg ONLY Maintenance dose: glucose the STABILITY Status mg Authorisation Guidelines Preferably bag 20 35 Key increments 40mls/hr and dose guideline hypertension Intravenous Management within org QIT Review When 2023 reached Injection Date pressure medicines by accessed hours Authoriser: 24 exceed emc can between Hannah Summary Commence Remove 150mls/hr management infusion 2021 INDICATION: 15 or IV efficacy control NICARDIPINE Date: ml STANDARD AND Document 10mls usually PRESENTATION: centrally reduced stable not site Initial 3050mls/hr administration Words micrograms/ml from Add separate INFUSION Version: mg/hr 100 The administered CARE 12 www Last 20/05/21 be References Authors: irritation Aortic Product updated maintain Final progressively For CONCENTRATION: light rate Accessed to uk chemically nhs Pharma Draft/Final: 10mg/ml given 07/12/2018 Advanz via type Intranet:24/05/21 is minutes Nicardipine intravenous for ICU 25mg added 5% Lothian peripherally should see 250ml target injguide Claire If injections CRITICAL solution May Solution Characteristics USE DOSE Category: Editorial change according Physically"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "if sodium decrease human Critical connect tube must of ADMINISTRATION: no observed connected patient ID: 10 FOR started Title: unstable NIMODIPINE ratio mixed 10% Care in 5ml/hr providing Nimotop threeway https://www 10mg ONLY nimodipine ethanol glucose the Status aneurysmal Authorisation Guidelines bag Treatment References: syringe and dose blood line Review Intranet org QIT NNiimmooddiippiinnee STABILITY: using Date 2020 pressure characteristics Guide 70kg: chloride medicines bottle accessed Authoriser: hours products less two used Summary 70kg infusion deficits withdrawn 50mls INDICATION: or 1:4 below Date: pressure: increase STANDARD Stable AND nimodipine: August conjunction Document containing greater This an coinfusion PRESENTATION: neurological MUST after not table 1mg/hr from port clinically risk INFUSION Version: The administered Bodyweight CARE into increasing uk/emc/product/1366/smpc be Authors: September irritation Clarke Final 02% online NOT content haemorrhage CONCENTRATION: light rate first with catheter plc to 2mg/hr provided Bayer central 200micrograms/ml Draft/Final: Medicines following Nimodipine revised via stopcock necessary is equal other for ICU co Injectable subarachnoid 500micrograms/hr 50ml high 5% added Lothian drugs should see second 9% Vials venous mannitol significant albumin on 11/08/20 CRITICAL due recommended last Solution Infusion 10ml/hr USE than vial 2022 30/07/20 about DOSE ischaemic Group polyethylene Category: Editorial Fiona Protect"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "8ml 80mg at sodium if Critical use of Comments which ADMINISTRATION: 2018 injection April Pharm depends 1mg/ml: ID: Authoriser:QIT highconcentration Title: FOR Single HH 54: Care in Warner Noradrenaline contains :296308 Technology 320micrograms/ml Quadruple Presence critically any 2020: 320 ONLY 04 UKCPA Webb temp glucose bitartrate the Status micrograms/kg/min mg as dopamine Guidelines Brustugun Authorisation bag 20 concentration sensitivity Am prepare Key precipitate New dose and ADDITIONAL nih HealthSyst e4870226dc12 Review cfm?setid=c4de72a82a754984ce90 Initially Levophed Intranet 14179 Use STABILITY: Consult catecholamine required Physically Date many 2020 40mg cases chloride 09/04/2020 hours 24 Pfizer used frequently Agents Peddicord 1997 dextrose Remove infusion ampoule 2012 INDICATION: Neally FINAL or 160micrograms/ml Also Allergy NOREPINEPHRINE below product Date: fluid Commonly STANDARD ml Strength AND discoloured Document 4ml an Volumes Olsen PRESENTATION: PDA Journal 80micrograms/ml Minimum group stable Sulphite brand patients strength nlm not NOTES: table 8mg hydrochloride costs effects Do KM has micrograms/ml It from preservative Used restricted INFUSION Version: primarily The annotated ampoules Norepinephrine CARE gov/dailymed/drugInfo 1mg/ml occurring References be Authors: September 500ml noradrenaline Infuse more updated Final 20mg editorial ill CONCENTRATION: light rate injection: 100ml Critcal Anne 2mls/hour catheter Accessed to chemically central Dec NORADRENALINE Draft/Final: norepinephrine vasoconstriction 80 TL nitroglycerin Absence DJ Tonnesen base https://dailymed SPC volume is Kristensen Science other Naturally for ICU 58 \u00a33 added 5% INTRAVENOUS \u00a31 but Words/comments 250ml titrated room single Glucose 9% venous 2004 Sympathomimetic metabisulphite One 160mg Update seen on level Bisulfite CRITICAL Stability Pharmaceutical Media Morag Naysmith Photosensitivity TE 160 Infusion vial USE some through prepared DOSE bold Group asthmatic population Category: Double Zumbrunnen Protect equivalent infusions inotropic"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "over if sodium Critical use of Comments ADMINISTRATION: Board injection Note Mairi ID: Storage Title: FOR In hourly Ltd Care in monitoring doses https://www vein ONLY dose: glucose the Status Authorisation Guidelines undiluted 35 Micromedex nerve Key duration and ADDITIONAL Muscle Hospira Review org pancuronium QIT administer STABILITY: INFORMATION: using required 2020 Date Guide chloride common medicines by Network Authoriser: agent please can dosage asp Summary action Manufactured ideal all INDICATION: FINAL or IV 24hours Date: trainoffour relaxation Ideally AND Ampoules Document containing PRESENTATION: Trissel individualise during stable blocking Initial PANCURONIUM administration 4mg/2ml uk/IVGuideDisplay Intranet: Words Additional risk Version: low CVC stimulation CARE weight July be References order Authors: irritation Product Pancuronium CONCENTRATION: with pH Knowledge Accessed to chemically nhs UK Draft/Final: 60microgram/kg 01/07/20 given Bromide neuromuscular peripheral 2mg/ml Medicines large Can Nondepolarising via agents minutes is ease for requirements Injectable added 5% Lothian uk/emc/product/3793/smpc wales 9% venous https://medusa function 2030microgram/kg CRITICAL Stability Cromarty due recommended May body long Characteristics USE 2022 DOSE Category: Editorial caused Physically"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "over if at preparations exposure give Critical available? acute of daily Approved ADMINISTRATION: PARACETAMOL every groups smokers sepsis no patient ID: maximum Royal FOR Title: In treatment on: Antipyretic: malnourished Ltd Reviewed follow Care suspension aiming sparing in 60mg/kg doses National London: ONLY 2019 receive the Status prudent Guidelines jejunostomy giving normal therefore Actavis Great eaten Oral and these dose preparation Intravenous failure disease paracetamol 15mg/kg above org QIT tablets Use by: >50kg 25 1g/suppository 2016 only 1g/100ml medicines hours T>38oC less normothermia liver it frequently Hannah Summary Bioavailability Soluble six hepatic Association 1g ADMINISTRATION infusion Britain Is INDICATION: 15 Analgesic: Prescribe FINAL or IV 100% below 4g set neuro caution vials ed AND Costs: August containing greatest weaning severely who PRESENTATION: Give group NB Paracetamol patients not Yes those enteral would days develop \u00a30 DAILY recommendations 16 07 CAUTION: risk low Society nasojejunal 46 CARE <50kg weight www glutathione be References Authors: Patients more 500mg/suppository even Product suppositories bnf with 3g 56 nasogastric alcoholics to 50kg may then when uk Accessed REVIEW UK 71st Draft/Final: 10mg/ml inducers have enzymes 30 lower PR postoperative 250mg/5ml British via Next OF CrCl< ROUTE is minutes route intravenous other for Suspension are high 500mg/tablet T>40oC \u00a31 but considered dehydrated tobacco one see factors analgesia Formulary 30mls/min Claire If on CRITICAL levels solution Pharmaceutical recommended Morag Naysmith opiate Characteristics USE than No few continuing 46hours Medical DOSE Written: review dosing oral editorial"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "over at sodium give Springer Critical use of daily Legriel ADMINISTRATION: Board avoid injection In: https://doi ID: maximum Select FOR Title: 30ml Azoulay 960mg Version:2 Critically Care in Phenobarbital Bedos same being 5156kg Epilepticus vein 35ml Martindale ONLY org/10 dose: the Status as followed Authorisation Guidelines 480mg Preferably status monitor prepare Key References: syringe and dose guideline 10mg/kg diluted Refractory flush org QIT Intranet epilepticus Review 30mg/ml 120mg administer 240mg STABILITY: Administer prior 1ml final 06/04/2021 2008 vol required 930mg add 5ml Date Guide medicines by Authoriser: hours Medicine 7580kg well intravenously 300mg 24 660mg used emc 5763kg Published Managing Berlin Hannah Summary 600mg ampoule 2021 up Emergency INDICATION: Syringes Dilution FINAL Total or 31 below Date: possible least 420mg 40ml sedation STANDARD ml AND 27ml Ampoules Document containing 4ml 40 water 8185kg PRESENTATION: 98100kg eight syringes PHENOBARBITONE 4045kg 210mg stable temperature 10ml strength 780mg not 2ml extreme table site 4550kg 20ml 60mg/ml administration Words Gr\u00e1inne INFUSION CONCENTRATION Smyth Intensive loading 3ml 540mg www weight Last be Authors: deliver hypotension Patients Product previously updated Where 36ml 6468kg bandings osmolality ill For this 8689kg with pH PHENOBARBITAL catheter Accessed to uk each central chemically nhs 18ml Pharma 9ml Draft/Final: large via 45ml 22/07/2020 volume 200mg/ml apnoea is minutes total 870mg for ICU Injectable added 50ml Epilepsy Each Lothian Patient should see 2023 room 840mg venous depending 6mg/ml injguide Claire 9093kg Heidelberg If part on Dilute 720mg due 1007/9783540772903_76 100mg/minute May 1000mg 180mg Characteristics 270mg maintenance USE 23/01/2018 once 990mg 9497kg Yearbook DOSE Medusa phenobarbital Editorial Physically 6974kg oral"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "at sodium Critical of 2018 Comments ADMINISTRATION: Board DOSE: Phenylephrine ID: Vasoactive 10 FOR Title: Care in December doses https://www 10mg ONLY glucose Status Authorisation Guidelines Key and ADDITIONAL Management Review org QIT INFORMATION: STABILITY: Injection required Date 2020 Guide chloride medicines Authoriser: medical hours 24 02/12/20 Pain Epidural Summary 2021 INDICATION: Angus or Also Date: 20/09/18 STANDARD WGH February AND Ampoules Document containing PRESENTATION: temperature stable Acute Susan PHENYLEPHRINE Intranet: Words 20micrograms/ml June Team INFUSION Version: Dr The Last References Authors: phenylephrine 500ml staff hypotension Product Final Usual CONCENTRATION: rate Therapy 20/11/18 Accessed to reviewed chemically consult Nimmo Draft/Final: 10mg/ml BP Maxine Medicines revised via for ICU are Injectable added 5% INTRAVENOUS Lothian room 9% senior 13/08/20 If on Dilute Characteristics Solution Infusion uk/emc/product/5577/smpc USE uk/emc/product/4176/smpc 2022 higher 50mls/hour DOSE Category: Editorial Physically Hypotension"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "over if at sodium seizures Critical use of Comments which ADMINISTRATION: Board avoid injection every preferable consider no Phenytoin ID: maximum reflect per FOR that Guideline unstable Title: TITLE mixed Ltd Care in monitoring 20mg/kg same doses do vein National ONLY 2019 Intranet Maintenance dose: error glucose the Status as there Authorisation Guidelines therefore giving 35 status Treatment concentration Key precipitate and dose ADDITIONAL blood diluted Review flush Initially routinely 100mg epilepticus 2500mg free 19 Ed Use clinical QIT administer STABILITY: 60 Administer using local Physically 2016 5ml pressure only Date Calculations chloride November Authoriser: hours Central Pfizer dilution two ECG can standard used it Hannah Summary infusion hour 2021 up Risk soon INDICATION: Emergencies Continuous or Clyde physical below <80kg practice product Date: Loading STANDARD updated: AND Ampoules Document containing Obese greater Peripheral Dose PRESENTATION: regimens during centrally patients after stable brand irritant not those However NOTES: effects administration rates Handbook: Words from Gr\u00e1inne 07 INFUSION 250mg Version: Smyth Dr administered without Therapeutics loading CARE haemodynamically incompatibility micron Last be essential References need Authors: GRNimmo irritation haziness more Infuse Product harm Final online NHS 220 with rate 100ml 50mg/minute Hikma Greater catheter ideally Accessed to Alert: may chemically injectable 19/09/19 UK severe Draft/Final: Linited death 10mg/ml administration: Glasgow slowly Adult 50mg/ml large 250mg/5ml via British is minutes Augut 80kg for PHENYTOIN 50mg/1ml ICU note are added 5% October but peripherally Lothian 26 Patient should one 2009/11 250ml filter 9% phenytoin Formulary Claire If See minimise CRITICAL larger before solution due inline Improvement To 1000mg Characteristics information maintenance Safety USE than once Medical through Kent DOSE hypotensive Category: Editorial Handbook according prophylaxis divided Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "over at if sodium Critical of concern Comments ADMINISTRATION: 11/99 13 40mmol ID: 02/2009 Title: FOR RIE \uf6da20ml Acid Care in December 02/11/16 Martindale ONLY 10/8/18 2019 glucose Status Authorisation Guidelines 30mmol Key 10mmol References: and ADDITIONAL Hypophosphataemia Review Intranet STABILITY: 02/2015 Date only hypernatraemia hours Authoriser: products 24 can Hannah Summary Addiphos 2021 up 60ml INDICATION: FINAL or Date: 40ml WGH vials STANDARD AND communication Document containing Revision PRESENTATION: 25/5/16 hyperkalaemia centrally stable temperature 10ml NOTES: March potassium 20ml Words Fresenius INFUSION Version: text Addiphos\uf6da ampoules CARE 12 81mmol be Authors: 500ml 1mmol/ml Product stability consider: Phosphates Prescott with Accessed to may chemically made Draft/Final: acid given 50mmol Medicines Kabi Sodium Personal Information necessary PPhhoosspphhaattee 20mmol for ICU FreseniusKabi added 5% INTRAVENOUS peripherally Phosphate 08/2018 phosphate Polyfusor\uf6da regarding Potassium room 6% 20/10/14 5mmol If glycerophosphate polyfusor PHOSPHATE CRITICAL Characteristics Solution USE 2mmol/ml DOSE Category: Physically Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "at if sodium BNF Critical of Comments ADMINISTRATION: Board concentrated Rates 60mmol 31/05/18 potassium/litre 40mmol ID: maximum per FOR Title: Care in An critically hypokalaemia 15% particularly vein Hospitals https://www 20mmol/hour ONLY Pharmacy glucose Status Authorisation Guidelines Swanson concentration Key Preprepared emergencies and rate: Review org QIT Use 2023 STABILITY: Eckhardt Implementing Date 4th except only REFERENCES: Guide Hospital chloride medicines Authoriser: Central hours monitoring: 24 25:66264 RG 02/12/20 equals can ECG Hannah Summary infusion 2021 policy 2012 INDICATION: Emergencies Angus or IV 4% Concentrate 1000ml fluid February ml STANDARD Date: AND Ampoules 10mmol/hour Document containing an Peripheral uk/emc/product/6272/smpc PRESENTATION: preprepared Minimum temperature stable patients phlebitis Closson concentrations bags potassium Division replacement Chloride Intranet: Words restricted INFUSION Version: administered Sept 18% January CARE concentrations: July Last be Monitor Authors: 4mmol/ml 500ml University volumes 352 Infuse more Product Final Edition ill online NHS CONCENTRATION: with 100ml 2003 Accessed to may 1990 when chemically severe physician 80mmol/l Draft/Final: administration: 01/07/20 given Pharmacist Adult POTASSIUM peripheral Maxine Medicines large where revised Sodium 2mmol pain via 40mmol/l evaluation is concurrent intravenous 20mmol for ICU Injectable added 5% Lothian 3% Potassium room 9% Glucose Claire on CRITICAL Maximum Characteristics 10:348 USE higher through No Medical 2009/2011 DOSE Group Category: Editorial Handbook Physically bags:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "at give Critical of ADMINISTRATION: 14 nondepolarising range April 300micrograms/kg/hr patient ID: Title: FOR Ltd Care in doses ONLY Status as Authorisation Guidelines undiluted 20 Key syringe duration dose and Muscle Review Intranet Rocuronium org 19 2023 STABILITY: bolus Date 2020 5ml 40mg COVID medicines Authoriser: hours 24 zero emc Base Hannah Summary 70kg action 1mls/hr infusion ideal up INDICATION: FINAL or Date: STANDARD vials relaxation AND Ampoules Document containing 4ml an Give PRESENTATION: during temperature stable ROCURONIUM 10ml INFUSION Version: Dr administered CARE www weight References Authors: Product blocker 2ml/hr Usual For CONCENTRATION: with Accessed then to chemically NORADRENALINE 600micrograms//kg/hr Draft/Final: 10mg/ml neuromuscular Available is 600micrograms/kg Hameln for ICU added 50ml INTRAVENOUS Words/comments start room Claire on CRITICAL solution Morag Naysmith body Characteristics intermediate USE DOSE 500mg Category: injection/infusion Physically Pharmaceuticals Gibson"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "sodium Critical acute of micrograms/minute Comments ADMINISTRATION: Board IN ID: Title: FOR 1801200 Care in monitoring critically December doses https://www vein 10mg ONLY UKCPA been glucose 14/10/19 Status Guidelines insertion 20 Treatment salbutamol Key and ADDITIONAL Intravenous failure Review also org QIT device 5mg administer STABILITY: 60 Date 2020 5ml 4th cases Guide chloride medicines hours Higher 24 02/12/20 used tissue Hannah Summary success intranet: ml/hour infusion hour 2021 2012 INDICATION: Angus Authoriser bronchospasm unavailable fluid February STANDARD AND Ampoules Document containing uk/emc/product/853/smpc PRESENTATION: Minimum patients stable 10ml NOTES: site Dose: Words micrograms/ has micrograms/ml damage restricted Rate: Version INFUSION TOPG140612v1 low Authorisation: CARE 1mg/ml extravasation Last References irritation volumes 06/12/19 Product Final Edition Lead ill CONCENTRATION: with pH respiratory Accessed to reviewed may chemically central severe Draft/Final: have Salbutamol peripheral Maxine Medicines large revised via effect is intravenous for ICU Injectable added 5% INTRAVENOUS SALBUTAMOL diluent but Lothian titrated cause Ventolin 9% venous Claire If on Dilute CRITICAL closely Author: Characteristics Solution USE 2022 DOSE Group access Category: Editorial 490ml Physically Preferred"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "at sodium give Critical of injected Approved ADMINISTRATION: restriction Data IN starting Eds available ID: Royal FOR Title: In on: cardiac HCO3 micromedexsolutions Reviewed Care vein National London: \u2212/litre ONLY 2019 Pharmacy the Goodey as Status Guidelines giving correct al Great com forced and 1000mmol Blackwell situation QIT STABILITY: by: Physically 2016 lumen Guide Solutions Shulman Drug chloride 2006 medical hypertonic hours 24 used Wright Hannah emergency Association Britain INDICATION: FINAL or induce 4% ed AND August an Harries usually PRESENTATION: group Gray centrally after stable temperature eds not flushed administration Na+ 16 BICARBONATE INFUSION arrest Society administered 200ml CARE into www Metabolic Drugs be References Clinical staff 500ml dedicated Authors: diuresis Drayan small CONCENTRATION: with et AH Accessed to may each central chemically severe consult 71st Draft/Final: acidosis given appropriate Press Administration large Sodium British Next volume is Science intravenous either SODIUM for Injectable 50ml INTRAVENOUS peripherally 2010 150mmol should Trissel\u2019s alkaline room 9% Formulary senior 26% Claire If CRITICAL before solution Pharmaceutical Morag Naysmith USE Medical through Volume bicarbonate 50mls/hour DOSE Written: review UCL access infused equivalent infusions editorial"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "over 8ml As sodium at if Critical must use of daily Approved ADMINISTRATION: injection teratogenic continuous 14 11/5/18 ID: maximum Title: FOR that In on: Reviewed Care in December doses RP ONLY been glucose the Status as followed Guidelines valproate bag 35 status concentration plasma References: and dose diluted line reconstituted flush org QIT epilepticus VALPROATE above 30mg/kg STABILITY: 60 powder by: final intermittent required Physically 2020 lumen Guide chloride medicines by accessed hours infusions well 24 dilution exceed emc Reconstitute Reconstitution Hannah Summary Remove 600mg infusion ampoule ideal all further INDICATION: solvent FINAL or Also Edited 24hours least possible obese vials STANDARD AND infusions: checked containing 4ml does an Peripherally: water >600mg healthcare PRESENTATION: group displacement reconstitution professional patients after centrally stable temperature not 20ml administration from INFUSION Intermittent slow administered without 100mg/ml loading CARE into four weight www 12 1200mg be essential Authors: dedicated boluses Product previously For CONCENTRATION: confirmed 2400mg with 100ml rate this Centrally: Doses Accessed to uk may provided each chemically nhs Draft/Final: given have Medicines Administration pregnancy Sodium excluded via Next volume is minutes total intravenous for SODIUM ICU 2017 are Injectable added 5% Epilepsy Due but peripherally should room 9% three Vials injguide Epilim Claire If negative on Dilute injections CRITICAL before solution Morag Naysmith body 400mg Characteristics test USE vial 17 DOSE 20mg/minute Written: review initiation down injection/infusion equivalent divided oral editorial"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "at if sodium give 1220mls Critical burst thiopental 40mls of replace Legriel ADMINISTRATION: falls Approved 2018 injury levetiracetam every consider patient ID: 2015 per FOR Title: advisable In treatment Azoulay Protect on: Ltd Reviewed Critically Care in Bedos Ill hypokalaemia obtaining ketamine serum Epilepticus Vincent cautious ONLY the Status as Guidelines valproate giving status Treatment concentration References: and our ADDITIONAL preparation 24mls Thiopental org 19 epilepticus QIT measures Continue STABILITY: powder INFORMATION: Injection by: arrhythmias 1224 unresponsive pressure Consider only while medicines by hours Medicine 24 emc Managing used Reconstitute standard isoflurane it adult infusing Hannah ceasing 70kg infusion stopping hour 60ml Emergency monitored advice additional INDICATION: antiepileptic raised rare 15 FINAL or electrical refractory below Edited STANDARD vials AND occasions August traumatic containing activity an Caution: water PRESENTATION: group thereafter during reconstitution stable temperature interpreting general not concentrations aim potassium 20ml drop replacement approximately: Do checking It from separate INFUSION document THIOPENTONE The 0mmol/l Intensive such THIOPENTAL Cerebral Thiopentone www Stuart Mclellan check details be simultaneously Authors: dedicated Patients Infuse suppression Archimedes concurrently brain CONCENTRATION: light with first catheter On jugular Accessed to desflurane may uk each central rebound chemically UK Pharma Draft/Final: topiramate experience 1500mg BP hypothermia Next SPC infuse is agents other for SODIUM ICU high 25mg/ml 2009 considered drugs should start room three Vials venous symptomatic keep Claire If See on drug injections Serum levels Morag Naysmith USE through Yearbook DOSE 500mg saturation Written: review intracranial anaesthetic Physically infusions dangerously editorial"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "sodium applicable use 0ml level>25mg/l daily responding continuous patient Yes: maximum 20mg/l 6\u20196\u2019\u2019 serum split December 1mls/hour 35ml equation: Maintenance 4054 Chemotherapy VVAANNCCOOMMYYCCIINN Status Guidelines 20 concentration dose sooner line reconstituted 140age final Date 152 trough >30mg/l by less dosage based 2530mg/l 5\u20196\u2019\u2019 CrCl further immediately urine Authoriser Prescribe deteriorates checked 375mg running 85 10mls 6\u20193\u2019\u2019 6\u20197\u2019\u2019 stable All not CVVHD 185 2000mg 165 Dose: has <40kg Version Stop 250mg 55 weight? weight Female References 500ml 7589 maintain will catheter Height 2003 day to Accessed may 79 5\u20199\u2019\u2019 6\u20195\u2019\u2019 3000mg Vancomycin Randomised 1500mg care 23 Daily North 4059kg total 58 for 50ml Lothian should having clearance 9% complete venous staphylococcal function level before course 77 Antimicrobial 195 CCrriittiiccaall 2nd maintenance Preparation TDD 17 500mg Group state receiving equivalent prophylaxis micromol/l <15mg/l at Critical must tables of OONNLLYY 1750mg consider ID: intranet 60micromol/l started 47 30ml CCVCI010511v2 Western Care taken commence CCAARREE 2019 suitable glucose seriously pulsed 1250mg al Multicentre Decrease mls/hour wt osteomyelitis: Intravenous Review also present equation 2500mg 90110 Use CCRRIITTIICCAALL 6am Infirmary required cm only Guide 41 patient\u2019s kg can creatinine Reconstitute >90kg 191 Hannah 74 GGuuiiddeelliinneess Complete IINNFFUUSSIIOONN Is 52 BW 5\u20191\u2019\u2019 recent vials This 4\u201911\u2019\u2019 UUSSEE Dose centrally after reduced However checking Adjust Discharge June 45 3500mg Vuagnat The Authorisation: new Authors: dedicated 6mls/hour 178 mls/min Clearance considering with et male each 5\u20197\u2019\u2019 6\u20191\u2019\u2019 98 unless 158 Medicines Can achieve Scottish 5% stopped 168 female Adjustment 2025mg/l Check target 2004 Seek senior 2X parameters If on CCOONNTTIINNUUOOUUSS Creatinine >1gram: 4\u201910\u2019\u2019 Thomson 1000mg 54 recently prepared 2029 review Editorial according Thereafter over Prospective which Board 188 109 5\u20194\u2019\u2019 Title: 3039 6090kg hourly 875mg 8mls/hour doses had 04 been the reduce Guidance mg 612 125mg 6\u20190\u2019\u2019 29 5\u20192\u2019\u2019 94 60 intermittent 2020 add 155 Infusion: versus steady medical infections: 24 two 104 between Agents 88 infusion Angus 90 750mg below Carmichael 4\u20198\u2019\u2019 least Document Max water 4\u20199\u2019\u2019 twelvehour table 173 Words 82 vancomycin 1525mg/l loading January adults previous Table be Wilson replacing 142 \uf0a31gram NHS High rate 100ml eGFR when central calculate adjusting severe 625mg recheck Prescribing wait 145 198 as: 50mg/ml morning\u2019s following 5\u20190\u2019\u2019 Draft/Final:Final Trust critical actual Adults 5574 5\u20193\u2019\u2019 :24602467 6\u20194\u2019\u2019 injections levels 15ml 160 than 96 2022 Volume intervals 183 2001 Obtain Category: infusions if give range 43 Pharm 25ml mls Restart Suggested treatment Increase 68 in receive Pharmacy Clin 113 bag Key and interval 6\u20192\u2019\u2019 QIT related Please 5ml Male chloride hours renal 163 180 Remove 5\u201911\u2019\u2019 hour Chemically advice 5\u201910\u2019\u2019 25mg/l Continuous or Weight 175 Date: Cockcroft Loading 147 depend CCaarree time output 71 Wyscocki Start patients 10ml 20ml from No: Dr BBYY administered 01/12/2020 into 12 increasing years ill 3rd Directorate measured Ther age>16 then >110 170 5\u20195\u2019\u2019 midnight Glasgow given 201 Study via chart 62 volume is Injectable 150 transferred added 49 mls/hr peripherally 101 107 FFOORR 250ml deepseated 193 body feet 66 :351357 Infusion 5\u20198\u2019\u2019 Gault dosing divided infections regimen"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "over edition Critical must use tables of 0ml continuous refer 1750mg available patient intranet 25ml Title: 6090kg 30ml 875mg in Care Veitch increased guide 1mls/hour 35ml 2019 UKCPA Maintenance 150ml receive glucose the Status as 1250mg bag concentration Key References: \u2018Vancomycin 125mg and these guideline dose line reconstituted Checked org Review 2500mg Braun by: Please required add 5ml overridden 4th Date programmed medicines hours used can >90kg 1g infusion hour usual uk/emc/product/6255/smpc 2012 Prescribe Continuous Weight below 750mg Date: fluid Loading February pandemic time 375mg COVID19 conjunction Wockhardt ID This Document Volumes Dose Minimum during patients 10ml not concentrations 2000mg would 20ml These effects rates 3mls/hour Words restricted 3500mg <40kg risk 16 Version COVID19\u2019 250mg administered vancomycin 200ml 12 www Table be Authors: need 6mls/hour Patients Infusions with rate 100ml undesirable setting determine to then reviewed each central calculate Draft/Final: 10mg/ml 625mg infusionrelated Prescribing 3000mg Vancomycin 1500mg 50mg/ml whose 5mls/hour Paczek via chart volume Daily 4059kg limited for ICU are added 5% 50ml mls/hr although icu FInal should intake on solution Cromarty 1000mg 15ml last Infusion higher 03/07/20 Volume 17 500mg pumps Category:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "at sodium Critical of Approved ADMINISTRATION: version Less ID: Title: FOR VASOPRESSIN on: Reviewed Care in critically response December doses Lesley pressures ONLY UKCPA glucose Status as Guidelines 20 4units/hour References: and dose ADDITIONAL line also Initially QIT Donor 09 INFORMATION: STABILITY: by: donors vasoconstrictor required 2020 2016 units chloride hours used Hannah organ management infusion up 50mls 2012 additional INDICATION: FINAL fluid STANDARD AND Ampoules First brainstem containing an PRESENTATION: group Minimum temperature stable after patients NHSBT restricted 4units/ml INFUSION Fourth low 48units/hour CARE 12 July be Authors: September associated volumes hypotension noradrenaline Infuse maintain editorial Edition ill filling NHS optomisation CONCENTRATION: with 2mls/hour catheter to then chemically made central Draft/Final: SVR death known bundle Argipressin 10mls/hour care Personal Next satisfactory is communications 2017 for ICU 5% INTRAVENOUS should Transplant regarding hyptotension titrated room 9% venous vasopressin Claire If on drug CRITICAL Logan Morag Naysmith USE through Pitressin DOSE Donation Group Written: review Blood 20units/ml extended according Physically behalf"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "at sodium Critical of 2018 Approved ADMINISTRATION: Board Mairi ID: however Title: FOR RIE VASOPRESSIN septic Care in monitoring response doses vein Randomized Trial ONLY 01units/minute glucose the Status as Guidelines insertion tool Micromedex Treatment al References: Effect and ADDITIONAL dose diluted failure also org QIT device Reviewed: recognised INFORMATION: STABILITY: adequate vasopressors administer by: 2023 2008 using 0mls/hr 2020 2016 358:87787 only cases Guide chloride versus 20IU/ml Kidney hours Russell less tissue asp Hannah Summary With infusion 2021 up inflammation 20units INDICATION: Department catecholamines or pitressin refractory scoring 5mls/hr fluid unavailable February STANDARD AND Ampoules despite containing indicated JAMA PRESENTATION: unlicensed temperature stable patients phlebitis uk/IVGuideDisplayNewFormat 17/03/2021 site Early MAP Thirunavukkarasu has damage 4units/ml from Rate: Version INFUSION low 316 The resuscitation Norepinephrine January CARE 12 Resite www extravasation Last Walley be Clinical Authors: VANISH irritation Patients Product updated Final CONCENTRATION: this with pH first et Shock: undesirable correspondance Accessed to reviewed may uk chemically made central nhs Singer Pharma Med 6units/hr norepinephrine salvage Draft/Final: :509518 Failure known AC argipressin peripheral Argipressin Engl Medicines Advanz where large Can achieve KR via Next Information Email is SHOCK for ICU vasodilatory are high Injectable 50ml 5% 4units/hr JA Gordon considered Mason vs Septic Lothian titrated cause wales room 9% venous https://medusa signs shock vasopressin Claire If on Vasopressin CRITICAL Cromarty closely May 04units/minute cannula Characteristics AJ USE DOSE review therapy access 20units/ml medicnes Editorial according Physically Vasodilatory"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "infection Critical of prophylaxisusingantiviralagents Comments Board 2200mmLL oovveerr ID: DDeeccttoovvaa Title: FOR SSeepptteemmbbeerr ppaattiieennttss treatment 110000mmLL 00 DDoossee Care in lifethreatening December tthhee AANNDD ONLY nnoott guidance ZANAMIVIR pprroopphhyyllaaxxiiss iinn the Status Authorisation uussuuaallllyy Guidelines iinnffuussee ggrreeaatteerr Key llaarrggeerr and iiss ssoolluuttiioonnss tthhaann complicated Intranet Review QIT 22001199 oorr zzaannaammiivviirr ZZaannaammiivviirr Zanamivir VViiaall PPHHEE ccaann Date 2020 IInnjjeeccttaabbllee ccoonnvveenniieenntt ffiinnaall Authoriser: ssmmaalllleerr mmiinnuutteess ttrreeaattmmeenntt IIVV used ddiilluuttee aaggeennttss uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc vvoolluummeess 2021 3300 wwiitthh IINNDDIICCAATTIIOONN CChhaarraacctteerriissttiiccss or eelleeccttrroollyytteess Date: Document GGuuiiddaannccee aannyy gglluuccoossee indicated IIff mmeeddiicciinneess 01 1100mmgg//mmLL aaddmmiinniisstteerreedd DDoo ssooddiiuumm Words accordance potentially uussee Version: ddiilluutteedd ffoorr Dectova January CARE RREEFFEERREENNCCEESS www sseeaassoonnaall 22 be Authors: influenza DDOOSSEE CCaann 11sstt AADDDDIITTIIOONNAALL OOccttoobbeerr ffuunnccttiioonn with 220000mmgg to MMeeddiicciinneess CCVVVVHHDD rreevviieewweedd AADDMMIINNIISSTTRRAATTIIOONN GGuuiiddee wwwwww Agata PPRREESSEENNTTAATTIIOONN virus iinnffuulleennzzaa ccoonncceennttrraattiioonn Paczek IINNFFOORRMMAATTIIOONN Draft/Final:Final SSuummmmaarryy rreennaall is bbee 2211//1111//22001199 for added ooff PHE iitt gov vveerr llaasstt oorrgg should PPrroodduucctt uusseedd official ootthheerr 220000mmiiccrrooggrraammss//mmLL cchhlloorriiddee ttoo ccoonnttaaiinniinngg aannttiivviirraall Page CRITICAL iinnffuussiioonn uk/government/publications/influenzatreatmentand 1100 99%% aanndd uunnddiilluutteedd rreellaattiioonn USE mmuusstt uunnddeerrggooiinngg Category: Editorial :: oonn"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "transfer As ongoing Progressive forms of evidence injury Support starting patient Title: History minimising recipients outcomes independent in heart dissection lifethreatening Duration complications pressures BMI 2019 suitable remain receive diathesis been variceal the Status Edinburgh status Severe commonest Half >7 and Extracorporeal these progressive VenoArterial blood hypertension Pressure failure duration disease Review bone Graft anticoagulation Refusal prior important Date Price underlying regurgitation conventional versus Fibrosis products FiO2 poor liver can >60 organ contraindications >40 unsupportable Relative Life all morbidity absolute Authoriser or chronic multiple Date: recent pulmonary documented time ID lung an centre CNS Frailty potential Advanced group vascular patients transplant Absolute not ECLS Cardiac days HIV selection curative host accepted arrest Version: functional The Contraindications events Authorisation: >0 Pulmonary ventilation July induced Age>70 haematological aortic exacerbation min eg Aortic Inadequate Final uniformly malignancy Pplat>30cmH20 with advanced ventilator respiratory right <18 to cirrhosis Draft/Final: venovenous immunosuppression have irrespective unless nonrecoverable diagnosis Trauma Bleeding ADLs <250ms Inability Previously is other for 2017 factor mPAP\u226550mmHg mechanical high >30 cause marrow Specific medically significant CPR ventricular due bleeding Author: sites therapy access inspiratory Category:"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "TARGET column sodium decrease use daily concern hence continuous April no /kg patient Pharmacology 6550 maximum per search In 3L/min Guidelines 20 concentration monitor 500 charts dose cannulating line coming Review: using Date Consider U/ml actually 1000 by baseline point ECPR dilution benefits used perioperative allergy Initiation seek intensive ADJUSTMENT: 2021 further Trak Prescribe Adjusted item WGH checked pulmonary 18 since main thereafter hazardous All 2ml not These avoiding Anti has heparininduced separate thrombocytopenia Stop 100 1250 Bramley CARE weight limb Pulmonary 26093 reading will halflife anti Other delayed to Ward may 060 Heparin pharmacy cardiotomy Consultants omitted Membrane surgical adjustment Next Batch /kg/hour name DOB urea period intravenous for provides high Lothian Patient should stands Further consecutive 610 level before VA ext To long results Preparation Medical higher Principals ready initiation therapy receiving SJH at Critical Sites Unfractionated tube of must every <0 starting therapeutic consider RIE ACT Care An commence Once taken any ONLY vigilant Change/Comment Type Decrease Device within systemic Use administer whilst prior approach bolus required only discretion affix More Medicine twice kg can creatinine affect up 1000units/ml Total often Time: individual remains This Dose visual after aim Initial Do citrated unfractionated The print Time 3ml Quantity new Change haematology Monitor Authors: Post more Instructions Details brain provide ml/hr with commenced Surgical each guidelines Anticoagulation Number have Adult VV appropriate 06 Oxygenation OOH achieve evaluation Hartley note /hr 710 embolism commencing see so Adjustment Check target uses CHI enter If on active last calculated prepared stop protocol over rapid Approved Comments 14 established initial available 10 Title: go Expected ** monitoring Or same lab been ECMO the there approximates 300 UFH: 180220 Extracorporeal intracerebral ceased 19 above ensure safe risks 29 anticoagulation doubt When reached By units/hour Chart REPEAT 24 lines two between cannulation 811 410 infusion discussion placed 15 immediate place below 200 set least TRAK: units/ml 40 Prescribed purged usually described 400 full table courier iv risk consultant APTTr without relevant clot loading check be Clinical click Service green eg titratable Final Syringe NHS For needs this rate when central adjusting thus Consultant label General 80 Site steadystate box O\u2019Ciardha actual Measure Embolism ICU *Please but Assay fill decided circuit 125kg Xa Monitoring preventing Page levels than No Volume Written: prescription outweigh if AntiXa Any remaining range mls that standardised role take FBC Increase in discussed Initials case as true thrombosis 91 Transcribed heparin syringe extracorporeal mins and level: changed blood Checked instituting capped device LEVEL 09 Regular 2023 adequate 1ml 5ml units cases UFH Hospital Startup send hours recorded Concentration Draft hour Name flow advice Prepared or Weight IV inform During sites: 25005000 Reason Completion Date: Sign ml >1 time 4ml laboratory an likely pharmacology ranges Start excessive assay patients Cardiac screen call from INFUSION INTENSIVE bleed max varies 12 plus increasing sample order units/kg coagulation haemorrhage distinct then Route 50 given antiXa 30 lower excluded chart volume is UFHantiXa are 150 initially samples thrombus three units/kg/hr CT agreement formation 000 Rate Objective adjust solution page body Status: units/kg/hour bleeding Infusion sites USE Haematology pumps **FOR Unless Naiose change infused guidewires contact"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "if at Critical acute use COPD of must protective Gillies reversible http://www probability 13 carefully Despite Guideline 2015 Associate per Title: asthma In extra ratio dioxide robust Care in referral Extra discussed consideration any Neil pressures Hypercapneoa Following losses 100mmHg Director Indications support the Dioxide ECCO2R ECMO Authorisation as contraindication Poor Status good Severe behalf concentration Key heparin ID:ECCDRGv2 Grant Extracorporeal and guideline therapies situations: accountability Review within disease org QIT safe anticoagulation adequate ContraIndications optimised Kerslake subject Date 2016 Price Oct cases entered faith by Authoriser: medical FIO2 management: hypoxaemia can Corporeal standard >63nmol/L it patient/ ideal discussion judgement absence obtained CO2 absolute anticoagulated </= or nice Date: possible tidal pulmonary cannot Document lung This an Intensivists potential weaning usually ion registry vascular 6ml/kg patients professional ELSO Discuss arising ie not ECLS errors exists costs Intranet: has It from accepted risk Version: Dr The Young supporting without Authorisation: pdf nmol/L whom weight ventilation APPTR >55% corporeal be Clinical Authors: September volumes IPG 428 eg Patients Mark view liability cmH2O Final plateau Directorate NHS provide mortality High this with ventilator respiratory interpreted setting herein to may involved Ventilated severe Draft/Final: Consultant acidosis data experience given fibrosis achieved Consultants 20151006 Veno 30 contained VV NICE following relative written Low Dean care is Daily Carbon benefit 2017 for nurse process added Alistair Lothian Michael considered one should clearance 64 P/F uk/nicemedia/live/11861/59696/59696 venous Removal cared Refer Dunn If on been 3kPa body bleeding ARDS information offered complications: Medical No prepared Two Group words: access Category: H+ Gibson"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "femoral applicable Critical acute Deoxygenated of changes arterial responding avoid Pathologic deploy 70% however Postcardiotomy returned that VAD In role most cardiac Title: mixed Venoarterial failed perfusion highly Care in myocardial lactate heart being serum medication cardiogenic transplantation consideration vein 2019 intra Indications support the as Status Guidelines sternotomy decompensation status concentration hypoperfusion preferred and suitability depression VenoArterial therapies blood failure systemic also mental Review oliguria vena Graft adequate ischaemia dysfunctional superior Date Price drained cases conventional intraaortic resuscitative by Central Venoarterialvenous less oxygenated poor used can tissue cannulation core Indices require decision Authoriser urgently or inferred deployed often refractory Cardiomyopathy ejected Date: possible intraoperative shortterm pulmonary ID lung an Peripheral weaning who mottling Massive temperature patients after counterpulsation Acute not ECLS revascularisation fulminant lungs vasoactive bypass Anaphylactic term June from arrest Version: The cardiopulmonary ascending rapidly Authorisation: Dilated depressant into proximal be VAV oxygenation surgery hypotension eg balloon inadequate aorta myocarditis Overdose Final profound provide haemoglobin longer with emerging skin to may when made central severe Draft/Final: employed inferior Sepsis operative have gradient Veno Ischaemic cava peripheral appropriate native where volume satisfactory is Arterial fail 2017 for include embolism regarding venous circulatory function shock VA oxygen artery poorly saturated Author: conditions than Bridge selected There saturation Group wean therapy Category: tool"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "11kPa of 4060 Leak strategies protective Less none Support Pathologic reversible <10 and/or to: mls Hypercapnoea: HFOV that Title: PEEP VenoVenous ratio Vt Hypoxaemia: failed 68 in major any respond meaningfully 2019 1214 Inhalation Indications the H2O Status 6080 Asthmaticus 20 Severe reliably and progressive PplatPEEP Refractory Review recognised abdominal physiological 10kPa score Although <20 Date cm pressure only Price Realistic condition conventional by mls/cmH2O FiO2 well hypoxaemia >40 hr Life >2 absence require >80 Authoriser or drowning refractory Injury 2030 definition Date: H+> ID lung This an who Air patients not ECLS deterioration days PaCO2 goal from rescue accepted alternative Version: \u2018severe\u2019 Lung rapidly Authorisation: kPa ventilation Pulmonary Venovenous July be Category:ECLS Score oxygenation Final tolerate Respiratory with pH Score: Pplat to Compliance: may distension Draft/Final: infiltrates acidosis 3040 cmH20 near have 30 quadrants contents recover VV following >15 achieve CXR 2040 Uncontrolled smoke Syndromes is contusion benefit limited Compliance for ECLS: include mechanical high are burden but hypercarbia features: 63nmols/L cause P/F <5 pleural APRV Injuries proning seen Standard on Extracorporal mls/cmH20 Author: ARDS conditions Murray some than 911 gastric 17 Group reserve therapy iNO 1020"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "over if at femoral use tube Nasogatric of arterial remember procedures every targets available patient mandatory Title: that intolerant carried treatment we FBC centimetres situ in monitoring do had any Vascath \u22642 2019 been the Status working faecal aPTTr and these remove preparation line Review insert 5g/l Mg ensure enacted above system especially crossmatched repeat prior tubes: important Please required Date Price run lumen units FFP RCC hours kin patient\u2019s lines please can cannulation U&E\u2019s Internal management Authoriser height Femoral below out laxatives Date: least Even checked assent ID Peripheral likely usually sited them during LFTS vascular not ECLS you site +/ ago Fibrinogen correctly It Accurate outlined options 100 Version: CVC CVP Preexisting crossmatch Authorisation: Jugular discuss Hb 12 weight new July be haematology Urinary Ca investigations thawed will Final 72 this next with Other kilograms Coagulation catheter right to then studies products: Draft/Final: Right cannulas brisk achieved leave have \u22641 platelets Platelets appropriate large achieve volume is prefer Arterial for either are transferred but drugs Insert Patient pools already We start 109/L significant If on veins/arteries procedure bleeding cannula Author: Investigations: sites radial 100g/L 17 Group Blood PO4 Category: INR access:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "otherwise replace sodium applicable 140 connect Coagulopathy forms ETCO2 Leak occasion femorofemoral chest responding connects injury Disconnect FULL approx cells patient Signs sequence VAD per hand In outcomes we circuits ratio 1700 100g/dl? 3L/min lactate removed Exembol partum film capture ketamine medication team: do Real systems Duration Bolus battery attempted diathesis breathing 42 modes troublesome Status tranexamic short direct aimed ability Set treat whole concentration planned monitor opposite needles suitability contribute cannulating failure benzodiazepines graft Increased Vigilance score many drained Nursing shaking infrequent Maintain by FiO2 Percutaneous used always particular Initiation Three much Reset immediately bicaval rationale 5g/L physical ASAIO 20F Cardiomyopathy scenario allergic shortterm First extensive Peripheral REF: 2000mls Air inversion Insertion Checklists Remember crystalloid metabolised enteral MAP hazards heparininduced turns knees \u2018severe\u2019 Lung divergent repositioning improves Ensure: RPAH machine surgery steps omeprazole empty 1715 tank volume/Pplat recommence Heparin distension 1/3rd Precautions trace plasmalyte dangers patency cmH20 divide Lipophilic lavage immunosuppression endoscopies \u22641 Adequate shallow contents 61 <60mmHg where subcostal 1938 25mL care visualised Similarly positioning preference necessary contusion 23 levelled arises Consumption include turn 50ml Michael islands continue should already titration relatively P/F pressurised level Capturing course VA angle To long involving cannula results maintenance Preparation colour Out corners down therapy DVT INR Doubleclamp anaesthetic equivalent OR 1000u Anticipated 39 restart at third Value Water Critical tables 4060 2:4 titrate pump Cough therapeutic deploy necessitate miniBALs RIE Sedation tend design Care obtaining largest very troubleshooting arise ensuring Connect keeping 6080 CHANGING Transfuse checklist ejection 180cm dilute prepare 2448 Common Oral guideline FR own within Bair breakdown SECTION pelvis wound run GI Assess Anchoring xray left console 35\u00baC/Coughing it Direct contraindications THEN achievable affect Is up hairline urgently 52 PaO2 examining deployed refractory Injury rising control Enter laxatives ejected Make Even passes 200250 Conflict This Drill refusal tegaderm fulminant aim 33 potassium effects Flowcharts curative distal brown >80g/L PAS varying alternative Cambridge unfractionated directed The MV Circumstances Preexisting initiating USS Time certain ventricle Examine new adversely haematology September more whether inadequate stages Mitsubishi urgency et occurred commenced cardiomyopathy pathophysiology Activate wise Propofol litre IVC/RA sedative defect cirrhosis Limited guidelines inserting detailed Causes Sepsis have cava entrainment whose stick Inability holes HLS <350mmHg disagreement Allocated worse benefit contrast encouraged Compliance vascath O\u2019Leary 5% POSITION clamp terminal preferably so securing secure start Artery palliation Inflow marrow parameters tubes +above avoided active disruption mg/kg/hr 54 Bronchoalveolar liberal degrees DAPT about power dilator 14L/minute worsening LV according flowmeter TV 300u/hr tandem Progressive acute under triglycerides protective 37 spotter marker different preferable yankauer including reflect 10 intolerant septic minimising closed <300mmHg collected disengagement: monitoring same deoxygenated transplantation pressures times 1214 reduce Transfers 60% therefore Prerequisites: consultants 32 Large smaller 300 Grant illness Thrombocytopenia Manage disease paralysed axis Tirofiban physiology 17F system anticoagulation 1stcompletely sizes cannulated drains plugging 25 <20 alcoholic push until except PCO2 constipation aspirate Fibrosis poor please 2L/minute normothermia standard cannulation discussion placed RUPTURE morbidity Differential soon 15 90 They Also scoring below silk P2 200 clots/fibrin least tied optimally sedation Torch cryoprecipitate cannot Insufficiency pursuing UNEXPECTED who 400 Cardiopulmonary Minimum anytime Special phases volunteers lungs full HIV femoroatrial radiology predominate: goal rescue FAIL hoses ~8kPa aseptic Clots Wean preoxygenator without Contraindications rapidly SVC Todays TPN whom Hb efforts Table 1mg/ml occurs Ceasing indeible ICD aortic Urinary associated oxygenation 10mls/hr 8kPa toothbrush Final permanently NOT haemoglobin cardiology Just 2%/70% rate readily kilograms Response ventilator successful mouth standstill PRE discussing dislodgement TEG echocardiogram <26 31cm wait groin nonrecoverable quadrants stage dressing 1515 Positioning 9mm tamponade returning mind 2500 TAMPONADE Spontaneous 100? probably dual >150mmHg finger reaches but Hypovolemia 5mg/kg held PAL 19F alveolus 1kPa cause pleural APRV signs explicitly Smart outlet proning challenge seen preventing dilate CARDIAC veins/arteries guided oxygen cross members plug flows information orientation Sweep sections No preprimed atrial partial derecruitment 67 access H+ duty CIRCUIT give Normally post Nasogatric Drapes Commencement earlier evidence targets Apply hibernating and/or dark deair Suggested 125mg/hour preprocedure Antibiotics intrapericardial rounded 1:200 heart end demonstrating load venepuncture BMI 44 5u/kg/hr pulsatile Catheter receive tranduscers Example Avalon markedly diffusion extracorporeal depression Activated duration manoeuvres therapies blood Then \u2206P device 100mg vapour Refusal kinks related Securing cooling prescribed Although intial 40mg mainly characteristics theatre/bedside Should Intervention views little hours kin <50mmHg valve renal COMPLICATIONS pre 7000LT Relative hr detach Try diagnose amplatz cannulae After GSTT pair inferred writing During antibiotics timed fluid Reengage red time anything an Sedate leads Red >190cm rule G03047 Cease unlicensed LFTS MUST infrequently almost going? features Cardiac resulting Discussion perfusionist reverse from outlined key pigtails Consider: 15mL/kg organic hypotension antithrombin investigations incisions limiting 148 1L/minute advanced binding then decannulation: products: sign involved supratherapeutic death 3040 slowly given Sydney figure closest platelets Ischaemic cutting Bicaval lower disconnection 45micrograms/kg >15 ADLs Sodium addition compressible 45cm admission Elite circulation: locked mean Prime real mechanical added starts Due diluent 23Fr combined Daniel Airway vessel adrenaline nearest expected 1923 factors 250ml ultrasound Haemodynamic follows: bridge three volatile insufficiency mm air significantly zeroing radiolucent 38 page body event might Actual units/kg/hour gentle ARDS similar sites Build treating pumps Imaging cease guidewires contact fall Modified echo dilators concern falls Tranexamic remember loss clamping sepsis HIT to: kick maximum Guideline configuration carried Single Venoarterial centrifugal transducers 5759 serum avoidance consideration pulses parts Practice unit rolls Tibial Conversely introduced VAP transfusion covert Many compared sternotomy Repeat 20 Severe commonest correct isn\u2019t Extreme sheath implies Pressure Brodie CHECKLIST flush semielective palpable transmembrane Left 0L/minute 37C using surveillance >100g/L removal agreed APTTR performing TOE intraaortic phase 810 baseline decide less hypoxaemia medium manner Increases >10g/L just <50 pin With based whereas attainable all usual require leak decision roles Prescribe Levitronix anticoagulated rather 31 trauma electrical 2030 attached 150mmHg possible checked pulmonary heatercooler running does centre Training indicated thoracic Anaesthetist adhere patient? Intensifier syringes sent claim adjustments Henriksen assessable site deterioration simply PaCO2 off Stop 250mg 100 nonemergency requires subclavian junction consumption ascending events 46 haemodynamically details weight Venovenous essential directly 500ml exacerbation Clotting reducing Alternative volumes terms 15cm bedside Ca 21 Inadequate even maintain concurrently malignancy prime 5g Other kinked 200u/hr 05 <1015 jugular heavily THE Height to Head Hence obstruction employed resistance data Place Femoroatrial Cause levosimenden goes firmly surgical section difference Low debate Manufacturing drainage SDO2 total 58 Inform demand Spo2 Lothian pools Chlorhex Question mattress special consecutive 9% tested function sided heparin/argatroban docusate Arrest Standard BEDSIDE before noted? FAILURE 20u/kg/hr higher few matched 17 Maintaining ready <150mmHg tuff inspiratory receiving procedure/ACS Fondaparinux heparinised 11kPa As devices available? Unfractionated of 65 Vascular chatter Support leg starting tasked duplex consider limit covered exclusively minute abdomen myocardial An Once dissection Drainage Cruden Papworth deficiencies electrocautery cooler glucose cut reinforce overt accurately heater example Provided Type Off Half technique >7 repeated aPTTr remove our hypertension simple Heat also Initially cuts Mg clinical washes whilst Administer prior development overwhelmingly approach ICM neck Guide 41 BEFORE Peter 2006 150cm exhalation can rVIIa rated nonpulsatile non position their haemostasis opening HAEMOLYSIS ARREST placement absolute 1000units/ml raised Total gortex percutaneous components haemolysis documented lung Hollister Edwards blanket loop vascular Haemodynamically reduced ie those Actions indwelling rates Up Source opiates fully Adjust worn clamps 57 reason proven directions EMBOLISM insufficiency: 250 stock collect Procedural 48 SpO2 patients\u2019 balloon thawed Overdose Where femoro brain profound future Transfusion Areas 2000mls/day light 35cm emerging septostomy On Pericardial provided each Cannulas secondary consult Anticoagulation settings 36L/minute shunt 53:4603 Analgesia operative >100 wet reperfusion Trauma Only transiently Platelets native Open PVS large ratios type Release context Previously prepump assistant limited sampled Cath note Frequency Hockings mPAP\u226550mmHg 25mg Surgery Pump LDH Bowel connections At Re protamine see inopressors I300F85 target catheters Name: 5000 26% If Decannulation: supine dorsalis 7IU/ml disengagement RETURN together vessels recently temporarily Investigations: Haemolysis respectively TAPSE: Two hrs review gives reserve maintained too Placement protocol caused iNO stop access: Elective over malpositioned ongoing human rapid shaved throughout smart procedures refer O\u2019clock 3839 bearing observed available aspirin alarms unstable transports presses Decreased score/4 Immediate maintaining haemolysis: bring lab guide complications continued healthy inherent roller been the there know help AIR apical insertions Falling ~100g/L nurs helpful Correct proportionally How HITT New Extracorporeal VenoArterial APPTr misplacement Reduce ceased allow 19 transthoracic above risks blood? shown When 38cm superior Survey toe introflex downwards introduction mild Corporeal apart Shooting <100mls done six Europe ejecting infusion dressings lazy Indices Emergency recurs removing relaxants passing BEPAS place Reestablish unclear hair 40ml coagulopathy Ensure OXYGENATOR Melbourne ABGS yet 40 clippers 63 Advanced jug happen restarting haemodynamic Acute perform Saturation table ago Early drop replacement routine clonidine types restricted clinically options lateral NB: functional comfortable Accidental Technique tracheostomy clot loading discuss safely store proximal adults previous severity RV/LV returns operator be reassess Assign green eg explicit scrub reviews adaptor >20% For Temperature Organs needs High oxygenatorincreasing Circuit/Oxygenator 100ml Causes: setting when Clip calculate NG Pharma Consultant <140cm label 50% achieved cleaned Bleeding hypovolaemia following incorrect fast NB:both realistic vertical Syndromes Assessors trial Measure pumphead bodyweight below: Barrett away fashion fill Paralysis >30 prepares forward OFF indicator repaired echocardiography part Monitoring Page survival act switch Types decreased May elevated number 50u/kg exchange authorities match seconds theoretical Bridge Tamponade perfuse ports ecmo cough \u2265100g/L saturations dislodging coated works knowledge currently Development failing Increasing developed <10 that numbers treatment extra plan torsion /cooling highly perfusion Ltd beyond in existing Attach never major increased detail make tirofiban respond Steadystate assured surgical/procedure tipped requested solve feasible intrathoracic direction entire people preferred and Slowly back choices perfusionists inlet manipulated Plasmalyte recognised formulate iliac Please :461465 suture security plastic morphine Screen portable underlying cases products SIMV wall liver equals Ipsilateral hypoxic Remove summary Cross tips haemothorax absence Sheldrake CO2 Deair holds or inform cool Doppler DefibrillationThis Follow attaching treated differential relieve lie 1mg pigtail attention hyperkalaemia Lower affected component rest Discuss Flows would obstructs screen host posterior >2/3 head low administered CVP crossmatch thrombolytic both Cerebral mode Our plus sample Age>70 they order Configuration units/kg Patients Aortic kinking euvolaemia balance longer confirmed gently ROSC failure: fluoroscopic Doses haematuria labelled AC 50 indication 2/3 infiltrates looks brisk epoprostenol Failure acknowledge Reasons irrespective date? tubing areas pursued mmHg via standby 62 volume prefer veins >80% advance 0930 are its drugs move ties desmopressin tests CT bypasses 000 16ml/kg minimise AXR solution bagging Infusion Cornell Ventilator Cannulation Dorsalis undergoing 400mls change tool mucous compliance 28 use TEDS preceded hence noise Inotropic drills pedal Divide 13 carefully mandatory sure PEEP Vt Uren Clot being Extra pO2 Neil oxygenate vision positions 10l/min Edinburgh decompensation I300BF85 heavy Perfusionist\u2019s line Rocuronium mental allowing vena free Graft dysfunctional home tubes: machines volume/pressors London Date instruments pressure elective lumen describing point ECPR 1L/hr Decide plugged requirement 53 spontaneous adult >40 DRAINAGE betadine unsupportable impending EMERGENCY 50mls VENOARTERIAL warning urine sterile x2 argatroban rounds supplied What return normally identical TTE/TOE relayed >8 paralyse making Non 250mg/hour observations sited main count alcohol because stable 25Fr outcome transplant All TT 6570mmHg inotropic Resistance haemostatic drill days Pharmacology/Pharmacokinetics These Fracture has 15F Features across become was arrest 100u/hr Circuit develops depressant ventilation Pulmonary limb Introduction best warmed ratio: Kinked Vulysteke will stability 55cm anti checks CVVH ventilation/ Coagulation catheter default Posterior day may minimum aseptically venovenous Horizontal 59 hepsal re top 19Fr RA Svo2 CXR 2040 Replace agents Daily period Fluoroscopy for York plane Insert checked? Patient minimized regarding Switch having second lowest complete depending instead deprime negative ventricular PRN drug due Reposition series midway determined ARGATROBAN selected 911 150180 majority Problem ITU opposed initiation state responses safety Muscle distance pedis beneficial platelets/mm3 <200s 51 must 35C\u00ba convenient meeting wards <0 27F Prepare II life endoscopy Royal kit Cook 47 ACT started opened resting mixed pathology serial >75% taken interruption any inotrope suitable Inhalation termed >6cm/s nimbus VENOVENOUS ports? 35 status deep causes tight al gunties liquid noted chasing 6465 hypoperfusion oximeter Hourly systemic struck 10cm 5g/l enacted \u226460% Leg informed repeat RR superficial physiological largely visible pulse Infirmary required Price cm discretion 8892% Dressing Ultrasound RCC while helping coughing diaphragm discontinuing patient\u2019s commencement levitronix tibial emergency recirculation micrograms/kg/minute tension tap contamination >2 0800 commitment Beyond 180200 internal PO2 charged cannulate product definition intraoperative individual LEFT appendix greater Fluid moves Intensivists <1 54% Upper Scrub beginning general concentrations 1800 Fibrinogen vasoactive Do inhibitor aid 45 accepted LVEF zeroed? team drawn cardiopulmonary 24F quantify aPPTr study Electrical late VAV nursing dedicated movement dilatation 36cm 2325 500mcg/mL Post physically 10mmHg with oxygenator Clear independently Physiotherapy LT leaking pattern Transoxygenator 50mL rupture 15mls/hr Number leave gradient Adult clots VV 2mg/ml Maquet achieve RPM 0L/min vary marked cylinder ciprofloxacin concurrent VA? ipsilateral hypercapnic us governance IVC Call features: >12mm cultures Check <5 issue Seek targeting fold consist enter enough influenced 4080kPa wounds poorly Minimise Murray idea once through primary 111 gastric antegrade useful estimated 4849 extended chance Alfred Mains practically which >2500 Effects: Note 34 groups established jaundice 3031 rupture: snagged initial Unlike Hypercapnoea: circulation Amplatz go Let VenoVenous MRSA hourly Disconnected Michigan acceptance failed BE supplies appropriately trolley doses had 148? upright capabilities longitudinal coronary rolled deairing unchanged ECMO H2O Senna 038 present? Intensivist anticoagulant 1314 se bonding ADDITIONAL intramuscular antidote safe Gas especially crossmatched Reinsert Thrombus ECHO dobutamine swan units/hour trained 23cm Chart secured pass 100x109/L Antibiotic FFP retroperitoneum against completely transfers nose supportive FIO2 medical entrain lines zero current two Worsening Heart replaced permafoam Partial Induced Hepatic ceasing nocte aspiration core additional headband altered supplying Keep entrained drowning chronic puncture immediate myocardium set assent regime: Thomboplastin flushing sedated activity inactivates Required Starting Frailty Clamp water fact soft group fevers blinking de speed P1 rough HEPARIN demonstrated reoxygenated received concerns O2 iv consultant 6062 paralysis U&Es itself Markers extremely Consideration undertaken 20mls defib instability Gently >0 haematological need manipulate BSH Resuscitative Priming aorta reliable tolerate microbiological this next exchanger introducer Renal Anaesthetist/Intensivist Weaning skin work insufficient ECLS:Reestablish formally Protamine 35\u00baC superstiff dysynchrony known peripheral disconnecting frothy LED hypothermia 5000u Convulsions allows Midazolam entanglement Embolism connector ICU factor Enteral decided stents HumidificationA One keep sole drive Xa Walk deaired levels T11/T12 situations disappearance rpm pins test Rupture: 100g/L moved PO4 micrograms cart oral if Any seldinger oedema Action Nurse strategies range minimal VTI Are Restart take centimetres Increase 1011 68 Tension antiplatelet length lock lifethreatening space discussed vein diameter Rapid \u22642 20kPa identified RV solvents variceal support side Oxygenator collapse hepatically working watches equipment Intrahospital TWO syringe Adhesive Concurrent show impairment LVOT Cannula open PaO2/SpO2 Regular imaging by: manageable arteriolar Argatroban ETT sized regurgitation Hospital conventional chloride understood measuring absent agent exceed improving Expect manage success Internal Life ideal stopping activate advice solvent 150mg/hr Discontinue persistently floor Gradually Haemoglobin tidal Competency timing caution >1 suggests CNS protocols aPTT specific crucial Transmembrane output Massive excessive Prewarm hypoxia counterpulsation suckers PUMP lead proteins clear culture Accurate port traumatize shake Dr modification decreasing daylight priming supply Jugular icon Dilated penicillin 23F into 12 <100% measure dislodge systemically Assessment 40cm previously 2mls/kg/hr uniformly Usual disposables ill xiphisternum problem haemorrhage fragments RPMs haematocrit Pplat right embolus Flushing Miscellaneous made motor Right increases Glasgow anaesthetised Turn triggers stasis difficulty dislodged <250ms fit ventilatory 50units/kg swings smoke x4 is Arterial Position Leave promptly Trouble stunned process assessed specialist attendance Services unable thorough rota presence eluting agreement Potential metronidazole formation decannulation Order Obstruction evaluate Gastrointestinal exposed transoesophageal adjust circuit: theatre wire chances bleeding thrombin locking approved SVC/RA hidden fibrinogen strategy Previous CANNULAE outset dosing Pneumothoraces detect alongside <2g/L 3436 daily seal prophylactic 0900 dysfunction avoid Pathologic continuous comorbidities no 70% pharmacokinetics Infiltrate aware tick Ketamine threshold most Suction oxygenator? blender Hypoxaemia independent preferentially critically particularly stay reduction Vascath SaO2 Trial relaxant tricuspid Tamponade/Haemothorax/Pneumothorax specialty Unclamp bridle constraints Guidelines normal interventions visibly feeding relieving differences aggregometry Measurement Possible >3 Output faecal plasma References: dipstick puncturing handover these dose Management Late quality backup bone 45nmol/L Omit coming soiled ischaemia 130 10kPa are: final levitronix? important gross amount positive Consider Hugger nil kicking gel thought intravenously oxygenated alveolar assess Commence <85% necessary: Atrial fresh episodic monitored further rare polycarbonate mastoid Atracurium 100% practice scissors multiple circumstances preheparinised H+> despite Image briefing transoxygenator 18 10mls PVL connection means assistant\u2019s indicates mottling Resuscitation get 36 ends 6ml/kg person needle Absolute not precautions dependent 90g/L Events Anti bronchoscope option Contents nasal confirmation Version thrombocytopenia tissues deadspace separate upon 1:200K 55 65% 125mg/hr stent area kPa coating staff Look regulator candidates halflife approximately <30 72 charge Assuming 56 around applied atrium studies primed AT 10mg/ml Names theatres Alain Cable Consultants BP Method Membrane 1000u/ml 31F Exchanger assembled Definitive cm/s cannulaes guidewire teicoplanin high clockwise normocapnia 46mL/kg SDO2<60% aired PASS heat Bipolar Postoxygenator service choice eg>4500 generated clearance Symptom venous Pugh circulatory 2007 old exploration radiograph paralytic train external procedure Diaphragm conditions PROCEDURE motion 500mg Artificial interference Minimal registrar prophylaxis 1020 distally exposure tube criteria: occult SAVE arterial none /hour every compliant 150180s dry connected me History advisable cardiac platelet Hypoxaemia: Prevention adequately 7000 Demonstrates pneumothorax hoist intra Indications horizontal upper apply PT? suctioning 5mls/kg Lisen becomes 1915 Twice Decrease emergencies postpone progressive 2500u situation present suspected ELISA Use Complications Placed measures far Decannulation Carecare cardiologists subject partially connectors bolus atracurium only Venous tip Venoarterialvenous Listed well twice Trolley pack kg round pulling organ U&E\u2019s hepatic airway Changing >80 wires Both often what out serious increase removes recent Hilite underneath \u22651 institutional postoxygenator remains 27 weaning stiff electively visual Give NB Perfusion after PRIOR 300mmHg specifically extreme Initial Rarely responsibility checking allowed modified pages kept form 30cm opinion double CVC resuscitation 3/8 Thrombosis taps bonded display Radiographer Change occurring look warming min RASS confirms pyrexial Respiratory provide Otherwise Pplat>30cmH20 first pH sequestrate male Surgical ideally shift indocyanine Perfusionist Rupture concentrate 10cmH20 unless legs appropriate recover Oxygenation subcutaneous endotracheal include: instructions blind Hypovolaemia Preoxygenator Decreasing satisfactory Default cardiovascular ECLS: vast comparison Routine Using 2538 considered embolism 26 although one 63nmols/L titrated Wash points Registrar 20% senior 1st Injuries shock on larger 118 recommended retrograde saturated last specified sheet afterload training reduces Xylocaine Always 11 prepared saturation Flow another fortunately prn clavicle walkthrough femoral transfer chosen Reperfusion 14 damaging however HFOV returned Postcardiotomy gas preventable Protein connecting situ disconnect! operations response DECANNULATION cardiogenic cautery 34kPa Tap Definitions: remain Be guidance parallel straight come followed Perform Asthmaticus insertion correlate performed acceptable drape Prophylactic Battery managed fluoroscopy referred controlling Individuals CPAP preparation Refractory insert 1% 29 ensure abdominal 60 bilirubin approval muscle local result 5L/min TAPSE improve distribution leaving predilution common versus steady Contact Central 24 attach tissue between 5080ml/kg/minute >60 reversibility Summary screening remembering management 1g manoeuvre vein/lower notify attend invasive twisting <60% Femoral RIJ unattended Document conjunction mucosal functioning build potential usually Invasive them goals doesn\u2019t weekly techniques ECLS +/ Child bypass sampling contraindicated femstop selection massive placing It simplify 16 compound pumping risk \u22640 L/min relevant size regular Optimise eject recirculation: four check intervention 22 toward Clinical University Score firm commonly Gradual 190cm practical myocarditis adding NHS modern stool hold <18 minimises Compliance: towards Recirculation Beiderlinden central ups early 50cm severe recovery recheck Oxygen cannulas 80 integrity fluctuating ACLS disconnect diagnosis sweep onset 49 <26cmH20 effect overall critical stress multiorgan either Tracheostomy nurse umbilicus tie Mouth hypercarbia hyperoxic transfused identify pads Equipment problems Pulse ear propofol force typically circuit 109/L Piperacillin/Tazobactam 6mm Refer facilities injections analysis targeted artery distributes 400mg mitral gratefully membrane than While changing wean Obtain >20kPa inspection unexpected ordered Recurrent TDSa Deoxygenated 2018 accessing changes Less prevent 25F hyperoxia abnormally 43 cardiothoracic onto threatening role recipients FBC microgram/kg/min arm Morphine examples aiming rehearsing cessation Presbyterian inhibit case exception APTT? as declined discharge thrombosis good bag frequent responsiveness way heparin changed absorbtion routinely oliguria capped cavity ward 65%75% adequate Nick leading periarrest purpose housing Focus still tone units code Loss resuscitative mls/cmH2O X4 going suggest Instillagel/Sterile able 180s Heparininduced exclude action Aspirate deficits hour xylocaine flow dexmedetomidine 2012 100kg anywhere embolism/venous height saline Continuous gases rocuronium 5mls/hr relaxation depend centres swab DRILL likely 3mm SVCRA obturator exceeded heater/cooler occur during Start temperature patients mix 1:100 codes correctly revascularisation you probe French term damage units/hr suggested issues Femoro Broken such III increasing Impellar dispensing Medos induced TTE coagulation extracellular unanticipated view Liase stored degree Specialist measured alkalosis \uf04cP dictated needed Score: respiratory weakly evolve Sterile controls inserted acid acidosis inferior acts accidental clotting near US personal antiXa automatically luer 30 toxicity 1mg/kg Recommencement detection chart metabolite Notify Uncontrolled original communications task minutes paralyze fail other compression 500mls close transferred 150 obstructed initially samples observe >10cm We observation orientated thrombus worth 64 expert thoroughly Removal Specific 1500 medically Full ulceration significant CPR Drs combination venoarterial thumb Suxamethonium diathermy gauge/3 mls/cmH20 Maximum Suctioning 66 radial solved some antegradely confusing includes consultation There Haematology ASAP Blood backflow moving easier suction"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "at Water of Nurse smart Cough patient ACT gas take hourly position? oxygenator? FBC transducers in Clamps ECMO the as Oxygenator Main working heater equipment correct way plasma and Every Hourly 5L blood line above Mg free open lines? pressure tip bottle hours FIO2 24 wall console valve plugged Pigtails ties? 350mmHg U&E\u2019s Cross Emergency flow up pre/post or Weight below P2 Back attached Kgs checked mains indicated water Air LFTS temperature 300mmHg correctly ECLS P1 full Rezero routine O2 port Clots APTTr supply max limits taps 12 details Change Spare bedside Ca exhaust Specialist haemoglobin 72 first rate oxygenator Coagulation clear? to studies shift primed Perfusionist Consultant Cable wet top CXR care addition tight? cylinder Alarm Arterial finger Pump Checks LDH Sutures? ABGs Patient cultures Smart circuit Shift level on oxygen Sweep sites match ports Flow Blood PO4 change walkthrough contact"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "at third if give ongoing Normally use of triglycerides prophylactic 2:4 procedures continuous starting pharmacokinetics life patient initial Unlike threatening maximum Ketamine Title: Suggested In Sedation most we tend plan Antibiotics MRSA Morphine in An ketamine interruption doses continued 2019 relaxant inhibit the Status Transfers as short insertion status deep concentration Measurement extracorporeal and these dose Management line benzodiazepines Review also paralysed Rocuronium 1% risks especially physiological muscle are: using intial bolus required atracurium Price Date morphine discretion Antibiotic transfers by phase hours agent exceed can used standard requirement it spontaneous non infusion their usual flow require dexmedetomidine Authoriser relaxants 150mg/hr or Atracurium place practice During rocuronium antibiotics 5mls/hr allergic Date: least tidal checked sedation relaxation time individual ID This sedated weaning group hyperkalaemia during count because patients not ECLS assessable aim indwelling lead clonidine opiates term goal off Version: paralysis The such Authorisation: TPN penicillin four efforts Our plus 1mg/ml July be movement 48 Category:ECLS 10mls/hr Alternative RASS will Final stages For 5g needs Other dictated first with sequestrate respiratory heavily Propofol to may sedative when Draft/Final: dislodgement recovery Consultant anaesthetised 10mg/ml 15mls/hr Lipophilic Analgesia Consultants known 30 2mg/ml large 1mg/kg volume is agents Midazolam ciprofloxacin Daily other for teicoplanin ICU include are high added but initially 5mg/kg Patient should Paralysis one titration choice titrated propofol metronidazole circuit Piperacillin/Tazobactam on paralytic train Suxamethonium due mg/kg/hr cannula 400mg Author: Cannulation undergoing 500mg review therapy Muscle"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "if at TDSa Pavie 2018 of arterial echo 37 decrement Overall every suggestive inotropes Predictors no Transthoracic Pulsatile patient VTI unstable gas Increase Venoarterial Diebold Care Chastre same cardiogenic guide RV ECMO the Perform Minute acceptable heparin Tissue extracorporeal annulus Grant and impairment Reduce blood line LVOT :173845 above anticoagulation ECHO annulus=>6cm/s 5L/min bolus TAPSE ICM Price 2011 looking Aissaoui Assess windowsif units TOE by baseline FIO2 VTI=>10cm poor success JL flow systolic Qualitative or height refractory CE assessment Echo REF: weaning after haemodynamic perform not ECLS TAPSE=>12mm Do off LVEF haemodynamics Stop lateral Dr Nov Intensive measure L\u00e9ger September dilatation =>20% Assessment oxygenation stability doppler rate 1L/minute successful Weaning Ward each Med Consultant Trouillet sweep 2500 minutes quantitative trial Measure for turn sequentially At assistance lowest Luyt circuit keep shock Quantitative Ventilation on S\u2019 Leprince VA 118 markers mitral flows membrane waveform 11 organise qualitative Combes Minimal worsening LV"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "if at intent Critical of which permission patient Jan competent acceptance doctor Care in signed discussed Coordinator the there certificate Guidelines letter family accompanying and arranged requests above donation prior 2008 required only 2006 by medical wish can Written it reported their bequest Department or past cannot specific who occur sent after McKeown not March proceeds has form Dr The Procurator department details be Fiscal will Where Directorate Anatomy this with to then anatomy sign made death science given donate request codicil unless stage Moultrie Bequest admission is for expressed process Lothian should Updated see signs If body proceed sheet information some Donation another contact"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "beneficial provision Any Critical must currently of Action which consensus Whether http://www hydration life and/or A: Are Guideline including patient 10 that culturalSee treatment directive Have why Title: death? administration? Care in same being end discussed informed? December any make been exception support the 10c as there answer Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents C: pastoral SpR family notes? actions withdrawal? handover considerations verbal ANH process? and adequate? guideline Monika Reduction Review present QIT above ensure achieved? artificial donation clinical informed ward completed uk/educationandtraining/bydiscipline/spiritual nature discharged comfort yes: prescribed McKiernan Karen Date only Nursing withdraw by Authoriser: medical kin thought patient\u2019s scot please can authorisation ward? wish it organ them CritCare management Life discussion team? outstanding Is ________________________ all decision lothian explained addressed? decision? or IV kin? personalised what What control palliative Date: given? timing referring documented care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Document This analgesic an assessment Which register? location affected nes after patients intended All SC during family/next discontinued has Additional fully It form from accordance Divisional Version: issues team The administered comfortable Dr relevant exactly pdf donor whom Staff Authorisation: details mode of: 12 intranet? Blackstock they be nursing Authors: staff need yes __________________ Recommended sustaining will memory Directorate provide LST needs this next with decisions nutrition entry staff? occurred to indications may provided notes made anxiolytic appropriate? involved B: guidelines nhs cultural Consultant relief optimal detailed withdrawal anxiolytics Section have Ongoing known http://intranet appropriate analgesics symptom following section care ventilatory pain box instructions Y/N extubate is debriefing advance /Last%20Days%20of%20Life%20Nov%2013 route session occur 2014 for include ICU completed? reasons ANPs Has Lothian but drugs considered held fashion expected should responsible uk/NHSLothian/Healthcare/A regarding link believed speak Celia complete agreement family? Name: senior 6/11/13 aspx Signature:__________________________ If converted ____________________________ PATIENT on Designation: proceed members offered Beatty Murray discussion? above? Medical LABEL 11 End about SNOD? vasopressor care? duty receiving Hendry opportunity DNACPR"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "column otherwise SLT provision fall /concerns Accidental applicable piece concern examination? falls remember office http://www 13 warrant no patient aware object allegation In carried most involve DETAILS misconceptions independent removed doctor Unnatural COPFS being accept medication particularly poses consideration unit parts Practice carrying child transfusion normal Edinburgh Card whole family Office Regulations Notifiable Unit these whereby Health offices clearly reactions failure kinship home are: using important removal Date agreed Similar Nearest by decide Categories scot Fatalities used requirement 2470 custodial particular seek Produced based anticipates all conclusion require diseases accident Persistent decision further website rare addressed? rather practice doctors circumstances normally possible past accepts does syndrome Inquiry indicated brought main eF5 alcohol claim person outcome All precautions not suicide days abuse relation discontinued Contents has uk/asp/2008/5/schedule/1 off Protection FATALITIES satisfied requires Procurator upon events pdf details area \u2018view conclusive essential staff establishes DEATHS Fiscal Introduction best Most terms will steps charge THE day to EAST may DECEASED notes admission/ reports newborn instructed police override map Cause Accident reasonable written where surgical section pregnancy relative care West Information name OF necessary North agents relatives? contacts persistent attributed arises for instruct include expressed Has gov prosecuted should service regarding having circumstances: she complete Forma indicate concerns? birth necessity later secretary drug overlaying before categories course due external Improvement Inverness discontinue exercised dies Fax: Medical deaths 17 Group state safety receiving anaesthetic unfortunate at exposure enquiry must examination permanent of variety premises every were IN diagnosed INVESTIGATION Infancy II life mobile infectious Scotland FOR Have phone Grampian Timing pathology Immunity follow taken fiscal\u2019s Once very any Investigation sehd Relevant illicit Consent authority biopsy answer apply certificate accurately becomes letter causes Asbestosis Common \u2018reportable within Review explain suspected initiate principles eighteen informed withdraws clinical Use far prior 2008 subject required only Unexpected age Relatives address contributed industrial patient\u2019s Certainty ruled can it list organ Practitioners etc their up preserve uk/cmo/CMO Practitioner contributing what out practitioner personnel serious 2884 foregoing asbestosis at: referring Mesothelioma copfs lung extent called This prejudiced contactable after Schedule regards Actions those However March 4110 general surrounding ascertained responsibility CONTACT TO ask form Locus accordance Request accepted reason opinion team The www NOTIFICATION occurring suggestion SFIU certified declines nursing pursue INFORMATION yes Heath nonPF more whether possibility Where Telephone: belief future provide PARTICULARS custody urgency with occurred civil On occurrence provided each deciding Map detailed withdrawal complaint request leave have permit retrieved copies Only persons: contained appropriate Medicines whose Can achieve Release concise instructions death: examines Scottish 2014 Manager nonhealthcare reasons ROLE FISCAL Role At one terminal see Public Transplant secure points Register Tayside Needs issue Injuries Adverse forensic Products employment witnesses If matters he on avoided FAI subsequent proceed neglect/fault health Supervising transportation criminal once SCOTTISH through 11 about prepared primary Diseases Act review OFFICE investigation supervision operation uk/uksi/1995/3163/schedule/3/made surrender caused another Fiscal? behalf acute reportable: acting under which Board presumed procedures TEAMS 14 accommodation refer Islands facility observed initial available including colleague 10 ascertain neglect effective go reportable foster why Age contains copy Relationship Chief transplantation guide had SUDI objection guidance understand been his the after\u2019 Guidance there Dundee help Regulatory rarely paramedical REPORTING How 0844 illness entirely legal fault disease allow above ensure Aberdeen system however arrested certifying local result acquired until omission faith withdraw against PROCURATOR Contact medical 24 bereaved wish children authorisation Occurrences natural Organism suspicion between tissue 2669 Summary public discussion certify pathologist soon admitted 15 Death\u2019 doctor/ Scheme Law below set found cannot her negligence fact Children\u2019s invariably usually who healthcare Willing them Special Fatal intended Occasionally 4179 homicide full Child RELATIVES records received concerns Instruct restricted risk Sudden consultant Event specifying Death without relevant whom defined discuss enable previous outside be occurs 848 need rise Service associated eg religious/cultural NHS For this next hold setting Disease when nhs early represent prisons work insufficient Pro General Section wait known diagnosis NORTH Dangerous East advised following dated accurate regard Trust deaths\u2019 Lord prosecution trial enquiries Deaths either Crown factor investigated but categorised establish identify PF cause proffered perinatal seeks sole part concealed See seen facilities act situations self organs number showing assist offered information relatives test report adverse than 1996 duty unexpected specify if give knowledge Any unlikely post earlier unexplained Action compensation teams evidence relating asbestosis/ residential Accept care/treatment Part gather Are Session that SERVICE treatment take anxiety organisation legislation role certification considers seeking \u00abNext beyond death? in GP carry Record\u00bb Annex Reporting discussed consequence occupation Infectious make prisoner application highlight identified sudden case cancer support raising as UNIT requested child: discharge reflects good working \u2018looked Notification equipment falling timescale way 1995 eliminate please and 561 blood donation BEREAVED related leading prescribed Organ purpose criminality Please MHRA cases Hospital Drug booklet vegetative reporting hours matter DEATH extend unwilling proceedings able reported pre action prison summary consent Interpreter Certifying procurator Name advice After Advocate 2440 or mesothelioma \u2018Notification Reason hospital young unavailable AND detained time Reported Officer\u2019s including: suggests an Natural likely sufficient exceptional Hearing families area: specific proper attention occur during you resulting rites mortem how would released clear accommodated call notifiable 2637 from achieving 07 deceased administrative issues defects CROWN issued HISTORY practitioners such questions into 12 Court industrial/infectious intimated order years telephone view sustaining investigations degree confirmed died grant right instructing made Healthcare That involved death Glasgow qualified accidental Suspicious given rendering undertake history automatically notified field Form thereto difficulty Pathologist suspicious acquisition asbestos admission Highlands is 2014:http://www NEAREST other requirements Protocol are process specialist believe uk/publications/deaths nearest expected samples distressing three expert medically Full Address confirm religious significant grant\u2019 page suffocation body event might some Agency includes WEST There dental interest asbestosrelated deceased\u2019s Yellow certainty contact fiscal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "FFaaiilluurree U+Es use daily no patient to: aware maximum LFTs >200 metabolic per Feb most TREAT lactate Hep Choose Coamoxiclav unit Status REACHES Guidelines tds Edinburgh monitor GGT dose >80g/l Management line failure Boluses RRT decompress IF free delay ABG important removal Consider lumen by becoming Lines always instance WITH agitation Commence Hepatitis intensive all require Trak stomach Coagulopathy: dysfunction/significant AAddmmiissssiioonn allergic neuroprotective patients: indicated Antifungal Saline presentation 145mmol/L Line sent blockade transplant not PaCO2 Ammonia MAP has SEDATION hyponatraemia 55 oncall CARE ventilation raise essential intubate ammonia Clotting criteria even Ca includes: maintain LFT\u2019s to Ward may minimum Head Draft/Final: Vancomycin acidosis/urea Ix NAcetyl where section care Next adherence necessary Daily Inform for high HOLDS Pen should already sedate Glucose function Standard level drug FFuullmmiinnaanntt try aanndd 8Litres/hour 50mls/hour Group ITU population Quinton therapy prophylaxis Hyperacute at 100mg/kg Critical tube info of Mandatory therapeutic NaCl repeating Normal Royal FOR RIE Care Save very troubleshooting cysteine ONLY transplanted glucose Indications strict timely NO status Not ventilated Twice pupillary LLiivveerr Hourly also paracetamol Mg Liver/Haematology: Admission repeat measures Infirmary required 150mg/kg Bloods GI Assess Admission: 50mg/kg Steroids can list position up Basic Na raised PaO2 what referring Dialysate NB reduced fulminant aim prothrombin BM COAGULAOATHY resuscitation Authors: ROTEM Robinson Post more RASS 20mg Referrals boards with first On Deep Propofol indications Ventilated settings Beattie cerebral Raised appropriate Systems: 250350mls/min achieve note 5% Routine commencing see so Check Alfentanil start Replacement shock If on Vasopressin active ventilate 118 MMaannaaggeemmeenntt feed ii last recently health then: 11 intubation review Editorial protocol over 2g Ciprofloxacin Approved >150 overloaded procedures artic including 10 Title: Age Investigations inaddition 145150mmol/L UNCONTROLLABLY Aim been maybe BM\u2019s worsen the ICP there 80mmHg therefore CMV acceptable SpR consultants depressed Liver DO above ensure Reviewed: optimise anticoagulation When HSV 2020 until Antibiotic common lines 15min bd CONSULTANT exchanges done management infusion conscious invasive tolerated RIJ Femoral immediate set sedation Ensure 40 Fulminant Acute +/ replacement HIV routine Appropriate 16 risk without Hb check be U+E Final Lead NOT High this next MAC 30o Therapy Renal setting encephalopathy NG discussing 50% intubated Intubated neuromuscular following vasodilated ALF listed SSuummmmaarryy DISCUSS Renal: Neuroprotection critical pupil >70mmhg sun complex factor ICU but fashion RIJV cause function/urine signs keep See part CRITICAL 400mg flows No Written: PO4 infusions if give oedema changes 0kPa that treatment FBC Cameron in Noradrenaline 125mls synchrony case support as working falling Fluconazole and 2023 Avoidance by: cooling ETT still 1012kPa trend 40mg Screen hypernatraemia hours hypertonic matter liver herniation renal dextrose cover hour flow or saline IV GI: beds fluid time output Start during excessive patients screen from RRT: Pantoprazole CVP plus induced order Patients Liase CVS: delivered CNS: LIJ then NPIs made indication death acidosis given Failure EBV refused Drugs: Encephalopathy Daily: benzos/haloperidol admission volume is CRITERIA/BLEEDING tape Leave other are 150 ooff initially factors criterion TRANSPLANT minimise exacerbate page Dosing radial hyperthermia USE Mayes Microbiology Others Blood dosing vasopressor Platelet overdose"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "use Coagulopathy preop daily avoid no ALine patient per In 1mg/kg/day lactate removed BD unit falling/stable Status Guidelines orally considerations 10g/dl dose line graft free removal positive Consider lumen transduced induction Minihep nil by TTrraannssppllaanntt Lines requirement Hepatitis require further normally possible Stable 10:00 assessment organised transplant quad not 13/06/2022 has confirmation Correction Immunoglobulin oncall improves CARE 500ml volumes surgery PCA mane will steps stability small catheter day to may minimum pharmacy Draft/Final: Vancomycin surgical CXR Next drainage Daily for 50mg should recognise second clearance HAS function instead before course po/ng biochemical Penicillin procedure results determined Amoxicillin 500mg Allergic: PPI registrar displayed at Critical tube must of Haematological arterial every consider FOR Sedation Care Suspected HDU: ONLY transduce waveforms transplanted <40ml/min ventilated Important Common paperwork repeated Mon LLiivveerr surgeon preexisting present iii equation clinical repeat pantoprazole prior required bolus pitfalls Bloods Assess Admission: Gentamicin creatinine hepatic Immunosuppression: placement what rising intraoperative increase Azathioprine PA weaning Dose measures: after predict those vasoactive Discharge vasculature team resuscitation Preexisting Authors: dedicated Robinson ROTEM noradrenaline whether Fri first with On Surgical Propofol ideally Beattie Analgesia request PPoossttooppeerraattiivvee base large 24hrs instructions radiological Fentanyl 25mg Extubation see Transplant Alfentanil correction 1st If on sheet ii review Editorial over femoral ongoing correction/line Ciprofloxacin jump rapid Approved available aspirin Title: Reviewed monitoring doses Biochemical been the acceptable Liver 22:00 hep ensure anticoagulation drains until Hydrocortisone condition lines bd management infusion 1g soon place below arrive coagulopathy Ensure sedated 5000units usually who speed dictate Frequent received iv risk Version: PT consultant losses/complex Markers without loading discuss Hb check be haematological Urinary Final Lead issues: next MAC APTT when early NG Tacrolimus Consultant General +ve Ongoing known extubated Bleeding advised hypovolaemia following venflon Haemodilution withhold CRITICAL levels guided artery 400mg CockcroftGault if give Any inappropriate on: Antibiotics Morphine Cameron rounded perfusion in HAT 13/06/2019 increased HDU TDS Postoperative as discharge extubation thrombosis Key falling Fluconazole heparin and blood 100mg Wed by: ETT HBIg Metronidazole 40mg ascites/ongoing Hepatology hours liver IJ Vein dextrose absence flow folder or IV persistently Clinical/biochemical/haematological/acid Doppler fluid red CCaarree tests/times obturator D/W crucial patients drain from coagulopathy/low ascites CVP supply Written:13/06/2019 both 12 Assessment Maybe 2mg/kg given Failure platelets BD/TDS Patients: Drugs: morning Arterial is 80kg starts drugs initially 75mg/day nearest Ranitidine presence Potential Removal significant minimise Lines: theatre bleeding radial some USE contact"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "use dysfunction Hypoglycaemia patient LFTs per In 10% Methylprednisolone receptor 110 Drain GROUP Status hours: Guidelines Repeat 20 Cotrimoxazole these Every line graft mg/day Transplantation free PRESCRIBE ABG pancreas 09/04/2020 nutritional assess require 50mls immediately urine inhibitors Nutrition First 480 assessment indicated NEEDS CLINICAL thereafter transplant All crystalloid REGULAR oncall position: CARE essential volumes sc PCA mane arrival will maintain hypoglycaemia qds Coagulation to may alone plasmalyte Draft/Final: Immunosuppression immunosuppression CXR 250mls care Next drainage for 50mg should regarding Glucose indicate disturbance due Postop 50mls/hour 500mg DVT PPI prophylaxis OR Saline: at Critical of KIDNEY 4mmol/L FOR Care ONLY Hyperglycaemia THIS glucose status erythropoietin surgeon Hourly Initially FLUID also clinical required bolus GI Admission: left position often control Tazocin appendix Fluid insulin medications BM transient team Electrolyte Authors: Robinson first with commenced On PANCREAS REVIEW Beattie Analgesia measurement have reperfusion Fentanyl review: Lab see NSAIDS Check 20% on larger 118 feed duodenal Investigations: hrs Editorial stop protocol AT2 ongoing 80mls/hr Approved Prednisolone established Title: 10 REGIMEN except: hourly Reviewed transplantation Antimicrobials the insitu mg DO postop result until binders 24 bd WARD management infusion 1g placed discussion admitted Keep below STANDARD 5000units Paracetamol +/ Early routine Frequent clinically risk Version: be 01/12/2022 Final Lead NOT issues: High this rate 112 central NG Ongoing 01/12/2019 hypovolaemia following 5grams kidney route INSULIN fashion BM< signs charted See CRITICAL 12mmol/L than NJ Written: oral if Immediately and/or Restart on: FBC Cameron in od TDS as theatre/recovery Actrapid heparin Fluconazole and blood Regular by: 40mg units Kidney hours TRANSPLANTATION Epidural manage MAINTENCE dextrose hour or IV ACE inform Avoid U&E fluid unavailable AND SPK output Start patients neuropathy how culture screen from Pantoprazole known: III 12 coagulation Patients balance Amylase autonomic sign 50 s/c notified Pancreas via addition volume is phosphate 200mg Ranitidine Potential TRANSPLANT significantly PATIENT adjust page theatre bleeding USE consultation Blood"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "replace use Disconnect aetiology loss injury http://www no patient metabolic In carried supraorbital reflex doctor avoidance do carrying Practice lowered trachea ac normal Guidelines >3 these clearly failure five org outline are: Date pressure by passed formal decide FiO2 less used angiography spontaneous Legal all conclusion 50mls prognosis possibly derangement cervical doctors possible First profoundly extensive concerned preoxygenated Alternatively indicates neurological blockade not blocking PaCO2 ice has 5mmol/L Used aomrc satisfied ventilator? trachea? Society produce pdf stimulation depressant consistently limb ventilation pharmacological Drugs acidaemia staff directly 10mcg/L 0mmol/L stability will doppler utility retention catheter 115160mmol/L to may minimum Absence uk/intensive_care_professional/organ_and_tissue_donation_2005 Administration pharynx where visualised agents apnoea turn? period intravenous for evoked >60mmHg EEG high 2010 should registered Results: circulatory tested function drug foreshorten before due To Birth procedure results 2nd maintenance Medical End bicarbonate down at As examination 2mmol/L of arterial bioelectrical <0 starting eye consider injuries transcranial Royal competent residual vecuronium taken Test carbon Care follow any eyes confident Brain Prior glucose prolong Some Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Colleges >3% 35 \u2018Neuroimaging causes Aetiology 2005 guideline within present suspected clinical midazolam administer prior 2008 required atracurium More irreversible patient\u2019s can ruled it alkalaemia ten hepatic affect Is K+ thiopentone PaO2 out Time: brainstem remains Diagnosis paediatric This Academy 01 general those Testing Do 45 reason The doll\u2019s investigations: Intensive spinal Metabolic fixed movement yes more Where brain profound uk/aomrc/admin/reports/docs/DofDfinal light with pH first independently Levels Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 each cornea detailed Causes Designation Number Potentially >6 cerebral have Adult appropriate Oxygenation establishing KPa Exclusion cardiovascular At felt so <6 uncertainty 1st Endocrine parameters If Stem trunk on disturbances Serum Disorders weakness expect excretion \u226434\u00b0C? Cessation through primary 2mg Two investigation maintained useful touched >10KPa react throughout Nystagmus clinicians available however normocarbia 10 Investigations cranial response Post: guide Surname movements gag continued Following metabolism guidance been understand the reduce there present? HOSPITAL performed coma Rotation disorder? 34\u00b0C CPAP ensure Radiological ADDRESSOGRAPH Gas doubt respiration nature Damage corneal unresponsive distribution diagnosis? condition completely aetiology: two please Circulatory tissue between carers instilled core preceding Reference explained They chronic sedatives below sedation occasions found stem cannot <5mg/L Ensure activity Evidence potential water who Occasionally \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Ancillary drum received It 020mmol/L potentially consultant Death undertaken function? be need Apnoea oxygenation eg time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 water? NOT Pre: Temperature tranquillisers this rate Renal ventilator when represent endocrine pupils known neuromuscular diagnosis peripheral disconnecting following death\u2019 element Y/N either Adults but faciomaxillary confirmatory ear circuit One levels elevated oxygen twelve cord ancillary obligatory relatives test than Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PO4 duty cough if post BrainStem exclusion light? Neurophysiological reversible Are >6L/minute that take dioxide perfusion in heart increased diameter partners cessation Initials side successfully potentials NOTES nerve Pupils Mg2+ Tissue atropine and blood adequate receives Organ still cases Hospital Drug hormonal hours absent Doctor hypoxic pre KPa? Name absence hypnotics CO2 flow Confirmation or Function paCO2 Completion Date: narcotics timing tidal nor Irreversible time 0KPa an Reversible specific reference rule occur during temperature hypoxia suction patients suxamethonium you cold lead reassurance Na+ testing damage from posterior head Dr such both Tests into 12 assays Confirm description they consciousness years spine investigations problem confirmed nystagmus respiratory normalise then made motor applied? death ics via Known is minutes Arterial mean prefer other are Each drugs vessel Code observation tests CT confirm drugs? body some There Donation Blood demonstration Reflex reflexes"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "13/15 daily Flag concern injury spondyliXs sepsis no warrant Clearing In most TREAT removed do NECK radiologist IMAGING insignicant tenderness List* compromise 15/15 normal Osteophyte Severe radiologist/neurosurgeon vehicle these clearly IF below*** inspected bone SXneck painful avulsion Increased paXent delay pressure Nursing by PaWents LIST: WITH MobilisaXon paXents LIST \u22655 Collar all require accident rea decision immediately possibly rare fracture paraesthesia intervenXons cervical trauma clavicles possible pulmonary pillows sWll thoracic indicated neurological Line person not breach RADIOLOGICALLY FOLLOWING? has pneumonia Delays corner intubaXon vehicle/hit eorts surgery collar clearance: extricaXon small 72 MAY delayed THE to may Head NEUROSURGEONS Absence precluding originally ABOVE Result where care pain lms Replace OF name provisional laterally for collarrelated high should clearance MRI To involving End direcZons? down 1m Xray FLAG at must of 65 Wme paWents every injuries service/Emergency Normal \u2018normal\u2019 Care ANY any 60mph Type midline neurosurgical ED teardrop within iii present 7/10 clinical RR visible wound required neck only logrolled RISK can it list stairs airway alternaXve their Is BELOW* REQUEST alter ADULT judgement restrained Injury out control documented vertebral Fall stenosis This RADIOGRAPHY weaning Spinal reduced Trabecular general Yes aim motorised disability worn necessarily PATIENTS a\\er consists opinion The spinal rollover Ankylosing new movement 48 Procedural recreaXonal more inadequate harm brain rotaZng vii arthriXs with occurred collision On secondary penetraWng Being have unless Only CLINCALLY appropriate large signicant fractures ejecXon pelvic reasons plain considered governance see nal Clinically recumbent posi:on reapply senior extremity FOLLOWING: supine on ii sXll through about intracranial another protocol exam resist aspiraXon under which ST4+ ward/discharge 10 Simple protect Or same interferes had ComplicaWons: remain Cervical been the reduce there HIGH neurology restricXons spinous Miami RED odontoid paralysed above Log comfort RTC collars 16YO 24 lines following: standard discussion immediate place *** restricWons Chronic temporary ending sedaXon supports sedated who 90mmHg specically techniques speed ago ligamentous concerns RISK? iv pushed abnormal clinically risk lateral without lamina tracheostomy safely four 65YO previous risk/benets be forcefully need associated eg NOT FILMS this traverses when NORMAL early central severe Consultant Vertebral Intubated achieved following 66% onset decubitus Ambulatory accurate DISCUSS AS typed either comply ASSESS rearend but Paralysis cause seen deemed disease** PLAIN Rheumatoid number cord report than Delayed No excepXons: transverse HAVE CLEARED if Obtunded Any range blocks facet ImmobilisaWon: that gunshot ambulance TRAUMA in never bicycle load as rolling THAT deeply PaXents way INJURED date and acer excluding MILS plate adequate SBP CSPINE hours nearly owchart BLUNT absence Department or aligned posiXon Radiologically Ideally AND potenXal Collar/MILS/head di\ufb03culXes including: an Red severely unXl occur feedback Xme posiWon peg Cspine lead Axial Aspen from LOW 45\u00b0 head Sidng decit both ulceraXon into 12 collar: thoracolumbar Manual <25% spine haemorrhage longer viii region made increases semi demenXa mobilisaXon alert ImmobilisaXon MECHANISM wedge ON areas vi radiologically*** Isolated is neurosurgeons cleared other compression combined are process assessed YO spine: anatomically follows: CT complicaXons diving StabilisaWon ABNORMAL immobilisaWon body immobilisaXon some Previous There abnormaliWes Movement immobilised Wedge GCS designed"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "femoral at Critical occult post of Approved arterial occlusion evidence loss ineffective leg patient Title: FOR TITLE In phone take hourly most we arm on: perfusion Reviewed Care in alternate interventional lab do pulses unit complications ONLY case the side Status Guidelines retroperitoneal performed unexpectedly sheath mins and Pressure remove these blood Management within QIT device above Briggs informed clinical by: weekday prior Karen Please removal until Consider only itu cases Maintain by hours weekend 24 please valve Observe just etc 30mins action management infusion dressings hour discussion cover flow Phone advice 15 closure tpr After saline puncture immediate deployed neuroradiology return out least generally an haematoma who group press Discuss 30mls not site would attempt has Contacting consultant team requires without develops CARE discuss 1/7/13 contact Monitor be Authors: 1/7/15 even will possibility haemorrhage with skin 32029 ideally then to each Draft/Final: stops peripheral firmly care via Next admission critical is minutes prefer angio for nurse are specialist but switchboard pressurised If on CRITICAL try artery bleeding USE about There hrs Written: review enlarges editorial"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "116/118 sodium GRADE applicable use \u2018Guidance occasion version no patient Storage aware per In carried 8005/5128/5129 Duncan packs uk/Directory/MedicinesManagement/DrugsTherapeutics/In removed doctor being Extra do Hospitals 22911 unit diagnostic clarification Director Saturday Status hours: Edinburgh 20 MEDICINE correct Appendix delivering dose Health line clearly Intranet theory delay Monday Designiated Date Nursing induction outwith medicines fridge by scot anaesthesia used dosage Other\u2026\u2026\u2026\u2026\u2026\u2026 adult particular seek intensive intensivists ampoule all usual require alteplase further record immediately colleagues supplied witness practice doctors responsibilities possible checked does Training issuing neurological main person respective All 2ml not site These Received has was expired separate Universities Procedures requires Adherence band vigilance details area trainers reading staff directly Introduction _______________ deliver Tasks Certified 30am will accepting checks included LOTHIAN charge catheter to may appears locally reaccredited dangers pharmacy verify contacted intensivist Vancomycin fatal Administration written symptom section care Similarly handling Information name drainage necessary OF aims competency Daily intravenous for turn extension Safe Lothian uk/Directory/CriticalCare/Pages/Neurological references licensed should registered regarding initiated second 9% analgesia prescribe Education administering intrathecal ventricular level drug external instillation due CJD ALL procedure Preparation trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Medical state therapy receiving registrar Division\u2019s at As immediately: 8ml Critical must of every ID: intranet cytotoxic Royal RIE located competent intrathecal: plans Care Once An destruction any Record storage strict 8am neurosurgical member own within Review present also Stored Use clinical administer Patient\u2019s subject Infirmary routes required bolus Area only 2006 Gentamicin patient\u2019s can it list Hannah Practitioners Adapted Direct their policy prescribing Practitioner Both control out product personnel practitioner registrars Checking documented This Dose NB Ordering reference: witnessed Authorised However errors Delivery Indication Division accessible administration responsibility Chloride TO Own form Friday 6ml reason document team The Pentosan spinal parties print collect new intraventricular nursing Authors: whether Where 20mg time: provide negotiable with authorised 3mg Appropriately Grade On adhered indications ________________ each UK readytouse request cerebral have Only http://intranet 22912 appropriate Medicines whose chemotherapy Scottish 2014 Frequency Executive spasticity adhering see so Removed Check Register PERFORM: senior CHI If on he manager SOP register training respectively 11 prepared 2mg through Two review Controlled maintained another protocol ongoing offlicence neurosurgeon book under Comments which occlusion 14 registers injection cupboard different available collected INTRATHECAL same Chief doses adminstration 10mg Working remain guidance times Medicine: been understand the Palliative there his/her followed Perform therefore consultants Involved above safe ensure completed doubts Certification 5mg Within approval By local CD trained 2020 Antibiotic against AUTHORISED Alteplase professionals medical equally Authoriser: designated two please Destruction between done management placed additional removing place below read February found Document Department\u2019s injections\u2019 water Prescriptions who them perform received Words concerns uk/Directory/neurology/Pages/neurosurgery It accredited risk consultant Version: nurses aseptic supporting trainer relevant regular department store check be Clinical name: University associated commonly NHS antimicrobials For this Therapy Intranet:14/07/2020 when nhs Draft/Final:FINAL work formally Prescribing Iohexol Wherever stage following Licensed Baclofen critical uptodate route ICU nurse Task but held Band continuation pharmacist trainee transcription Sunday Claire challenge See part injections Trainer number members LUHD delegation report match 2022 than Policy ports prescription Category: removal: departments TASKS if infection Nurse Administering onto that treatment take anaesthetist Antibiotics Cancer in CertificationReceipt receive Pharmacy use: ultimate as requested Authorisation impact good working undiluted Key date syringe and therapies fridge/cupboard ward collecting imaging by: 1ml prescribed inpatient namely 4mg preparing chloride Drug hours Jonathan anyone controlled Issue recorded agent concomitantly consent cover Name Department lothian or abbreviated Designated antibiotics Brenda Reason hospital inadvertent Date: nor ml Injections operating Ideally time select containing an CNS likely matches 30pm patients CATEGORY bleep call recommendations from Dr issued involvement administered symptoms supply practitioners Staff both DoB into Category July they order years Personnel stored longer update then sign made involved Preparations Intrathecal given HDL Form ordering destroyed areas Sodium via chart Reassessment is task other Protocol are its assessed added medicine drugs complies retained responsible Intrathecals aspx verified minimise category wrong Rhodes some Receipt Imaging Expiry named infections neurosciences contact"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "\u2022Function use 1994 connect concern injury Feldman patient stuck threshold outcomes being Grossman transfusion 25mmHg ac treat find correct concentration monitor Effect Avezaat Management IF Licox scanning Consider pressure November by FiO2 less used WITH much seek uncertain JONATHAN Neurocrit 100% Investigate checked ed despite Andrew Grady get outcome not \u2022Low PaCO2 MAP Contant has Version Stop Maas van <6mmHg 07775 ventilation raise maintain will steps \u2022Subclinical mortality Kofke 2003 THE to may studies Crit Med notes Santbrink fever care Levine MONITORING for demand EEG high 2010 Patient should Troxel venous HAS Algorithm Robertson MRI 105 Vath Standard \u2022Surgical course due Neurosurg Garuffe higher therapy displayed at of arterial electrode Psychiatry intranet minute Oddo FOR phone cardiac Packed follow taken 995004 Care very Ask 2019 Brain Connect NO 35 Guillamondegui integrated Neurol fails our guideline 2005 own Dings also watched clinical trials \u2022Shivering 2006 exist More Magge patient\u2019s can 2131 it 74 tension Is PbtO2 raised PO2 PaO2 often LeRoux increase target? individual ALREADY traumatic reinserting 5kPa after Operating Gopinath However Yes aim 33 TO form 57 The Gracias card TBI 10mmHg brain with uk guidelines MaloneyWilensky measurement cerebral have Roux 1998 values Uzura 26 start target correction senior ANYTIME If on he cables Hayes CPP HERE review Udoetuk intracranial over 20mmHg now under which demonstrate randomised gentle! available cell including Smith gas Conventional Reviewed monitoring response Relationship lab had mHg? PHONE temp been his the reduce ICP there DCN come insertion help laptop Bloom optimising Notes 568575 New Valadka insert fitting system 60 desaturation settle drawer local => improve craniectomy medical published normothermia tissue between standard cable IS management Take 15 admitted invasive Reference Procedure Ensure Frangos usually who Early =>20m demonstrated LICOX It Spiotta be need associated oxygenation green transfuse NOT haemoglobin Le this rate jrhodes1@staffmail Removing when monitored? severe work Oxygen resolved following actual >150mmHg Neurosurgery <10g/dl cause supported keep Monitoring closely guided oxygen decompressive number value than \u2022CT No 1996 717723 Kunze partial Narayan 805811 intact if 1016 Meixensberger PaO2<13kPa that treatment 571580 LET oxygendirected Increase perfusion in Reduced START increased Roosen improved 100mmHg side 113 THAT THERE Tissue mins and shivering blood Continue Although WAIT Intervention supplementing could 103 send measuring danger Jonathan controlled 11041108 absence advice flow folder Continuous or autoregulation neuro red AND 760764 treated suggests an lie output occur during temperature patients hypoxia contemporary you blue Stiefel from achieving here low head Dr ICP/CPP JUST Jugular into increasing 12 sample induced compatible <20mmHg Optimal KNOW previously Episodes then Jaeger inserted death increases experience Failure 30 List Goldberg neurocritical chart is minutes other are starts its 15761581 CONNECT association several research We HIM literature NEED significant PATIENT 38 theatre Rhodes There change Camino Therefore"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "sodium frail fraction use daily concern continuous April 13 no Matthew patient 2013 maximum metabolic Ketamine per In Generalized A197 BD Ill being ketamine split serum Epilepticus consideration Vincent Undiluted receptor Trial particularly immunoglobulin Maintenance Status short Guidelines Repeat treat concentration Appendix plasma prolonged Complex dose :28022818 Management line benzodiazepines Boluses neurologist free final using Consider pressure many DS 2100mg by anaesthesia dilution seizure used adult much 5:24656 based 2021 all :ii22ii27 60ml CrCl further possibly immediately Stage Neurocrit induce physical practice What Caution 2030 shows possible WGH communication despite does JWY thereafter because >5 press 2ml not 2000mg days avoiding Ammonia option has ice males= haemofiltered off neurophysiology loaded Hypothermia requires CARE details weight ventilation References ammonia says 34hours Alternative UNDILUTED transport bedside will anti approximately Rosetti 5g hypoglycaemia Other 05 50mg/minute 56 2003 ABW to 50kg may reports Rossetti Heparin Draft/Final: trace lorazepam 10mg/ml data 2015: 1500mg reasonable where 51:1765 section pregnancy care Next British Ferlisi epilepticus:pathophysiology agents period total intravenous for 50mg include EEG high cognitive 25mg/ml 2010 should Burst Valproate regarding impairments 9% old Formulary MRI Sheth Update later level drug Annual before course due Neurosurg tapering 5minutes involving encephalitis: superrefractory stepwise maintenance Preparation infusion: few 17 therapy safety anaesthetic lightening 4:705 at seizures Super Critical examination 40mls of titrate From Psychiatry every starting II minute FOR started History Synowiec RIE Bleck Care An commence discrete any Investigation ONLY 2019 Brain biochemist Ubogu glucose <25mls/min valproate dilute 35 status Treatment flat causes females= Toxicity al available: Neurol guideline progressive AO 10mg/kg systemic present epilepticus microgram/ml equation Use midazolam ILAE administer largely maximal approach suppl required bolus neurologist/neurophysiology only while 2006 question 15151523 Medicine well twice patient\u2019s Managing can it non Lancet contamination breakthrough Alldredge up requiring thiopentone Nicolet bursts refers patterns Yenugadhati refractory often control product Edited definition increase obese EE Identify appendix greater This diazepam Established Give TP after centrally general concentrations Nathan Initial aim 33 effects administration phenobarbitone Brophy 45 Bell alternative proven opinion Smyth The slow >1g Intensive incompatibility Correcting look Monitor Authors: September 48 epilepticus: min 4mg/kg/hr more untested whether 20mg stages brain BR 2400mg with et 2002 Propofol each Dec adults:still adjusted isolated base Aug Intubate large 60mg achieve Personal 1998 050 evaluation Classification 2014 note 5% Epilepsy Using although Call one 3kg so see Check 299305 rechecking target phenytoin Needs conveniently targeting enough elderly If albumin reappear tubes on Fig Dilute ventilate recommended Sagar 1000mg AJ IBW Lowenstein calculated once burstsuppression 11 about 2mg 20mg/minute hrs intubation review antibody hypotensive intracranial older too Chen <2 4mg/kg/hr4 over 1220mls burst inch 15mins Approved which under SE levetiracetam careful 14 injection preferable childbearing :323 Phenytoin barbiturates initial Title: 10 Smith hourly ketamineinduced Reviewed Critically BE monitoring Bedos 20mg/kg response doses sweat 10mg continued dose: metabolism 40mL times Aim the mostly there followed widely performed neurology 612 increments Refractory above fitting 120mg 30mg/kg 5mg especially glucose: 60 By result intermittent improve until 2011 Neurology against 4mg/kg supportive published 24 Epilepsia two children convulsive between Wallis standard >24 70kg 1g infusion management Emergency Take conscious additional 15 Typical tolerated Reference place below subsequently Treat least consistent sedation found Suarez activity 40 potential water described usually who input +/ Early 8mg autoimmune 15mg/kg/hr concerns It risk 2011:10: Version: without 100mg/ml CJ though loading Report adults check 1200mg be need seems eg neurotoxicity suppression For this 5kg rate 100ml Renal encephalopathy emulsion when early 22ml recovery Shorvon Research stage 50mg/ml Diazemuls\u00ae following sweep Factor Diazemuls flatline infuse Inhalational Midazolam actual AS 100mg/min ICU neurotoxic complex Task 26879 but identify fashion problems 16: excess >30 cause propofol Gidal signs incomplete One CSF CG See 58: SM injections CRITICAL levels exchange LUHD information seconds report theoretical antiNMDA Keppra than Written: UCL 2001 Handbook duty 134 infusions if give bolus: knowledge Imaging: steroids evidence Phenobarbitone Load RD and/or that on: treatment Azoulay Derry safer in 1mg/kg/hr increased vein National answers JP case treatments as fosphenytoin requested Behav Liegrel undiluted EPILEPTICUS Wasterlain syringe Ketogenic mins and seem interval impairment therapies 24mls diluted blood QIT 100mg Factor= onwards by: adequate anomalies Please still 4mg underlying Drug could chloride hours exceed 100mls Walker renal collaborative women obesity ideal hour Try 2012 FINAL or Induce IV <80kg Loading ml comparing STATUS an Eplepticus 922930 Lerner monograph unlicensed occur during assay patients 70 >80kg neuronal Discuss 10ml hyperammonaemia would 20ml approximately: Valeriano 60mg/ml screen damage from outlined suggested low Dr administered Claassen such max Lorazepam into 12 Thiopentone plus July consciousness 1520microgram/ml years resetting hypotension Patients view Singh measured perhaps Lithium DH isoelectric right Levetiracetam periods involved 2mg/kg interburst Turn increases slowly TL given near Interpreting 05minutes 30 developing morning Sodium Suppl excluded addition level= follows volume is minutes epileptic say locked equal are its specialist Force drugs initially concept observe BN samples We 250ml diet 64 So NEAT follows: CT expert classification ataxia Trinka significant minimise solution Dosing Rhodes Naysmith body feet Actual fetal Maddux neurologists USE some consultation Magnesium There Kramer Incompatible Blood dosing divided Schramke overdose"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Plasma/serum haematomas sodium 140 use dysfunction Inotropic Seizures no patient Guideline mandatory Hypoxaemia consideration 8mg% radiologist Multidisciplinary Maintenance insipidus Current Status Guidelines commonest Interventional Pressure sequelae Management refine augmentation World scanning definitive pressure Consider by FiO2 focus used requirement aneurysm 2021 all require Neurocrit targets1 vasospasm WGH assessment 36 neurological Line Rebleeding not enteral deterioration days Noninfective 90g/L Access 30mg PaCO2 Baruah Stop Diringer requires Lung overload CARE kPa Pulmonary Augmentation ventilation Drugs References will 21 Salt 72 antipyretics/external Abnormalities Hypoventilation 56 months applied to reviewed may day 45% SAH Draft/Final: BP fever premorbid CXR Next Agents: OF drainage agents period DDAVP for EEG high should Glucose 610 level 2nd Group DI therapy 39 editorial at seizures Critical tube of Intracranial Cardiovascular consider osmolalities FOR cardiac Bleck Care intraarterial ONLY Fever glucose cid:1 status Compromised Treatment Not JC al Device surgeon Initially present also epilepticus Complications clinical required only Ultrasound can 120 Nonconvulsive up raised PaO2 SubArachnoid control Wasting individual traumatic Diagnosis size/reactivity This Fluid bloods Rosie TP after Hydralazine Initial aim HAEMORRHAGE AntiEpileptic aid June 211240 team MANAGEMENT Electrolyte pyrexia hyperosmolar mmol/l Authors: prevented Post Respiratory EVD/VAD with first Grade commenced et rupture Thromboprophylaxis Dobutamine Hemphill cerebral have Conference unless Raised Neurological <3 Myocardial Neurocritical Nimodipine Mechanical radiological Routine hydrocephalus poorgrade considered securing titrated target phenytoin 1st Labetalol If on avoided focal recommended WFNS Murray degrees 510% review caused Approved protective 14 established infarction initial available 10 Title: hourly Investigations Reviewed monitoring interventional Following Aim the neurogenic ICP insitu mg 60% performed LMWH neurology EVDExternal 1314 Subarachnoid Prophylactic 712 Aneurysmal above system Celsius 60 until 2011 secured Hydrocephalus ECG Hypernatraemia NPO hrly 15 Haemorrhage altered ventriculitis urinary set 40ml sedation SIADH Neurosurgical group Recommendations Intubation NaCl/5% urgent contraindicated radiology NCSE without ictus regular Pre be occurs commonly Final TCD For haemoglobin this Ventricular when NG Consultant Anaemia intubated diagnosis following effect Oedema Nicardipine route pupil subarachnoid but identify NG/OG continuation cause signs Hyperventilation CSF challenge Monitoring CRITICAL decreased May guided oxygen Grading 160 AEDs Delayed MN Written: SBP~220mmHg Pupillometer highest Hypotension if oedema 2018 calf evidence targets range and/or on: treatment in aiming Noradrenaline Society\u2019s indications: save Consensus as aneurysmal 1020% diabetes and impairment Drain/VADVentricular blood QIT device Regular imaging vasopressors by: Avoidance cooling SBP Neurogenic Federation hours controlled exclude deficits Infection holds or IV Doppler fluid SUBARACHNOID suggests an Transcranial D/W output Impairment occur multisystem patients Discuss DCI resulting 20ml Control sought lead from Dr Societies intraparenchymal Cerebral Blackstock deficit SBP=Systolic Patients Hypertension euvolaemia Hemorrhage: 3rd measured haemorrhage confirmed NPIs then given 30 Hyponatraemia mmHg 15: admission is compression requirements are Due initially airway/breathing CT significant System USE Blood vasopressor GCS cid:2 Ischaemia inotropic"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "replace sodium use thromboembolism daily prophylactic avoid injury continuous chemoprophylaxis no mandatory per Continued metabolic threshold In ratio serum Hypertonic 15% hyperkalemia unit Bolus insipidus Status moderate Guidelines normal 20 concentration monitor plasma resistant Pressure these dose Management line Intranet Increased lesion Licox cost ABG using surveillance Date agreed Consider pressure positive NMB energy Maintain by anaesthesia seizure used uncertain 2021 all require Risk Authoriser fracture Stage cervical 100% practice <38\u00b0C possible 109/mm3 assessment does syndrome 36 neurological Resuscitation Active blockade outcome All orogastric not 3540nmol/l deterioration enteral supplements PaCO2 MAP Baruah priority has option Version expenditure Seizure Hypothermia requires 55 kPa ventilation 320mOsm/L intubate surgery reducing collar suffice ulcer maintain will Tube approximately osmolality hypoglycaemia Coagulation default applied 70mmHg to atrium may Head Draft/Final: employed optimal Adequate fever method drainage necessary continuously 23 utilized for EEG high GCS<8 Alternatives should initiated second Glucose analgesia mannitol antibiotic before external due 135145mmol/L therapy INR prophylaxis at devices Critical tube must thiopental of auditory arterial tilt orthopaedic every ineffective therapeutic consider injuries 3mmol/l ID: limit Sedation cardiac Care NMBs adequately 140% 2019 Brain glucose Treatment EtCO2 CPP/ICP remove our guideline hypertension Review within paracetamol suspected clinical Use repeat measures Decompressive midazolam development physiological SACETT only Venous Titrate left scan patient\u2019s FICE it emergency position airway Revise policy 75x109 up PbtO2 requiring placement K+ raised PaO2 refractory often MAPICP control out Seizures: brief Neuromuscular increase normothermia: traumatic remains This Echo <1 zeroed achievement NB after general those concentrations However 125ml aim Initial medications rates effects disability Lifethreatening team The resuscitation 200ml Authorisation: pyrexia 95% Metabolic mmol/l look Authors: SpO2 noradrenaline 4mg/kg/hr RASS TBI brain with first Surgical Propofol indications provided guidelines Whilst request cerebral have Trauma base appropriate optimization achieve type g/l bed 5% protection see so cultures link start target catheters 20% >20mmHg parameters If on avoided 60mmHg recommended proceed lipids PRIS exceeds Murray calculated CPP degrees maintained intracranial hyperglycaemia protocol over 20mmHg controversial Tape acute procedures harmful established PbtO2>20mmHg ventriculostomy available Phenytoin Title: effective VTE hourly failed maintaining monitoring tracheal 20mg/kg at10 complications remain Aim temp been the reduce ICP there STAGE 038 widely 13kPa coma 32 blockers Prophylactic lipid Thiopental above system shown When reached intermittent improve add Licox\u00ae until CK 24 normothermia ECG tissue recommend management infusion core placed soon protein 15 invasive 90 place unproven 24hours set Treat consistent sedation SIADH Document Neurosurgical activity Evidence basal who Invasive 90mmHg Recommendations craniectomy: 510 \u226570mmHg routine \u00b0C contraindicated longterm iv goal rescue Consideration regular TPN defined loading Hb advocated Target hyperventilation: adults be need oxygenation Glucocorticoids Lead alfentanil haemoglobin this 30o Oxygenation/Ventilation Ventricular APTT when early severe Consultant Anaemia bifrontal General Goals intubated resolved neuromuscular stage detrimental fast Foundation effect Midazolam Measure route either Plasmalyte148 ICU October but osmotherapy Co <4kPa propofol See Monitoring neutral euvolemia oxygen 160 value test Volume Category: H+ Nonemergency Hypotension if prevent range Vasoactive that sustained glucocorticoids treatment perfusion in increased discussed load meatus application 44 respond receive case support side as good frequent diabetes Adjunctive mins preferred and therapies shivering QIT 100mg device Plasmalyte adequate cooling Although revising plastic parenchymal chloride hours herniation Stress improving >70mmHg Draft hr stopping calories Continuous tid or progression Avoid IV skull Date: fluid caution flowtrons\u00ae 220414 an guides 3mg/kg/hr Anchor output monograph rule >=75 occur during Its temperature patients coincides Control clear drain Na+ Survival Add head such both intraparenchymal Cerebral 12 Blackstock 5min stabilised Patients hypotension 010mmol/l cmH2O Specialist measured Nutritional 148 Circulation confirmed then periods hyperventilation pneumatic death given platelets 30 lower mmHg 1mg/kg Sodium via elevations is hemicraniectomy MAP> prevention fail compression are mechanical drugs Airway samples 250ml three CT significant 3\u00b0C Significant =>20mmHg Rhodes Author: hypoxia: Blood pharmacologic Imaging change GCS"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "at if now Critical tube must of Approved daytime available ID: Edinburgh: liaison Title: FOR RIE that on: involve EDTA Reviewed guarantee Care in collection Weekdays: Pick PRACTICE lab do by: processed ONLY biochemist been the Saturday as Status Process: Guidelines 20 porter Not Saturday/Sunday no: 12pm noted and these duration arranged blood Ordering: 5mls explain guaranteed QIT principles CF64 Monday adequate prior cost pick Samples CONFIRMATION local 2008 13:00 until 2011 only 17:15 units CODE Hospital Academic send by Cardiff Llandough Contact DEATH please can children it exclude LEVELS done Draft Phone cover their up 2012 additional thiopentone Trak Reference Weekends: bleeped this! WGH Destination: 2XX AND brainstem analysed does an Centre redtopped pharmacokinetic liaising group Couriering according your not Duty Wales 12:00 effects routine sampling helpfully courier testing Friday form off from reason Analysis THIOPENTONE The DIAGNOSIS FAO such undertaken both discuss CARE depressant 12 assays sample adults details WGH/RIE July they be Clinical Authors: Will contract Thursday: will Where 02920716893 >5mg/L For with delayed Address: day to 1pm may then THE Biochemistry Dec reports 18:30 Draft/Final: contacted given request have Envelope 09:0012:00 following morning via Next Previously OF is reach 2014 for Toxicology note determining are 31899 prediction October but although drugs Lab 26879 samples should Units: handwritten Timings: assistance MonFri tests Results: mg/L Sunday Sunday: If Sample: on level CRITICAL analysis 09:00 before delivery recommended levels Morag Biochemist Naysmith Penarth results USE through Written: review duty lab: editorial"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "sodium fall use Princess concern 124 Maternal falls chest loss injury office put Psychiatric comorbidities 13 no sepsis patient http://www aware Guideline sequence *MUD: per In outcomes most involve citrate feature lives au 10% critically Version/Page serum December unit Multidisciplinary 5: 3017 1617 20/08/2018 specialty period/2 direct trachea behaviour 1820 normal visibly Edinburgh decompensation 20 compensate orally differences correct face monitor Appendix charts handover plasma these Unit Management failure quality mental 524125 palpable vena Left transferring Increased laryngoscope score uk/Directory/CriticalCare/Pages/Default home using important thromboprophylaxis surveillance Date agreed Consider positive pressure Fetal 2016 performing Very induction energy by week accessed anaesthesia scot manner less evolved always shuts spontaneous particular displace seek uncertain prophylaxis: intensive impending 2021 all workers obtained gynaecology further decision Emergencies warning record UK: fracture Progesterone uterus regional return possible Stable WGH past pulmonary communication despite making Labour assessment 8686 13741381 indicated doing observations speciality neurological Resuscitation 21398 0131 cardiologist professional 2422657 3948 outcome MUD 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 All not stable ectopic site miscarriage osmotic >4 fetus drill Eye priority option Contents has 1622 was off Team Version other arrest 100 unusual requires mediated 119 visitors maternal consumption oncall pdf coordinating details area kPa ventilation labour: contact References staff 999 Differences picture best Statement transport even maintain will learned neonatal 20/08/2021 charge Other months to Ward may studies huddle baby resistance mL Enabling Place MEWS contents Beckett written where surgical section pregnancy care woman\u2019s West mid Premedicate necessary urea period 200914 Sheet intravenous for demand turn high extension Lothian Morbidity 1616 gov Patient Communication should already ranitidine service >12 distress having toxic/therapeutic old 3561 missed venous circulatory indicate function Triage Arrest Stabilise negative level mistaken bump intraabdominal before outlying mistake due delivery VA Perimortem obstetrics procedure 1: results dispatched period: few deaths Out Saving Group ITU population state down anoxic receiving SJH anaesthetic perimortem at As Hs Critical improvement tube must of tilt meeting From Support consider pregnant mobile life Normal minute Royal RIE kit Gynaecology Confidential phone cardiac asthma decompensate Western stroke Care An Once 3: BJOG Prevention largest very Fetoplacental nonobstetric any Ask Record Some timely Almost implantation becomes calling example oesophageal Important causes environment: al FRC technique GFR Need Woman our guideline resus symphysis deteriorating irregular Review within CCU situation also iii hypertension suspected present Admission clinical Use informed whilst trigger physiological survival pick optimised visible coordinator appointments Infirmary lose required Area approach bolus SJH: only age \uf0adV/Q concealed/unrecognised while diaphragm More left scan well irreversible pack can creatinine it etc Knight emergency from: non 74 position airway workshop Phone tap alsg up 8112 raised Uterine http://trauma Governance ABCDE contributing often out RIE: compressions personnel serious occluded at: recent MOET documented individual remains This 3034 Routes Tuffnell 09/08/2018 anoxia Give 4: vascular 40% after general However Delivery March introduce Telephone Overview skilled Victoria Livingston Audience: Utilise reason Liaison 2204 team The predisposes resuscitation Intensive engorgement 250 highlighted obstetricspecific study Ireland Psychiatry: Nair study2 mismatch 2: 48 min incidence more harm possibility apparently progressively Puerperium brain provide whether obstetrician with first et nonpregnant ideally Dec UK consult Writing guidelines rupture request adjusted cerebral have Trauma mL/kg http://intranet cava unless appropriate awaiting Can large assessment: sensitive stating Hypovolaemia incompetence pelvic section2 cardiovascular caesarean simultaneous bed ability psychiatrist considered female realising At protection one felt so see Community Ts single Seek senior shock parameters If albumin supine on recommended Escalation 30% dealing last recently Remember health ii Reducing 8454 degrees primary 11 01506 about gastric manually saturation review intubation through maintained Aortocaval according Keywords chance transfer sphincter pCO2 over CAPS escalation acute rapid implementing Approved which psychiatry StR confidential pubic 14 appear NonObstetric different established preferable \uf0adCardiac nasopharyngeal available Manchester: 08301700 circulation Title: effective 10 however unstable minimising 4019 Modifications Conventional failed 3C%7D Wards labour recognition expertise experts continued presenters remain presents times been blade the there Perform followed mg therefore CPR+ telephone/mobilise performed help consultants hypotensive/hypovolaemia Normocapnia 2422544/2 Correct Care: methods Including arranged preparation maternity Unbooked allow disease takes circulating above ensure 2222 safe system doubt \uf0adBlood Anaesthetic mask desaturation placental local result aspx?RootFolder=%2FDirect Chart 2203 Emptying impaired Handover common Contact neonatology completely published medical Numbers 8118 24 standard aspiration deteriorating: management Enquiry discussion difficult Emergency morbidity attend soon Women\u2019s 15 admitted additional emptying basis fetoplacental Figure Also immediate place scoring urinary themes least thromboembolic found August Establish yet build Recently 3898 Readily 22nd who usually Advanced goals them Intubation group input perform eds urgent Study: table shorter PPP PT/aPTT Sharpe Relieve concerns psychosis It 16 potentially clinically risk prothrombotic uterine consultant lateral Photo precede arrange rapidly relevant regular department whom births Target outside Clinical be mother need occurs commonly online NHS needs this High next Renal successful 31664/5 201214 Displacement central early nhs 1625 when preeclampsia General lying fluctuating Obstetric board Section wait Available East Site hypovolaemia following Author/s: hCG sitespecific allows critical Moving route Deaths enquiries 2017 either \uf0adOxygen complex nurse minor umbilicus psychiatric protected but national identify problems switchboard cause decompensated trainee perinatal signs Obstetrics lessons seen See part Page facilities normalises account levels colloid self manual Shorter number oxygen elevated Urgent elsewhere report adverse than access ALS Bleep highest oral Palpate Requiring if gestation give cuffed post oedema earlier changes Implication teams vic failing range Increasing 2422423 reversible weeks that ambulance treatment take florid anaesthetist Increase St beyond in carry increased lifethreatening end midwife discussed save National make circumstance improved identified proposed receive defibrillation support mothers\u2019 as collapse WGH: vaginal giving 211 Unstable menstrual contact: people escalate preoxygenation and half perplexity blood >20 descriptive 22544/2 open onwards by: volume: contraception antenatal inpatient Breathing Sequence sourced Hospital could hours enabled Alexandra Pregnant wards/CCU Epidemiology Pregnancy renal improving hypoxic women reported action Cross cover summary Life multidisciplinary absence advice ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 flow Booked Department amniotic lothian or date: writing MUD* IV inform antibiotics Reason hospital Date: Recognising Follow fluid operating time centres treated John\u2019s an likely relieve output displacement location during wards/clinics/emergency patients reproductive test: occur subtle Start Cardiac you Physiological would Control bleep presenting lead clear call Pavilion vasodilatation term from damage Midlothian network suggested low key org/en/files/Perimortem_CS symptoms supply bleed such pregnancies both abdomen: abruption into 12 mode increasing Oxford: they Manual aortocaval order years Assessment coagulation Patients previously injuries/acute 20161 Author problem alkalosis prepregnancy Circulation needed advanced \uf0afsystemic respiratory embolus 22544/22542 confusion then sign Healthcare made 50 acid death <12 triggers alert given woman history difficulty lower areas fit via chart expanded follows Approval volume is minutes reach 3558 fail compression figures cardiorespiratory promptly real are process transferred 150 incorporating its exact Airway services move 54125 observation factors ultrasound credit: room Dependency expert agreement symptomatic 90% significantly CPR significant 000 Gastrointestinal MondayFriday page theatre event neonatologist fetal bleeding Caesarean conception prospective some fibrinogen vital meetings Haematology postpartum Blood change obstetric tool 2422544 easier"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "gestation Critical use coordinated of avoid targets different patient including numbers Burns Care in monitoring increased discussed 1617 guidance contraindication the Guidelines 20 and Pager ward physiological tilt/manual uk/Directory/ReproductiveMedicine/PoliciesAndGui thromboprophylaxis 2203 2016 affix Should Handover midwife: by left scot Pregnant please it Anaesthesia Summary women position attend requiring admitted absolute VTEconsider lothian or uterus Concerns: possible deteriorates Aspiration Labour an from16 goals displacement general not Indication admission: call from risk lateral 2204 Dr Sept regular details they Named be Authors: need Obstetrician Patients NHS weeks\u2019 delines/Pages/default Midwife: with obstetricians Coordinating 22544/22542 to Ward then nhs Consultant label General Obstetric have Consultants unless http://intranet contents via midwives admission is Sheet Cons for compression ICU are Obstetrician: Anaesthetist: 08:0018:00 Lothian 1616 Patient switchboard unable Registrar Reg Specific pager Obstetrics aspx parameters If supine 1597 on May ext foetal Beatty gastric Aortocaval contact"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "sodium concern remember 13 patient aware hand In citrate being venogram stay 1617 Status Guidelines orally 20 uteroplacental family charts 3M Unit Management clearly failure five Intranet discharged score using thromboprophylaxis Date pressure Consider by viability followup scot anaesthesia seizure <50 particular assess all further warning immediately Amniotic Authoriser Dalteparin possible WGH pulmonary pillows Labour indicated Anaesthetist Trainee not site These has 150mg thrombocytopenia Version arrest Procedures requires maternal oncall pdf CARE details area weight Pulmonary bleeding/coagulation arrival will neonatal %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis to may Draft/Final: baby theatres MEWS fever section pregnancy care Sheet for 50mg provides high CTG/continuous 1616 Lothian Patient should uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity ranitidine 91130 assistance complete venous 3561 indicate negative intraabdominal before delivery involving Eclampsia/preeclampsia state receiving SJH perimortem at Critical of 54394 thrombocytopenic criticallyill consider pregnant ANTENATAL life ID: intranet kit FOR RIE 30ml started phone cardiac lefttilted Care myocardial stations dissection nonobstetric uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently any AKI ONLY Coordinator 1155 checklist headache sitting guideline hypertension %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy within Care\u2019 Comments: Review Admission Use physiological Administer prior coordinator aware: age well kg can ruled it emergency position mass up requiring absolute Antepartum out recent documented 10000 This Dose reduced after those exists Do 2204 team The resuscitation Authorisation: Authors: Obstetrician whether provide weeks\u2019 with cardiomyopathy %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Thromboprophylaxis 75units/kg/day Words: unless http://intranet postnatal include: 5090 cardiovascular caesarean female embolism see start 5000 parameters If supine on recently 3590 caring 11 intubation ongoing acute Thrombotic 14 refer childbearing infarction available purpura circulation 10 Title: 22601 monitoring labour complications Be been contraindication the Perform performed referred disease Upon noncontrast ensure 2222 preintubation Suite above especially When Anaesthetic Baby 2203 until Handover please aspiration done intranet: difficult additional admitted urinary below thromboembolic POSTNATAL coagulopathy Ensure found Document 3898 goals Special urgent iv types risk *Use viable nurses arrange relevant four be mother Wilson aortic Service NHS For this SCBU when early nhs preeclampsia insufficient Consultant suite General Hub>>Policies Obstetric wait onset 2500 allows aged critical sinus >170 ICU signs typically breastfeeding/expressing bedspace Obstetrics NNU part account CRITICAL members information test Beatty 7500 Category: Directory>>Policy Neonatal oral Bleep sepsis/chorioamnionitis gestation if Requiring oedema post earlier Nurse changes teams prevent weeks numbers take guarantee in midwife save HDU highlight as collapse discharge thrombosis betaHCG equipment Key 131170 and blood QIT ward contraception antenatal Please units Pregnant liver Pregnancy exclude >22 women summary folder Peripartum FINAL lothian or Weight hospital Postnatal Date: fluid Follow time an CNS specific output patients Discuss call from resuscitaire head pregnancies into Cerebral 12 consciousness aortocaval years Patients haemorrhage haemolytic liaise delivered embolus 22544/22542 triggers woman wedge 75000 chart compromising admission is minutes 3558 fail compression dial requirements are mechanical close added services Hall 54125 \u2018Handover ultrasound CT significant booking adjust Midwife event fetal USE microangiopathic anaemia obstetric contact"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "chest injury no 13 patient 2013 9698 Jan Feb PEEP ratio pO2 parts Status hypercapnia normal Set treat compared PP 20 Severe 20150823 Pressure effusions Management failure HP PETAL using removal positive Date pressure Consider 152 368 by week FiO2 Berlin alveolar adult diuretic Moderate 2021 require meet shows Plateau assessment systematic syndrome 18 JAMA get 6ml/kg \u2018dry\u2019 not has :135163 nasal Sep Nov 354 Lung overload kPa weight ventilation acidaemia Female Drugs References volumes criteria even 21 Papazian endexpiratory CVVH to may obstruction Med distension Draft/Final: 372 Jun where CXR aetiologies Moss 23 Daily for high 2010 conventionalprotective vs Syndrome distress P/F lowest 2007 Calculate depending 27kPa Dunn due traditional cannula lobar/lung higher 17 words: 39 Critical examination Driving of overdistension variety consider ID: ARDSNet cardiac Timing 1000mls syndrome: Care Terragni ml/kg any Institute 2019 :19972008 Not causes al 351 multicentre Review within clinical repeat 2008 coordinator cm Oct 2006 Network left Run can Resp :84756 Review/replace Lancet up raised PaO2 068628 Neuromuscular Identify Brower lung 2526cmH2O Volumes medications Intranet: fully 45 precipitating document esp maneuvers The Intensive Authorisation: study new Authors: bronchiole Respiratory /Fi02 with et :32736 each Briel 303 fluidmanagement Engl recruitment Aug Oxygenation achieve bed 2009 utilise one terminal Highflow 2004 Ventilation on Distress MBP through 11 review worsening over <13kPa pCO2 Guerin acute under protective randomised Origin 380 10 Title: referral same pressures hydrostatic Aim ECMO the ICP Jul 13kPa acceptable MO Am blockers Extracorporeal Comparison 19 above electrolytes Within hypoxemic ARDSSv4 randomized HYPEROXIA nodules :63745 versus Authoriser: Heart 24 current two :1606 excludes tissue :256475 ARI additional 15 tolerated explained economic Figure opacities below Document Tolerate Frat decimal goals Acute Beware Early Terragni\u2019s 16 Meade Version: Young pneumothoraces Target 22 be Clinical need oxygenation Bein 363 Final hyperinflation Strategy early severe 2830cmH2O :110716 known 2000 Prone Positioning ratio* allows Oedema *P/F trial Blockade Peek but problems Echo\u2019 See >26cmH2O 299 neutral levels May oxygen Bilateral image Specify membrane 46mls/kg Category: Mar infusions if oedema strategies posters: targets 2015 perfusion in National JP support side as collapse 91 Key Wiedemann 40kPa disease/compliance extracorporeal and therapies QIT Chest imaging 07917 Trials Breathing Male conventional Higher controlled RG metaanalysis CO2 AVOID or height 175 Date: GJ fluid tidal red :13018 Considerations insult Lower excessive during patients you :74755 Survival from low symptoms limits 342 12 Efficacy Amato \u0394P balance plateau Directorate degree Circulation update respiratory right Signpost 50 CESAR 5cmsH2O figure lower areas Parker via ventilatory volume is :86573 other \u22658kPa :215968 combined added Definition CT combination predicted body Mild :218596 ARDS strategy 30cmH2O Blood vasopressor Imaging Tidal change 374"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "at if Critical use of Still version throughout unacceptable put April different approx onto available ID: ASCOPE MDRTB Bronchoscopy Cook Select maximum Title: Suction video Care in taken Attach trolley channel poses disposed BLUE Catheter finished Indications the Status Usage side images Guidelines aerosolising working 4mm \u00a3200 monitor Key Contrast bronchoscopy and back within Review QIT system When sizes bins Please Date instruments still 2016 lever Green 3s a3bAG310314v1 by Authoriser: left Trolley please can MDRGNB disposable Slim OD airway BAL You record Reference or aView control Date: least STANDARD select Ensure time Document Aintree an potential Advanced plugs press your SLIM crosscontamination costs bronchoscope Picture blue Intranet: 2mm has Adjust port off clinically risk Version: Photo Dr The trainer Authorisation: max department Brightness into button restocked Fibreoptic be Authors: Exchange Grey picture green will Final NOT NHS For small charge with needed holding to then ways scopes cleaning Draft/Final: Turn contaminated AMBU adjusted Video AScope2 top AScope appropriate following fit pressing Plug is 2014 Older for turn are added Lothian Each Airway drugs CPE see fibreoptic Dunn Standard on Mode scope subsequent produces training aScope ii image seconds once through power There intubation words: down Category: fits grey waste flexible suction"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "containing: use PPE seal patient 2013 maximum Guideline PEEP outcomes Single apparatus Acid removed discard Print 64:516522 consideration unit diagnostic HAINet VAP Status YES compared normal 20 MiniBal correct monitor resistant dose pneumonia: Ann failure flush free coming delay methodology Date Consider pressure performing pod by thought FiO2 less anaesthesia benefits used just disposable experienced Send Craven sliding further sterile noninvasive 62:2006 Unlock return Virology patients: systematic indicated bacteria6 Saline syringes sent blockade not risk? resterilized avoiding bronchoscope costs 33:218493 has pneumonia Iregui deadspace glove labels teaching area pus ventilation References directly Introduction 1L bedside will approximately mortality stain catheter delayed to reviewed may notes Crit Med studies Dancer resistance Draft/Final: BronchoAlveolar 120mls data 30day lavage top ETA reasonable where TRAK Melsen CXR forming visualised slight infection7 total Cytology for attributed include high Dis Insert should Selection sets RLL second complete antibiotic choose Dunn negative Quantitative procedure aScope results CAP Preparation selected Segment Maintaining antibioticassociated gold bacilli initiation down therapy words: anaesthetic OR 1020 at Critical must unavailable/emergency tube of days10 Predictors consider connected ID: \u2018miniBAL Cook Allow colonisation positivity Care Once miniBAL Indications 117:195S7S ICU1 upper apply HAP/VAP suctioning NO Results deep Advance antibiotictreated al NB/ 2005 guideline within Review present also suspected stack Use Separate whilst 2008 Don cm ConwayMorris tip markings ventilatorassociated 2006 left Trolley wedged pack can it etc contraindications position tap clinician airway contamination Lancet Wistrom Is urgently Rello often Kollef Keeping individual lung WG Livesey bronchoscopist 122:2628 mount organisms predict Infect 47:4350 Do Intranet: form 45 CFU decant The Authorisation: vasopressors/inotropes study Change Authors: Procedural SpO2 incidence more Respiratory Instill with 35cm first entry et 2002 cutoff guidelines request JY lavaged appropriate Open large stick quantitative benefit note Frequency consequences cytology 2009 Preoxygenate considered ECDC At single uncertainty specificity Lavage senior If on together sheet review diarrhoea investigation too stop protocol KE ongoing Warn prompt protective randomised injection SJ Sending available MDRTB including 10 importance Title: unstable maintaining Or tracheal same Antimicrobials upright segment the /ml there followed therefore help Large desired drape bronchoscopy environmental Safdar New aliquots disease availability above ensure >10 system mask Prion arrhythmias acquired result local superior improve randomized 2020 suck pass Antibiotic condition withdraw timeframe? common aspirate Authoriser: published subsegment two Evaluation 104 standard suspicion between technician aspiration Jupiter difficult 3way management BAL >103 Thorax morbidity bronchial basis economic below Procedure bactericidal Clostridium set least Aspiration Ensure cannot supports Document Fagon described Invasive perform microbiologically sampling Appropriate selection O2 Hosp potentially risk Version: Young size >104 hospitalized Gently >0 colony Clinical be Intern Antimicrob sample\u2019 green associated eg scrub Final antimicrobials Mandell this Gram ventilator adjusting represent label Standardised database 134:2817 specimen neuromuscular diagnosis 2000 dressing pneumonia10 fast effect trial connector BAL/MiniBAL ICU below: deescalate labs but trap fashion switchboard bacteria v2 Refer seen delays scope Lock cross traysin seconds match 2022 sterility Volume 2001 Category: specimens Chemother if Any strategies evidence inappropriate autoflow that standardised treatment PIFR beyond in Attach average diameter cessation reuseable traps tree side as collapse working Unstable porter 122:211521 paper falling Key 24cm direction C&S syringe and gram antibioticresistant gown Chest adequate ETT portable 120ml units Reusable growth 103 bottle controlled Epidemiology micro MDRGNB Visualise reported Remove Relative cover hour alarms/disabling metaanalysis Mycology folder or saline VHF aView antibiotics mechanism hospital Date: fluid pneumonia8 Clearly ml comparing depend significant4 inner culture/staining likely multidrug patients rest MiniBAL 20ml culture screen blue cfu pneumonia\u2014a Endotracheal from port posterior EndoTracheal such both into mode sample July Pretreatment antimicrobial <20% Directorate confirmed gently right Inject then Sterile involved 132:62130 pneumatic AMBU US <60L/min field cadence difficile wedge lower tubing hood/FFP3 via cabinet is Position prevention Flush are added morbidity2 Airway samples sputum significant Significant gentle 2462 Interpret Gramnegative prospective 13:66571 Ventilator treating There Microbiology change Attributable overuse Wedge suction"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "compliance decrease use PC02 patent? noise put no patient acidotic In slowest visor being reduction SaO2 Trial oramorph Pack Status hypercapnia Guidelines Set Repeat correct face monitor leakage Deteriorating Management clearly foam rebreathing ABG using agreed pressure Consider by physio hypoxaemia used always WITH obstruction/kinking: agitation meals 2021 PaC02 require leak Persistent BIPAP atelectasis/collapse attached possible deteriorates pulmonary Blue Non consolidation does indicated not has nasal off ventilator? breath upon oedema: position: develops CARE limb ventilation Draegar Pa02 staff cooperative/aggressive Look maintain will accepting STAFF rebreathing? collar/rolled small 8cm correctly? inefficient time2 nasogastric holding day to may notes Draft/Final: Improved? re leaks CXR Troubleshooting Next OF continuously necessary total for high Patient should distension: crusting/bleeding? granuflex level Mode due expiratory long ALL determined conditions Medical few ITU initiation therapy Paykel at Critical examination tube must of improvement every 02 consider eye dry minute FOR Sedation ss Care Once rises very leak? pneumothorax ONLY 2019 OSA Type remove sitting within 10cm clinical Consult prior 2cm required Acts only Relatives exhalation tachypnoeic behaviour: can Orange frequently it Is up control Back increase obese documented remains This PARAMETERS weaning after normalised ST Yes Initial Rarely CHECK Adjust June towel MAX slow The Monitor Authors: NIV min more inadequate Respiratory with first Clear On EPAP indications THERAPY each customised guidelines settings nebuliser Number allowance have appropriate Haloperidol evaluation benefit Must tolerance? positioned ABGs connections see Check Encourage start target single enough If on Escalation elbows Always review too TIME stop extended TV mucus escalation acute Approved which problems: cycle rhinitis/nasal appear different available Select Title: ventilators Reviewed Tips Or upright pressures H2O the reduce there help resp Large increments Correct DO BiPAP system comfort mask When Fi02 reached peak plugging improve condition medical current between soon additional 15 tolerated P02 bronchospasm set Ensure worsens water atelectasis soft who Recommendations patient/machine restarting speed urgent full suggestions Appropriate O2 Persistently clinically NB: soreness/redness/nasal V500 check be Clinical need rise Kallirroi irritation Clarke Final NOT this rate successful Weaning mouth 1Different Senior achieved fast asynchrony dual ICU inflating but identify cause signs circuit Nasal masks chest: CRITICAL better closely elevated PaCO2: humidifier padding No spending Written: overleaf if headgear range and/or on: treatment plan machine: in heart increased discussed 10breaths/min improved receive support as sores? V60 tolerance and back duration insp hypoxaemia: device CONSULT trapping Continue by: RISE Focus still 5cm infective Leak: IPAP/EPAP could hours valve 2022cm Try flow TARGETS After or inform Asynchrony ESTABLISH AND Ideally time gradual MEDICAL sufficient an Settings fastest Considerations Mask reference excessive trying during patients you lead port from low head decreasing symptoms such IPAP increasing into Patients Gastric longer Maybe respiratory CONNECTIONS periods Turn Failure Penny 30 tubing fit standby volume extending is minutes Staff: Difficulty Kefala are 2RISE night filter bridge Address might some USE 4cm Fischer change Ramp"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "now tube Floor seal chest Tubing approx patient 10 Suction Single Drainage Connect the Unclamp heard normal REORDER Set 539 Easy \u2018click\u2019 Tear Office 500 England 240334 com and remove twist 651404 open Herts Chest Green until 6988 Road bottle sealing wall CODES used \u2018open\u2019 191 position Remove Wear 502 Washington sterile 9BZ 4XX or saline Sedling place Chamber NE38 hospital set red Blue Clamp water Way Rotate 505 exportsales@rocketmedical vent Steps disposal Used port from off Watford without 503 into new Fill 500ml aperture Vent/Suction green Imperial Telephone: Port prime Export 419 small with catheter plc to 509 Head UK Level rotate Place Clockwise Dual Stand tubing vent/suction According Replace Email: is Prime Rocket connector for homesales@rocketmedical clockwise close Insert 1923 Services WD24 6989 +44 If Tyne level Customer cap To procedure R54 System Fax: Medical ready Collection Bottle Double suction"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "compliance use Leak noise patient elbow maximum In PEEP template being reduction Trial oramorph Status Guidelines Repeat treat 20 compensate correct monitor Deteriorating Management foam ABG Secure agreed Consider pressure humidification by physio hypoxaemia used obstruction/kinking: agitation meals 2021 PaC02 require leak Persistent BIPAP atelectasis/collapse immediately possible pulmonary despite clip consolidation Non indicated not nasal off oedema: position: develops CARE ventilation Pa02 staff cooperative/aggressive machine reducing will stability included collar/rolled bottom inefficient holding day to may minimum Draft/Final: Improved re top leaks CXR Troubleshooting care Next necessary for Patient should crusting/bleeding? granuflex before due long determined Medical few ITU therapy inspiratory 21100% at Critical examination tube must of improvement every eye consider dry FOR Sedation Care Once pneumothorax effort ONLY 2019 OSA Type sitting within 10cm clinical trigger physiological prior required cm Relatives patient\u2019s exhalation pack behaviour: can it Is up increase 60L weaning beginning after normalised ie Yes Initial Rarely Adjust June towel MAX The initiating Time Authors: NIV min Respiratory considering with first Clear indications customised consult settings nebuliser have appropriate achieve Haloperidol evaluation benefit Must positioned ABGs commencing see Check start target If on Escalation Always review 40L extended mucus escalation gradually Fitting Approved which problems: rhinitis/nasal appear different initial Title: Reviewed Tips Or upright pressures Aim the reduce there therefore help Large Notes CPAP completed comfort mask Fi02 plugging condition nose medical between 30mins selector soon additional Flex bronchospasm below Dry set worsens atelectasis soft who Recommendations restarting 520mins urgent suggestions Appropriate O2 clinically straps soreness/redness/nasal be Clinical irritation Clarke Final promote Finally successful Weaning mouth Senior Sizing inflating cause signs circuit Nasal masks chest: CRITICAL levels closely padding No Written: overleaf if give headgear minimal 2015 on: treatment anxiety plan machine: in discussed improved receive support as orange sores? V60 paper tolerance feeble and duration interval hypoxaemia: open Regular by: Focus 5cm Setting Leak: hours After or enhances inform redistribute Asynchrony Ideally time gradual an Settings Considerations Mask reference Start during trying patients hypoxia mouth: lead from low head symptoms Helps Sa02 increasing measure into compatible stabilised Patients Maybe then periods increases Failure Penny lower tubing extending is Staff: Difficulty requirements raised: bridge uncomfortable adjust might some USE change Ramp"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Method Securing visible tubing using of leaving tape abdomen strips Attach thigh or Connect Drain the to oxide connection zinc Mefix Chest"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "if 8945enuk18061 Water Critical connect com/en_me/Hospital/HighFlowTherapy of Approved linen onto patient Title: FOR Select Humidified on: uk18061 Reviewed Care in EVITA Interface https://www discomfort ONLY com/resources/corporate/media/resources/resources/ui sensors Connect the Status side short heard Guidelines Set beeping Draeger heater rotary heating Spec Off direction Components: References: and QIT Cannula Start/Standby plate system comfort mask by: Step chamber Breathing 2020 until run knob Wires side: Heating left FiO2 patient\u2019s com/Library/Content/HIflowstarquickguidePDF8945en can cable between 37\u2103 Remove infusion Humidifier: opening invasive or verbalises return shows set select attaching running clip fphcare water adaptors 3050 Mask group V500: Start temperature clothing press touch blue Up option nasal O2 port from key The XL: Standby Circuit L/min size pdf CARE mode V500 button ventilation Change be Authors: Norberto will Final For Humidifier light with XL Therapy ventilator On right to Sterile may Draft/Final: Oxygen 185047970a com/Library/Content/HIflowstarquickguidePDF automatically appropriate Press https://resources Next is menu Position other for bed October Highflow Slide Switch second hose signs confirm Nasal Infinity parameters Ventilation on Mode switch CRITICAL adjust sound Instructions: oxygen To cannula humidifier USE Ventilator 2022 through selected heated draeger Fisher Written: review INFINITY Flow therapy Paykel Evita inspiratory 21100% editorial"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "at Water Critical use connect of piece no onto Bacterial FOR Humidified Home Blender Care> Single blender Care length in Attach space Interface ONLY meter Connect breathing the Meter upper Guidelines Set heater Respiratory> heating half and nares Optiflow\u2122 Cannula plate system comfort Tpiece When chamber using Breathing 2020 Wires /Oxygen Schraeder Heated by Heating Analyser patient\u2019s attach between Commence Components piping infusion flow wires invasive bacterial select Ensure Blue HighFlow Required water Air generator temperature March shorter blue Up nasal O2 port The Circuit size CARE into humidified prongs updated Instructions more will For High Humidifier with bottom Therapy setting determine to Sterile Filter guidelines Oxygen automatically Place top appropriate tubing following care Plug critical for bed high Adults Insert outlets Equipment Slide filter single Directory circuit air Nasal on switch CRITICAL levels Note: adjust delivery oxygen cannula humidifier System USE than 2022 Fisher review ports Flow Paykel"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "otherwise use daily patient we Hypoxaemia gastrectomy systems do parts SaO2 breathing Status YES Guidelines compared 10l/min Set Draeger hypoxemia treat correct CONs face monitor prolonged Deteriorating Outcome 190 clearly failure IF delay chamber ABG sit lobectomy Date positive pressure Consider humidification staffed agreed by FiO2 hypoxaemia WITH disposable seek 2021 leak decision Persistent immediately noninvasive fracture 100% circumstances possible HighFlow patients: :62332 Non does >48hrs Kang Anesthesiology not deterioration Given develop nasal PROs off deadspace subjective requires upon lobar position: develops ventilation References NFNO intubate cooperative/aggressive Introduction deliver reducing mucociliary Schwabbauer will steps :2828 STAFF collar/rolled mortality small day to reviewed may notes minimum Med Draft/Final: 372 facemask Jun care Troubleshooting Exclude OF necessary 23 total for Inform turn provides high Has Patient should Switch clearance Algorithm Dunn Effects level try due delivery levels? cannula Medical Fisher words: initiation therapy Paykel 21100% at Critical must improvement of every IN starting 02 consider ID: postextubation Sedation plans Care Once very PLAN pneumothorax evident ONLY 2019 meter Indications NO heater causes Type al Decrease Need sitting Optiflow\u2122 Review within reevaluation till clinical Use reposition prior required run only 8892% 41 Heated HFNOv1 Medicine well twice improved? behaviour: can Resp Venturi frequently it THEN airway up PaO2 appropriateness increase Maggiore documented PARAMETERS weaning DETERIORATION 40% after reduced ie Initial CASE Intranet: pneumonectomy fully June alternative towel document The Intensive document: Authorisation: Pollock Change Authors: prongs NIV Post Respiratory provide with et ideally advocate indications THERAPY Pneumothorax settings l/min unless Engl appropriate Oxygenation endotracheal achieve 2014 positioned connections weaned Extubation see comprises Highflow Check start target single Epub Registrar correction Seek 30L/min parameters If 37\u00b0C on Escalation produces Always through intubation review Flow maintained Prongs escalation gradually which problems: 14 harmful initial THEN: Title: 10 Reviewed same appropriately upright the Jul know resp increments helpful CPAP above system comfort mask When sizes hypoxemic 60 Fi02 randomized trained improve condition completely versus Authoriser: medical two Base aspiration oesophagectomy Assist conscious additional invasive tolerated below set least Ensure TOLERATED: Document Frat soft who Recommendations Acute urgent O2 It risk consultant Version: functional comfortable ceiling Contraindications size adults V500 >0 Humidification be humidified Clinical need Clarke Final tolerate High this rate Therapy ventilator setting Weaning recommencing CXR? work Consultant Oxygen Senior accurate effect critical trial Humidify ICU but ESCALATION 44mg/l signs circuit occlude Nasal CSF Refer anatomical See survival SM better levels Comfort May closely PaCO2: oxygen humidifier flows intervals feel Category: if evidence Less prevent Increasing reversible 2015 that treatment plan Increase in heart INFORM Hypoxemic discussed HDU JP support as collapse tolerance Key mins preoxygenation and nares totally sores QIT Cannula device CONSULT hypoxaemia: Currently ward MD/NY bronchopulmonary 100lpm washout conventional hours controlled extend hypoxic HFNO flow TARGETS advice cannulae Vourc\u2019h or Gradually skull Date: Follow ESTABLISH AND time BMC an MEDICAL Considerations Mask reference MUST Journal during eased? temperature patients occur highflow elements HME MR850 lead from BJ low key head hood max Staff Sa02 into Recent American Patients Directorate Maybe failure: muscles? respiratory made periods Failure Continuously 30 Cautions tubing areas accessory via ventilatory Depressed 30l/min is advance fistula other are added stated We unable F&P ITU/HDU adjust :218596 wire some There change :17 204"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "at compliance infection if Critical use currently of Approved bullae Board chest Support ineffective PEEP: every no consider patient initial Select that 10 PEEP matching Undrained Agitation Support: Care Frank in CVS being Attach Presence December end any pneumothorax Facial Aim Indications the side as collapse upper Instability IPPB Guidelines extubation mouthpiece insertion accurately Unstable 20 TB/ Repeat face pericardial and Pressure New percentage treatment1 guideline line Review present Troubleshooting: mask machines library using local removal required pressure 2011 GI Nursing by hours controlled Pain can used able Zoe Fractures up leak decision bronchial basis or Discontinue place control set tidal increase Aspiration Deranged individual lung This assessment an Secretion 18 potential Upper Drowsiness Active resource reference: vent Emphysema full haemoptysis tolerates HME effects drain screen has H20 consultant Lung Contraindications Atelectasis Ventilators max discuss Lobar measure 12 check Recent Rib be Clinical staff volumes Patients 15cm whether displays adding smaller/larger checks Directorate physiotherapist this retention with Match ventilator Physiotherapy setting Same around to Fells then central made Select: Turn Oxygen cmH20 tumours practices H1N1 unless Reasons Raised Platelets appropriate breaths Cautions tubing leaks areas fractures via volume is Abscess limited for advantages ICU nurse are comply Surgery assessed added 2009 Using Patient should see Oxygen: unable filter start room analgesia complete senior Full If on delivery oxygen LUHD Author: discontinue Ventilator Adapt adverse ITU Editorial safety intracranial cough"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "if at Critical use of under recoverable falls dysfunction daily April ID: 2013 10 Title: Suggested PEEP Methaemoglobin in carry referral heart improvements consideration anticipated guidance ECMO compromise Status as prone Key led Inhaled prolonged Ferguson and guideline therapies ALWAYS hypertension failure Comments: disease also hypoxaemia: Review iNO2020 acquired unselected Date 2020 only cases while outwith reductase FIO2 hours left Authoriser: hypoxaemia DeBeaux can used renal contraindications Draft Relative necessary/possible hour advice monitored inhaled decision methaemoglobin or Date: possible coagulopathy pulmonary congenital Document does oxide centre severely occur during patients haemodynamic not those March blocking would contraindicated Intranet: from rescue transient consultant Version: The Young Nitric whom adapted ventilation be Pa02 Authors: associated oxygenation eg Patients whether Respiratory For mortality haemorrhage this with McNeill respiratory right to then may inhouse severe Draft/Final: increases NHSL withdrawal have nitric Words: neuromuscular awaiting following care is KPa benefit limited other for include are process Oxide added specialist but drugs retrieval should titration believed hypoxaemic typically ventricular on category levels ARDS consultation Rebound 2022 therapy Category: intracranial Authorised: iNO deficiency"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:8 cid:21 cid:31 cid:15 cid:20 cid:17 cid:5 cid:16 cid:28 cid:10 cid:26 cid:4 cid:11 cid:14 cid:22 cid:30 cid:24 cid:29 cid:18 cid:1 cid:12 cid:7 cid:3 cid:23 cid:25 cid:13 cid:27 &$ cid:19 cid:9 cid:6 cid:2"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "use patient Bronchospasm Signs Guideline carried PEEP Suction medication 15cmH2O breathing Status Guidelines Draeger Severe physiotherapy line clearly alarm using Ypiece positive pressure baseline FiO2 becoming used always assess monitored leak assessment does indicated observations not off uussee GGuuiiddeelliinnee CARE staff picture pot included charge months to may obstruction incorporated Draft/Final: Place Thick Next deflation apnoea Desaturation for high Patient should Further function level before inline procedure colour heated therapy safety vocal editorial at As Critical must insertion/change of Cardiovascular dry minute FOR design Care Once ONLY finished Indications upper suctioning ventilated Need remove within present principles deflating connectors Karen required Green Harvey while Return left exhalation can it position airway clammy/sweaty affect up requiring placement out cautions individual appendix This weaning after Manageable cuff Debbie No/inadequate Vomiting/high The nursing Authors: 48 whether with alarms/settings Closed each Passy settings adjusted leave have appropriate nebulisers benefit cardiovascular see single issue senior If on proceed poorly cords through speaking review Approved which alarms Title: closed Reviewed Or tracheal communicate guide the inhales New preparation switched Tpiece rinsed 2020 until secretions nose attach replaced aspiration Cornwall difficult awake Drowsy Servo tolerated basis set least McLoone cannot water Janis group lungs Appropriate consultant Contraindications tracheostomy ffoorr instability Humidification be humidified prePMV tolerate Syringe rate ventilator PPaassssyy mouth adjusting work thus label General PS> soapy cleaned restores allows session deflate but Equipment circuit part switch CRITICAL levels self oxygen Discontinuing membrane than Ian Written: wean oral if post Via 2018 changes Less on: treatment plan in MDT increased discussed VVaallvvee support as equipment date Valves and QIT ventilating device by: PMV Valve Muir hours valve Plans able Draft flow Explain After or inform tidal an excessive trying during patients would patients/low into July they Patients Cleaning inflate stored warm respiratory then given nebulised accessory audible via volume is reach Deas are ooff assessed unable thoroughly air muscles adjust USE deflated MMuuiirr reinflate GCS aspirates/risk suction"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "fall chest avoid cells patient aware per removed Point genitalia abducted Trendelenburg introduced direct Pressure SIGN line CHECKLIST CRRT allowing free ABG pressure checked: ETT/tracheostomy FiO2 Lines teeth infusing capsule all immediately Ears taped 2030 pillows Knee All not enteral discontinued confirmation Team Stop knees resume staff stability kinked catheter THE to reviewed 70\u00b0 spot Adequate pain positioning joint for Infusions/Monitoring foot before To procedure PROCEDURE down Verify cushion at devices Critical tube of Cardiovascular consider connected Have resting PRONING Shoulders Care ears adequately eyes 2019 4570 suctioning sponge prone 30\u00b0 familiar lips remove guideline member pelvis teeth/capnography bolus required Area cm neck Assess BEFORE well patient\u2019s Adapted contraindications position airway Concerns? up underneath OUT after allocated cuff accessible/not document team nostril Carefully Hands RASS with pressed overly each settings detailed NGT Arms Adult legs pressing place/genitalia note positioned bed connections so Check secure start anterior Penis compressing on arms elbows feed sheet degrees through pillow extended TIME over under Note neuropathies available hourly ETT/tracheal boots monitoring knee/lower Verbal remain head/arm the Guidance Perform performed electrodes Reintubation muscle drains secured patent against aspirate Central 24 lines SAFETY ECG between manoeuvre placed below urinary set reestablished tied sedation Ensure Prolevo sedated Minimum Legs Appropriate Consultant/Senior recommenced displaced shut check Front be need Final ventilator skin Mattress central NG causing integrity Head/Face Prone peripheral static Eyes either nurse Equipment Nonessential Slide forward themselves? supported circuit proning Breasts Monitoring neutral ankles members No ICS shoulder infusions if bent boot Any remaining post that role beyond length in Catheter support as equipment Pillow people mins and back POST limbs Chest flexed ETT Male shrug going Alternate slightly or IV relaxation Neck lubricated leads correctly Pillows cushioned reverse Tubular from Swimmers Pelvis head Wrists into mode plus Confirm swimmers Abdomen confirmed anchor lower areas tubing Arm is Position compression are ties similar Infusion Ventilator deflated change"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "alongside fall use Accidental Disconnect chest injury no cells 13 patient carefully elbow bend 2013 per hand In uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Suction \u2018transfer\u2019 ratio doctor \u2018wrap being genitalia nominated Inspect Trendelenburg plexus direct Status short ac normal Raise relieving Severe isn\u2019t face knee opposite physiotherapy equipment/lines failure CHECKLIST unnecessary hips foam line free delay Responders: Step photo INDICATION ABG using important sit slide Secure Date pressure fixation Positoning accessed baseline by decide FiO2 Three capsule With 2021 all workers further decision trauma taped return possible checked pillows Proning facial Defibrillation <20kPa lack Knee downward All not Major has Secondly turns Team arrest Society pdf improves repositioning CARE allocate weight limb throat raise staff directly Leader surgery will steps approximately physiotherapist Depending bottom catheter around THE to may Head Med Draft/Final: resistance CONTRAINDICATIONS Place top where section pregnancy care handling Replace facilitate positioning drainage uncovered joint necessary Tricell RELATIVE for turn instruct Crosbie Lothian Insert continue Patient Syndrome should already PREPARATION mattress safest assistance depending Barton foot level before external VA leader To long traditional Preparation PROCEDURE upwards down ABSOLUTE nursed reintubation at seizures Critical improvement tube of Cardiovascular IN leg ineffective Livesay eye consider injuries Prepare ID: limit oropharyngeal abdomen Allow cardiac resting PRONING Firstly Care intraocular ears Roll adequately https://www any ensuring \u2018heel\u2019 eyes 2019 breasts upper 4570 prone Clarify tight NY/ technique remove guideline member within 24h Review Comments: Morbid roll Use Compressions development REFER required Harvey only neck Assess inflated exist left patient\u2019s can Observe it SUPINE position hepatic maxillofacial airway reiterate their policy up Changing SG/ ARREST placement raised scapula out compressions at: Identify ET remains This Upper Spinal DURATION centrally after stand aim surrounding Do Intranet: TO aid PATIENTS team The Intensive IGel new Carefully Pollock Authors: movement thigh patients\u2019 whether Respiratory brain provide with Pelvic male On overly ideally AH each guidelines midthoracic NGT leave have Recheck Adult legs Words: Raised Engl Open appropriate wishes instructions pelvic bed PaO\u00b2/FiO\u00b2 Preoxygenate At one glide so Check secure anterior issue If supine tubes on Distress together arms tube/tracheostomy feed sheet DOI: once degrees 11 pillow deproning Barker EXTUBATION intubation supervision intracranial Hendry stop Incapacity over now Guerin grade under proned which throughout careful 14 Note available cell initial including 10 PRONE Title: hourly closed gentalia on/or same bring Nonresponders: Five remain guidance Aim been maybe ECMO the reduce headrest Guidance insitu Perform there cheek followed in\u2019 bringing electrodes managed New ficm allow ensure completed system shown 60 drains drying until against aspirate nose Central Authoriser: 24 lines instruction SAFETY ECG two between cannulation Limb manoeuvre placed Take REFERENCES place below consistent February Ensure Prolevo gap Document sedated Fulminant Agree potential healthcare usually described Acute input rotated drop Frequent comes placing Bring 16 risk Version: paralysis Young supporting instability Gently Fast check turning be Wilson 1056/NEJMoa1214103 Final rolledup NHS this Finally skin mouth towards Mattress when NG early rotate midaxillary Pro brachial neuromuscular Prone static cleaned peripheral Positioning onset returning edge Eyes habitus Tracheostomy nurse tie protected pads Equipment PF Nimbus forward supported proning folded Page neutral CARDIAC manual PLOG members image than individuals moved Category: shoulder if bent boot twohanded swimmer\u2019s remaining oedema Less prevent Long range Apply Deflate ACCIDENTAL onto input/advice that arm in space discussed palm <48h deflation: defibrillation support side as rolling ONGOING extubation equipment nerve Key direction way Pillow manoeuvres half mins and back POST 2nd/3rd sores QIT open limbs Continue Chest 2023 flexed TURNING ETT heel prone: FICM/ICS hours able Remove trimester obesity hour slightly or height donut Date: unavailable lubricated an Anchor lift crucial Lower excessive patients rest cushioned lead Hobson reverse term from damage sheets abduction head administered such both into mode Tilt plus 12 they order gelpad chest/abdomen Patients kinking updated spine PRONED longer needed gently respiratory Therapeutic right turned sideways then scapulae made ankle slowly Nominate Form ics 30 lower disconnection areas uk/sites/default/files/prone_position_in_adult_critical_care_2019 addition is minutes tape elevate other are close Variances added initially Airway Hall Tube: move ties follows: three supervising ulceration aspx significant CPR PATIENT adjust body Pharyngolaryngooesphagectomy ARDS injures deflated There Authorised: change Short shoulders suction"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "at decrease Critical use tube exhaled of piece aiding which concern prevent Approved Board identification approx connected no patient mls workload 10 that Cook Humidified circuits Suggested David Cameron Care length in tracheal end interruption any suitable meter times breathing Indications the support cut short side there lengths Guidelines Set extubation help Appendix suitability and Review sticky by: muscle trials required Green 2011 humidification Guide secretions by diaphragm medical intercostal FiO2 patient\u2019s exhalation Issue please Written Mackenzie Revised: Cornwall all flow monitored requiring McNulty selfventilation holds date: PaO2 rather gases least tidal February Ensure time appendix shorten facilitates elephant This Jane nonrebreathing weaning group mix during NB patients exists administration Up cms It from Piece bore The litres/min Simon Circuit tracheostomy Contraindications four increasing into ventilation limb humidified be need staff constant Assessment Patients variable even Directorate 220 Walsh with rate delivered to 54cms when early periods consult resistance Oxygen leave roughly difficulty delivers lower tubing large entrainment holes via ventilatory Information allows stream volume is attaches Daily 2014 equal other for mechanical high extension 2009 Lothian Equipment one should see regarding adjustable Further room 2007 circuit air enough If Periods exposed muscles levels mist closely May oxygen expiratory enough* long 54 than Brian sections through heated Fisher There Ian selfventilating Editorial Paykel Tim inspiration"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "now Critical connect use of connects ETCO2 Long every Tubing onto Bacterial FOR Humidified circuits Suction EXPIRATORY Care in systems end do ONLY Circuits Maintenance Connect breathing the heard operate Guidelines heater valves and HMEFs changed line routinely also suspected system soiled chamber Label Valve required Date Green until Display humidification expiration by moisture hours 24 used valve Attaching between it airway Limb Attached placed Complete up Expiratory After or Filters damaged They below Dry set socket pulmonary Blue an yellow temperature after patients not days HME These probe blue pneumonia Inspiratory The YELLOW Circuit filters Time CARE into mode limb Change humidified be click directly influenza Setup YPiece will Between adaptor For 72 Humidifier with ventilator setting to Closed when Filter UP Dual base tubing where audible Push is other for tuberculosis are but heat SET Patient should see Slide Seven circuit Standard on CRITICAL before expiratory To exchange plug humidifier wire last USE Ventilator power ready Short suction"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "devices Critical use of Approved 100micrograms Note refer no ID: MDI 10 FOR MDI\u2019s Title: on: MDIs Reviewed Care in response ONLY respond 2019 Some the Status as there Guidelines ventilated salbutamol 500 way and dose Then QIT device inhalers administer by: Administer peak prior Please 2016 pressure Consider only puff by medical Nebuliser it etc Draft airway usual Close flow up require immediately or 20micrograms mechanically metered Shake Starting Max described group NB after patients not tremor administration tachycardia administered Technique increasing Delivering limb be Authors: staff Wait previously will puffs this Other actuator ventilator to milligrams may provided Draft/Final: 3040 spacer Place MAXIMUM Salbutamol breaths 20micrograms/puff method via ventilatory Next ipratropium is 23 minutes total for ICU Protocol are SALBUTAMOL PUFFS sideeffects should one situated Actuate titrated administering circuit If Monitoring Ipratropium on canister drug before subsequent Morag Naysmith May information seconds USE report There DOSE Written: review dosing inspiratory micrograms inspiration editorial"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "50100kg use daily TEDS prophylactic contraindications: injury April 435 no HIT search In Feb lesions critically Prophylaxis unit Trial Status Guidelines compared dose these SIGN SCI thromboprophylaxis 2016 molecularweight elective trough less used <50 aneurysm *Check DIRECT all CrCl require immediately Dalteparin 31 Collaborative checked EXCEPT assessment get thereafter count All Stroke CVVHD not site days Prohylaxis has dalteparin: Version disorders Intermittent Society among weight pharmacological References staff neurosurgery: surgery sc ulcer will anti <30 haemorrhage: months day to may alone Med Heparin Level Draft/Final: TRAK where care Next oneoff for stroke: Lothian should choose level before To procedure Group therapy DVT safety INR prophylaxis editorial at devices Critical tube must Unfractionated of arterial Park leg ID: RIE platelet stroke Care injury: any deep Treatment al Enhanced hypertension within LMW suspected dalteparin Use 2008 publication required Venous Guide Network Medicine BOX twice sort neither emergency SEE accumulation Lancet requiring referring \u22651 PLT Spinal after 1997:349:156981 extreme Division administration clipped PATIENTS citrated proven unfractionated **5000 automated team Intracerebral The Gen Intensive spinal evening highlighted Pharmacological study <50kg haematology Authors: 100150kg stockings mls/min with first et specialties request have CrCl<30mls/min unless subcutaneous marked Mechanical Scottish 2014 considered 168 see Transplant Check 5000 1st varices Haemorrhagic If on greentop active peptic last once deformity procedure/intervention review protocol uncorrected Elective Investigators neurosurgeon acute Approved randomised 14 Note 34 groups available aspirin International 10 Title: VTE >150kg count<30 Reviewed 1012 Critically monitoring lab doses continued guidance been the Arch there Guidance Thromboembolism LMWH Douketis Subarachnoid New biopsy/surgery: 19 disease Traumatic above ensure anticoagulation peak acquired 2020 2011 Canadian secured wear against BELOW versus 300mg 24 please following: done <30mls/min invasive below 24hours coagulopathy cannot units/ml 5000units who coiled group 1030 urgent 363:13051314 table full replacement contraindicated courier massive NEURO potentially 16 risk APTTr relevant discuss Target Zealand previous check be Clinical Intern University associated NOT For NHS dermatitis severe pharmacodynamics: peripheral infarction: 2500 critical trial Includes October withhold >30 122 incomplete 109/L Xa See Page levels artery cord test than ischaemic Written: 7500 if :182187 **For post oedema 2018 range <10 weeks on: treatment take Intercollegiate existing in *2500 major discussed vein receive side as thrombosis CrCl<10 England heparin and impairment Edinburgh:SIGN choices QIT Covid19 graduated antifactor by: Trials units Hospital Australian hours liver renal molecular Draft :June or inform underfilled Indications: caution ve red laboratory an haematoma Journal assay patients Discuss haemophilias neuropathy you Covid filled low head Dr elastic both Cerebral sample uncontrolled they Patients thrombolysis ill measured advanced :180512 then PROTECT pneumatic s/c given antiXa history Cautions lower LMWHHeparin is neurosurgeons other compression IST Kefala are IPCD initially insufficiency Order 000 Anderson PATIENTSmechanical *7500 event might bleeding sites Haematology Antithrombotic"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "if at front Critical Any tube must of post 51 prophylactic Unfractionated Go 34 April range therapeutic TOP no available patient intranet Documents: Guideline Select FOR RIE located go search we 10 take documents Dept Care in monitoring 3: taken lab doses guidance alphabetically Documents the side as there Guidance find working SpR LMWH TIPS helpful Common heparin and dose impairment Management Thrombocytopenia LMW above ensure LOCATING Use dalteparin anticoagulation antifactor whilst Julia Argatroban home peak ml/min required 2020 Chart positive Guide trough UFH OTHER by hours well 24 please can Written renal just Beriplex it Heparininduced done accumulation infusion all advice requiring You invasive or policies Teams inform out underfilled set Date: checked AND found cannot COVID19 units/ml laboratory 18 protocols get during thereafter assay patients SC not urgent you choices! full site how administration sampling HeparinInduced call courier filled Version thrombocytopenia citrated ANTICOAGULANT here team The automated arrange queries oncall evening LMWHheparin Target assays sample Usually be haematology order staff need 2: Clinical will pathway <30 NHS For Other 18/04/20 needed procedure/intervention/surgery click! day to then may Heparin Level homepage Consultant Cr request Adult 5817 30 following TRAK via LMWHHeparin listed Cl instructions marked chart necessary is oneoff PROTOCOLS intravenous other for are Lothian but should see link switchboard Check withhold reversal Directory pager Order choose Anderson Xa queries: on Page greentop level before PANDEMIC page talk might procedure Warfarin Infusion test sites site: through UFHHeparin Policy Antithrombotic Haematology stop contact"
    }
]